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Abstract 
Mixed methods investigate the association between HIV, ART and fertility following scale-up of HIV 
treatment and care in South Africa. Two longitudinal analyses of surveillance data from the Africa 
Centre for Health and Population Studies compare factors associated with live birth by HIV and ART 
exposure. Semi-structured interviews with women enrolled on ART and healthcare providers explore 
perceptions of childbearing and contraceptive use.  
A quantitative study reports on one open cohort analysis and a subsequent closed cohort. Crude 
Birth Rates declined since 2005 and an open cohort analysis (2007-2013) found consistently lower 
birth-rates amongst women on-ART, compared to HIV-positive ART-naïve women and HIV negative 
women. One exception was found in the 25-29year age group: incidence was 38% higher to women 
on ART than ART-naïve women. Crude incidence of live birth was 6.6 births/100 women-years and 
decreased with increasing age, higher parity, poorer self-reported health, urban area of residency, 
knowledge of own HIV status, being single or engaged/married, not living with a partner, awareness 
of the benefits of ART, use of contraception and use of injectable methods. Annual likelihood (aHR, 
0.39; 95% 0.347 – 0.441) was 61% lower to HIV positive versus negative women in multivariable 
Poisson analysis and exposure to ART was associated with 38% reduced likelihood (aHR, 0.62; 95% 
0.487 – 0.799). In a subsequent closed cohort, HIV ‘unknown’ women demonstrated similar 
incidence and associated factors of live birth compared to HIV negative women. HIV positive women 
were less likely than HIV negative and HIV ‘unknown’ women to use contraception.  
Women described inconsistent injectable use in semi-structured interviews due to side effects and 
perceptions that injectables make women ‘watery’ or are unnecessary on ART. Family planning 
counselling was under-prioritised within the health care service and women were unaware of safer 
conception topics. Recent pregnancies were considered unintended and most women desired to 
avoid childbearing considering current family size, economic and health risks. Partner expectations 
could override strong concerns for health, however, and HIV positive women were at similar risk of 
live birth to HIV negative women when in a regular relationship or living with a partner. 
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Glossary 
 
3TC 
Lamivudine 
An anti-retroviral therapy drug 
ACDIS 
Africa Centre Demographic 
Information System 
A collection of multiple datasets housed by the Africa 
Centre, each corresponding to a different household 
surveillance questionnaire and year 
ANC 
Antenatal Care 
Healthcare delivered during a pregnancy  
Anderson-Gill  Statistical model to handle recurrent event data, used to structure a bespoke dataset in this study  
ART 
Anti-retroviral therapy 
Drugs administered for the treatment of HIV, according 
to national eligibly criteria  
ARTemis Clinical database used in this study, containing information about HIV treatment and care 
ASFR  
Age specific fertility rates 
The number of births occurring during a given year or 
reference period per 1,000 women of reproductive age 
classified in five-year age groups. 
AZT  
Zidovudine 
An anti-retroviral therapy drug 
CBR  
Crude Birth Rates 
The number of live births per 1,000 people per year 
CD4 
Cluster of differentiation 4 
White blood cell count, measured at clinics to determine 
immunological control of HIV virus 
CDC  
Centers for Disease Control and 
Prevention 
National Public Health Institute in the United States of 
America 
COC  
Combined Oral Contraception 
Form of hormonal contraception 
Cox Proportional Hazards Survival model for time to event analysis, used in a cohort analysis reported in section 4.3 
DHS  
Demographic Health and Survey 
Programme collecting national data on health and 
population in South Africa 
DMPA 
Depot medroxyprogesterone 
acetate 
Hormonal injectable form of contraception  
EC  
Emergency Contraception  
Methods used after unprotected sex to prevent a 
pregnancy. Usually refers to a progesterone pill taken up 
to 72 hours after sex 
EFV  A type of anti-retroviral therapy drug 
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Efavirenz 
ELISA 
Enzyme-Linked Immunosorbent 
Assay 
Technique to measure the concentration antibodies or 
antigens in a blood sample 
Fertility ‘desire’ 
Measure of pregnancy planning that precedes 'intention' 
and 'behaviour' along the Theory of planned behaviour.  
Often interchanged with 'intention', 'desire' reflects 
respondent’s feelings according to Miller (1994). 
Fertility ‘intention’ 
Measure of pregnancy planning that follows 'desire' and 
precedes 'behaviour' along the Theory of planned 
behaviour.  Often interchanged with desire, 'intention' 
describes a commitment to act that incorporates external 
factors according to Miller (1994). 
FTC  
Emtricitabine 
An anti-retroviral therapy drug 
HC  
Hormonal Contraception 
Birth control methods that act on the endocrine system 
and include the combined oral pill, DMPA and Nur-
Isterate  
HCT  
HIV Counselling and Testing 
One of the primary entry points in to the HIV continuum 
of care, in which an individual receives counselling prior 
to being tested for HIV 
HIV 
Human Immunodeficiency Virus 
Pathogen that affects the immune system and develops 
in to Acquired Immunodeficiency Syndrome  
Hlabisa 
A municipality situated in the Umkhanyakude District of 
KwaZulu-Natal in South Africa, where this study took 
place 
ICPD POA 
International Conference on 
Population and Development 
Programme of Action  
The steering document for the United Nations Population 
Fund (UNFPA) to guide action on a range of population 
issues, including reproductive rights 
IEC  
Information Education and 
Communication  
Programme strategy to improve knowledge on family 
planning issues 
Inhlawulo Damages paid to the family of a woman who became pregnant out of wedlock by the father of the future child 
Injectable Hormonal form of contraception, usually referring to DMPA and occasionally Nur-Isterate in this setting  
IPPF  
International Planned Parenthood 
Federation  
A global non-governmental organisation promoting 
sexual and reproductive health  
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Isilobola 
Bride price' paid in cash or cattle by a prospective 
husband or head of his family to the head of a 
prospective wife’s family before marriage 
IUCD  
Intrauterine contraceptive Device 
A method of birth control that is inserted into the uterus. 
It is often a small 'T'-shaped device containing either 
copper or levonorgestrel. 
ND  
Neonatal Death 
The death of a baby within the first 28 days of life 
NSFG 
National Survey of Family Growth 
A survey conducted by the Centres for Disease Control 
and Prevention to understand trends related to fertility, 
family structure, and demographics in the United States 
NVP  
Nevirapine 
An anti-retroviral therapy drug 
PEPFAR 
President's Emergency Plan for 
AIDS Relief  
An initiative launched by the US government to provide 
HIV treatment and care to resource limited settings 
PHC  
Primary Health Care  
The first point of contact in the South African healthcare 
system, providing 'essential healthcare' services such as 
HCT and family planning 
PLHIV  
People Living with HIV 
Individuals that have received a positive HIV diagnosis 
PMTCT 
Prevention of Mother to Child 
Transmission  
A cascade of interventions to prevent transmission of HIV 
from an infected woman to her child during pregnancy, 
labour, delivery or breastfeeding 
Poisson Model used for count analysis reported in section 4.2 
SADoH 
South African Department of 
Health  
Governmental department responsible for health policy 
development 
Safe conception Approaches to minimize transmission in HIV-affected couples planning to have children  
SB  
Stillbirth 
Foetal death after 20 weeks of gestation 
SGA  
Small-for-gestational-age 
Babies that weigh below the 10th percentile for the 
gestational age 
STI 
Sexually Transmitted Disease 
Infections that are commonly spread by vaginal 
intercourse, anal sex and oral sex 
TB 
Tuberculosis  
A bacterial infection spread through inhaling tiny droplets 
from the coughs or sneezes of an infected person. It 
usually infects the lungs and is particularly prevalent 
amongst HIV-infected persons 
TDF  An anti-retroviral therapy drug 
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Tenofovir 
TFR 
Total Fertility Rate 
The average number of children born to a woman over 
her lifetime if she were to experience the exact current 
age-specific fertility rates (ASFRs) through her lifetime 
and she survived to the end of her reproductive life 
TOP 
Termination of Pregnancy 
The medical process of ending a pregnancy so it does not 
result in the birth of a baby 
Umkhanyakude A district of KwaZulu-Natal that includes the Hlabisa administrative municipality  
UNAIDS 
Joint United Nations Programme 
on HIV and AIDS 
A member of the United Nations Development Group, 
with a mission to lead, strengthen and support an 
expanded response to HIV and AIDS  
WHO 
World Health Organisation  
A specialized agency of the United Nations Development 
group concerned with international public health 
 
 
  
 
 
16 
Conceptualisation of thesis  
The concept of this thesis arose from a personal interest in the social impact of HIV on life-course 
activities, a gap in the HIV and fertility literature in an era of ART, and a reported need for improved 
integration of family planning and HIV services in South Africa. A preliminary review of the literature 
of HIV on childbearing and fertility was conducted in 2011 and published as a chapter in the book 
‘No time for children’ (Buchanan and Rotkirch, 2013). The review identified gaps in:  
1. Studies investigating a possible increase in fertility rates amongst women living with HIV 
after initiation of treatment 
2. Implementation of family planning services for women living with HIV that caters for those 
who do and do not desire a child.  
 
A systematic review of the literature identified that studies had found different effects of ART on 
fertility and fertility desires in various settings in sub-Saharan Africa. Studies had different 
comparison groups, with some comparing the fertility of ART-naïve women living with HIV to those 
initiating HIV treatment, but none included HIV negative women. Furthermore, none addressed the 
issue in KwaZulu-Natal. These findings highlighted the importance of exploring the impact of ART on 
fertility in KwaZulu-Natal, and of including HIV negative women as the comparison group.  
 
National policy documents and publications from the South African clinician’s society identified 
family planning on ART as an important issue. They described a progressive policy for integrated 
family planning and HIV services and successive gaps in implementation. The South African clinician’s 
society published recommendations for operational guidelines to reduce this gap but did not report 
on the use of these recommendations in HIV services in South Africa. Formative discussions with 
clinicians in the Hlabisa sub-district and health managers for KwaZulu-Natal emphasised that family 
planning had been historically neglected and its importance was being increasingly recognized. 
Particularly, safer conception of wanted pregnancies were not viewed as well supported or 
implemented. This confirmed the importance of the topic. 
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The Africa Centre for Health and Population Studies (hereafter the Africa Centre) was well placed to 
address the topic of HIV and fertility in a rural setting. Demographic surveillance data allowed a 
unique comparison of fertility rates between HIV positive women on ART, HIV positive ART-naïve, 
and HIV negative women living in the Hlabisa sub-district of KwaZulu-Natal. The setting and the 
novel comparison to HIV negative women in this study are unique contributions to the current 
literature investigating ART and fertility. To gain a richer understanding of the topic a qualitative 
study was conducted. The study aimed to achieve a deeper understanding of the contribution of HIV 
treatment and care towards childbearing decisions, and perceptions and experiences of family 
planning for those on ART in this setting. The Africa Centre has a well-established relationship with 
the local Department of Health, and this collaboration facilitated the qualitative data collection.  
 
Rationale to investigate childbearing within South African HIV treatment and care  
Use of combination ART has led to reduced mortality (Ndirangu et al., 2010, Herbst et al., 2009), 
improved physiological capabilities of women to carry a pregnancy to term (Newell and Bunders, 
2013, Turner et al., 2013, Kaida et al., 2013) and changes in reproductive behaviours across sub-
Saharan Africa (Smith and Mbakwem, 2007, Ndlovu, 2009, McClellan et al., 2010, Kaida et al., 2011, 
Ezeanochie et al., 2009, Kaida et al., 2010, Kaida et al., 2008).  The impact of ART use on fertility in 
this setting, and the implications for family planning to women on ART in this area, are unknown. 
Male partners can provide an important perspective to the family planning literature, and use of ART 
is also likely to affect male physiological capacity to father a child. This study on the complex topic of 
childbearing does not address male perspectives to childbearing, following an early decision to 
prioritise interaction with health workers and clinic observations for the qualitative work.  
Widespread access to contraception was a key driver of the slow and consistent transition to low 
fertility in South Africa since the 1960s (Moultrie et al., 2012, Lopez et al., 2013, Swartz, 2009). 
Contraception is the dominant proximate determinant of aggregate fertility patterns (Bongaarts et 
al., 1984, Stover, 1998), can be a behaviour modified by a change in childbearing desires and 
associated factors or HIV-related health (Kaida et al., 2008), and is commonly used for monitoring 
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and evaluation of unintended pregnancies (Trussell et al., 1999, Stanford et al., 2000, Sedgh et al., 
2014).  
Family planning is now an important component of HIV prevention strategies. Antiretroviral therapy 
and prevention of mother to child transmission (PMTCT) programme have made huge gains in 
reducing the burden of high HIV prevalence in South Africa since 2004 (Goga et al., 2012, Shisana et 
al., 2013). Efforts to integrate are recommended by the Department of Health but no universal 
consensus exists for the operationalization of such services (Schwartz et al., 2014, SADoH, 2012). 
‘One-stop shop’ services aim to deliver integrated FP at the HIV point of care (SADoH, 2012). 
However, services often neglect the concept of an ‘intended pregnancy’ and create missed 
opportunities for comprehensive care for women of reproductive age (Smit et al., 2012). Progress is 
further restricted by the absence of appropriate measures for pregnancy planning, as western 
concepts of intention often fail to address the underlying structural and cultural mechanisms driving 
changes in HIV and fertility in sub-Saharan Africa (Johnson‐Hanks, 2007). 
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Structure of thesis  
Aim and objectives  
This study aims to determine how national scale up of anti-retroviral therapy has influenced rates of 
live birth and attitudes to childbearing amongst women living with HIV in a rural setting of South 
Africa. Three objectives were outlined to address the research question, as follows.  
I. Investigate whether use of ART is associated with an individual woman’s likelihood of 
experiencing a live birth in the Hlabisa sub-district of KwaZulu-Natal.  
II. Explore how use of ART influences fertility and family planning desires amongst women on 
ART. 
III. Determine the role that HIV treatment and care programs play in the provision of family 
planning services, including client’s expectations of family planning and whether they feel 
their expectations are being addressed. 
 
Chapter One: This chapter introduces the drivers of transitioning fertility in South Africa. Cultural 
norms are important to childbearing in Hlabisa, shaped by; a historical context of population control, 
work based migration, disruption of marriage and the role of children to ideologies of masculinity. 
Widespread use of injectable contraception has asserted female autonomy over fertility, resulting in 
wide birth intervals and long-term fertility decline. An effect of ART influencing fertility in this 
context may, therefore, differ to settings where fertility is high, or contraceptive use is rare. 
Chapter Two: A literature review details demographic theory of proximate determinants of fertility 
and cognitive models of pregnancy decision-making (Kaida et al., 2006, Hall, 2012) and describes 
literature on the ‘postponement’ of childbearing in South Africa as an established reproductive 
strategy. Studies present evidence of reduced fertility amongst HIV positive women in sub-Saharan 
Africa and a possible reversal of this effect associated with use of ART. The review identifies the 
absence of HIV negative comparisons and limitations in current measures of pregnancy planning. 
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Chapter Three: Chapter three outlines quantitative methodology used to a) create a bespoke 
longitudinal dataset of women of reproductive age, using surveillance datasets from the Africa 
Centre for Health and Population Studies b) link information about HIV treatment from the clinical 
database, ARTemis and c) construct two cohorts for survival analysis. Chapter three then describes 
qualitative methodology used to conduct observations of five clinics and semi-structured interviews 
with 23 clients and 12 health workers from the local HIV treatment and care programme. 
Chapter Four: Quantitative results first present descriptive crude birth rates to show declining 
fertility since 2005. Two longitudinal (one open and one closed) analyses then compare likelihood of 
live birth to women living with HIV on ART, HIV positive naïve women and HIV negative women. 
Multivariable analyses assess associated proximate and distal determinants of fertility between 2007 
and 2012. A final analysis compares factors associated with contraceptive use in the closed cohort. 
Chapter Five: The first of two qualitative results chapters, chapter five presents results from semi-
structured interviews with 23 clients. It describes key themes that influence attitudes to childbearing 
on ART and previous experiences of reproductive management in an environment where planning 
for a child is considered rare.  
Chapter six: This chapter reports on attitudes to contraception and safe conception strategies in HIV 
treatment and care. Results from semi-structured interviews and clinic observations inform this 
discussion on the barriers and facilitators to use of contraception, and structural factors that 
influence women’s ability to implement their childbearing intentions once they have entered the 
‘one-stop-shop’ continuum of care.   
Chapter seven: Findings from this thesis are discussed in relation to current literature on this topic 
and moves on to draw implications of this research and consequent recommendations for 
operationalization of family planning services for women on ART and future research. 
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Chapter One 
Transition to low fertility and rapid onset of the HIV epidemic in 
South Africa 
1.1 Introduction to history of fertility and HIV in South Africa 
Childbearing is rarely considered in isolation to family ties, relationships and sex (Preston-Whyte, 
1993). In the context of HIV and treatment, the decision to have another child can be even more 
nuanced (Awiti Ujiji et al., 2010, Berhan, 2008). South Africa has experienced political, economic and 
geographical transformations of low fertility in an extreme HIV epidemic (Swartz, 2009). Vast 
inequities persist and experiences of these trends vary by geography and gender. State-mediated 
changes have shifted cultural perspectives to pre-marital childbearing and contraceptive use in the 
context of poverty, migration and often loving, concurrent partnerships in KwaZulu-Natal (Hosegood 
et al., 2009, Lurie et al., 1997). In an ethnographic study of Mandeni, a town about 150km from 
Hlabisa, the study area of this thesis, Hunter describes ‘the changing political economy and 
geography of intimacy’ and how expansive changes in ‘intimate relations’ including concepts of 
gender, fertility, pleasure and love have altogether contributed to the rapid onset of the HIV 
epidemic (Hunter, 2010).  
In an era where antiretroviral therapy has become widely accessible, the effects of the virus upon 
mortality and health are potentially lessened. Yet women have asserted control of their own fertility, 
primarily using injectable contraception, for decades (Swartz, 2009, Moultrie and Timaeus, 2002). 
Chapter One compares the structural drivers of a slow transition to low fertility and rapid onset of 
the HIV epidemic, resulting in inequitably high HIV prevalence against a backdrop of low fertility in 
KwaZulu-Natal. Chapter Two then examines the potential consequences that HIV may have on 
fertility in this area. 
In South Africa birth rates have fallen steadily to less than half the rates in 1980 and are the lowest 
in sub-Saharan Africa (The World Bank 2008). The 2013 Total Fertility Rate (TFR) was 2.34 births per 
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women in South Africa and it has been predicted that by 2035 the TFR could reach below 
replacement level, both nationally and amongst the black African population (WorldBank, 2013, 
Kane-Berman and Holborn, 2012). TFRs are frequently used measures of fertility and defined by the 
World Bank as the number of children that would be born to a woman if she were to live to the end 
of her childbearing years and bear children in accordance with current age-specific fertility rates 
(WorldBank, 2013). 
Figure 1.1. Total Fertility Rates in South Africa compared to sub-Saharan Africa (including all countries of all 
income levels (1960 – 2012) World Development Indicators, (WorldBank, 2013) 
 
 
 
The causes of a sub-Saharan transition compared to the earlier European transition have been 
explored (Moultrie and Timæus, 2013). Lower mortality followed by reduced fertility instigated the 
start of a demographic transition that has since spread globally and at a diversity of pace 
(Espenshade et al., 2003). TFRs have accelerated below 2.0 children per woman in the ‘global north’: 
in Europe the TFR has remained at 1.4 for some time and in Asia and North America, the TFR is 1.8. 
Yet in sub-Saharan Africa as a whole the TFR remains higher at 5.1 in 2012 (WorldBank, 2013). In 
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transition (Caldwell et al., 1989). He and others speculated that HIV-related mortality rates are 
highest in men and women of reproductive age and would remove the most fertile cohort of 
individuals. They predicted a population fertility effect through a) increased mortality amongst 
reproductive age groups b) reduced fecundity of HIV infected women and men and c) changes in 
reproductive behaviour to avoid pregnancy and prevent spread of the disease.  
Sub-Saharan countries represent distinct historical, political and cultural contexts and have disparate 
experiences of the demographic transition decline in the context of HIV [Galloway 1986]. South 
Africa faces one of the fastest growing and heaviest burdens of HIV in the world with 6,300,000 
people living with HIV at an adult prevalence of 19.1% in 2013 (UNAIDS, 2013). The arrival of a major 
HIV pandemic coincided with a long-established and steady decline in fertility within South Africa 
(Terceira et al., 2003). HIV is not considered a driver of the fertility transition, but an understanding 
of the mechanisms through which HIV may have accelerated or stalled this transition must include 
the impact of the inequities in fertility, and effects of HIV, resulting from decades of social unrest. 
South Africa has one of the largest economies in Africa but shows characteristics of both a 
developed and developing country, with the greatest inequalities across both racial and geographical 
divisions (Swartz, 2009). 
 
1.2 Shared structural drivers of high HIV prevalence and low fertility in South Africa 
HIV is primarily transmitted through heterosexual sexual intercourse in South Africa and the risk of 
HIV acquisition or transmission and pregnancy stems from the same coital act. Yet the South African 
HIV epidemic is disproportionately distributed by age, sex, race, locality type and province (Shisana 
et al., 2013). South Africa is composed of nine provinces, each with their own legislature and 
premier. The current nine provinces were established under the Constitution of the Republic of 
South Africa, 1996, and shortly after the first non-racial democratic elections in South Africa. Prior to 
this constitution, South Africa was divided in to four provinces and twelve homelands under a 
discriminative apartheid system of rule. The 1996 Constitution served to restructure existing 
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provinces, incorporate prior homelands and to equalise the provision of state services such as health 
and education. Inequitable HIV prevalence and, to a lesser extent, fertility rates, illustrates a lasting 
legacy of geographical discrimination. KwaZulu-Natal, a prior homeland region, bears the highest 
burden of HIV prevalence and one of the highest total fertility rates in the country. In 2012, HIV 
prevalence was 27.9% in KwaZulu-Natal, compared to 7.8% in the Western Cape. Using the same 
comparison, the total fertility rate recorded in KZN was 2.67 compared to 2.14 in the WC.  Figure 1.2 
serves to show that neither trends in HIV or fertility are homogenous by province. 
Figure 1.2 HIV prevalence (2012, %) and Total Fertility Rate (2013 mid-year, TFR) by province (Shisana et al., 
2013) 
 
 
Western Cape 
TFR = 2.14 
HIV % = 7.8 
Northern Cape 
TFR = 2.65 
HIV % = 11.9 
North West 
TFR = 2.68 
HIV % = 20.3 
Limpopo 
TFR = 2.69 
HIV % = 13.9 
Mpumalanga 
TFR = 2.51 
HIV % = 21.8 
Gauteng 
TFR = 1.87 
HIV % = 17.8 
KwaZulu-Natal 
TFR = 2.67 
HIV % = 27.9 
Eastern Cape 
TFR = 2.72 
HIV % = 19.9 
Free State 
TFR = 2.11 
HIV % = 20.4 
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Deep inequities in areas of education, health care, employment, and resettlement along racial and 
geographical lines were inherited from an era of apartheid policies, and are pervasive still (Shisana et 
al., 2013, Burgard, 2004). The Population Registration Act of 1950 divided South Africa into four 
major ethnic groups: African, Asian, White and Coloureds, and the Group Areas Act allocated ‘nation 
states’ or ‘homelands’ by racial grouping (SADoH, 2003). Discriminative welfare, education and job 
reservation policies forced many men in KwaZulu-Natal to relocate to urbanised areas for long 
periods in search of employment (Newitt, 1973). A rise in migration for industrial employment and 
growth of an informal work sector further opened the corridors for increased female mobility in to 
employment (Muthwa, 1995), but also transmission of HIV to rural women when migrant men 
returned to their homestead (Pison et al., 1993, Decosas, 1996). However a study in the Hlabisa sub-
district of KwaZulu-Natal found that reverse direction of infection from rural women to returning 
migrant partners was often likely before ART was made available (Lurie et al., 2003).  
Marriage is still highly regarded but expensive and rates have almost halved since the 1960s as a 
consequence of repressive apartheid policies of labour migration, tribal homelands and living 
restrictions placed on most African couples (Harwood-Lejeune, 2001, Hosegood et al., 2009). 
Ambiguity in the definition and changes in the legal recognition of customary marriages make exact 
estimates difficult to compare over time (Budlender, Chobokoane et al. 2004), but census data from 
1996 and 2001 reported lower rates of marriage amongst Africans and Coloured compared to 
Whites and Asians. Black Africans were more likely to live with a partner or avoid marriage and 
cohabiting altogether, a trend that has been attributed to a culture of female empowerment that 
has situated higher levels of education and employment at odds with marital rates (Gustafsson and 
Worku, 2006).  
Values for marriage and childbearing in the province are deeply respected and intrinsically tied to 
income (Preston-Whyte, 1993). Traditionally, the practice of isilobola involves an exchange of cattle 
from the hopeful husband to the father of the future bride (Evans-Pritchard, 1931). To this day both 
monetary and cultural values of isilobola are high. Cultural expectations for children, and the efforts 
taken to save for isilobola placed a huge value on marital fertility and a man may even see his 
isilobola returned if his wife is infertile, resulting in some to refer to isilobola actually as a ‘child 
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price’ (Evans-Pritchard, 1931). A formal expectation of 21 cows and the rising price of cattle has 
rendered marriage more of a middle class institution (Hunter, 2010), and unaffordable for most 
people living in the Hlabisa sub-district (Hosegood et al., 2009).   
Divergences in acceptable courting behaviour arose under new opportunities in the way that men 
might choose to use their limited resources and have led to a re-working of relationships and ways in 
which men and women make a living (Preston-Whyte, 1993, Moultrie and Timaeus, 2001). When 
partners ceased to send income or were unable to earn enough to support the household, women 
were increasingly forced to enter employment to support their households, leaving less time for 
childcare (Gustafsson and Worku, 2006). Childbearing is culturally tied to the concept of isilobola but 
now relates to the reality of ‘making a living’ in newly altered ways. Individuals engage in new, often 
loving, models of ‘material’ sexual relationships based on forms of gift exchange (Hunter, 2002). 
Changes to household structures affect not only fertility, but transmission risks for HIV also: 
currently unmarried cohabiting couples have longer term sexual partners and the highest HIV 
prevalence nationally (Shisana et al., 2013).  
 
1.3 Childbearing and making a living  
Tradition is not static. Men have traditionally paid inhlawulo, a fine for impregnating a woman 
outside of marriage, so that the woman’s family receive financial compensation and the child takes 
on the surname of the father (Evans-Pritchard, 1931).  Now, when pre-marital childbearing is 
increasingly common, there is greater acceptability and modifications to the practice of isilobola and 
inhlawulo, and in some instances, no money may be exchanged at all (Hunter, 2010). Economic 
uncertainty and structural distrust in the absence of supportive family polices have guided 
behaviours towards postponed childbearing in Europe (Mills et al., 2011), and in KwaZulu-Natal, 
women also face uncertainty where contact with partners is easily lost and men can, and often do, 
abandon children (Timæus and Moultrie, 2008). Childbearing outside of marriage has become more 
culturally acceptable and gift relationships have replaced the practice of isilobola, at a lower cost. A 
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man’s ability to pay for gifts can thus ensure his status as a lover and it is more acceptable for 
women to take ‘secondary’ partners, according to the ‘main’ partner’s ability to support her (Hunter, 
2010).The South African National HIV prevalence, Incidence and Behaviour Survey found multiple 
partnerships were still less common in women than men: 20.1% of males reported to have more 
than one sexual partner in the last 12 months compared to just 4.6% of women (Shisana et al., 
2013). Financially successful men tend to be older and have more disposable means to attract 
younger women, leading to what is commonly described as a ‘sugar daddy’ culture, and a steady 
increase of age-disparate relationships amongst women aged 15-19 years old in a context of high 
unemployment and poverty (the unemployment rate was 52.6% in Hlabisa in 2013) (Ott et al., 2011, 
Shisana et al., 2013). A study of 458 HIV seroconversions amongst women living in Hlabisa, the 
setting of this thesis, found that age-disparate relationships are common but not associated with HIV 
acquisition risk in this setting of high HIV prevalence between 2003 and 2012 (Harling et al., 2014).   
 
1.4 Apartheid-era family planning for population control 
A slow and steady decline of fertility in South Africa is the consequence of widely accessible 
injectable contraception available to all women wishing to control their own fertility (Swartz, 2009). 
Unique to South Africa was an apartheid-era policy targeting African fertility since the 1970’s and 
driving an earlier onset of fertility decline compared to neighbouring countries (Swartz, 2009). 
Restrictive family planning policies and discriminatory provision of contraceptive methods under the 
1974 National Family Planning Programme mostly limited the contraceptive method mix to long-
term hormonal injections for African women (Swartz, 2009), and many African women chose to 
adopt the available contraceptive methods in order to limit their own childbearing in a difficult 
economic climate (Mokomane and Khan, 2009, Moultrie and Timaeus, 2002). The result was 
increased contraceptive use and a prevailing disparity in childbearing found along closely aligned 
racial, geographical and socio-economic margins (SADoH, 2003, Cooper et al., 2004). Multiple 
Demographic Health Surveys (DHS) show how the South African fertility decline actually pre-dated 
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the arrival of the 1974 programme, indicating an early effect of economic growth upon household 
choices for childbearing (Moultrie and Timæus, 2003). 
Sustained use of hormonal contraceptives for the postponement of childbearing is a key factor in 
driving the South African fertility transition, yet high numbers of women relying solely on oral, 
injectable or sterilisation methods places them at prolonged risk of acquiring a sexually transmitted 
infection (Timæus and Moultrie, 2008). In South Africa, Demographic and Health Survey (DHS) data 
on birth intervals, calculated as the average number of months between birth dates, was last 
collected more than a decade ago. A study suggests that birth intervals increased to  6 years among 
women aged 25-29 in the late 1990s, an interval longer than observed in other sub-Saharan African 
countries with higher fertility rates (Camlin et al., 2004, Timæus and Moultrie, 2008). Access to 
Central to the ability to postpone births for such long periods is women’s ability to access long 
lasting and effective injectable contraceptive methods. Moultrie and Timeaus found that 
postponement, of childbearing was important in the lengthening of birth intervals and the slow pace 
of a gradual decline in total fertility rates observed in South Africa since the 1960s (Timæus and 
Moultrie, 2008). Patterns of delaying a decision are consistent with a continuously changing political 
economy and political environment and have been noted as an established family building strategy 
across sub-Saharan Africa (Moultrie et al., 2012) and elsewhere (Mills et al., 2011).  
 
1.5 Resulting inequities in fertility and HIV  
As a result of the homeland policy of racial segregation, fertility rates are tightly associated with 
ethnicity and province. Prevalence of the HIV epidemic is also highly disparate with respect to sex, 
age, race and locality type, placing the heaviest burden amongst Black Africans, a demographic that 
also accounts for 79.4% of the total population and a disproportionate 95% of the poverty gap 
(Statistics South Africa, 2010, Shisana et al., 2010).  
The South African National Survey found that black African’s were more than 85% less likely to live in 
urban formal settlements and have access to formal housing and health services than any other 
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racial grouping. Black Africans also had the lowest rates of marriage. Black African women reported 
increased use of modern contraceptives in 2003, reaching 63% in comparison to a contraceptive 
prevalence of around 50% in 1990. Even in light of this increase, Black Africans, nulliparous women 
and people living in rural areas were less likely to report using contraception (Burgard, 2004). 
Fertility remains highest amongst Black Africans since a steady decline from a TFR of 6.6 in 1960 to 
TFR of 2.9 in 2006 (Department of Population and social development, 1998, Statistics South Africa, 
2006).  
Data presented in Table 1.1 from the 2012 HSRC survey illustrate variations in HIV prevalence for 
men and women of reproductive age (Shisana et al., 2013). KwaZulu-Natal had the highest 
prevalence of HIV in South Africa, approaching 27.9% in 2012 (Shisana et al., 2013). A rise in 
prevalence in this area has been attributed to successful scale up of ART coverage, and resultant 
improvements of life expectancy amongst people living with HIV (Bor et al., 2013). Average life 
expectancy increased in the Hlabisa sub-district from 49.2 years in 2003, just before roll-out of ART 
in 2004, to 60.5 years in 2011. At this time, authors also report that all-cause mortality declined by 
over 50% amongst all individuals aged 25-44 years old. These findings reflect the survival and social 
benefits of roll-out of ART. One consequence for this setting is an observed increase in HIV 
prevalence due to a greater number of individuals living to older age on ART (Bor et al., 2013). 
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Table 1.1 HIV prevalence among adults in the 15-49 age group by race province and locality type, South Africa 
2012 ((Shisana et al., 2013) 
Variable N (%) 95% CI 
Sex 
Male 6,468 14.5 12.8 – 16.3 
Female 8,252 23.2 21.3 – 25.1 
Race 
Black African 9,363 22.7 21.1 – 14.3 
White 881 0.6 0.2 – 1.8 
Coloured 3,013 4.6 3.3 – 6.4 
Indian/ Asian 1,418 1.0 0.5 – 2.0 
Locality type 
Urban formal 7,882 14.7 12.7 – 17.0 
Urban informal 1,815 29.9 25.9 – 34.2 
Rural informal 3,408 22.6 20.5 – 24.9 
Rural formal 1,615 16.1 11.7 – 21.8 
Province 
Western Cape 1,890 7.8 5.5 – 10.9 
Eastern Cape 1,963 19.9 17.1 – 23.0 
Northern Cape 1,207 11.9 6.8 – 20.2 
Free State 1,071 20.4 15.4 -26.5 
KwaZulu-Natal 3,536 27.9 25.2 – 30.8 
North West 994 20.3 17.5 – 23.4 
Gauteng 1,673 17.8 14.6 – 21.6 
Mpumalanga 1,125 21.8 17.5 – 26.9 
Limpopo 1,261 13.9 10.2 – 18.7 
Total 14,720 18.8 17.5 – 20.3 
NB figures for ‘whites’ are considered unreliable due to low response rates 
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1.6 Rights-based dialogue reprioritising family planning in the public health agenda  
Programmes of action have directed signatory state obligations to promote sexual and reproductive 
health and rights. The 1994 International Conference on Population and Development (ICPD) 
Programme of Action (POA) defines reproductive rights as the rights of couples and individuals to:  
“Decide freely and responsibly on the number, spacing and timing of their children, and to 
have the information, education and means to do so; and to attain the highest standard of 
sexual and reproductive health, and make decisions about reproduction free of 
discrimination, coercion and violence.” (ICPD, 1994) 
 
The first democratic election in 1994 launched a new Department of Health and a transition towards 
holistic primary health care services that required a restructuring of district health systems, away 
from a centralized hospital (Maharaj and Cleland, 2005). Progress was originally confounded by an 
era of AIDS-denialism when an estimated 330,000 HIV infected people died without access to 
treatment between 2000 and 2005 (Chigwedere et al., 2008). The country has since seen a rapid 
implementation of biomedical prevention strategies, including access to ART, PMTCT, HIV 
Counselling and Testing (HCT) and medical male circumcision (Goga et al., 2012). Since 2001, PMTCT 
programmes have provided free and accessible antiretroviral therapy for pregnant women and a 
framework to address maternal health in the global response to AIDS (Stevens, 2008). ART was made 
available to all people with advanced HIV via HIV treatment and care services after 2004 (SADoH, 
2004).  
Exposure to ART has increased among PLWHIV from 16.6% in 2008 to 31.2% in 2012. Gender 
differences in health seeking are widely observed in South Africa, a trend that resulted in a greater 
increase in the number of women accessing HIV treatment compared to men in 2012 (25.7% vs. 
34.7% respectively) (Shisana et al., 2013). One of the major successes of national scale up of HIV 
treatment and care is the broadly equitable access to ART for individuals irrespective of their 
residency in either urban or rural areas. In the Hlabisa sub-district, 37% of all HIV infected adults had 
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initiated ART by 2011 (Zaidi et al., 2013). Rapid scale up of ART also has a protective effect for the 
community:  the risk of a HIV uninfected individual acquiring HIV was 38% lower in areas where ART 
coverage was high (30-40% compared to less than 10%) in the same site as this study (Zaidi et al., 
2013).  The protective effect was also measured in a study of serodiscordant couples, which found a 
reduced risk of HIV acquisition associated with increased household coverage of ART in this setting 
(Vandormael et al., 2014).  
Millennium Development Goal target five outlines universal access to family planning, and South 
Africa responded by setting national targets of 100% contraceptive use for all women with unmet 
need using all methods, and 100% antenatal care coverage (at least one visit and at least four visits 
respectively) (STATSSA, 2013). South Africa has already been successful in achieving 100% antenatal 
care coverage but is lacking appropriate data on contraceptive use (STATSSA, 2013) since the 2003 
DHS round, reported as 50.2%. The country did not set an initial target towards adolescent birth rate 
or unmet need for family planning among married women or those in a union.  
Indicators suggest that South Africa still has some way to go in addressing maternal and 
reproductive health. Since 1998, the maternal mortality ratio has increased from 150 deaths per 
100,000 live births to 269 deaths per 100,000 live births, far from a 2015 target of 38 deaths per 
100,000 live births. Data was sourced from civil registration and vital statistics systems, as there has 
been no comparable DHS round since 2003 (STATSSA, 2013). The WHO defines a maternal death as 
the death of any woman while pregnant, or up to 42 days after the termination of a pregnancy, from 
any cause related to, or aggravated by, the pregnancy or its management, but not accidental or 
incidental causes. The maternal mortality ratio (MMR) describes the number of maternal deaths per 
1,000 live births and the 1998 South Africa Demographic and Health Survey was used to measure 
national maternal mortality ratio in order to set a target for MDG Five by 2015. No maternal 
mortality data has been collected in subsequent Demographic and Health Surveys, and information 
on MMR is sparse. Instead, estimates since 1998 have been calculated using information on 
household and pregnancy-related deaths in the South Africa Population Census or Community 
Surveys. 
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A series of reports from Saving Mothers indicate five major causes of maternal death: AIDS and 
other non-pregnancy related infections, complications of hypertension, obstetric haemorrhage, 
pregnancy related sepsis and pre-existing maternal disease.  An increase in each of these causes of 
death, with the recent exception of complications of hypertension, reflects a gap in the 
implementation of progressive sexual and reproductive policies in to adequate health services 
(SADoH, 2007b) 
Family planning can reduce transmission of HIV from mother to child, contribute to birth spacing, 
lower infant and maternal mortality risk and lower maternal morbidity associated with unplanned 
pregnancies, abortions and particularly unsafe abortions (Tsui et al., 2010, Sedgh et al., 2014).  
The 2012 National Contraception and Fertility Planning Policy and Service Delivery Guidelines frames 
contraception as both an important tool for public health and a critical element of women’s health 
(SADoH, 2012). Safe conception conceptualises methods and interventions aimed to reduce HIV 
transmission to a HIV uninfected partner in sero-discordant couples or minimising the risk of 
superinfection in HIV-seroconcordant couples, and civil society groups have recently addressed the 
issue (Bekker et al., 2011). Bekker et al provide guidance on risk reduction strategies for a range of 
scenarios including when the partner is on ART and in low-income settings. These guidelines include 
a flow diagram of questions to approach pregnancy-related issues in HIV infected women and men, 
suggestions for other options to consider in making a decision around fertility and childbearing, 
effectiveness of contraceptive methods for PLWHIV, guidance on topics to be covered in pre-
conception counselling and optimal conception support strategies according to resources available 
in the setting and the HIV status of each partner. Support strategies may include ART regimen 
changes, adherence support and CD4 monitoring, sperm collection with self-insemination, safer 
conditions for unprotected sex, including timed sexual intercourse and limited exposures, 
preconception HAART for male partners, mono- or dual-therapy PrEP, on-going HIV testing or 
antibody testing and male medical circumcision (Bekker et al., 2011).  
Abortion became legally accessible with the 1997 Choice on Termination of Pregnancy (TOP) Act, 
(SAFLII, 1996), and government commitment has been resilient to legal and moral objections, but 
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barriers to access stem from the number of trained healthcare providers citing conscientious 
objection and the absence of formal systems to guide providers through this process, in some cases 
encouraging women still to seek unsafe abortions (Cooper et al., 2004, Harries et al., 2014). In Cape 
Town, some even felt that abortion was more stigmatised than a HIV positive status (Orner et al., 
2011). 
 
1.7 Approaches to integrated HIV treatment and family planning  
In response to the global HIV pandemic, the WHO, the World Bank and the European union 
specifically recommend the integration of FP services and HIV care as an efficient way to combine 
resources and address the comprehensive HIV and Sexual and Reproductive Health needs of women 
living with HIV (UNFPA, 2013). The Hlabisa HIV treatment and care programme is a joint initiative 
launched by the Department of Health and supported with funding from the US President’s 
Emergency Plan for AIDS Relief.  
When the PMTCT programme was launched in 2001, HIV infected pregnant women were issued 
single dose Nevirapine (NVP). The regimen changed to dual therapy in accordance to updated 
guidelines in 2008 adding Zidovudine (AZT) (SADoH, 2008), and in 2010 switched to lifelong ART 
amongst all pregnant women with a CD4+  ≤350cells/mm3. Lifelong ART composed of a triple first 
line regimen of Tenofovir (TDF) + Lamivudine (3TC) or Emtricitabine (FTC)  + Efavirenz (EFV) or NVP 
(SADoH, 2010) and in 2012, HIV infected pregnant women became eligible for lifelong ART 
irrespective of CD4+ count (SADoH, 2011). Under the early years of PEPFAR, use of HIV resources for 
family planning activities was prohibited and no measures of family planning indicators were taken 
in these programmes. Since then, studies have demonstrated the cost effectiveness of integrated 
services (Reynolds et al., 2006, Stover et al., 2003, Sweat et al., 2004), with 120,256 unintended HIV-
positive births averted in South Africa annually through contraceptive use (Reynolds et al., 2008). 
A Cochrane review assured feasibility from 20 intervention studies exploring the impact of 
integration, representing 19 peer-reviewed articles, but warned against the dangers of ‘add-on’ 
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services due to the absence of evidence that integration does improve healthcare delivery or health 
status (Dudley and Garner, 2011). In the absence of integration, ‘routine’ or non-integrated care 
refers HIV clients onwards to Maternal and Child Health services or a Family Planning clinic with a 
separate appointment. Full integration suggests that all services for people living with HIV be 
provided under one roof. Partial integration could involve a number of options; a reproductive 
health room designated in the continuum of HIV care, two services linked under the same 
management to preserve role specialisation or a form of management integration to allow same day 
‘one-stop-shopping’ appointments with a central check in/out, use of the same patient chart and 
consistent and structured messaging on all FP methods (Kosgei et al., 2011).  
“Patterns of integration depend on local situations. A single blueprint is unlikely to be 
appropriate” (Lush, 2002) 
 
The 2003 National contraceptive guidelines outline a commitment to integrated Sexual and 
Reproductive Health services for people living with HIV, delivered through free and universal point of 
care services (Mokomane and Khan, 2009). It provides guidance for a client-centred, rights-based 
approach for comprehensive sexual and reproductive services delivered through a ‘one-stop-
shopping’ integrated service, including referrals for family planning services, complications of 
pregnancy, delivery and abortion, infertility, reproductive tract infections, breast cancer and cancers 
of the reproductive system, and sexually transmitted infections (STIs) including HIV/AIDS (Ravindran, 
2005). Family planning is a highly cost-effective strategy to minimise mother to child transmission of 
HIV and maternal mortality when provided to HIV infected women. Implementation is determined at 
decentralised service level and siloed avenues of funding, vertical organisation and limited co-
ordination between departments and service providers hindered implementation efforts (Delvaux 
and Nöstlinger, 2007).  
“In South Africa, healthcare providers in HIV care settings identified the need for additional 
training, including in family planning. Some HIV programmes refer women to family planning 
services but do not really ensure there is follow-up.” (Delvaux and Nöstlinger, 2007) 
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A 2012 study of key policy and service level challenges to integration of sexual and reproductive 
health and HIV services in KwaZulu-Natal identified lack of policy guidance and weak referral 
systems, high client load and insufficient training for skills in sexual and reproductive health delivery 
(Smit et al., 2012). Considering the high work load of health workers and the need for specialist 
medical competencies, a partial facility-led integration was deemed by respondents as more realistic 
than a form of full, provider-led integration. The review noted that such a strategy would rely on 
internal referral systems within the same facility and emphasised the need for ‘provider-initiated 
SRH’ discussions with clients (Smit et al., 2012). Breaks in the continuum of care have still led to 
missed opportunities for FP integration within the HCT to ART initiation stages (Scott et al., 2011), 
and other authors have raised the question of how best to monitor and evaluate integration efforts 
(Chabikuli et al., 2009).  
The 2007-2011 HIV and AIDS and STI Strategic Plan for South Africa galvanised a vast scale up of 
access to ARVs between 2009 and 2001, while recognising that ‘fertility options for women known to 
be HIV positive are still lacking’ and financial contribution was too low (SADoH, 2007a). The 
Department of Health has since responded with the 2012 National Contraception and Fertility 
Planning Policy and Service Delivery Guidelines to provide an expanded scope to policy, inclusive of 
both contraception and conception services for women living with HIV, under a framework for 
human rights, quality and integration. A focus on health systems strengthening calls for a ‘re-
engineering of primary health care’ mandated to provide specific counselling on fertility intentions, 
and prioritises the engagement of men (SADoH, 2012). The current national strategic plan (2012-
2016) is shaped around the UNAIDS philosophy of zero new infections or AIDS-related deaths and 
zero stigma, adding to this pot, zero new infections through mother to child transmission (SADoH, 
2011).  
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Chapter Two 
A review of the association between HIV and use of ART on 
childbearing 
 
2.1 HIV and fertility trends in sub-Saharan Africa before the availability of ART 
Early research investigating the link between HIV and fertility, conducted before HIV treatment was 
made widely available, presumed that, at a population level, high HIV prevalence would lower 
population fertility through increased mortality, infection avoidance behaviours and adverse 
physiological capacities for childbearing. Some definitions of fertility used in this section are 
presented in Box 2.1.I. 
Box 2.1.I Study definitions of fertility presented in this section 
 Total Fertility Rate: the sum of the age-specific fertility rates over all ages.  
 Population Attributable Change (PAC) in Total Fertility: the difference between current total 
fertility rates and estimated rates of total fertility in the absence of HIV, based on cohort or 
antenatal data and modelled in a regression analysis on national HIV prevalence (Zaba and 
Gregson, 1998). 
 Fertility differentials: the difference in age-specific fertility rates between HIV infected and 
uninfected women based on aggregated data from antenatal surveys (Carpenter et al., 1997, 
Hunter et al., 2003), Gray, Wawer et al. 1998, Allen, Serufilira et al. 1993). 
 Difference-in-difference analysis: as above for fertility differentials but using individual based 
data from HIV population testing (Fortson, 2009). 
 
A review of sub-Saharan Africa studies published during the pre-ART era determined that HIV is 
strongly associated with reduced fertility: clinical and population based surveys estimated a 25-40% 
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reduced fertility compared to uninfected women from Uganda, Zimbabwe, Tanzania, Rwanda and 
Democratic Republic of Congo (Lewis et al., 2004).  
Mathematical modelling has been used to estimate the population fertility effect of HIV prevalence 
in sub-Saharan African settings. Zaba and Gregson modelled a ‘population attributable change’ (PAC) 
in total fertility, defined as the difference between current total fertility rates and estimated rates of 
total fertility in the absence of HIV. First, the sum of all age-specific fertility rates determined the 
‘total fertility’ of HIV infected and uninfected women. A population attributable change in total 
fertility was then derived from the difference between the total fertility of all women and of 
uninfected women. A regression of PAC on HIV prevalence then deduced a 0.4% reduction in fertility 
per 1% increase in HIV prevalence in six countries across sub-Saharan Africa with low rates of 
contraceptive use (Zaba and Gregson, 1998). They identified HIV-associated illness and mortality of 
male partners, women’s reduced fecundity and higher risk of adverse pregnancy outcomes as 
principal mechanisms through which HIV lowers fertility in these settings.  
An additional 13 studies were analysed using the same methodology applied by Zaba and Gregson to 
calculate a fertility rate ratio of pregnancy rates between HIV infected and uninfected women. This 
review by Lewis (Lewis et al., 2004), described above, determined a similar population attributable 
reduction in total fertility of 0.37% per 1% increase in HIV prevalence and ascertained no effect of 
HIV prevalence on fertility amongst HIV uninfected populations before the availability of ART.  
However, the generalizability of evidence from this time should be carefully interpreted. Studies 
largely emerged from countries where contraceptive use was low and fertility high. South Africa 
carries one of the highest HIV burdens in sub-Saharan Africa but also low total fertility rates and high 
contraceptive prevalence compared to neighbouring regions. Consequently, such studies are likely 
to overestimate the effect of high HIV prevalence in South Africa. 
There are some limitations to these findings. Primarily, these models do not take into account a 
reduction of births due to premature mortality amongst women of reproductive age, and does not 
adjust for proximate determinants of either fertility or HIV, such as contraceptive use. They also do 
not account for prevalence of STIs in the absence of a HIV pandemic, or changes in behaviour. 
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Accordingly, the study found a much smaller PAC in countries where contraceptive use was high, and 
was likely to overestimate the negative effect at a population level.  
 
2.2 HIV associated mechanisms of sub-fertility in the pre-ART era  
Advanced HIV can result in a reduced coital frequency and amenorrhoea (Gray et al., 1998), and may 
also lead to adverse pregnancy outcomes such as prematurity and perinatal or neonatal death 
(Rollins et al., 2007). Early work of Zaba and Gregson, suggested that underlying sub-fertility 
(associated with risk factors for HIV but not directly measured in these studies) would affect a 
decline in population fertility. 
A systematic review of 31 prospective studies, investigating perinatal outcomes in both developed 
and developing countries before 1998, found increased risk of stillbirth and infant mortality to 
women living with HIV in the absence of antiretroviral treatment. The review found significant 
heterogeneity between reported outcomes between studies and countries, illustrated in Table 2.1 
(Brocklehurst and French, 1998). Greater risk of adverse pregnancy outcomes in HIV infected women 
could be driven by high background rates of STIs such as syphilis, the nutritional status of pregnant 
women and progression to advanced HIV disease.   
A significant mechanism of sub-fertility amongst HIV infected women would be the increased risk of 
co-infection with sexually transmitted infections (STI) such as syphilis, Chlamydia or gonorrhoea 
(Bracher and Santow, 2001). Co-infection can dramatically increase risk of pelvic inflammatory 
disease (Cates et al., 1988), leaving women unable to bear children after two episodes in 20% of 
cases (Bracher and Santow, 2001).  
Findings from industrialized countries in the pre-ART era were mixed and suggested an increased risk 
of spontaneous abortion amongst HIV infected women (De Vincenzi et al., 1997, Johnstone et al., 
1988) or no difference by HIV status (Sunderland et al., 1992, Selwyn et al., 1989). Higher rates of 
spontaneous abortion were found amongst HIV infected women in the sub-Sahara (Ryder and 
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Temmerman, 1991), and studies have since noted the possible underreporting  of sexually 
transmitted disease in women with HIV (De Vincenzi et al., 1997).  
 
Table 2.1:  Odds of perinatal outcome measures amongst HIV infected women versus HIV uninfected women. 
Adapted from Brocklehurst and French, 1998 (Brocklehurst and French, 1998) 
Perinatal Outcome Odds Ratio (95% CI) Number of studies 
reporting outcome 
Spontaneous abortion 4.05 (95% CI 2.75, 5.96) 4/31 
Stillbirth 3.91 (95% CI 2.65, 6.77) 11/31 
Foetal abnormality 1.08 (95% CI 0.7, 1.66) 7/31 
Perinatal Mortality 1.79 (95% CI 1.14, 2.81) 6/31 
Neonatal mortality 1.10 (95% CI 0.63, 1.93) 3/31 
Infant mortality 3.69 (95% CI 3.03, 4.49) 8/31 
Growth retardation 1.70 (95% CI 1.43, 2.02) 12/31 
Low birth weight 2.09 (95% CI 1.86, 2.35) 17/31 
Pre-term delivery  1.83 (95% CI 1.63, 2.06) 22/31 
 
Studies of pregnancy outcomes in Tanzania determined that untreated HIV infected women were at 
higher risk of small-for-gestational-age births (SGA), pre-term birth and perinatal death (Habib et al., 
2008). Similar results were found in a prospective cohort of 2368 live births in KwaZulu-Natal, South 
Africa, where HIV-infected women were more likely to give birth to small-for-gestational-age babies 
and were less likely to carry a pregnancy to term than HIV-negative women in the same setting, but 
did not experience any difference in rates of pre-term birth (Ndirangu, 2013).  
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Evidence from high HIV prevalence countries suggests that underlying sub-fertility associated with 
STI prevalence could lead to reduced fertility (Gregson et al., 2009), in addition to stress, a weakened 
immune system and weight loss, and that an association between HIV and adverse pregnancy 
outcomes may be stronger at advanced stages of disease progression. Research from Uganda found 
that 85% of pregnancies to HIV infected women resulted in a live birth and the physiological effects 
were most established at later stages of an infection (Ross et al., 2004). Other early studies emerging 
from sub-Saharan Africa report an association between HIV infection and low birth weight amongst 
women living with HIV (Temmerman et al., 1990, Taha et al., 1995) (Bulterys et al., 1994), and more 
recently, have estimated a higher risk of adverse outcomes in HIV infected women associated with 
lower CD4 physiological measures of health. In South Africa, HIV infected women had a 63% 
increased risk of adverse pregnancy outcomes (Rollins et al., 2007). Risk was doubled in women with 
a CD4 count below 200 cells/µl compared to women with a CD4 of 500 cells/µl or greater, and 
specifically when adjusted for mothers micronutrient status. In comparison, HIV infection and CD4 
count were not associated with risk of mortality at 6 weeks (Rollins et al., 2007). 
 
2.3 Fertility projections for a generalised HIV epidemic in the pre-ART era 
Population-based or antenatal surveys often use aggregated data for estimates of HIV prevalence or 
fertility which makes it difficult to disentangle heterogeneous behavioural or physiological causal 
pathways (Glynn et al., 2001). Early cohort studies from Uganda and Tanzania used aggregated data 
to calculate fertility differentials between HIV infected and uninfected women and found reduced 
overall age-adjusted fertility rates in the range of 0.74 to 0.84 compared to HIV negative women 
(Carpenter et al., 1997, Hunter et al., 2003), and even as low as 0.45 before ART was made widely 
available (Gray, Wawer et al. 1998). Lower fertility rates were determined in women of all age 
groups except 15-19 year olds and differentials increased with age (Allen, Serufilira et al. 1993, Gray, 
Wawer et al. 1998), possibly due to the reduction in fertility at later clinical stages (Ryder et al., 
1991). It was not possible to assess the importance of behavioural changes or fertility preference but 
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a study found lower fertility amongst HIV positive women whether or not they were using 
contraception (Hunter, Isingo et al. 2003). 
A subsequent 12-country analysis of multiple DHS rounds employed a differences-in-differences 
analysis with the benefit of more recent population based HIV testing and individual level data, 
which were aggregated to achieve more precise fertility estimates (Fortson, 2009). This analysis 
determined a small effect of HIV on fertility at the individual level, but found no correlation between 
HIV and population fertility or individuals not infected with HIV. Studies are often conducted in 
vastly different contexts of fertility and HIV burden and it is possible that a minimal association 
between HIV and population fertility is explained by a heterogeneous behavioural response to HIV in 
the general population (Durevall and Lindskog, 2011). Findings from Fortson (2009) are supported by 
other studies reporting little or no impact of HIV prevalence on population fertility, or a positive 
association in high prevalence countries such as Kenya and Lesotho (Juhn et al., 2008).  
A study from South Africa examined the likely causes of recent stalls in fertility decline in the Hlabisa 
sub-district until 2005 (Moultrie et al., 2008b). Authors report that ‘the fertility of HIV infected 
women at that time was less affected by their infection than it was previously’. Furthermore, recent 
stalls in fertility decline in Hlabisa coincided with an increase in contraceptive use between 2003-04 
and 2005. Together findings suggest that predictions of a decline in total fertility, directly 
proportional to HIV prevalence, do not generalise to this setting (Lewis et al., 2004).  
 
2.4 HIV and fertility choices in the pre-ART era 
European studies have found little effect of knowledge of own HIV diagnosis in shaping fertility 
desires and decision-making (Fiore et al., 2008). Rather, HIV infected women have continued to 
desire children in line with existing cultural norms and encouragement from HIV services (Cliffe et 
al., 2011). Cultural perspectives to childbearing in sub-Saharan Africa are likely to be shaped by 
different individual concerns for future health, risk of transmission to future children and the welfare 
of existing children (Rutenberg et al., 2000). Stigmatised views from partners, family or the 
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community have the potential to also discourage fertility amongst HIV infected women (Rutenberg 
et al., 2000, Gregson et al., 2004).  
In a survey of women living in South Africa before ART was widely available, childbearing desires 
were lower amongst HIV positive women than HIV negative women (Peltzer et al., 2009). In this 
study knowledge of PMTCT was associated with increased desire amongst HIV positive women, 
suggesting that women were deciding to limit their own childbearing in response to their HIV status 
at this time (Peltzer et al., 2009). Even at a time where ART was not widely available, women 
described decisions that were influenced by factors beyond their HIV status. For example, negative 
attitudes of health workers reportedly deterred some women living with HIV in South Africa from 
childbearing, although strong desires for parenthood did override such concerns in others (Harries et 
al., 2007).  
 
2.5 Fertility in South Africa at a time of high HIV prevalence and roll-out of ART 
National trend across South Africa reflects little population effect of HIV on fertility. National rates of 
contraceptive use have been high, and the TFR has remained low in the midst of high HIV 
prevalence. UNAIDS estimated a peak mortality of 207,865 AIDS-related deaths in 2010, before 
national scale up of access to ART brought about a decline as shown in Figure 2.1. Access to ART has 
reduced mortality amongst children and adults by 43% and 20% (Mayosi et al., 2012), with a 
resultant increase in life expectancy and HIV prevalence in the Hlabisa area (Bor et al., 2013).  Figure 
2.2 illustrates the consistent decline towards low fertility during an era of high AIDS-associated 
mortality and a subsequent reduction in mortality attributed to ART.  
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Figure 2.1. Annual HIV Deaths (at all ages), number of individuals receiving ART and TFR in South Africa 
between 1990 and 2011. Data taken from UNAIDS (AIDSinfo Online Database, last accessed 07.09.14) 
 
 
National data can often obscure a range of hidden inequalities, and HIV associated mortality has had 
an inequitable impact upon the age population structure of South Africa. Prior to ART availability, 
the proportion of children younger than 9 years old declined relative to other age groups in a rural 
area of KwaZulu-Natal, indicative of demographic transition (Herbst et al., 2011). However, 
improved survival of mothers and children living with HIV through antiretroviral treatment helped to 
alleviate the impact of changes to the population age structure attributable to HIV (Herbst et al., 
2011, Herbst et al., 2009). Since the introduction of PMTCT and ART services in 2005, reduced under-
5 mortality rates have brought a reversal of this trend, with infants under-5 now accounting for the 
single largest age group in the area (Herbst et al., 2011). 
A consequence of scaled up access to ART has been a shift in burden towards older women. National 
HIV prevalence is now highest amongst females aged 30-34 years and males aged 35-39 years, which 
could be attributed to improved survival on ART and also new infections in these age groups. Issues 
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of fertility on ART in South Africa thus appear pertinent to a demographic of women that have 
progressed within their reproductive lifespan. The effect of HIV on fertility may be heterogeneous 
according to risk group, and small population attributable changes to total fertility may mask 
opposing fertility effects. Additional research in to both biological and behavioural effects may 
elucidate these trends amongst women on ART. 
 
2.6 Theoretical frameworks to address the impact of ART on childbearing  
Theoretical frameworks have guided the demographic investigation of fertility and are well 
established in the current literature. Early work of Davis and Blake (Davis and Blake, 1956) and later 
developed by Bongaarts (Bongaarts, 1978) presents a framework aimed to understand the 
numerous mechanisms affecting fertility in the developed world. Bongaarts was the first to provide a 
quantitative framework to analyse the heterogeneous effects of multiple proximate determinants of 
fertility and to assess the most important determinants of fertility decline in various contexts. It is 
now one of the most frequently used models for evaluating fertility and fertility changes (Stover, 
1998). The framework supposes that structural factors such as education and areas of residence are 
important distal determinants of fertility and may indirectly influence population-level changes 
through a range of biological and behavioural mechanisms through more proximate (or 
intermediate) determinants. The proximate determinants outlined by this framework include the 
proportion of women married, contraceptive use, rates of induced abortion, postpartum 
infecundability, frequency of intercourse, onset of permanent sterility and spontaneous intrauterine 
mortality (Bongaarts and Potter, 1983). Together, the framework explains how marriage (or stable 
union) and permanent sterility will determine the duration of a woman’s reproductive lifespan, 
while the other proximate determinants (use of contraception, abortion, lactational infecundability, 
sexual activity and intrauterine mortality) will determine rate of childbearing and interval between 
births (figure 2.2).  
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According to Bongaart’s framework, the ‘conception wait’ period is the most variable factor 
determining birth intervals, a time when women may decide to control or lengthen time between 
births. Accordingly, the framework considers birth control as one of the most important proximate 
determinants of fertility (Bongaarts, 2006). Chapter one described that, in line with Bongaart’s 
framework, women employed the use of contraception to postpone childbearing and created 
extremely long average birth intervals that drove a slow decline to low fertility in South Africa even 
prior to the arrival of a huge HIV epidemic. Bongaart’s framework has since been updated for sub-
Saharan context (Bongaarts et al., 1984), and the context of a high HIV prevalence (Gregson et al., 
2009, Ntozi, 2002) via the same behavioural and biological proximate determinants of fertility.  
Recently, Kaida et al further developed Bongaarts model for the impact of ART therapy on fertility 
(Kaida et al., 2006). This framework recognises the influence of broader social, economic, cultural 
and gender related determinants of fertility and conceptualises the effects of these broad factors at 
the community, household and individual level, suggesting individual improvements in health, 
quality of life, survival and ART optimism related to ART use. Using this framework illustrated in 
Figure 2.2, Kaida et al demonstrate that ART could either increase or decrease fertility rates of HIV 
infected women via multiple mechanisms and the population impact of ART on fertility will be 
largely contextual.  
Kaida and colleagues demonstrated the possible directions through which use of ART may either 
increase or decrease trends in each of Bongaart’s proximate determinants of fertility (Kaida et al., 
2006). The biological and physiological mechanisms through which HIV and HIV treatment are able 
to affect fertility are clearly identified, and this is really the key virtue of Kaida’s model. The model 
presents each proximate determinant as a quantitative measure, such as rates, duration or length, 
and the hypothesised effect of ART. The external arrows illustrate the hypothesised increased, 
decreased or unknown effect of ART on each proximate determinant, already assuming a prior 
change associated with HIV. For example, Kaida suggest that ART could counter the ‘reduced’ effect 
of HIV, and increase rates of coital frequency amongst women living with HIV. Rates of other 
determinants are hypothesised to increase in response to HIV infection, such as induced abortion or 
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amenorrhea. In these examples, Kaida et al hypothesise that use of ART will reverse this effect and 
decrease the rates of induced abortion or amenorrhea amongst HIV positive women.  
Importantly the model highlights areas where the effect of ART remains largely unknown. The model 
is explicitly quantitative and its limitation, for the purpose of this study, is the absence of any 
comment on the decision making processes hypothesised to lead to the direction of these changes, 
or the possibility of changes in behaviour that are not necessarily cognitive. I thus continued to 
search the theoretical literature to elucidate how HIV treatment might influence fertility desires and 
the different possible dimensions to childbearing decisions.   
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Figure 2.2. Illustrating the effect of ART on fertility through Bongaart’s proximate and distal determinants of 
fertility, taken from (Kaida et al., 2006) 
 
 
It is the more distal links between successful family planning implementation and changes in fertility 
that are difficult to quantify, particularly in the absence of appropriate indicators of assorted 
mechanisms through which programmes can effect behaviour change. Fundamentally, family 
planning is a political issue: politics have shaped international discussions about funding, the societal 
role of contraception and implications of population control (SADoH, 2011). Family planning services 
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play an important structural role by regulating the cost and availability of contraception that 
ultimately determines the use and effectiveness of birth control (Bongaarts, 2006). In South Africa, 
public services determine free access to contraception and can encourage behavioural changes for 
women living with HIV.  
Economic and fertility models have been used to quantify the role of family planning programmes in 
national transitions to low fertility. Economic studies measure the ‘cost’ of children and the value of 
a woman’s time through indicators such as female wages and education or costs of contraception 
(Gertler and Molyneaux, 1994). Such models consider state mediated factors as key to lengthened 
birth intervals, but are imperfect in their absence of biological and other behavioural determinants 
of individual fertility.  
Fertility preferences strongly influence reproductive behaviour in Europe, where contraception is 
widely available, although preferences are realised differently in regional contexts (Régnier-Loilier 
and Vignoli, 2011). In South Africa, the issue is also culturally nuanced. Women may assert control of 
their own fertility through covert use of contraception, an act that is considered representative of 
engendered conflicts under modern day reworkings of the ‘patriarchal bargain’ (Hunter, 2010).  
Behavioural changes are the most powerful determinants of fertility decline in South Africa 
(Chimere-Dan, 1994).  
Fertility preferences and intentions are causally intermediary to the socio-economic and the 
proximate determinants of fertility’ (Timæus and Moultrie 2008). 
Both desires and intentions are commonly used constructs to describe the motivational antecedents 
of a behavioural outcome (typically conception) and are sometimes used interchangeably (Stanford 
et al., 2000, Miller, 1994, Trussell et al., 1999). Definitions of ‘intended/unintended’ or 
‘wanted/unwanted/mistimed’ are standardised in DHS survey questions for simplicity and 
comparability of measuring childbearing desires. Surveys such the National Survey of Family Growth 
(NSFG) measure retrospective perception of planning and timing using the following standardised 
definitions of intendedness in figure 2.3.  
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Figure 2.3 Definitions of an Unintended, Mistimed and Unwanted pregnancy according to the National Survey 
of Family Growth (Chandra et al., 2005) 
Unintended: 
Not wanted at the time conception occurred, irrespective of whether contraception had been used  
Mistimed: 
Unintended but wanted by women at some time, but which occurred sooner than they were 
wanted. 
Unwanted: 
Unintended and occurred when the woman did not want to have any more pregnancies at all 
 
These definitions are included in South Africa DHS rounds and allow limited understanding of fertility 
intentions in this setting, for four reasons. Firstly, individual intentions extrapolated from population 
data (i.e. DHS) cannot reflect the complexity of decision-making. Second, western concepts of 
planning do not always hold the same meaning for respondents and do not often consider enhanced 
patterns of migration, disrupted family units and high levels of single parenting found in areas of 
sub-Saharan Africa. Third, survey date by nature is retrospective, and risks under-reporting due to 
abortion (Moos et al., 1997). Fourth, these surveys are founded in the social principle that 
pregnancies within marriage are intended: early surveys did not recognise that pregnancy within 
marriage may not be wanted or, as in South Africa, a pregnancy outside of marriage could be wanted 
(Moos et al., 1997).  
All measures of intention assume individual cognition of a woman’s ability to control number and 
timing of future births and in fact many theories assume direct pathways between desire, intention 
and behaviour. Childbearing can hold a great cultural significance and many women still decide to 
continue having children even when it doesn’t make economic sense. Further complexity may be 
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introduced when women’s actions are mediated by factors other than intention, or in the absence of 
an actionable intention.  
The Theory of Planned Behaviour (TPB) identifies intention as the antecedent of behaviour (Fishbein 
et al., 1994, Ajzen, 1991). It assumes that behaviour is the result of rational decision-making, 
attributed to an individual’s beliefs, and perceived social norms and own ability to adopt the 
behaviour (Montano et al. 2002). This model prioritises the individual woman’s own perceptions and 
normative beliefs (Denison, 1996), so that external negative perceptions of childbearing amongst 
people living with HIV may dissuade individual intentions. Miller distinguished between ‘planning 
for’ and ‘wanting’ a child in his four step psychological ‘Traits-Desires-Intentions-Behaviour’ 
sequence (Miller, 1994). Childbearing decisions are dynamic and desires may relate to current 
desires or a future wish to have a child (Hofferth, 1983), so Miller’s framework positions desire as a 
precursor to intention and supposes that desires for a child can exist without further intention to 
act. Stanford’s model further classifies five retrospective dimensions of pregnancy intention and 
emotive responses to a pregnancy (Stanford et al., 2000).  
Traditionally, a one-decision model of fertility decision-making suggests that couples follow a plan 
for an ideal number of children they would like to have, and strive to achieve this goal regardless of 
changes in their circumstances (Udry, 1983).  Sequential decision models are rooted in utility theory 
and instead propose a constant re-evaluation of the costs and benefits of the number of children 
that individuals or couples wish to have, in relation to their economic and social environment. They 
allow for changes over time resulting in decisions to have another birth, postpone another birth or 
to stop reproducing (Udry, 1983).    
Current understanding tells us that planning is not always a meaningful concept, that concepts of 
intention are not clear cut and simple typologies of limiting and spacing are of limited value to 
specific contexts (Trussell et al., 1999). For example, Moultrie and colleagues showed that current 
patterns of fertility in South Africa were largely inconsistent with ideologies relating to limiting and 
spacing (Moultrie et al., 2012). Current definitions consider limiting as the cessation of childbearing 
when a desired family size has been achieved, and spacing as the decision to have another child 
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when the current youngest child has reached a certain age (Moultrie et al., 2008a). These typologies 
are problematic in South Africa where the formation and maintenance of sexual relationships have 
been disrupted by the legacy of apartheid era policy, economic and political instability and the 
dissolution of marriage (Hosegood et al., 2009). In South Africa, Moultrie suggested that patterns of 
childbearing are principally shaped by ‘uncertainty’ faced by individuals in response to their 
environmental instability, affecting a pattern of childbearing that is more akin to a concept of 
‘permanent postponers’ (Lightbourne, 1985, Moultrie et al., 2012).   
Models that assume a linear pathway of desire and intent before a behavioural act to conceive a 
pregnancy, cannot accurately account for the evolving ‘uncertainty’ determined amongst postponing 
women in South Africa. Other psychometrically validated measures of pregnancy intention are 
available and in sub-Saharan Africa but not yet in isiZulu, the predominant language of KwaZulu-
Natal (Hall et al., 2013). 
Lightbourne considers postponement as an ‘economic survival strategy’ in South Africa where 
women consider ‘a vague and weak desire to have additional children in the future coupled with a 
stronger desire to avoid one in the present’ (Lightbourne, 1985). The concept suggests that women 
are in fact not planning a set timeframe at which point they intend to get pregnant and stop using 
contraception. Instead, women described a desire to avoid pregnancy in the present while being 
potentially amenable to one in the future. It considers multi-faceted challenges that women living in 
South Africa may face inequitably, such as HIV and general health, the cost of marriage, relationship 
instability and infidelity, inadequate and overcrowded housing, saving for existing children’s 
education, gender relations and family planning policy and services (Timæus, 2014). 
Postponement is viewed as a delayed decision about childbearing, rather than a delay of the birth 
itself, that later becomes a permanent avoidance of childbearing and a key driver of long birth 
intervals and the subsequent decline in population fertility in South Africa (Timæus and Moultrie, 
2008). During periods of postponement women may still discontinue contraceptive use for reasons 
other than childbearing and desires are subject to change, with implications for family planning 
programmes. A study of the influence of ART on contraceptive behaviour in Hlabisa requires 
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grounding in health and behavioural theory that encapsulates changing structural (economic and 
relationship) uncertainties. Socio-cognitive models such as the Health Belief Model (HBM) are 
commonly used in family planning research and recently academics have modified this framework to 
encapsulate the complexities of fertility intentions in the study of modern contraceptive behaviour 
(Hall, 2012). 
Figure 2.4 Contraceptive Behaviour Health Belief Model for science and practice (adapted from Hall, 2012) 
 
 
The model illustrated in figure 2.4 fits well within the more complex context of ‘uncertainty’ 
documented in South Africa. The adapted Health Belief Model (HBM) for contraceptive behaviour 
states that an unplanned pregnancy is not always viewed as a negative health condition, as asserted 
Motivation to Prevent an Unwanted 
Pregnancy 
Perceived 
Threat of 
Pregnancy 
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Action 
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in other HBM frameworks. It recognises a possible ambivalence to a pregnancy or the risk that a 
pregnancy may pose to the individual woman. It includes multiple and modifiable dimensions of 
decision-making, which allows for complex and sequential childbearing behaviour. Key constructs of 
contraceptive behaviour include perceived threat, cost-benefit analysis, cues to action and 
modifying and enabling factors. Another benefit of such a model is that it also encompasses 
structural and health facility factors that are known to be important to the South African fertility 
decline, and are discussed in Chapter one. Consequently, HBM provides a useful tool to elucidate the 
complex motivations pre-empting contraceptive decisions of women on ART in Hlabisa.   
 
2.7 Biological mechanisms through which ART may impact fertility  
ART use may influence changes in both biological and behavioural determinants of fertility. While a 
comprehensive review of the physiological mechanisms through which ART may affect fertility is 
outside the scope of this thesis, recent research suggests multiple possible mechanisms that will be 
summarised here.  
HIV has been previously noted as a risk indicator for adverse pregnancy outcomes and subsequent 
studies from Europe and the US indicate a higher risk preterm delivery amongst women using 
antenatal combination ART, between 1.5 and 3.5- fold greater then HIV infected women on single or 
dual therapy (Study, 2010, Thorne et al., 2004). A review of these studies noted high heterogeneity 
in the association between combination ART and preterm delivery that could not be explained by 
methodology but were attributed to differences in ART regimen comparisons (Townsend et al., 
2010).  
Few studies have evaluated the effect of combination ART therapy (or highly active antiretroviral 
therapy, ART) with attention to the type of regimen used, in sub-Saharan Africa. HIV infection was 
associated with a higher adjusted odds between 1.3 – 1.8 greater for stillbirth (SB), pre-term delivery 
(PTD), SGA and neonatal death (ND) outcomes in Botswana (Chen et al., 2012). Relative to HIV 
infected women not yet enrolled on treatment, risk of PTD, SGA and ND was higher still amongst 
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women that had continued on ART from before pregnancy. Use of ART compared to Zidovudine 
alone was associated with higher odds of all adverse outcomes. These findings demonstrate possible 
adverse effects of combination ART on pregnancy outcomes, and the need for careful consideration 
of ART regimen choice in studies of pregnancy outcomes or used in PMTCT programmes for women 
that do not yet require ART for their own health (Watts and Mofenson, 2012). The applicability of 
these findings to the South African context are limited due to the absence of a comparison with 
Efavirenz-based ART, which is part of South Africa’s first line regimen (SADoH, 2010), and possible 
population fertility effects are yet to be determined.  
There is strong biological plausibility for an association between hormonal contraceptives and 
reduced ART efficacy, although clinical associations have not been widely assessed or determined for 
progesterone injectables (Robinson et al., 2012). Pharmacokinetic studies have shown evidence to 
suggest that hormonal contraceptives (HCs) may interact with ARVs to reduce contraceptive efficacy 
when taken in combination. HCs are metabolized in the liver by cytochrome P450 enzymes such as 
CYP3A4 (Rhoda Lee, 2009). Protease inhibitors used in combination ART can disrupt this metabolism 
by inhibiting the cytochrome P450 pathway (El-Ibiary and Cocohoba, 2008). The effects are 
dependent on hormonal contraceptive type and appear to be smaller in studies of depot 
medroxyprogesterone acetate, a high-dose progestogen-only contraceptive, compared to combined 
oral contraception (COC), which includes a mixture of oestrogen and progestin (Robinson et al., 
2012). Clinical studies have found little evidence of an association (Watts et al., 2008), and the 
Centres for Disease Control and Prevention considers DMPA use to be Category 1 (no restriction for 
use of contraceptive method) for all women living with HIV on ART (Control and Prevention, 2010). 
A reverse association between HC use and efficacy of ART has been recently discussed in the 
literature. The REACH cohort study in the U.S determined a link between duration of hormonal 
contraception and average reduction in viral load amongst adolescent females on ART, specifically 
ZDV (Johnson et al., 2011). The sample constituted 107 adolescents, surveyed every 3 months and 
found a significant association between duration of hormonal contraceptive use and average VL 
decrease per day. It is important to note the small sample size and that women primarily used COC 
while Depo-Provera accounted for just 28.2% of contraceptive use (Johnson et al., 2011). HC has 
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subsequently been associated with both increased risk of transmission and acquisition of HIV 
between sero-discordant partners (Heffron et al., 2012), but an extensive review found no strong 
evidence of a definite association and led the WHO to endorse continued DMPA use amongst 
women living with HIV (WHO, 2012). 
A speculated reversal of reduced fertility amongst HIV infected women through reduced mortality 
and behaviour changes attributed to access to ART has been explored in the literature in recent 
years. The topic is nuanced with difficulties in finding an appropriate counterfactual to women living 
with HIV on ART. 
 
2.8 Systematic reviews of the association between ART and fertility in South Africa 
2.8.1 Review methodology  
This section presents the methodology of two systematic reviews of the literature that are later 
presented in Sections 2.8.2 and 2.8.3. An initial scoping exercise identified the different disciplines 
studying HIV and fertility, and included a preliminary search for fertility studies and studies of 
childbearing desires amongst women on ART. The initial search conducted in February 2011 
generated more than 10,000 responses in Google scholar and UCL MetaLib. It was most feasible to 
divide the topic into two systematic literature searches that investigate:  
 
1. The effect of ART on fertility rates amongst women living with HIV in sub-Saharan Africa, 
when used for either personal health or prevention of mother-to-child transmission. 
2. The use of ART and attitudes to, and desire for, childbearing amongst women living with HIV 
in sub-Saharan Africa. 
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Search criteria  
Studies from any sub-Saharan African country were included in both searches. The preliminary 
search of the HIV, ART and fertility literature informed the key word criteria for two systematic 
searches. The final key words were: 
 
x Search One: (ART) OR (antiretroviral therapy) OR (HAART) OR (antiretroviral) AND 
(pregnancy) OR (fertility) OR (birth) AND (rates) OR (incidence) OR (risk) AND (sub-
Saharan Africa) OR (Africa).  
x Search Two: (ART) OR (antiretroviral therapy) OR (ARV) AND (pregnancy) OR (fertility) 
OR (birth) OR (child*) AND (intention*) OR (desire*) OR (planning) AND (sub-Saharan 
Africa) OR (Africa). 
 
The searches using the above search terms in PubMed were conducted in September 2014; the 
University College London’s own e-library database called ‘Metalib’ was also searched, which 
extended the search to five additional data bases: Geobase, JSTOR, SCOPUS, UCL Library catalogue 
(Explore) and Zetoc. The dates of the searches were not limited as the roll out of antiretroviral 
therapy is a recent intervention, and I anticipated that no relevant studies on the effect of ART on 
fertility would be published prior to 1990. 
 
Inclusion criteria for Search One specified that studies: 
x Were population, individual or facility-based 
x Used a cohort or cross-sectional design 
x Had an exposure group of HIV positive women enrolled and using ART  
x Had a comparison group of HIV positive women not on ART, or HIV negative women (for 
cross sectional studies) 
x Included time since initiation on ART (cohort studies) 
x Had pregnancy or birth outcomes  
x Included an analysis of multiple factors associated with the described outcome 
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x Were conducted in sub-Saharan Africa 
 
Inclusion criteria for Search Two specified that studies: 
x Reported a qualitative study or quantitative survey design 
x Included question about pregnancy intention or desire to get pregnant  
x Described themes related to attitudes to childbearing  
x Reported perspectives from HIV positive women using ART at time of conception  
x Were conducted in sub-Saharan Africa  
 
Screening process and eligibility 
Search One:  The search of PubMed returned 670 unique titles and the search of MetaLib a further 
28 unique titles. These 698 non-duplicate titles were screened against the above criteria.  
Subsequently 54 abstracts and 13 full texts were screened. Nine studies met the eligibility criteria 
and were included in the review. 
 
Search Two: The search of PubMed returned 177 unique titles and the search of MetaLib a further 7 
unique titles. These 184 non-duplicate titles were screened against the above criteria. Subsequently, 
75 abstracts and 46 full texts were screened. Thirty-six studies met eligibility criteria and were 
included in the review.  
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Figure 2.5 Flow diagrams to illustrate the systematic process of two systematic literature searches  
a) Flow diagram of screening and exclusion for Search One 
 
 
 
670 records 
identified from 
‘Search One’ of 
PubMed 
28 additional records 
identified from 
MetaLib 
698 records screened 
54 abstracts screened 
according to ‘Search 
One’ criteria 
644 records excluded if not 
investigating fertility in 
women on ART from an 
African setting 
13 full texts screened 
according to ‘Search 
One’ criteria 
9 studies included in 
review of the effect of 
ART on pregnancy and 
birth rates 
41 abstracts excluded if 
methodology did not fit 
inclusion criteria   
4 texts excluded as not 
reporting pregnancy or birth 
outcomes to women on ART 
and a comparison group, or 
offers no baseline 
comparison including 
multiple factors 
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 b) Flow diagram of screening and exclusion for Search Two 
 
 
 
177 records 
identified from 
‘Search Two’ of 
PubMed 
7 additional records 
identified from 
MetaLib 
184 records screened 
75 abstracts screened 
according to ‘Search 
Two’ criteria 
109 records excluded if not 
investigating fertility desire 
amongst women on ART in 
an African setting 
46 full texts screened 
according to ‘Search 
Two’ criteria 
36 studies included in a 
review of attitudes to 
childbearing amongst 
women on ART 
29 abstracts excluded if 
methodology did not fit 
inclusion criteria   
10 texts excluded if study 
did not fit inclusion criteria   
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Abstraction and summary 
The reported outcomes, comparison groups and design of the nine eligible studies retrieved by 
Search one were detailed in an Excel spread sheet. Studies were ordered by publication date and 
novel findings or methodological approaches were then summarised. Factors associated with 
outcome were also noted according to study authors’, and researcher explanations of the results. 
These factors later informed the methodological approach for this thesis. No formal assessment of 
quality was done but study limitations were noted and described in the discussion. 
 
In Search two the qualitative studies were grouped according to region of study and date of 
publication. This was important considering the possibility of a changing ‘effect’ of ART as an 
influence on attitudes to childbearing. Reported desires and emergent themes were summarised for 
each publication. Summaries helped to identify regional variations in childbearing desires and 
consistency with quantitative studies. No formal quality assessment was done; the utility of such an 
assessment for qualitative studies is debated (Buchanan and Rotkirch, 2013, Dixon-Woods et al., 
2005). 
 
2.8.2 Search One: The Effect of ART on Birth Rates in sub-Saharan Africa 
Results from this search identified nine studies of the impact of lifelong ART on incidence of 
pregnancies or birth. Eight were cohort studies and one presented cross-sectional results. Two 
studies reported findings from multi-country cohorts, four studies originated from Uganda, two from 
South Africa and one from Malawi. There was broad heterogeneity in clinical, behavioural and socio-
demographic characteristics measured at baseline and presented for multivariable analysis (Table 
2.2). All studies reported pregnancy as the key outcome, which was either self-reported, clinically 
determined or both. Of these studies, four also reported measures of desire and intentions, 
including one that measured planning and unmet need for contraception associated with incidence 
of pregnancy.  
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Multiple cohort studies in the U.S. reported conflicting effects of ART on fertility rates. Early work 
suggested an increase in pregnancy rates among HIV positive women since ART became available. 
Blair et al provided a comparison of pregnancy rates amongst HIV infected women in pre-ART (1992-
1996) and post-ART (1997-2001) years to determine 20% higher rates of pregnancy in the post-ART 
era (Blair et al., 2004). Pregnancies were less likely in women with a history of AIDS-related illness 
and CD4 below 200cells/µl. Yet two subsequent multicentre studies did not find a significant 
association between use of ART and fertility in the time periods 1994 to 2002 and 2002 to 2009 
(Massad et al., 2004, Linas et al., 2011).  The earlier study determined a reduced risk of abortion 
during pregnancy amongst women on ART and also a lower risk of conception (Massad et al., 2004) . 
Both studies reported lower pregnancy rates amongst HIV infected women; approximately half of 
those compared to HIV uninfected women.  
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Table 2.2: Studies reviewing effect of exposure to lifelong ART on incidence and predictors of pregnancy 
Author Setting Design Comparison Key finding Outcomes Sample size Follow up (months) 
(Burgos-
Soto et al., 
2014) 
IeDEA West 
Africa: 
Benin, 
Burkina 
Faso, Cote 
d’Ivoire, 
Togo, 
Guinea-
Bissau, Mali, 
Nigeria and 
Senegal 
Retrospective 
analysis of 
IeDEA 
database, with 
data from 15 
HIV/AIDS 
clinics 
Predictors of 
pregnancy 
on ART  
Incidence of 
pregnancy 
after ART 
associated 
with higher 
CD4 at 
initiation and 
ART regimen  
- Incidence rate of 2.85 pregnancies/100PYs in first 12 
months, increased thereafter. Low comparative to 
region.  
- Overall pregnancy probability of 11% by 4 years of 
follow up on ART 
- CD4 count was a good indicator of pregnancy and 
recurrent pregnancies. 
- Increase in incidence highest amongst women aged 25-
29 years old.  
- Women initiating with Nevirapine based regimens had 
higher risk compared to Efavirenz-based regimen in 
adjusted analysis. 
- No measure of family planning indicators such as 
contraceptive use or marital status 
29,425 
women 
followed, 
with 2,515 
pregnancies 
to 2,304 
women 
Follow up 
between 
1998 and 
2011 
(Homsy et 
al., 2009) 
Uganda Prospective 
cohort of 
women 
receiving ART 
as part of the 
Home-Based 
AIDS Care 
study. 
Time since 
initiation 
Trends in 
desire and 
predictors of 
pregnancy 
on ART 
Low desire for 
children not 
associated 
with time 
↑ Incidence 
of pregnancy 
with time on 
ART up to 24 
- Over a median follow up time of 2.4 years, desire for 
more children remained constant and less than 7%. 
Low childbearing desires were reported amongst 
women experiencing an increase in incidence of 
pregnancy from 3.46 per 100 women-years (at 3 
months) to 9.5 per 100 women-years at 24 months 
(p<00001). 
- Women also reported increased sexual activity from 
718 HIV 
infected 
women 
Followed 
up 24 
months 
post ART 
initiation 
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months  24.4% at baseline to 32.5% at 24 months of follow up 
(p=0.0001). 
- Family planning use was around14% after 2 years of 
follow up 
(Kaida et al., 
2013) 
Uganda Prospective 
cohort  
Time since 
initiation on 
ART 
Peak in 
incidence 
between 6-12 
months after 
initiation  
↓incidence of 
pregnancy 
after 12 
months on 
ART 
- Pregnancy incidence 9.40/100 WYs 
- Cumulative probability of pregnancy was 28% after 3 
years 
- Incidence peaked between 6-12 months after ART 
initiation and declined thereafter until 48+ months 
- Recurrent pregnancies were responsible for a peaks in 
pregnancy at 24-30 and 48+ months 
- Younger age and having disclosed status to partner 
were associated with risk of pregnancy 
351 women, 
withy 105 
pregnancies 
to 84 
women 
2005 - 
2011 
(Maier et 
al., 2009) 
Uganda Cross 
sectional 
study of single 
HIV clinic. 
ART naive, 
surveyed from 
queue. ART 
exposed, 
recruited from 
pharmacy 
Pre-ART vs. 
receiving 
ART 
↑odds of 
fertility desire 
on ART vs. no 
ART 
↓ odds of 
pregnancy on 
ART vs. no 
ART 
- Increased odds of fertility desire associated with ART 
use (AOR 2.99, 95% 1.30-6.28) in multivariate analysis 
(not significant in bivariate) 
- ART associated with decreased odds of pregnancy 
(AOR0.56, 95% CI 0.33-0.95) and live birth (AOR 0.30, 
95% CI 0.13-0.66).  Lower odds of pregnancy were also 
associated with increasing age, which was significantly 
higher in exposed group. 
- Limited by non-random distribution of ages, ethnicity 
and other baseline characteristics between ART-naive 
and exposed groups.  
 501 
Ugandan 
women aged 
18-50 yrs 
attending 
HIV clinic  
Total 
survey 
conducted 
over 8 
months 
(Makumbi Uganda Prospective Pre-ART vs. ↑ Incidence - Incidence of pregnancy was 13.1/100 py among 712 HIV+ Follow up 
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et al., 2011) longitudinal 
study of HIV 
positive 
women  
receiving 
ART 
of pregnancy 
on ART vs. no 
ART 
Non-
significant 
association 
between 
desire and 
incidence.  
Association 
greater when 
both partners 
report desires. 
women in pre-ART care and 24.6/100 py among 
women on ART. (IRR= 0.54; 95% CI 0.37, 0.81, 
p<0.0017).  
- Incidence of pregnancy associated with higher CD4 
counts or improved CD4 beyond 100cells/mm3 after 12 
weeks post ART initiation.  
- Use of family planning methods was not significantly 
associated but this study did not separately address 
hormonal contraceptives. ‘Other’ revealed a 
significantly lower incidence in comparison to use of 
condoms only. 
- Interviews revealed a non-significant trend of incidence 
by reported desire for children. Incidence was higher 
amongst women initiated on ART when both partners 
reported a desire for children and lower when just the 
women reported a desire, compared to neither 
reporting wanting more children.  
- Prevalence of pregnancy at ART initiation was 
associated with CD4 count; 12% for those with CD4 
counts 100-250 compared with 3.2% for those with 
CD4<100 (PRR=3.24, CI 1.51-6.93) 
pre-ART 
women and 
244 HIV+ 
women 
initiating 
ART 
for 48 
weeks post 
initiation of 
HIV care or 
ART.  
Followed 
weekly for 
first 
month, 
biweekly 
for next 
two 
months, 
monthly 
until one 
year and 
every 2 
months 
thereafter. 
Pre-ART 
Individuals 
seen every 
3 to 6 
months.  
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(Myer et al., 
2010) 
Multi-
country 
Cohort study 
 
11 PMTCT 
programmes 
in 7 sub-
Saharan 
African 
countries. 
Pre-ART vs. 
receiving 
ART  
 
↑ Incidence 
of pregnancy 
on ART 
(9.0/100 PY 
amongst 
women on-
ART compared 
to a pre-ART 
of 6.5/100 PY)   
 
- Use of ART associated with increased incidence of 
pregnancy (adjusted HR, 1.74) 
- South Africa has the lowest fertility of all countries 
(3.29 pregnancies/100 PY compared to a crude rate of 
7 pregnancies/100PY) and one of the strongest 
associations between ART use and fertility out of 11 
countries (HR 2.33; 95% CI 0.70-7.73).  
- Pre-ART risk of pregnancy is relatively constant, 
peaking at 3 years. On-ART shows increasing risk with 
duration of treatment.  
- Non barrier contraceptives were associated with 
reduced risk of pregnancy (primarily IUD and 
injectables)  
4531 
women, 589 
pregnancies 
4 years. 
 
Every 3-6 
months for 
pre-ART 
and every 
month for 
on-ART 
(Schwartz et 
al., 2012) 
South Africa Prospective 
cohort from 
four public 
ART clinics in 
Johannesburg  
Time since 
initiation on 
ART.  
Planned vs. 
Unplanned 
 
Unmet need 
for 
contraception, 
but not 
incidence of 
pregnancy, 
associated 
with time 
since ART 
initiation. 
- Limited to women aged 18-35 
- Incidence rate was 21.6 pregnancies/100PYs 
- 62% of incident pregnancies were unplanned 
- No significant association with ART duration. Also 
found upon exclusion of women with a prior pregnancy 
on ART (data not shown) 
- Unmet need for contraception was higher in first year 
since ART initiation and associated with CD4 
≤250cells/mm3 
850 women 
enrolled, 
with 170 
pregnancies 
to 161 
women 
August 
2009 – 
March 
2011 
(Tweya et 
al., 2013) 
Malawi Retrospective 
cohort using a 
routine 
electronic 
Time since 
initiation on 
↑ incidence 
of pregnancy 
since initiation 
on ART 
- Pregnancy incidence was 9.3/100pys 
- In multivariable Poisson analysis, incidence of 
pregnancy was signiﬁcantly associated with current 
age, WHO clinical stage at ART initiation, BMI during 
4,738 
women 
July 2007 – 
December 
2010 
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data system of 
a single ART 
clinic 
ART.  
 
follow-up, and time on ART longer than 6 months (RR = 
3.25; 95% CI 2.47–4.28). 
(Westreich 
et al., 2012) 
South Africa Retrospective 
clinical cohort 
Time since 
initiation on 
ART.  
Incidence of 
pregnancy and 
ART regimen  
- Incidence of pregnancy 5.2/100PYs 
- Increase in incidence with annual time since initiation 
- Cumulative incidence of pregnancy was 22% by 6 years 
on ART 
- Higher adjusted rate ratio associated with CD4 ≥100 
and younger age  
- Use of lopinavir-ritonavir and Nevirapine based 
regimens associated with higher univariate incidence 
compared to Efavirenz, but not in adjusted analysis. 
72% of pregnancies exposed to EFV. 
5,996 
women, 727 
pregnancies  
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x Different outcomes reported 
Six studies reported on changes in incidence of pregnancy associated with time since initiation on 
ART. All presented multivariable analysis of characteristics at baseline and time-updated. These 
studies were better able to measure maternal clinical characteristics such as CD4+, viral load and 
mental health. Two studies explored whether any changes in incidence of pregnancy differed by 
type of ART regimen, but few presented comparisons to women before ART initiation and none to 
HIV negative women.  
Four studies presented relative risk of pregnancy and associated indicators compared to ART-naïve 
women. Two of these also compared desires for a pregnancy between on-ART and pre-ART women. 
The studies provide evidence for an increased incidence of pregnancy following initiation with ART in 
sub-Saharan Africa.  
 
x Direction of an effect of ART on fertility  
A MTCT-Plus study conducted across seven African countries determined higher risk of pregnancy 
amongst women on ART over time, reaching 80% greater than women not yet enrolled on ART but 
receiving post-partum care (Myer et al., 2010). The study followed 4,531 pregnant or recently post-
partum HIV infected women receiving PMTCT services across seven countries between 2003 and 
2007, and women receiving ART experienced more pregnancies (9 per 100 person years) compared 
to women solely receiving PMTCT services (6.5 per 100 person years). They determined an increased 
risk of pregnancy with duration of follow up ‘on-ART’, and reported annual pregnancy rates of 6.8, 
9.9, 10.5 and 13.7 pregnancies per 100 WYs at each year for four years since initiation with ART. 
Independent predictors of lower incidence of pregnancy included younger age, lower educational 
status, use of injectable contraception, severe HIV progression and low CD4 count. In particular the 
study noted an association between ART and incidence of pregnancy in South Africa at a hazard ratio 
of 2.33 (95% CI 0.70–7.73) although this hazard ratio did not reach significance. Disaggregated data 
was not presented, and authors attributed large variations between cohort sites to differences in 
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patient demographics and access to contraception and counselling (Myer et al., 2010). However, the 
large increase in incidence over time in this study may well be attributed to the selection of post-
partum women that have already established their fertility to ascertain entry in to the study. This 
may not reflect generalised population fertility, particularly in HIV infected women, as HIV is a 
known risk factor for STI acquisition and reduced fecundity.  
Regional cohort studies largely show an increased risk of pregnancy with time since initiation. Much 
recent evidence has emerged from a context of high fertility including Uganda, Malawi and West 
Africa (Kaida et al., 2013, Homsy et al., 2009, Makumbi et al., 2011) and most studies indicate 
increasing risk of pregnancy to women over time since initiation following restoration of health on 
ART (Homsy et al., 2009, Myer et al., 2010, Makumbi et al., 2011); this effect was slight (Westreich et 
al., 2012) or found not to exist (Schwartz et al., 2012) in studies emerging from South Africa. An 
initial increase in risk after initiation with ART may be short-lived depending on the context: women 
were most likely to become pregnant if they had recently initiated ART, with a peak at 6-12 months 
after ART and a consistent decline until 36 months interrupted by subsequent smaller peaks 
attributed to recurrent pregnancies at 24 and 48 months (Kaida et al., 2013). In this cohort of 
women enrolled in the Uganda AIDS Rural Treatment Outcomes study between 2005 and 2011, 
incidence was high at 9.40 pregnancies per 100 woman years since ART initiation, and partially 
explained by much higher total fertility rates in Uganda by comparison to South Africa (TFR=6 in 
Uganda Vs. TFR=2.4 in South Africa). Multiple pregnancies to the same woman were common during 
follow-up, but only 54% of pregnancies resulted in a live birth, with 21% ending in a stillbirth or 
miscarriage. 13% of women were still pregnant by the end of study. Of 84 women reporting an 
incident pregnancy, 15 reported a second and three women experienced a third incident pregnancy. 
Findings suggest that an association between ART and population fertility could be stronger 
following recent ART roll out and that a contextual interpretation of results is needed. Predictors 
associated with higher incidence of pregnancy were younger age and disclosure of HIV status to a 
partner after more than one year after initiation on ART, suggestive that couples may have been 
planning to have more children after this time. 
 
  
 
 
70 
x Factors associated with likelihood of pregnancy on ART 
Factors associated with higher likelihood of pregnancy to women on ART in these nine studies 
include: younger age, lower levels of education, being married or cohabiting, having a male partner 
enrolled in a program or disclosure of HIV status to a male partner, non-barrier forms of 
contraception, duration on ART, an Efavirenz-based ART regimen and higher current CD4 counts. 
 
x The association between a desire for a child and likelihood of pregnancy 
Four studies evaluating the role of pregnancy desire or planning do not illustrate a straightforward 
association. Longer duration on ART treatment was associated with desire to have more children in 
Uganda, although reported desire did not correspond to reproductive behaviours as women on ART 
for more than nine months had lower odds of pregnancy over 3 years of follow up (Maier et al., 
2009). Two further studies from Uganda found no association between desire and incidence (Homsy 
et al., 2009, Makumbi et al., 2011) Homsy et al determined consistently low pregnancy desires that 
were not reflective of increasing incidence of pregnancy since initiation on ART (Homsy et al., 2009) 
and later Makumbi et al found a non-significant trend of incidence by reported desire for children. 
Incidence was higher amongst women initiated on ART when both partners reported a desire for 
children and lower when just the women reported a desire, compared to neither reporting wanting 
more children (Makumbi et al., 2011). Just one study from South Africa determined recorded 
measures of pregnancy planning to women on ART and reported that 62% of pregnancies were 
unplanned amongst women aged 18-35 years old on ART (Schwartz et al., 2012). This study reported 
a large unmet need for contraception and found that unmet need for contraception was higher in 
first year since ART initiation and independently associated with CD4 ≤250cells/mm3. Furthermore, 
women reporting use of only condoms had similar cumulative incidence rates of unplanned 
pregnancies to women with no contraceptive use, while 34% of women using hormonal 
contraception reported problems with their method and most (61%) did not discuss this with 
providers. 
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An effect of ART on fertility in a population where contraceptive prevalence is high would likely be 
driven by improvements in quality of life leading to increased sexual activity and/or changes in 
fertility preferences and contraceptive behaviour (Myer et al., 2010). Major cohort studies are 
limited by the absence of data on sexual activity or reported fertility desires and information on 
these factors required a separate search of the literature. 
 
2.8.3 Search Two: The effect of ART on Fertility Aspirations  
Deeper understanding of the effects of exposure to antiretroviral therapy on fertility intentions 
typically emanate from qualitative studies reporting changing needs of women after initiation of 
treatment and in some areas, higher rates of intended pregnancies that follow the restoration of 
health on ART (King et al., 2011). 
Survey and cross-sectional studies have evaluated the influence of ART use on decisions about 
childbearing and contraceptive behaviour. All studies report desire to continue childbearing, to 
varying extents, amongst women on ART. Desires were contextually specific and the following 
review describes some of the familial, medical, cultural and socio-economic complexities.   
 
x The prevailing importance of social norms  
Perspectives on childbearing vary according to setting and existing social norms. A systematic review 
from 12 sub-Saharan countries found no change in reproductive desire associated with HIV 
prevalence, at a time that authors considered ART coverage as ‘sub-optimal’ (Nattabi et al., 2009). 
Educational and economic status and area of residence have been shown to affect reproductive 
intentions (Hoffman et al., 2008) (Desgress-Du-Lou et al 2002; Nebie et al, 2001). A strong negative 
association between HIV and fertility aspirations was reported by outpatients of a HIV programme in 
Uganda, after access to ART became widespread but irrespective of individual ART use (Snow et al., 
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2013). In the high fertility setting of Nigeria, however, personal aspirations or intervening social 
needs for a child would often supersede clinical health concerns (Wekesa and Coast, 2014, Smith 
and Mbakwem, 2007).  
Studies from South Africa show the prevailing social importance of parenthood in the context of HIV 
and use of ART in this setting of low national fertility (Cooper et al., 2007, Cooper et al., 2009). 
Continued or increased desire for parenthood was reported amongst 61 men and women living with 
HIV, and treatment with ART greater than six months was associated with favourable attitudes to 
childbearing (Cooper et al., 2007). A cross-sectional study of 311 HIV infected men and women 
attending a public sector ART service found increasing duration of ART was associated with fertility 
desire (Myer et al., 2007), and a later survey of women living in Soweto found duration of ART use 
had no impact on childbearing decision-making (Kaida et al., 2011). ART use was strongly associated 
with women’s fertility intentions in a cross-sectional survey of 459 HIV infected men and women 
both on ART and pre-ART living in Cape Town (Cooper et al., 2009).  
Continued desires for childbearing on ART in South Africa are in accordance with literature from 
other developing countries (Wekesa and Coast, 2014, Kaida et al., 2006, Kipp et al., 2011, Berhan, 
2008). Women that reported a desire for childbearing were typically younger, in a relationship and 
had fewer biological children. Clinical studies suggest that women are most likely to report 
intentions for childbearing with higher CD4 count, if partners also desire a child or if they have no 
living children (Negash et al., 2013, Mmbaga et al., 2013, Kipp et al., 2011). Women appear more 
likely to desire more children contingent upon availability of both ART and PMTCT services (Cooper 
et al., 2007), disclosure of HIV status to a partner (Makumbi et al., 2011, Kisakye et al., 2010) and the 
HIV status of a regular partner (Heard et al., 2007). Other important determinants of fertility include 
partner desire (Beyeza-Kashesya et al., 2010), pressure from family and desire for an heir (King et al., 
2011) and stigma of HIV and childlessness (Kisakye et al., 2010).  
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x Desire to preserve health on ART 
Perception of an individual’s own health and quality of life appears to be an important indicator of 
fertility aspirations (McClellan et al., 2010, Mmbaga et al., 2013) and can drive fertility aspirations in 
spite of serostatus (Kisakye et al., 2010). In a study from Cameroon, 55% of women on ART desired 
another child, a finding associated with a good physical quality of life and greater knowledge of HIV 
(Marcellin 2010). 
The role of ART in perceptions of well-being is nuanced: in-depth interviews with HIV positive 
women planning to conceive or recently having delivered indicated that good health related to 
taking antiretrovirals and eating for optimal nutrition were sufficient to achieve goals for 
motherhood (Awiti Ujiji et al., 2010). Furthermore, consultation with healthcare providers was 
viewed as interference with fertility aspirations. 
 
x Partner desires for childbearing  
A limitation of much recent work is the focus on women intentions, ignoring the importance of 
partner preferences or relationship complexities. In comparison to women, men have expressed 
greater desires to have a child when on ART (Kipp et al., 2011, Myer et al., 2007, Berhan, 2008) and 
an association with pregnancy incidence was stronger when both men and women reported desires 
for a child (Makumbi et al., 2011). Although largely cultural, gender discrepancies may, in part, be 
explained by the greater risk to woman’s health posed by a pregnancy (Berhan, 2008). In-depth 
research found substantial tensions between sero-discordant couples related to differences in HIV 
status, also impacting on reduced couple-desires to have children (Rispel et al., 2011). Sero-
discordant couples that had enrolled in a PreP study in East Africa expressed largely convergent 
fertility aspirations (76%). Discrepancies in fertility desire between partners were primarily reported 
in couples where the HIV-1 uninfected male partner desired additional children but their HIV-1 
infected female partner did not (Mujugira et al., 2013). The applicability for the study setting is 
uncertain however, where marital rates are low and relationship dynamics, more fluid. 41% of 
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recent mothers reported that they did not know the HIV serostatus of the father of their child in a 
peri-conception risk cohort of sero-discordant partners in South Africa (Matthews et al., 2014), 
indicating wider barriers to disclosure and pregnancy planning for women on ART.  
 
x Contraceptive use on ART 
Contraceptive knowledge is high in South Africa, with 97% reporting knowledge of one modern 
method. However, knowledge of a modern contraceptive method does not implicitly lead to its 
adoption (Subramanian et al., 2009). ART may result in changes to fertility through altered 
contraceptive behaviours, related to either fertility decision-making, or for reasons beyond a 
woman’s own desires for childbearing. Determinants of contraceptive use can vary with setting but 
access and knowledge of modern methods determined higher rates of contraceptive use in studies 
from Uganda, Ethiopia and South Africa among women using ART compared to ART-naïve women 
(Andia et al., 2009, Kaida et al., 2010, Asfaw and Gashe, 2014).  
Evidence suggests that women on ART in South Africa tend to choose methods of a less permanent 
nature than women not on ART (Cooper et al., 2007, Myer et al., 2007). In a cross-sectional study of 
HIV positive women receiving regular care in Brazil, South Africa and Uganda, current ART users 
were more likely to report condom use if sexually active (crude OR: 3.64; 95%CI: 1.419.38) but no 
other methods of contraception (crude OR: 2.15; 95%CI: 0.77-5.99), indicating priorities for both HIV 
and pregnancy prevention in contraceptive choice (Kaida et al., 2008).  
Fertility desire was a dominant factor in contraceptive discontinuation in Brazil and Kenya but not 
South Africa, where unpleasant side effects such as amenorrhea, excessive menstruation and weight 
gain were listed as major determinants of contraceptive discontinuation (Kaida et al., 2008). 
Perceptions of health are important to contraceptive choice in South Africa: current health concerns 
were primary barriers to use of the IUCD amongst HIV positive women, with 20.5% of women stating 
this as a reason compared to 3.9% of HIV negative women (Credé et al., 2012). Side effects of 
contraceptive use deterred contraceptive use amongst HIV positive women in Soweto, where 
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perceived vaginal wetness and amenorrhea related to injectable contraceptive use were barriers to 
use of this method (Laher et al., 2009). Elsewhere, overall contraceptive use remained low due to 
fears of side effects, despite high knowledge amongst sero-discordant couples from Zambia and 
Rwanda (Grabbe et al., 2009).  
 
x Planning for a pregnancy 
Little evidence was found of an association between fertility desires and patterns of contraceptive 
use or fertility rates, before the introduction of ART (Gray et al., 1998, Rutenberg et al., 2000, Bova 
and Durante, 2003). Further, the HIV epidemic is reported to have had little impact on sexual 
behaviours in some settings (Oster, 2005). Importantly, a relationship between reported desires and 
resulting fertility to women on ART is not well established (Homsy et al., 2009, Makumbi et al., 2011, 
Maier et al., 2009). This may be attributed to inadequate measures of fertility intentions or demand 
for family planning in the wake of ART roll out (Kaler et al., 2012).  
Rates of unintended pregnancies remain high in South Africa and in this context, an effect of ART on 
childbearing desires may be negligible: a study found 62% of recent pregnancies were unplanned in 
a cohort of women on ART and aged between 18 and 35 years old (Schwartz et al., 2012). Despite an 
association between HIV status, fertility desire and incidence of pregnancy, 69% of recorded 
pregnancies were unplanned amongst women in Zimbabwe before ART was available (Feldman and 
Maposhere, 2003). In KwaZulu-Natal, around one half of women who did not intend to have a child 
reported using contraception (Subramanian et al., 2009). Other qualitative studies have found that 
women on ART continue to have children ‘accidentally’ (King et al., 2011), feel satisfied with current 
family size, or do not wish for more children (Kaler et al., 2012, Heys et al., 2012). Women reporting 
intentions to have children are more likely to engage in risky sexual activity (Ezeanochie et al., 2009, 
Dessie et al., 2011), while concerns regarding re-infection pose a deterrent to childbearing for some, 
even in the era of ART (Forrest et al., 2009).  
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x Family planning services and planning for a child 
Family planning services have an important role in determining access to services, provision of the 
available contraceptive method mix, fees charged, attitudes of clinic workers and the comprehensive 
nature of family counselling (Grabbe et al., 2009). Convenience and provider recommendations were 
important in contraceptive method choice to women in the Western Cape, while exposure to family 
planning counselling strongly determined method use (Credé et al., 2012). Elsewhere, perceived 
negative attitudes of health workers have also been cited as deterring women from future 
childbearing (Cooper et al., 2007). Many clients reported discussing contraceptive use with a 
healthcare provider in a cross-sectional study of 227 women attending an ART outpatient clinic in 
Cape Town, yet women revealed very little knowledge of emergency contraception (7%) and 
termination of pregnancy (13%) despite these services being free and available (Myer et al., 2007).  
 
2.9 Gaps this thesis addresses 
Few studies address attitudes to contraceptive use and safe conception practices amongst women 
living with HIV on ART in sub-Saharan Africa. Many studies investigating an impact of ART on fertility 
rely on data from Europe and the U.S or countries in sub-Saharan Africa where contraceptive use is 
low. Studies are often limited by lack of behavioural and physiological data or the absence of an 
appropriate counterfactual group for women on ART. This study provides a novel comparison of 
fertility between HIV positive women on-ART, ART-naïve HIV positive women and HIV negative 
women. 
Data on childbearing decisions have relied on survey measures that do not often explore nuances in 
the way that ART may affect long term desires to avoid or achieve pregnancy (i.e. in a period of 
postponed decision-making.). Furthermore, interpretations may be limited by measures that depend 
on ‘Western’ concepts of planning for a pregnancy. This study uses semi-structured interviews to 
determine emergent themes amongst women on ART. 
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National contraceptive guidelines have outlined a commitment to delivering integrated 
contraception and HIV services, yet implementation is still lacking. Studies report high levels of 
unplanned pregnancy, an absence of support for safe conception and frequent discontinuation of 
contraceptive methods amongst women on ART in South Africa. There is a gap in the understanding 
for how family planning can be optimally delivered to HIV positive women accessing HIV treatment 
services in rural areas of South Africa, and specifically, the Hlabisa district of KwaZulu-Natal. This 
thesis seeks the perspectives of health workers on family planning, with the intention to determine 
how services could be adapted to respond to family planning needs of HIV positive women in the 
specific context of Hlabisa in KwaZulu-Natal. 
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Chapter Three 
Methodology and Data Analysis 
3.1 Aim and objectives 
A literature review described in Chapter Three was conducted to inform the study aim and three 
research objectives, outlined below.  
Study aim 
To determine how national scale up of anti-retroviral therapy has influenced rates of live birth and 
attitudes to childbearing amongst women living with HIV in a rural setting of South Africa 
Research objectives  
I. Investigate whether use of ART is associated with women’s likelihood of experiencing a live 
birth in the Hlabisa sub-district of KwaZulu-Natal. 
II. Explore how use of ART influences fertility and family planning desires amongst women on 
ART.  
III. Determine the role that HIV treatment and care programs play in the provision of family 
planning services, including client’s expectations of family planning and whether they feel 
their expectations are being addressed.  
Methodological approach 
Three research objectives were addressed in this study using both qualitative and quantitative 
methodology. An analysis of demographic surveillance data emphasised the value of a qualitative 
investigation, which forms the primary data collection component in this thesis. The following 
describes the methodology used to achieve each objective:
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Objective I: Investigate whether use of ART is associated with women’s likelihood of experiencing a 
live birth in the Hlabisa sub-district of KwaZulu-Natal? 
The first objective was addressed with an analysis of demographic surveillance data collected by the 
Africa Centre, to:  
 Describe the rates of live birth in the Hlabisa sub-district since roll out of ART in 2004 
 Quantify the likelihood of live birth associated with use of ART, allowing for potential 
confounders and compared to HIV positive ART naïve women and HIV negative women.  
 Assess the influence of ART on rates of contraceptive use as a proximal behavioural determinant 
of fertility. 
 
Objective II: Explore how use of ART influences fertility and family planning desires amongst women 
on ART. 
The second objective was answered through qualitative semi-structured interviews to explore: 
 How being on ART influences childbearing desires  
 How being on ARTs influences attitudes to contraceptive use and where family planning services 
are accessed.  
 How clients expect to be supported by ART services at conception or during a pregnancy 
 
Objective III: Determine the role that HIV treatment and care programs play in the provision of 
family planning services, including client’s expectations of family planning and whether they feel 
their expectations are being addressed. 
 
The third objective was answered through qualitative semi-structured interviews and clinic 
observations to explore: 
 Satisfaction with the availability of the contraceptive method mix and provision amongst women 
accessing the ART programme 
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 The family planning experiences of women that have delivered a child within the ART 
programme (i.e. access to safe conception counselling and information in the clinics, referral 
services, attitudes of health care providers) 
 Facilitators and barriers to optimal family planning for women on ART relating to partner, family 
and community values or service delivery. 
 
Results are presented in three chapters in the sequence that each objective was studied. Chapter 
Four presents’ results of objective one, Chapter Five objective two, and finally, Chapter Six presents 
objective three.  
 
3.2 Candidate’s role in study design and conduct  
Overview 
This section describes the candidate’s role in each phase of this study. Details of the methodology 
can be found in sections 3.3 and 3.4. My role in the conceptualisation of the study is described at the 
beginning of this thesis.  
 
Once the study had been conceptualized and the research questions developed, I conducted a 
sequence of quantitative analyses, and used these results to inform the following qualitative study. I 
began with a preliminary analysis of demographic surveillance data, then designed and constructed 
a unique cohort from a compilation of existing datasets, performed data consistency checks and 
finally selected and applied survival analysis techniques to the cohort. The details of my role are 
presented below.  
 
Role in the quantitative analysis 
Upon arrival to the Africa Centre, I conducted descriptive analysis of crude birth rates in the 
demographic surveillance area to familiarise myself with the data available in the Africa Centre 
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Demographic Information System and to describe general fertility in the setting. A summary of the 
surveillance procedures and the data available are shown in Box 3.2.I. 
 
Box 3.2.I  An overview of demographic surveillance undertaken by the Africa Centre 
x Since 2001 the Africa Centre has annually captured demographic information from a 
defined surveillance area.  
x This surveillance includes 16 ‘core’ questionnaires and 5 additional ‘modules’ 
x ‘Core’ questionnaires capture household and individual information including births, 
deaths and migrations 
x A key informant, usually the head of household, is asked to give consent for 
participation and to respond to core surveillance questions. 
x Additional ‘modules’ include Women’s General Health and HIV surveillance.  
x Core questionnaires and modules are all administered at the household by trained 
fieldworkers.  
x Data capturers then enter information in to separate datasets that are each unique 
to a questionnaire round and compose the ‘Africa Centre Demographic Information 
System’, known as ACDIS.  
 
I used these analyses to inform the design of a unique cohort of HIV positive and HIV negative 
female residents. In April 2010, I submitted a request for data to the Africa Centre data manager to 
access all ‘core’ and three of the five ‘module’ datasets: Women’s General Health, HIV, and 
Household Socio-Economic. I requested every annual dataset since 2001 and later updated this 
request for new surveillance rounds until December 2012.  
 
The 2007 HIV surveillance dataset served as the basis for my unique dataset, to which I first merged 
annual HIV surveillance datasets between 2008 and 2012. Merges were possible by linking 
individuals through a unique identification number and I used this feature to add variables from 
other core and module datasets between 2007 and 2012. Variable selection is described in greater 
detail in section 3.3.6. With each merge I also cleaned the data; duplicate, missing and erroneous 
data were identified through cross-tabulations and resolved through consistency checks with other 
variables. I corrected any errors in the merge coding or discussed discrepancies with data managers 
and removed duplicate records. Once clean, I applied exclusion criteria to prepare this cohort 
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dataset for analysis, as detailed in section 3.3.4. This unique cohort dataset provided the basis of 
three longitudinal analyses.  
 
I received training in techniques for longitudinal analysis during a short course on ‘advanced 
statistical methods in epidemiology’ at the London School of Hygiene and Tropical Medicine. I also 
received consistent informal support from staff and researchers at the Africa Centre to conduct 
complex analysis using STATA 11. The training helped to inform my decision to use Poisson and Cox 
statistical techniques for an open and a closed cohort analysis as presented in Chapter Four. 
 
Role in qualitative study  
To address this study’s qualitative research aims I decided to conduct semi-structured interviews 
with clients and health workers of the local HIV treatment and care programme. I was responsible 
for the design of this study and developed both client and health worker interview protocols. I 
decided a semi-structured tool was most appropriate because I had identified thematic areas of 
interest, but also hoped to capture emerging themes during the interviews. Before piloting, I sought 
and received ethical approval from University College London and the University of KwaZulu-Natal. I 
recruited an isiZulu speaking research assistant (RA) and prepared a training booklet, which I used 
during a week of training. I arranged and attended practice interviews between the RA and 
researchers within the Africa Centre and a later pilot in a local clinic, so that I could provide further 
training and gain an understanding of the contexts of the interviews.  
 
I observed three initial interviews conducted by the RA with clients in the clinics and provided 
feedback on how to improve interview conduct and probing. I waited outside of the room for the 
remaining interviews and arranged an immediate debrief with the research assistant, including a 
review of her field notes. The research assistant transcribed and translated all client interviews, with 
added details and interpretations of local or cultural nuances.  
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I conducted all health workers interviews in English. I piloted the health worker interview tool in a 
local clinic, conducted 12 interviews and made field notes during each interview. I transcribed 
electronic recordings of interviews on an on-going basis and used these results to inform areas that 
needed additional probing. When needed I sought the perspective of my research assistant to 
explain cultural nuances that I did not understand and to check consistency with client interviews. 
Finally, I adapted a tool from Johns Hopkins to conduct standardised observations of family planning 
delivery in each HIV treatment and care facility where interviews were conducted.  
 
I undertook the qualitative analysis of both client and health worker interviews. I first summarised 
data using an excel spreadsheet as interviews were conducted. I later completed a QSR two-day 
course to inform my conduct of a framework analysis using Nvivo software. Details of the qualitative 
methodology are provided in section 3.4 and the discussion from this analysis is provided in 
Chapters Five and Six.  
 
3.3 Quantitative Methodology 
3.3.1 Population  
The Africa Centre Demographic Surveillance Area 
The Africa Centre for Health and Population Studies is situated in the Hlabisa sub-district, in the 
remote uMkhanyakude district of northern KwaZulu-Natal, South Africa. The area is largely rural and 
unemployment in Hlabisa is high (52.6%), with most individuals engaging in household-based 
subsistence. Of these, 60% of households are female headed, reflecting common patterns of male 
migration. Where local employment is available, it is typically in the form of commercial sugar cane 
farms, forestry or tourism. The population is predominantly Black African (99.4%), and isiZulu is the 
most commonly spoken language (94.4%) (STATSSA). 
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The Wellcome Trust established the Africa Centre in 1997/8 with the mission to ‘conduct policy 
relevant health and population research, in an ethical manner, in partnership with the community in 
which it works’. The Africa Centre conducts demographic, epidemiological and evaluative health and 
population research in this setting where the HIV burden is immense. The Africa Centre 
Demographic Information System (ACDIS) is a collection of datasets, each containing information 
gathered by fieldworkers who administer different demographic surveillance questionnaires during 
frequent household visits. ACDIS is explained in more detail in section 3.3.2. The demographic 
surveillance area (DSA) spans a 438km2, including 12,000 households and approximately 90,000 
Zulu-speaking individuals. At any point in time, about a third of these individuals are non-resident 
members of households, and one quarter are women of childbearing age (Tanser et al., 2009).  
 
Residents are defined as ‘a member of a household who normally lives at the same bounded 
structure as the household, whereas a non-resident member does not’ (Herbst et al., 2009). To 
‘normally’ reside in a household, the Africa Centre makes the distinction that residents would ‘have 
spent most of their nights at the bounded structure in the six months since the last round’, while 
non-resident members ‘live elsewhere for most of the time, and whenever they visit the household 
at its bounded structure, they always leave again’. The distinction between resident and non-
resident is made by the fieldworker according to the following three criteria: the opinion of the key 
informant, how much time the person spends at the bounded structure and whether the person has 
recently moved into or out of the bounded structure. Most residencies are clearly defined by the 
presence or absence of an individual in the homestead within the last 6 months and labelled with a 
unique individual identifier ‘IIntID’ in the datasets. 
 
Patterns of migration are frequent in the area and ‘residency’ differs to the concept to household 
membership. Membership reflects the household social structure that changes usually through birth 
or marriage. In this definition, migrant workers may remain a member of a household but may be 
considered a non-resident if living outside of the DSA at that time.   
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Residents of the Centre’s surveillance area are served under the health infrastructure of the Hlabisa-
sub-district, typical of many other rural health districts in KwaZulu-Natal. Hlabisa district hospital 
offers primary health care services, including routine antenatal, prenatal and postnatal care, family 
planning, preventive child health services, treatment for TB, STI’s and non-communicable diseases, 
in-patient care, additional curative and emergency services.  
 
The Hlabisa HIV Treatment and Care Programme (ART programme) 
The Hlabisa HIV Treatment and Care Programme was initiated in 2004 as a joint effort between the 
South African Department of Health and Africa Centre to provide ‘safe, effective, efficient, equitable 
and sustainable ART’ free of charge (Africa Centre for Health and Population Studies). It supports the 
integration of HIV services into PHC, aiming to link treatment and care with prevention services 
(Houlihan et al., 2011).  
 
ART is provided at the 17 local primary health care clinics in the sub-district, staffed with counsellors 
and ART nurses. Six of these clinics and 40% of patients are located within the Centre’s surveillance 
area. One of the six clinics is particularly large and the only clinic to offer 24 hour delivery facilities 
for uncomplicated cases (Houlihan et al., 2011). Figure 3.1 illustrates the distribution of the 17 PHC 
clinics and shows the boundaries of the Africa Centre surveillance area (in yellow) and Hlabisa 
district hospital. 
 
The programme follows the South African DoH guidelines on HIV diagnosis, ART eligibility, screening, 
treatment regimens and follow-up (Houlihan et al., 2011). In 2011, national guidelines on ART 
eligibility were revised and extended to include any HIV infected person with a CD4 <350cells/mm3, 
all pregnant women and anyone with TB irrespective of their CD4 count (WHO, 2010a). Efavirenz 
constitutes standard first line regimen but women that are pregnant, or planning pregnancy, are 
placed on alternatives such as Nevirapine or Lopinavir-ritonavir due to concerns for teratogenicity 
(SADoH, 2007a, SADoH, 2010). Clients are initially followed up at two weeks in order to assess 
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adherence and toxicity and are then seen monthly by a nurse and counsellor. Monthly visits include 
group and individual counselling sessions before collection of treatment.  
 
Guidelines were updated in 2004 and again in 2010 and 2011. 2010 guidelines included all HIV 
positive patients with CD4 <200 cells/mm3 as eligible to start treatment, irrespective of clinical stage 
(SADoH, 2010). People with TB and HIV and pregnant women could start treatment at CD4 <350 
cells/mm3. People with WHO stage 4 or drug resistant TB should start ART irrespective of CD4 count. 
The 2004 guidelines only included adults with clinical stage 4 disease or a CD4+ count <200 cells/mm3 
(SADoH, 2004). The 2011 guidelines increased eligibility to <350cells/mm3 (SADoH, 2011).  
 
The National Health Laboratory Services at the Hlabisa district hospital have provided CD4 and Viral 
Load monitoring for HIV positive individuals for the Department of Health since 2008 and 2009 
respectively. A first positive rapid HIV ELISA is confirmed by a second test; a venous blood ELISA is 
requested if results are discordant. If the first rapid test is negative, repeat testing is recommended 
every 6 months. CD4 and viral load monitoring are performed 6-monthly. CD4 counts are analysed 
using Beckman Coulter EPICS® XL flow cytometer (Beckman Coulter, Inc.); viral loads using Nuclisens 
EasyQ® HIV-1 assay (Biomérieux) with a lower detection limit of 25 copies/ml (Houlihan et al., 2011). 
 
Most people access treatment at their nearest clinic. Reflective of elsewhere in South Africa, ART 
initiation in this setting is more likely in women at a time of pregnancy, individuals older than 25 
years, in patients with low CD4 counts and those engaged in HIV treatment and care prior to 
eligibility (Bärnighausen et al., 2013, Plazy et al., 2014). Incidence of disengagement from care was 
estimated at 3.4 per 100 person years (95% CI 3.1 – 3.8) amongst individuals initiating ART between 
2004 and 2011 (Mutevedzi et al., 2013). 
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3.3.2 Existing Data systems 
The Africa Centre Demographic Information System (ACDIS) 
The Africa Centre Surveillance has collected data on births, deaths, migration, and marriage since 
2000. Trained fieldworkers administer a range of demographic questionnaires to resident and non-
resident members of all households included in the demographic surveillance area.  
 
The initial household surveillance in 2000 involved a complete census of all homesteads (places of 
residence), households (social groups) and individuals, and collected demographic data as well as 
detailed reproductive histories from all women of reproductive age (Tanser et al., 2008). Since then, 
fieldworkers have collected socio-demographic data at six-monthly intervals (every 4 months from 
2012). Responses are recorded from a key household informant, usually the head of the household 
or the most senior member present when fieldworkers visit (Tanser et al., 2008). Key informants 
decide on household membership, and continue to provide information on members of their 
household who live elsewhere (Herbst et al., 2009). Fieldworkers administer 16 ‘core’ questionnaires 
on individuals, households, bounded structures, residencies, conjugal relationships, deaths, 
household residencies, migrations, pregnancies and vaccinations 
 
Fieldworkers also administer five individual ‘module’ questionnaires once a year, in addition to the 
‘core’ questionnaires, including Women’s General Health, Men’s General Health, HIV surveillance, 
Household Socio-Economic status, Illness and Death, and Verbal Autopsies. Depending on the 
module, questions are usually directed to the individual of interest where available rather than a key 
informant. Core and module questionnaires may be administered at different times (rounds), as to 
not overburden the fieldworker and the household.  
 
Data capturers collate and enter the information from each questionnaire round into a 
corresponding dataset, unique to that questionnaire and round. It is these individual datasets that 
constitute the Africa Centre Demographic Information System (ACDIS) (Tanser et al., 2008). Each 
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dataset contains an individual identification number so that individual information may be linked 
from any dataset and any round. Data managers at the Africa Centre link information from the 16 
‘core’ datasets to provide a general ‘Demography’ dataset that is accessible to visiting researchers. 
 
ACDIS is the collective term to describe a suite of 16 ‘core’ demographic datasets, 5 additional 
‘module’ datasets, and the composite ‘Demography’ dataset.  
 
ARTemis: the clinical database 
Clinical ART data is recorded in ARTemis, a large operational database developed and hosted at the 
Africa Centre. ARTemis contains Information on any person that has accessed services for HIV 
testing, CD4 counts and dates of ART initiation and follow up visits. The ARTemis database recorded 
women’s first line regimen but health providers did not always update changes and this information 
was not available for analysis (Colin Newell, personal communication). 
 
By the end of 2009, more than 11,000 patients were on treatment in Hlabisa with approximately 300 
new patients being initiated on treatment every month; by end September 2013 there were over 
28,500 people on ART in the sub-district. In the surveillance area, ART coverage of all HIV infected 
individuals was scaled from zero in 2004 to 31% in 2011, at a time when HIV prevalence increased 
from 21% to 29%, and was attributed to improved survival of people living with HIV on ART (Zaidi et 
al., 2013).  
 
With ethics permission it is possible to link data from the HIV treatment and care database to that of 
the surveillance database, for people that reside in the surveillance area (Plazy et al., 2014) as 
illustrated in Figure 3.1.  
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Figure 3.1: A map of the Hlabisa sub-district, showing coverage by the Africa Centre Demographic Surveillance Area and the HIV treatment and care 
database, ARTemis. The distribution of the 17 PHC clinics and Hlabisa district hospital are marked with red crosses. Coverage of the HIV treatment and care 
programme area, and data captured by ARTemis, is circled in red. The Africa centre demographic surveillance area is circled with a blue line and includes 6 
PHC clinics (excluding Mtubatuba) (Houlihan et al., 2011) 
 
ARTemis:  
 
x 2009: 11,000 people on ART 
x 2013: 28,500 people on ART  
Linkage between  
ARTemis and ACDIS  
 
x 2004: 0% 
x 2011: 31% 
 
ACDIS 
x 12,000 households  
x approx. 90,000 Zulu-speaking 
individuals annually 
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3.3.3 Dataset construction  
 
I created my own unique dataset for the purpose of this thesis. The use of individual woman 
identification numbers made it possible to extract and link information from the Africa Centre 
Demographic Information System (ACDIS) and the clinical database, ARTemis. Initially, I used two 
ACDIS module datasets, the Women’s General Health and HIV surveillance, as the basis of this new 
dataset. Additional ACDIS datasets and clinical ARTemis data linked to this bespoke cohort are 
summarised in Table 3.1.  
 
ACDIS datasets used to define entry to cohort 
Women’s General Health (WGH)  
This questionnaire asks all women questions about self-reported health, sexual partnerships and 
contraceptive use. Since 2000, information has been collected once a year and is entered and stored 
in separate annual WGH datasets. Every year, a new dataset lists women that participated in the 
WGH round, the date of the household visit, and their categorical responses to individual questions. 
Individual data are anonymised and listed according to a unique identification number. With some 
minor modifications to the questionnaire design over time, annual WGH datasets include the same 
variables and woman row structure each year. The unique identification number allows researchers 
to merge these annual WGH datasets, and indeed any core or module dataset, to create a 
longitudinal cohort for follow up and analysis.    
 
HIV surveillance  
Introduced in 2003, HIV surveillance includes approximately 10,000 adults of 15 years or older each 
year (Tanser et al., 2008). The HIV surveillance includes a questionnaire that asks about topics such 
as knowledge of HIV status, awareness of treatment, serious morbidity and health. HIV surveillance 
also asks participants to provide a finger prick blood sample to be tested in the Africa Centre virology 
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laboratory in Durban. Results of individual tests are not given to the participants, who are instead 
encouraged to access the well-functioning HIV treatment and care programme in the area (Houlihan 
et al., 2011). Information about individual HIV status is thus included in the HIV surveillance dataset 
even if individuals are not aware of their own HIV status.  
 
Operational design of HIV surveillance  
Operational changes have been made to the HIV programme's design since 2003 (Reynolds et al., 
2013). For those interviewed adults who wished to access their results, HIV test results were initially 
delivered by trained counsellors at community centres within the DSA (Welz et al., 2007). However, 
consent rates to test for HIV declined from approximately 60% in 2003-2004 to 40% in 2006 (Tanser 
et al., 2008). In response to a decline in consent rates for participation, rapid HIV testing was offered 
during home visits in 2007 in addition to the anonymous finger-prick sample. Fieldworkers made 10 
different requests for consent to partake in HIV testing, and allowed the individual the choice to 
receive results at home, at a counselling clinic or for referral for another test. However, attendance 
at purpose built counselling clinics was low and fieldworkers raised ethical issues of result 
communication and household confidentiality. This approach was replaced with a system of referral 
from HIV surveillance to the local HIV treatment and care programme, whereby individuals that wish 
to have their result may do so through linked, anonymous voluntary HIV testing. The strategy was 
informed by an internal operational review, discussion with the Community Advisory Board 
(Reynolds et al., 2013) and recommendations of the Joint United Nations Programme on HIV/AIDS 
(UNAIDS) and World Health Organization (WHO) Guidelines for Using HIV Testing Technologies in 
Surveillance, first published in 2001 and updated in 2009 (Martin et al., 2001).  
An ethical review process followed in 2010 and described extensive confusion around the purpose of 
HIV testing during surveillance. The HIV programme has since been clear to articulate a difference 
between ‘surveillance’ and ‘testing’, separating the philosophies of population surveillance and 
individual knowledge. Informed consent now explains the purpose of surveillance as to assist the 
community. Language of ‘testing’ shifted towards ‘analysis’ and the collection of bloods specimens 
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expanded to include more biomeasures (Reynolds et al., 2013). Mobile testing services now visit 
households after HIV surveillance has been conducted, to offer voluntary HIV testing and counselling 
as a distinct service under the Department of Health Hlabisa HIV treatment and Care programme. It 
was hoped that the separation would improve participation in the DSA. Further, shorter travel 
distances and the immediacy of access to HIV testing and counselling, without lengthy referrals 
through the Africa Centre, are advantageous to individuals. However, a high frequency of HIV testing 
within the DSA could prevent individuals from participating in the surveillance where they see no 
added benefit.    
 
`
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Table 3.1 A description of data contained in the Africa Centre Demographic Information System 
datasets and the ARTemis database used in this study. Adapted from (Houlihan et al., 2011) and 
http://www.africacentre.ac.za 
 
Africa Centre Demographic Information System (ACDIS) 
Dataset Examples of data collected 
Individual socio-
economic data 
Annually collected information regarding age, sex, membership of household, 
education, employment, receipt of grants. 
HIV surveillance  VCT history, dried blood spot for HIV status determination offered 
Women’s General 
Health 
Pregnancy history, contraceptive use, sexual activity (Women are still 
included if they are resident but they or a key informant refused to answer 
questions that year.) 
Deaths Location of death, description of circumstances, verbal autopsy data 
Pregnancy  Pregnancy outcomes, delivery environment, birth weight 
Demography Composite dataset linking most household and module data to residency for 
all years. Most data manipulation is already done in this composite dataset.    
HIV Treatment and Care database (ARTemis) 
Basic details Age, sex, address, South African ID number, contact details, treatment clinic 
ART record WHO clinical stage, Previous ART and/or PMTCT, ART regimen at initiation, 
changes in ART regimen during treatment 
Laboratory data Baseline and 6-monthly CD4 and HIV viral load, baseline haematology and 
biochemistry 
Clinic visits Receipt of treatment 
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3.3.4 Process of dataset construction  
Women were included in a unique longitudinal dataset if they participated in at least one round of 
Africa Centre HIV surveillance between 2007 and 2012. The 2007 HIV surveillance dataset formed 
the basis, to which subsequent 2008-2012 annual HIV surveillance datasets were then added. This 
process is depicted in Figure 3.2. Exclusion criteria were first applied to each annual HIV surveillance 
dataset. Individuals were excluded if they were:  
x Non-resident  
x Male,  
x Aged under 15 years old or above 49 years old  
x Not included in the Women’s General Health survey that year  
 
Non-residents were excluded because changes in ART use, relationship status and contraceptive use 
are unlikely to be captured as often during surveillance. Men and women aged <15 or >49 years old 
are routinely captured during HIV surveillance but were not of interest to this study. Participation in 
Women’s General Health was required for analysis of sexual and health characteristics. Participation 
and the proportions excluded with each criterion were comparable between annual datasets (Figure 
3.2). Further eligibility criteria were determined by each cohort design and analysis strategy and are 
reported in sections 3.3.9 and 3.3.10. 
 
The modified annual datasets were merged in Stata 11 to create a longitudinal cohort. Socio-
economic and birth data was linked from additional ACDIS datasets and a demographic composite 
dataset. Inconsistencies in the data were checked using cross-tabulations and were removed. 
Duplicate records and records following a gap in participation were also excluded. This latter 
criterion aimed to exclude any women that migrated and could have had an unrecorded pregnancy 
outside the DSA.  
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ARTemis data was linked to 26% of the resident women episodes in this cohort, including women 
that have enrolled on ART and HIV positive ART naïve women in the DSA.  The date of ART initiation 
was recorded in the ARTemis database and used to censor the end of an ‘ART-naive’ episode and the 
beginning of a new ‘ART-exposed’ episode for this time dependant covariate. 
 
Two cohort analyses were conducted using this bespoke dataset. Based on a preliminary analysis of 
the data reported in section 4.1, women were excluded from both cohorts if they reported never 
having sex or refused to answer the question ‘have you ever had sex?’ in the Women’s General 
Health survey. The purpose was to avoid a biased comparison of birth rates between HIV negative 
and HIV positive women in a setting where HIV infection is a strong predictor of sexual intercourse.  
 
Women of unknown HIV status were excluded from the first (open) cohort. The second closed 
cohort excluded entry after 2007/2008 but included women with missing information about HIV 
status. The final number of women and corresponding ‘episodes’ in dataset are presented in figure 
3.2. 
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2008 HIV 
surveillance 
2009 HIV 
surveillance 
2007 HIV 
surveillance 
Figure 3.2 A series of flow diagrams to depict a) the application of exclusion criteria to each annual HIV surveillance dataset and b) the cohort dataset construction process 
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2011 HIV 
surveillance 
2010 HIV 
surveillance 
2012 HIV 
surveillance 
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3.3.5 Description of dataset and woman ‘episodes’  
Women could first enter the unique dataset via 2007 household HIV surveillance and have multiple 
annual records, dependent on participation in subsequent years of HIV surveillance. Each record has 
a start and end date that describes the time a woman is observed. Records were further split to 
allow for time-updated survival analysis of characteristics, such as a change in age category or 
initiation on ART. ‘Episodes’ refers to these woman-specific and time-updated records in the dataset.  
 
The start of a ‘women episode’ is determined by the date of a household visit during HIV 
surveillance. Women-episodes were measured in days until censored by the next annual 
surveillance, or right censoring. Women were included in the unique dataset in later rounds even if 
they did not participate in 2007, or earlier rounds. All women were categorised as HIV positive, HIV 
negative or HIV ‘unknown’ and information was updated with each survey round. A new positive HIV 
diagnosis marked the start of a new episode, with a new start date estimated from the date of sero-
conversion.  
 
Individuals exit the cohort if they migrate or do not participate in the next annual round. Women 
were censored at 365.25 days after first observation if they either refused to participate in next 
annual HIV round or had a 50th birthday during that year and were no longer eligible for analysis. 
Loss to follow up was determined by information in the ‘EndofResidency’ variable taken from the 
Individual residencies dataset. 494 women were dropped due to lack of follow up information after 
migration. A small number of cases (80) could not be linked and were not included. 
 
3.3.6 Quantitative analysis plan 
Outcome measures  
I selected a live birth outcome, and not conception, as the least biased description of the available 
data. A conception outcome would better to compare behaviours leading to a pregnancy. However, 
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bias could be introduced in this analysis because HIV positive women are known to experience more 
adverse pregnancy outcomes than HIV negative women, and this information was likely not well 
captured by surveillance. Analyses that estimate a date of conception from birth data would 
overlook differences in stillbirths, miscarriages and abortions. Inferences would then risk incorrectly 
attributing all variance in rates of ‘conception’ to differences in pre-conception behaviour, without 
accounting for the unknown adverse physiological effects of being HIV positive or taking HIV 
treatment.  
I chose to report the likelihood of live birth because this is an important demographic indicator for 
population growth that captures the effects of ART on both behavioural and physiological 
mechanisms of fertility. Chapter Four presents the results of four demographic surveillance data 
analyses, using different analytical approaches to report either rates or likelihood of live birth. 
I. Annual trends in live birth between 2005 and 2012  
II. Incidence and factors associated with risk of live birth amongst women known to be either 
HIV negative or positive during annual surveillance rounds 2007-2012 (open cohort) 
III. Birth-free survival in a cohort of women including ‘unknown’ HIV status (closed entry in 
2007/2008) 
IV. Incidence and factors associated with contraceptive use 
Analysis one presents crude annual birth rates to women included in the Africa Centre composite 
‘demography’ dataset. It spans Jan 1st, 2005 until Dec 31st, 2012 and excludes women that were not 
resident or aged 15-49 years old. This analysis refers to the United Nations (UN) definition of Crude 
Birth Rates (CBR) and Age-specific Fertility Rate (ASFR) as study outcomes: 
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Analyses two and three report cohort analyses of likelihood of live birth. They report univariate and 
multivariable survival analysis of factors associated with likelihood of live birth.  
The outcome in analysis four is likelihood of contraceptive use. Contraceptive use is measured as a 
binary ‘Yes’ or ‘No’ outcome and compared in a univariate likelihood analysis for a range of 
proximate and distal factors. 
 
Variables for analysis 
A woman’s knowledge of own status and awareness of ART were recorded as self-reported 
categorical variables ‘KnowsHIVStatus’ and ‘UnderstandsBenefitsART’ in HIV surveillance. Also 
Crude Birth Rate:  
“The number of births over a given period divided by the person-years lived by 
the population over that period. It is expressed as number of births per 1,000 
population”.  
- World population prospects glossary. United Nations population division 
 
Age-specific Fertility Rate: 
 “The annual number of births to women of a specified age or age group per 
1,000 women in that age group. Unless otherwise specified, the reference 
period for the age-specific fertility rate is the calendar year”. 
- World Fertility Report 2009 
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recorded in HIV surveillance was ‘HIVResult’, the results of a rapid test administered at the 
household.  
Other covariates were added by linking different questionnaire datasets or selected variables using 
unique woman identifiers in Stata 11 software. Information about contraceptive use, method of 
contraception chosen, self-reported general health, relationship status and co-residency with a 
current partner were added to the unique dataset when annual Women’s General Health 
surveillance datasets were linked. Highest attained level of education was sourced from annual 
individual household socio-economic status datasets. The delivery date of pregnancies, area of 
residence and a woman’s parity were sourced from the Africa Centre composite ‘demography’ 
dataset.  
To retrieve clinical data, I submitted a customised query to the data manager for ARTemis. This 
query returned data from the variables ‘Datelastfollowedup’, ‘DateofDeath’, ‘DateLastART’, 
‘DateFirstART’ and ‘Followed’. It included the most recent CD4 count per woman, measured within 6 
months before or after an episode start date in the unique dataset. Women known to be using ART 
during the cohort period, meaning they had both a date of ART initiation and a date last known to be 
on ART, were recorded as ‘on ART’ in a new variable.  
A description of all variables included in the unique cohort dataset, the source of the variable and 
hypothesis are given in detail in Table 3.2. 
  
 
 
103 
Table 3.2: Description and origin of variables used in each of the four quantitative analysis presented in Chapter 4 
Characteristic Description  Survey question  Survey response Hypothesis/comment Variable in 
unique dataset 
HIV surveillance datasets 
HIV Status HIV status determined by 
testing in annual HIV 
surveillance. Presented as 
‘HIV Result’ in dataset 
N/A N/A HIV positive women will have a lower incidence of live 
birth compared to HIV negative women. 
Categorical  
Negative / 
Positive / 
Unknown 
      
Heard of ART Question about awareness 
of the benefits of using 
antiretroviral therapy to 
health. Presented as 
‘UnderstandsBenefitsART’  
Have you ever heard 
about anti-retroviral 
treatment?  
Yes / No / Refused Women will become increasingly aware of ART after 
2005 and could result in higher birth rates to ‘replace’ 
postponed children.  
Categorical  
Yes / No / 
Unknown 
      
Knowledge of HIV 
status 
Question asking whether 
women know their own 
HIV status from previous 
HIV surveillance or 
alternative testing 
facilities. Presented as 
‘KnowsHIV’ variable. 
 
Do you know your 
status from previous 
testing? 
Yes / No / Refused Knowledge of HIV status may influence desire for 
more children. HIV positive women may wish to limit 
childbearing compared to HIV negative counterparts if 
aware of their HIV diagnosis. While some HIV positive 
women may not be aware of their own status, all 
women on ART are. An association between HIV 
diagnosis and childbearing desires may be confounded 
by perceptions of general health. Use of ART is 
expected to increase self-perceived health and 
therefore intention to continue childbearing. 
Categorical  
Yes / No / 
Unknown 
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Visit date Recorded date of 
household visit. Used to 
calculate two variables for 
date of cohort entry and 
year of entry. 
Year – Month - Day Date An effect of ART on childbearing decision-making may 
be most effectual in the earlier years of roll out, i.e. 
2007 onwards. Unrelated to roll out of ART, rates of 
childbearing are likely to follow national fertility 
decline, or plateau according to a recent reported stall 
in fertility decline.   
Date (Start date) 
and Categorical  
 (Year) 2007, 
2008, 2009, 
2010, 2011, 2012 
 
Women’s General Health datasets 
Relationship 
Status 
Question about current 
marital status, and coded 
from a list of 18 options. 
What is your marital 
status? 
One of 18 possible 
codes corresponding to 
options for civil, 
traditional, 
polygamous marriage, 
divorce, widowed or 
never been married  
 
ART may encourage sexual activity when feeling in 
good health. This is a proxy measure for sexual 
activity, and a mechanism through which ART could 
increase rates of conception. ACDIS collects 
information about more than one current partner at 
a time. This analysis includes information only 
regarding the status that a woman perceives for her 
first or ‘main’ partner. 
 
 
Categorical 
(collated in to six 
levels) Single / 
Casual Partner / 
Regular Partner / 
Engaged or 
Married / 
Divorced, 
Widowed or 
Separated / 
Unknown 
      
Using 
contraception 
Question asking for self-
reported use of 
contraception in that 
annual round of WGH. 
This answer may apply 
before or after the actual 
Skip questions  
1. ‘Have you ever used 
contraceptives?’ Æ   
2. Which method are 
you currently using 
Yes / No / Refused Hlabisa is likely to reflect national trends of 
injectable contraceptive use. Women on ART may 
desire more children and modify their use of 
contraception accordingly. Alternatively, women on 
ART may have increased access to contraception and 
choose to use contraception to preserve their own 
Categorical  
response to the 
second part of the 
skip question: 
 Yes / No / 
Unknown 
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date of conception of a 
live birth event. 
health status. However, there is little evidence so far 
to suggest that women have changed contraceptive 
use in response to the HIV epidemic.  
 
      
Contraceptive 
Method 
Question asking for self-
reported method of 
contraception selected 
from a list of multiple 
options. This question is 
asked only if women 
respond yes to a filter 
question, have you ever 
used contraception.  
Which method are you 
currently using? 
(Tick all that apply) 
None, Male Condom, 
Female Condom, 
Female Sterilisation, 
Male Sterilisation, 
Injections, Pill, Other, 
Refused 
HIV positive women may report more dual 
protection to avoid HIV transmission and pregnancy 
at the same time. Women on ART may follow 
national preferences for injectable methods to 
prevent an unwanted pregnancy. ART-related side 
effects may affect preferences for reasons unrelated 
to childbearing towards barrier methods, which can 
be less user-efficacious and thereby increase rates of 
conception.  
Categorical  
Barrier / Injectable 
/ Dual / Other or 
unknown / No 
method / Use 
unknown 
      
Currently living 
with partner 
Question asking if a 
woman’s most recent 
sexual partner is living 
with her in the same 
bounded structure.  
Skip pattern questions: 
Remembering the last 
time you had sex, what 
was your relationship 
to that partner? Æ  
Are you still in a 
relationship with him 
Æ Where does he 
normally reside? 
With member, not 
with member, don’t 
know, refused 
Women do not commonly co-reside with their 
partner. This may occur before marriage and 
typically after initiation of childbearing.  
Categorical  
Yes / No / 
Unknown 
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Self-reported 
health 
Question asking about a 
woman’s self-reported 
health status, out of three 
categorical choices. 
How would you 
describe your health at 
present? 
Excellent/Very 
good/Good,  
Fair or Poor 
 
Health sits on the hypothesised pathway between 
knowledge of HIV status and childbearing intention. 
Women on ART are more likely to feel improved 
health and those reporting good overall perceived 
health are more likely to desire a child in the future, 
resulting in higher rates of conception.  
Categorical  
Excellent/Very 
good/Good,  
Fair/Poor, 
Unknown  
 
 
Individual notification form dataset 
Date of Birth Date of birth recorded on 
individual notification 
form  
Year – Month - Day Date I would expect to see a stronger association between 
age and fertility than that of HIV status or exposure 
to ART. Women on ART are likely to be older, already 
have children and have reached the desired family 
size. Incidence of live birth will be higher when 
adjusted for age and parity. 
 
Categorical  
15-19 / 20-24 / 25-
29 / 30-34 / 35-39 
/ 40-44 / 45-49 
years old 
 
Household Socio-economic Status datasets 
Education Highest level of education 
attained by women over 
the age of 6 years old 
Skip questions:  
1. Highest grade at 
school Æ  
2. Highest level of 
education completed 
after school  
Grade (code 1-12) or 
never, less than one 
year, don’t know, 
refused Æ  
None, certificate, 
diploma, bachelor’s 
degree, bachelors and 
diploma, masters, 
don’t know, refused. 
Women with higher education attainment are more 
likely to use contraception and reduce rates of 
conception.  Education also influences risk of HIV 
acquisition and access to treatment. 
Categorical  
None / 
Uncompleted / 
Primary / 
Secondary / 
Tertiary / 
Unknown 
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Demography composite dataset 
Parity Number of live children 
at start of episode. A 
sum of answers to four 
questions asking for a 
complete pregnancy 
history using the 
Pregnancy Notification 
Form when women first 
become a member of 
the DSA. 
1. Have you ever given 
birth? 2. Do you have any 
sons /or daughters to 
whom you have given 
birth who are living with 
you? 3. Do you have any 
sons or daughters to 
whom you have given 
birth who are alive but do 
not live with you? 4. Have 
you ever given birth to a 
boy or a girl who has been 
alive but later died? 
Numerical  Primiparous women are more likely to desire to 
continue childbearing, increasing rates of 
conception.  
Parity above one may reflect nearing completion of 
family size and a lower desire for more children, 
reducing rates of conception. Age will influence a 
woman’s current parity and so increased rates will 
been found only at comparable ages. 
Categorical  
0 / 1 / 2 / 3 / 4 / 5 
/ 6+ 
      
Live birth A new birth reported 
captured in the 
Pregnancy Notification 
Form.  
What was the date of birth 
/ did the pregnancy end? 
Date Date at which a live birth occurred (outcome event) Date and binary  
‘event’ variable 
      
Area of residence Area of residence – is 
urban or rural? 
 
Using GPS point location 
and the ACDIS definition: 
Rural is a population 
density below 400 per 
km2, peri-urban means 
over 400 per km2, and 
urban is defined as 
Rural / 
Peri-urban / Urban 
Women living in rural areas of residence are known 
to experience higher rates of fertility.  
Categorical  
Rural / 
Peri-urban / Urban 
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KwaMsane Municipality 
 
ARTemis query 
CD4 count. 
Clinical measure 
of health 
CD4 measured at start of 
episode 
Query for CD4 count 
closest to the specified 
episode start date 
within 6 months. 
Numerical count  Women with poorer physiological health at start of 
observation will experience lower rates of fertility  
Categorical  
<200 / 200-350 / 
350-500  / >500 / 
Unknown 
      
On ART Which women are 
enrolled in Hlabisa HIV 
treatment and care and 
using ART? 
Query for date of 
initiation of ART and 
follow up visits for all 
women in unique 
cohort. 
Query results 
determined when 
women became a ‘Yes’ 
or was lost to follow up 
Women on ART will be more likely to experience a 
live birth compared to ART-naïve HIV positive 
women, between comparable age groups and 
measures of health (CD4 categories or self-reported 
general heath).  
Yes / No 
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3.3.7 The Andersen-Gill model of ordered events 
This multiple event analysis defines live births as ordered events:  a live birth may occur at multiple 
times throughout cohort analysis time but more than one event cannot occur to the same individual 
at the same time (Andersen and Gill, 1982). The Anderson-Gill method assumes that all events are 
equal and counts the number of events k that occur at time t to calculate time to first event and 
time to second event. The risk set is defined as the number of women being observed at time t. Each 
analysis employs the Anderson-Gill method for ordered events to model the hazard that a woman 
experiences a live birth where multiple events are possible. Women-years provided the denominator 
to the hazard of birth at time t, assuming that the woman has remained birth-free until the 
beginning of the time interval. It transpired that there were relatively few sequential birth events to 
the same woman but this format also allowed for changes in HIV status at any time relative to an 
event (Cleaves, 2009).  
A woman is also at risk of changing HIV status at any time, if HIV negative or her status is unknown. 
Each woman may therefore have multiple observations during which time only one event can occur. 
The first observation spans the time from entry in to the study until the time of the event or a 
change in HIV status, and the second observation spans the time from the event/change in HIV 
status until the next event or change in status or until the end of follow up.  
 
3.3.8 Time and time-varying covariates 
Women can be observed from 2007 until 2013 but may not experience a live birth in this time, or 
may be lost to follow up but experience a live birth after exclusion (Kirkwood and Sterne, 2003). 
Data on social and health characteristics at baseline were measured at the date of the first HIV 
surveillance round and at each annual round whilst the woman remained resident in the DSS.  
A change in woman’s: age, relationship status, parity, HIV status, ART use, knowledge of status, self-
reported health, use of contraception, type of contraception used and most recent CD4 counts were 
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all updated at each annual HIV surveillance round. Time-updated analysis allowed women to 
contribute more than one ‘annual episode’ determined by the start date of each annual HIV 
surveillance round: the denominator in this cohort being woman-exposure years while reported as 
either HIV negative or HIV positive. 
Stata allows for co-variate data to be updated over time with a command to specify which variables 
are to be treated as time varying. Following the Anderson-Gill data structure, any change in one of 
the following time-varying covariates will result in a new ‘time zero’ and so the time-updated 
command does not need to be explicitly stated (Cleaves, 2009).  
 
3.3.9 Poisson statistical analysis of incidence and factors associated with risk of live birth 
amongst women known to be HIV negative and positive during annual surveillance rounds 2007-
2012 (open cohort) 
Analysis two presents an open cohort of women of reproductive age participating in surveillance 
years 2007 through to 2012, for a longitudinal analysis of risk of live birth. It explores how HIV-
related factors are associated with birth rates, including knowledge of own HIV status, awareness of 
ART, use of ART and CD4 count measures. Roll out of access to ART began in 2004, and 2007 was 
selected as the first cohort year, as HIV treatment and care approached full scale. Entry to the cohort 
was determined by participation in the HIV and WGH surveillance round that year. This approach has 
its limitations; consent to participate in HIV surveillance is approximately 50% for any single year and 
could risk selection bias (Tanser et al., 2013). Reasons to refuse the HIV surveillance may include, 
already knowing one’s status and fatigue with the DSS, or cultural and stigma barriers to 
participation. If HIV positive women are most likely to refuse then it is possible that the analysis will 
overestimate birth rates. Alternatively, if women of reproductive age are most likely to migrate for 
work then the analysis may underestimate birth rates in the area. While non-participation poses the 
risk that this analysis will not represent the wider community, operational and analytical approaches 
hope to minimise this bias. Household participation has always been high and these factors are 
unlikely to influence a comparison of fertility amongst women known to be HIV positive or HIV 
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negative. Fertility rates are relatively stable in this province and are unlikely to fluctuate greatly 
according to the decision to participate in HIV surveillance. Furthermore, prior studies of HIV 
surveillance have used imputation, modelling and community analysis techniques to show that there 
is little effect of selection bias by participation (Tanser et al., 2013). Finally, this analysis presents 
‘unknown’ responses for transparency about potential differences in non-response according to 
each characteristic, and the possible influence in fertility analysis. This methodology makes no 
assumption that information is missing at random.  
Women could enter this open cohort in any year between 2007 and 2012 and were excluded if: they 
were not a resident, had a HIV status that was ‘unknown’, or were above or below the reproductive 
ages of 15-49 years old during that annual HIV surveillance round. The HIV programme rapidly 
expanded after 2007 and an open cohort captures more women as they enter the DSS on ART, or 
initiate ART in later years, than a closed cohort would. These stringent exclusions result in smaller 
sample sizes but reliable estimates to compare HIV positive or negative women.   
The event in this survival analysis was incident birth. Unadjusted analysis presents crude incidence of 
live birth and tested for significance using the Mantel-Haenszel procedure. Incidence and rate ratios 
of live birth were estimated using Poisson regression, allowing for multiple events to the same 
woman using a robust variance estimator (Kirkwood and Sterne, 2003) and Andersen-Gill 
modification (Cleaves, 2009). Cumulative incidence curves for live birth were estimated using 
Kaplan-Meier estimators. Incidence rates of birth event, including recurrent events, were calculated 
per 100 woman years of follow up with a 95% confidence interval (95% CI). Poisson was chosen as 
the estimation method as the outcome frequency was around 10% (Zou, 2004) and goodness of fit 
tests were used to establish suitability of Poisson compared to negative binomial models.   
Rates included only time as the denominator and each woman contributed to the denominator from 
time of first observation in the open cohort until the end point or until censored. Variables selected 
for multivariable analysis were based on prior hypothesis, according to a review of the literature 
presented in chapter two, and according to the availability of data in ACDIS and ARTemis datasets 
(Houlihan et al., 2011). To identify associated factors of the live birth event, I ran univariable and 
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multivariable Poisson regression models with a manual backward selection method and assuming all 
associations with p values <0.05 as significant. Optimal categories for quantitative variables such as 
age group and CD4 groups were similarly tested using likelihood ratio tests.   
A Wald test was used to adjudicate between different parametric models and to ascertain the 
Poisson assumption of mean-variance equality (Cameron and Trivedi, 1990). A lognormal model was 
selected on the basis that a k value that was not significantly different to zero (p =0.7888) and strong 
evidence that p did not equal 1 (p<0.0001). Due to missing data in some variables, sensitivity 
analyses were also conducted without the inclusion of ‘unknown’ levels for selected variables and 
were included to allow for a wider sample. A Lexis Expansion split of the dataset to create current 
age bands tested the potentially confounding effect of time and age. Rate of live birth did not 
change very rapidly with time and so the Anderson-Gill dataset, with time updated age and year of 
entry, suitably considered the effect of time for multivariable analysis. 
 
3.3.10 Cox Proportional Hazards for statistical analysis of birth-free survival in a cohort of 
woman including ‘unknown’ HIV status (closed entry in 2007/2008) 
The key differences between analysis three compared to analysis two is a closed cohort design, 
including only women that participated in the 2007 and 2008, and the added inclusion of all women 
irrespective of HIV status and including those of ‘unknown’ status. Analysis three compares factors 
associated with annual trends of live birth to women whose HIV status was unknown to the 
surveillance. An intention of this inclusion is to allow inferences of a wider effect of roll out of ART 
on fertility in the Hlabisa area. Exclusion criteria and structure of the dataset was the same as for 
analysis two, with the key exception of the inclusion of women with ‘unknown’ HIV status: women 
were excluded if not resident or aged above or below the reproductive ages of 15-49 years old.  
Entry to the closed cohort was determined on a woman’s participation in the HIV and WGH 
surveillance round in years 2007 and 2008 and women were followed until the end of cohort in 2013 
or exclusion. Women could not enter the cohort after 2008. This closed cohort includes all women 
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that participated in the HIV and Women’s General Health surveillance in the years 2007 and 2008. A 
closed time to event cohort provides a measure of time to live birth from a standardised baseline for 
an appropriate comparison. A Cox proportional hazard model was used for a multivariable analysis 
of risk of live birth. Cox is a semi-parametric model that relies on an assumption that hazards are 
proportional for individuals with different values of the explanatory variables and makes no 
parametric assumptions about the baseline hazard.  
Unlike Poisson, Cox does not assume a constant baseline rate or estimates the changing baseline 
rate over time.  Instead Cox uses a different parameter at each survival time point to model the 
proportional change in the hazard for each of the explanatory variables, while allowing for rates to 
change over time. Cox Proportional Hazard was selected to control for time in survival data and to 
allow rates to change with time since entry to this closed cohort, under an assumption of declining 
fertility since 2008. The proportional hazards assumption was tested and non-proportional for 
women of different HIV status (positive, negative or unknown) and multivariable analysis were then 
stratified according to HIV status.  
 
3.3.11 Estimation of the variance with multiple observations  
Estimates of the variance refer to the estimated standard errors used to produce confidence 
intervals and significance tests in Cox proportional hazards analysis. Live birth events are assumed to 
be independently distributed between women but may not be independently distributed within 
clusters of individual women episodes.  The Huber and White, or sandwich estimator is a robust 
estimator of the standard errors and accounts for possible variation in the distribution of the error 
term. Robust estimation is therefore most appropriate for a valid statistical inference of this dataset 
(StataCorp, 2009).  
Stata 11 uses the vce(robust) command to specify the robust estimator of the variance-covariance 
matrix, corresponding to the parameter estimates. An addition to this command is vce(cluster 
variable), which groups women according to the hypothesis that women episodes are not 
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independent of each other. In this analysis it was not necessary to set the cluster option because the 
id() option was used in the stset commend: when declaring the data to be survival data, the id() 
option informs Stata that these episodes occur to the same woman ID (Cleaves, 2009).  
 
3.3.12 Efron method for handling ties 
Tied events, or multiple live births, occur by chance to different women after the same duration of 
follow up. In this dataset, the mean number of events per failure time is 2.1 births, with a range 
between 1 and 185 births per failure time. The Efron method for handling such tied events is an 
approximation to the exact marginal method, which calculates the conditional probability of tied 
failures. Approximations are commonly used in statistical computer packages for feasibility and 
Efron’s method for handling ties differs in that is adjusts the risk sets using probability weights. It is 
more accurate than other methods of approximation such as Breslow and is specified in Stata’s 
‘stcox’ survival analysis using the ‘efron’ command (Cleves, 2008). 
 
3.3.13 Cox Proportional Hazards of incidence and factors associated with contraceptive use 
The aim of analysis four was to determine whether likelihood of contraceptive use changed in 
response to HIV- or ART-related factors associated with risk of live birth. It tests for associations with 
the likelihood of contraceptive use analysis amongst all women included in the closed cohort 
described in analysis three. This cohort also follows the whole population of women that 
participated in the HIV and Women’s General Health surveillance in the years 2007 and 2008 and 
were followed to a maximum until 2013.The design of this cohort regarding entry, follow up and 
exclusion of women is as presented in analysis three. Unadjusted cox regression was used to test for 
associations between time-updated social and health characteristics and likelihood of contraceptive 
use. The Cox proportional hazards model was selected to account for variation in time sensitive data 
such as HIV status and exposure to ART over the observation period. It does not require knowledge 
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of absolute risk or that a particular probability model be selected to represent survival times, and is 
therefore more robust than parametric methods (Leffondré et al., 2003).  
 
3.3.14 Software for quantitative analysis 
All analysis was performed using the statistical package Stata 11 software for windows (Cleves, 
2008).  
 
3.3.15 Analytical framework of proximal and distal factors associated with rates of live birth to 
women living with HIV and on ART in the Hlabisa sub-district 
The following section describes an analytical framework for the mechanisms through which ART may 
influence proximate determinants of fertility on both behavioural and physiological pathways for 
women living in Hlabisa, KwaZulu-Natal, presented in figure 3.3. 
Based on the existing literature and an established effect of HIV on fertility, I hypothesise that HIV 
positive women are less likely to experience a live birth compared to HIV negative women of a 
similar age in this area. Improved health following initiation and adherence to ART has led to 
reduced mortality and health outcomes in the area (Herbst et al., 2009, Zaidi et al., 2013). In this 
study I consider that reduced mortality, improved physiological ability to carry a child to full term 
and changes in reproductive behaviour associated with use of ART will therefore result in a higher 
likelihood of live birth compared to HIV positive ART naïve women. 
An increase in rates of live birth should be associated with an observed improvement in measures of 
health if this effect is predominantly driven by improved physiological capacity, or women are 
changing behaviours in response to improved health. Research in the area found that ‘self-reported’ 
health was a reliable predictor of actual health and mortality within four years of follow up, when 
adjusted for HIV status and use of ART, in a sample of 9,217 adults (Olgiati et al., 2012).  Further, a 
comparison of older people (50 years or older) in Uganda and South Africa found socio-economic 
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circumstances to be important in shaping perceptions of self-health when HIV positive. Despite 
lower functional ability and higher rates of obesity, hypertension and unemployment, older people 
living with HIV reported greater subjective well-being in South Africa compared to Ugandans when 
adjusted for multiple socio-demographic factors. This unusual finding was attributed to the 
availability of social services for older people in South Africa, such as the pension (Nyirenda et al., 
2013). Consequently, I will draw on two complimentary measures of improved health attributed to 
use of ART for the purposes of this analysis: I included CD4 count as a clinical measure of 
physiological improvement in a woman’s ability to carry a child to term. I also measured self-
perceived improvements in health which has been determined as a reliable indicator of health and 
rests on the casual pathway between improved health and greater pregnancy intentions.  
For there to be any effect of HIV related factors on pregnancy desire and live birth as an associated 
outcome, women must be aware of their own HIV status. By virtue of being on treatment, women 
are aware of their HIV positive status. However, some HIV positive women and HIV negative women 
may be included in the surveillance without seeking the outcome of a HIV test. Hence some of these 
women will be unaware of their status and so ‘Knowledge of HIV status’ acts as a determinant of 
whether women are on ART and may also act upstream on the causal pathway to an effect of ART on 
pregnancy intention or contraceptive use.  
Contraceptive use is a proximate determinant of fertility that can be modified by distal factors 
influencing a woman’s childbearing intention. Generally it is unclear what advice HIV infected 
women receive on use of contraception or approaches to safe conception. If use of ART was 
associated with a change in desire for childbearing, I would only expect to see a related change in 
contraceptive behaviour where women are able to access family planning services. Any observed 
changes in rates of live birth, as attributed to a greater ability to access contraception through HIV 
treatment and care, are likely to be delayed by time taken to utilise contraception and for this extra 
contraceptive use to prevent births at a minimum of 9 months later. Thus a behavioural effect of 
access to contraception through HIV treatment and care on general rates of live birth would likely be 
observed as a delayed decline in rates of live birth sometime after ART initiation. This lag effect has 
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not been widely captured by other shorter-term studies and a benefit of this study is the ability to 
assess the long-term risk of live birth amongst women on ART.   
Alternatively, access to the HIV treatment and care programme could encourage initiation or 
continuation of contraceptive use unrelated to pregnancy intentions. In this situation, we could 
observe a decrease in rates of live birth amongst women on ART if family planning services have 
encouraged a change in contraceptive behaviour. A switch to less efficacious methods could 
alternatively result in higher rates of pregnancy amongst women on ART. 
Use of contraception can be associated with other factors such as a partner’s attitudes to 
contraceptive use and a wish to protect her self-perceived health. It is possible that these factors 
may change with ART initiation. I am unable to adjust for partner attitudes to contraception as data 
are not available but will include relationship status and self-perceived health as a measure of 
motivation for contraceptive use. 
Age and parity are typical predictors of birth spacing and associated with woman’s pregnancy 
intentions independent to a change in HIV status or initiation of ART. It is important to adjust for age 
and parity in an analysis of HIV negative, positive but ART-naive and HIV positive women on-ART as 
women on ART are likely to be of higher median age and at a further stage in their reproductive 
lives. As age and parity are associated with the likelihood that a woman will be on ART and also the 
outcome, a live birth, these factors will be included as a confounder of possible lower rates of live 
birth amongst women on ART. However, women in South Africa are thought to use postponement 
strategies for family building and long birth intervals that are largely independent of age and parity, 
so the overall effect may be small in this instance.  
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Figure 3.3: Analytical Framework of HIV, proximal and distal factors associated with rates of live 
birth in the Hlabisa sub-district 
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3.4 Qualitative aims and methodology 
3.4.1 Semi-structured interviews with clients and healthcare providers  
Qualitative interviews are commonly used to evaluate experiences and expectations of people 
within a program. This methodology allows for a detailed exploration of a client’s experience of 
family planning service delivery related to the HIV treatment programme and health provider’s 
attitudes and opinions on family planning. It is an appropriate method to explore perspectives and 
behaviour related to contraceptive use when on ART, and to explore how women are supported in 
their decisions to continue childbearing within the programme, considering cultural, community and 
service delivery factors. The aim was to achieve deep experience-orientated data that is 
informationally representative of different family planning clients and needs.  
Limitations of this method include the risk of courtesy bias, in which women do not wish to speak 
badly of the program they are currently accessing. To address this issue, participants were assured of 
the confidential nature of the study and importance of their own perspectives.  As per the nature of 
qualitative research, the results will intend to provide a deeper understanding of client family 
planning experiences within the Hlabisa HIV treatment and care programme. While the quantitative 
component of this thesis may strive to be generalizable, this is not usually the aim of qualitative 
research. The qualitative findings presented in this thesis are descriptive of the women resident to 
Hlabisa. As the researcher, I have aimed to describe the context of this setting in which women are 
making their childbearing decisions and the assumptions and methods of this study design in order 
to enhance the trustworthiness of this qualitative work (Krefting, 1991). Finally, design of the study 
was informed by limiting factors such as time and cost, in order to mitigate against the time-
intensive requirements of transcription, translation and analysis activities.  
Interviews with female clients were conducted at the clinic in order to limit transportation costs. A 
resulting constraint is the exclusion of male partners or HIV negative women not attending the clinic. 
I prioritised interviews with healthworker’s for their important perspective in this case study of the 
HIV treatment and care programme, which allowed time to train a research assistant and for 
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iterative feedback on interviews and transcription quality and preliminary analysis. This design 
prevented any compromise on data quality and process. The results are not intended for a 
comparison with ART naive women, or to comprehensively explain the household dynamics of 
childbearing. Rather, the constraint described here is that results are confined to a programmatic 
setting.   
 
3.4.2 Eligibility of ART clients 
Inclusion criteria for participation in this study were determined by the age criteria also used in my 
quantitative analysis, and to allow a reasonable duration of participation within the ART programme. 
The minimum age for inclusion was set at 18 years old, as opposed to 15 years old per the 
quantitative analysis. This is because girls aged between 15 and 18 years of age require permission 
from a legal guardian to participate, this would be sensitive given the nature of the discussions; 
including this age group was deemed unnecessary to meet the objectives of this study. Additionally, 
women must have been enrolled within the ART programme for a minimum of one year so that 
interviews are informationally representative to this study (Sandelowski 1995).  
 
3.4.3 Sample size and sampling methods for ART clients 
A total of 23 interviews were conducted with HIV positive women attending an HIV clinic in the  
demographic surveillance area. The planned sample size of 24 was not achieved due to time 
limitations and because responses had achieved saturation, meaning no new themes emerged in 
later interviews. The initial sample size was determined through a purposeful sampling strategy to 
achieve both demographic and phenomenal variation in relation to family planning experiences 
amongst women by age and reproductive history.  The sample was stratified according to a woman’s 
pregnancy experience in the programme. Half the sample had experienced a pregnancy within the 
programme since 2008 (12 women), and half of the women had never had a pregnancy within the 
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programme (12 women).  Views on the optimal purposeful sample size in are mixed, but samples of 
12 were generally regarded as sufficient to achieve maximal data codes and saturation in analysis 
while maintaining feasibility (Guest, Bunce et al. 2006). Results from my quantitative analysis 
indicated that the likelihood of experiencing a live birth differs by age. Consequently, women were 
selected for inclusion according to reproductive age groups of; 15-24, 25-34 and 35-49 years old.  
A total of 4 interviews with women of each age group resulted in a total of 12 interviews per 
reproductive history strata as illustrated in Table 3.3.  
Table 3.3: Stratification of study sample for client interviews 
Age 
Group 
Reproductive experience in ART programme 
Never experienced a 
pregnancy within the ART 
programme 
Experienced a pregnancy 
in the ART programme 
since 2008 
18-24 4 3 
25-34 4 4 
35-49 4 4 
 
3.4.4 Eligibility and sampling of health providers 
Interviews with 12 health care providers were conducted by the researcher, in English, to seek their 
perspectives on the role of FP for women on ART in the HIV care and treatment programme, and 
missed opportunities to provide comprehensive SRH and HIV services in the primary health care 
clinic. 
Participants were purposively sampled to include an equal mix of both ART nurses and HIV 
Counselling and Testing Counsellors, as these are key roles for the delivery of family planning 
services and counselling. No demographic criteria were used to select participants as the aim is 
simply to obtain views of health care workers providing HIV treatment and care.  
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3.4.5 Sample area 
Women accessing HIV care and treatment in the Hlabisa district may do so at one of 6 primary 
health care clinics within the Africa Centre Demographic Surveillance Area.  Prior analysis of the 
ACDIS data indicates that clients are most likely to choose their clinic based on closest proximity. The 
primary health care clinics within the Hlabisa sub-district show significant variability on several 
indicators of ART treatment and PMTCT service delivery. The following table demonstrates the 
variation in patient load determined by the number of clients attending the HIV services to pick up 
their medication in a single month. 
Table 3.4: Number of clients receiving ART at each clinic within the Africa Centre DSS as an indicator 
of clinic size 
Clinic Clients receiving medications (Nov-11) 
1 107 
2 251 
3 2,018 
4 253 
5 535 
6 759 
 
Clinics were situated in either urban, rural or peri-urban locations and can differ in proximity to main 
roads, size of clinic, typical patient load and health professionals available for SRH and HIV services. 
It is anticipated that the number of ART nurses and other characteristics such as size of the clinic 
could influence the provision and uptake of family planning. 
For feasibility for this study, a purposeful sampling approach was used to identify 4 out of the total 6 
clinics for inclusion in this study. Clinics were included if located within the DSA borders to limit 
additional costs of travelling and purposively sampled to include a variation of areas (i.e. peri-urban, 
rural), size and location within this region. However, due to poor recruitment at one clinic and a 
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limited timeframe, sampling was later opened to a fifth clinic within the DSA. An equal sample of 
clients and health care providers were obtained from each clinic (Table 3.5).  
 
Table 3.5 Number of client and health worker interviews per clinic 
 Sampled Clinics  
Clinic 1 Clinic 2 Clinic 3 Clinic 4 Clinic 5 
ART Clients 6 3 6 4 4 
ART nurses 1 2 1 1 1 
HCT counsellors  1 2 1 1 1 
 
3.4.6 Themes of client interviews 
Section one of the semi-structured interview schedule investigates how use of ART affects factors 
relating to childbearing by exploring their current childbearing desires, followed by a series of probes 
based on the answers (figure 3.4). Follow up questions explored participants perceptions of how 
initiation on ART has affected their views on childbearing, partner desires and the attitudes of family 
and friends in their decision.  
Section two consists of six questions on current and previous contraceptive use, awareness of 
methods, self-perceived effects of concurrent use of treatment and contraception and partner 
attitudes to contraceptive use. The third and final section explores participants’ experiences of 
accessing contraceptive and family planning services on ART. It asks where women typically seek 
family planning and if this has changed with initiation of ART, what family planning information they 
have received at the clinic and participant attitudes to delivery of family planning education and 
counselling for women on ART. Women that have experienced a pregnancy in the ART programme 
prior to interview were further asked about their experiences and expectations of counselling for 
safer conception within the HIV treatment and care programme. The full interview schedules can be 
found in appendix B and C. 
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Figure 3.4: Interview questions to explore childbearing desires 
 
 
 
 
3.4.7 Themes of healthcare provider interviews  
Semi-structured interviews with health care providers probe perspectives on service provision and 
integration of family planning within the HIV treatment and care programme. A series of questions 
explore service provider perspectives on: prioritisation and delivery of family planning to women on 
ART, the IntraUterine Contraceptive Device (IUCD) and Emergency Contraception (EC), which are 
considered underutilised methods in a review of the literature, and the availability of pre-conception 
counselling and pregnancy planning. Interviews concluded by asking about alternative sources of 
family planning and perceived barriers to family planning in the programme. The full interview 
schedule can be found in appendix D. 
 
Would you like to have more children now or in the future? 
(Exploring treatment, health and all other reasons why) 
 
[Yes] 
When would you like to have your next child? Why that time? 
Do you think you will actually have more children/children at this 
time? 
What things do you think will decide when you have another child? 
 
[No] 
Can you tell me what made you decide this? 
How do you feel about this? 
 
[Unsure] 
What things do you think will decide when you have another child? 
How do you feel about this? 
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3.4.8 Conduct of interviews with clients 
The study was explained to staff from the selected clinics and I sought advice on the best way to 
approach women for participation. Strategies involved asking a nurse to introduce women to the 
Research Assistant (RA) or the RA directly approached women in the waiting area between 
counselling and treatment visits. The characteristics of each respondent were recorded on a log 
sheet to ensure the required sample and strata were obtained. The study was explained to 
participants with the help of an information sheet before written consent was obtained.  
The client interview topic guide and information sheets were translated into isiZulu by a research 
assistant and checked for consistency by another isiZulu speaking researcher. Interviews took place 
on site in a private room within the clinic with an isiZulu-speaking research assistant trained on the 
use of the topic guide, and on when and how to refer women to appropriate services where 
available. Interview tools were pre-tested with two clients in a nearby clinic and refined as required. 
Interviews lasted between 30-45 minutes and electronic recording devices were used, and field 
notes were taken, upon permission of the participant. Both oral and written records were 
transported back to the Africa Centre on the same day of the interview and backed up on multiple 
hard drives. All files are anonymised and labelled by a unique identification. 
 
3.4.9 Conduct of interviews with healthcare providers  
For convenience, individual participants were nominated by a program manager and invited by the 
researcher to participate in advance of the interview. A convenient date was arranged with service 
providers to minimise disruption to their work. Health workers were provided with refreshments as 
a courtesy for their time. Healthcare provider interviews were also conducted on site at the sampled 
clinic by the researcher in English, as the standard language used in training workshops and that of 
the researcher. Interviews lasted approximately 1 hour. Electronic recordings were taken and 
consent obtained from the participants with the use of information sheets and a consent form. 
Electronic recordings were made and labelled by clinic, date and a code for type of health provider 
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(ART nurse or HCT counsellor and the number of this interview). Field notes were also taken in the 
course of the interview and returned to the Africa centre and filed for storage using the same code.  
 
3.4.10 Transcription and translation  
The same research assistant that conducted the interviews also transcribed client interviews in 
isiZulu, using audio files in Sony Digital Voice Editor V3.3. Data from the electronic recorder was 
transcribed with comparisons to hand written notes to fill inaudible phrases or gaps in the recording.  
The same research assistant translated interviews into English, and early samples of transcripts were 
checked for accurate translation by another isiZulu speaking researcher. The research assistant was 
asked to provide annotations for the researcher to explain nuances or slang terms for the purpose of 
analysis. Interviews were transcribed and translated on an on-going basis during the data collection 
period. Regular meetings between researcher and the assistants allowed for iterative feedback and 
tailored approaches to probing women on questions such as new concepts like the Intra Uterine 
Contraceptive Device. Health provider interviews were transcribed by the researcher from English 
also using audio files in Sony Digital Voice Editor V3.3 and with reference to field notes made during 
the study.  
 
3.4.11 Methods for framework analysis  
Transcripts were systematically coded with input from field notes to provide contextualised data on 
aspects such as the flow and context, and a preliminary content analysis was performed manually 
using Microsoft word during data collection (Seale 2004). During this initial stage, interviews were 
read and re-read to familiarise myself with the data.  
Framework analysis was performed once data collection was complete. Framework analysis is 
commonly used in policy relevant research where time-scales are often short and starts with a 
deductive approach whereby objectives are often set in advance (Ritchie and Spencer, 2002) and is 
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therefore well suited to the aims of this study. Analytical methods for framework analysis tend to be 
more explicit than other qualitative methods and I followed the five stages of framework data 
analysis illustrated in Figure 3.5 (Pope et al., 2000). Client and Health worker interviews were semi-
structured and the pre-determined themes were used initially to identify a framework as per stage 
two, to which emergent themes were later added. Nvivo 10 software was used to categorise and 
store quotes that represented common and emergent themes (Bender and Ewbank 1994). 
Interviews were originally indexed by hand, during the process of data collection, and then via Nvivo 
once all the data had been collected and entered. Nvivo software was used to display matrices of 
coded data according to pre-determined themes and emergent themes, which I then summarised. 
Data reliability was established through group comparisons of themes to test that similar responses 
have been given. Key themes that explain childbearing desires to women on ART were interpreted 
and discussed in Chapter Five, while factors influencing attitudes to contraception on ART were 
mapped and later explained through a Health Belief Model for contraceptive use, presented in 
Chapter Six (Ulin et al., 2004).  
This method allows a focus on the whole dataset rather than an individual interview and places the 
emphasis on the individual’s experience rather than constructing abstract concepts and theory, as 
with grounded theory analysis (Corbin and Strauss 1990). It enabled identification of unexpected 
themes grounded in the data once most of the data had been collected (Seale 2004).  
 
 
 
 
 
 
 
  
 
 
128 
Figure 3.5: Five stages of data analysis in the framework approach (Pope, et al. 2000) 
  
 
3.4.12 Checklist of communication materials and counselling activities in the HIV treatment and 
care clinic 
 Observations on the availability of communication materials counselling and contraception methods 
at the service delivery point were made at each of the clinics in which the interviews are conducted. 
Information, education and communication materials are an important component of primary 
health care and reproductive health specifically (WHO 2001), and have been used as a process 
1.  Familiarisation—immersion in the raw data (or typically a pragmatic 
selection from the data) by listening to tapes, reading transcripts, 
studying notes and so on, in order to list key ideas and recurrent 
themes 
2. Identifying a thematic framework—identifying all the key issues, 
concepts, and themes by which the data can be examined and 
referenced.  
3. Indexing—applying the thematic framework or index systematically to 
all the data in textual form by annotating the transcripts with 
numerical codes from the index, usually supported by short text 
descriptors to elaborate the index heading.  
4. Charting—rearranging the data according to the appropriate part of 
the thematic framework to which they relate, and forming charts. The 
charts contain distilled summaries of views and experiences.  
5. Mapping and interpretation—using the charts to define concepts, map 
the range and nature of phenomena, create typologies and find 
associations between themes with a view to providing explanations 
for the findings. 
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outcome indicator for integrated HIV and SRH services at primary health care facilities (WHO 2009). 
The quality of IEC materials on family planning topics for PLHIV accessing HIV treatment, including 
aspects of safe conception and health concerns for those on ART has not been explored in the area 
of Kwazulu-Natal. 
Each of the clinics sampled for client interviews were assessed using a checklist for the availability of 
contraception and communication materials. Specific indicators were based upon a search of the 
literature of tools used to assess communication materials in line with national policy standards for 
comprehensive primary health care. The tool used was adapted from a Johns Hopkins observation 
tool and the International Planned Parenthood Federation (IPPF) rapid assessment tool for service 
integration (see appendix E) to formulate a checklist of responses on the following indicators of 
service availability: 
 Contraceptive Methods available 
 Frequency of availability at study site 
 IEC materials available 
 Group talks/counselling 
 Materials used in talks 
 Format of talks 
 Topics in counselling (pre-planning for safe conception) 
 
Where observation was not possible a health care professional was asked to provide guidance on 
the frequency and availability of services. These indicators were tallied and presented in tables as 
descriptive data. The complete tool can be found in appendix D.  
 
3.4.13 Ethics 
The study aim and research tools were presented to the Community Advisory Board at Africa Centre 
to discuss any cultural and ethical considerations. Ethical approval and annual recertification for this 
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study has been granted by the Research Ethics Committee of the Nelson R. Mandela School of 
Medicine, University of Natal (Ref: BE231/12) and the UCL Research Ethics Committee (ethics 
application 4032/001) (Appendix F). The right to stop the interview or not answer questions was 
clearly explained to women during the consent process, but all were able to continue the interview 
until completion. 
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Chapter Four  
Live births by HIV status and ART exposure among women resident 
in the Africa Centre Surveillance area between 2005 and 2012 
4.1 Annual trends in live birth between 2005 and 2012  
4.1.1 Description of women included in annual 2005-2012 surveillance rounds 
The annual mid-year population of resident women of reproductive age was 25,143 women and this 
varied little by year. Annually, only 3-6% of these women answered yes to being married. Low 
marital rates are in accordance with the literature and pregnancy remains common outside of 
marriage (Swartz 2009).Further, the high non-response rate for this question suggests that the 
variable has limited value to this analysis.  
Information about marital status comes from the Women’s General Health survey, in answer to the 
question ‘what is your marital status?’ (Figure 4.1.) This question may be answered by the head of 
the household rather than the individual themselves but was not answered for the majority of 
women (71.35%). A higher proportion of women responded to the question ‘have you ever had sex’ 
(Figure 4.2).  
Amongst respondents to the question about marriage, more women reported being married or 
widowed in older ages (Figure 4.3). Rates of marriage peaked amongst women aged 45 – 49 years 
old at 15%. Reported rates of divorce were consistently lower than 0.2% and on average 3.41% of 
women were engaged at any time. 
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Table 4.1: Marital, sexual and HIV characteristics of women included in annual 2005-2012 surveillance rounds 
Year Mid-year population 
Number of married 
women 
Number of women that have made 
sexual debut 
Number of women with a known HIV 
positive status from HIV surveillance 
2005 24,253 1,513 (6%) 6,509 (27%) 1,951 (8%) 
2006 24,640 1,286 (5%) 8,243 (33%) 2,221 (9%) 
2007 25,103 885 (4%) 8,869 (35%) 2,452 (10%) 
2008 25,071 651 (3%) 9,127 (36%) 2,706 (11%) 
2009 25,788 849 (3%) 9,320 (36%) 2,883 (11%) 
2010 26,029 745 (3%) 8,406 (32%) 3,023 (12%) 
2011 25,323 805 (3%) 8,794 (35%) 3,442 (14%) 
2012 24,933 792 (3%) 8,895 (36%) 3,386 (14%) 
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Figure 4.1: Annual WGH survey question asking about marital status 
 
 
Figure 4.2: Annual WGH survey question asking about sexual debut 
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This question provided a more useful restriction, to adjust for possible variation in sexual activity 
between HIV positive and HIV negative women. A limitation of this approach is that it does exclude a 
higher proportion of women from younger age groups, as can be seen in a comparison of Figures 4.3 
and 4.4. 
Figure 4.3 Proportion of responses to question about marital status amongst resident women 
between 2005-2012, by age group  
 
Age 
Group Married Divorced 
Never been 
married Engaged Widowed Unknown 
15-19 9 <0.1% 2 <0.1% 14,013 30% 545 1% 0 <0. 1% 32,867 70% 
20-24 113 0.3% 1 <0.1% 7,974 24% 984 3% 4 <0. 1% 24,004 73% 
25-29 383 2% 0 <0.1% 4,472 18% 1,036 4% 13 <0. 1% 18,614 76% 
30-34 946 5% 8 <0.1% 2,734 15% 1,050 6% 49 0.3% 13,908 75% 
35-39 1,620 11% 11 <0.1% 1,900 12% 820 5% 195 1% 10,921 71% 
40-44 1,898 14% 28 0.2% 1,402 10% 665 5% 375 3% 9,327 68% 
45-49 2,043 15% 23 0.2% 1,187 9% 576 4% 543 4% 8,971 67% 
  
 
0%
10%
20%
30%
40%
50%
60%
70%
80%
15-19 20-24 25-29 30-34 35-39 40-44 45-49
%
 
Age Group 
Married
Divorced
Never Been married
Engaged
Widowed
Unknown
  
 
 
135 
Figure 4.4 Proportion of responses to the question ‘Have you ever had sex?’ by age group 
 
Age Group Never had sex Has had sex Unknown 
15-19 8,363 17.63% 7,909 16.67% 31,164 65.70% 
20-24 837 2.53% 16,526 49.96% 15,717 47.51% 
25-29 127 0.52% 13,238 53.99% 11,153 45.49% 
30-34 48 0.26% 10,228 54.71% 8,419 45.03% 
35-39 19 0.12% 9,231 59.68% 6,217 40.20% 
40-44 9 0.07% 8,802 64.27% 4,884 35.66% 
45-49 8 0.06% 8,805 65.99% 4,530 33.95% 
 
 
4.1.2 Decline in Crude Birth Rates between 2005-2012 
The number of live births that occurred each calendar year was divided by the total woman-years of 
residency observed amongst women of reproductive age in order to calculate annualised crude 
fertility rates.  
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Crude rates of live birth have declined annually in this setting, before adjusting for variation in sexual 
activity or marital status. A small stall in fertility decline is apparent between the years of 2009 and 
2011 (Table 4.2). And this finding supports other studies that also determined a brief stall in fertility 
decline and a recent return to decline (Moultrie et al., 2008b).  
In an analysis restricted to women that answered yes to the question ‘Have you ever had sex?’, rates 
were approximately half those calculated for all resident women and a stall in decline was observed 
between the years 2010 and 2011 only (Figure 4.5).  
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Figure 4.5: Crude annual birth rates to  all resident women and resident women that responded ‘yes’ 
to ever had sex 
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Table 4.2: Number of live births amongst resident women of reproductive age between 2005 and 2012 
Calendar  Year Number of live births Woman years observed Births/1000 women-years 
All resident women of reproductive age 
2005 1,851 17,240.91 272 
2006 1,829 17,373.30 204 
2007 1,857 17,872.39 191 
2008 1,817 17,966.31 182 
2009 1,704 18,154.78 166 
2010 1,644 18,034.62 175 
2011 1,585 17,890.77 163 
2012 1,317 17,284.98 132 
Restricted to women that have ever had sex 
2005 884 6,496.36 136 
2006 1022 8,295.61 123 
2007 1108 8,907.33 124 
2008 1081 9,178.31 118 
2009 984 9,346.38 105 
2010 800 8,426.72 95 
2011 852 8,810.32 97 
2012 764 8,935.62 86 
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A stall in CBR decline began in 2009 amongst women tested as HIV positive during annual HIV 
surveillance rounds. This is a slightly earlier transition when compared to HIV negative women 
episodes, which started in 2010. A decline in CBR followed a steeper gradient amongst HIV positive 
women between 2005 and 2012 (m=-5.73, R2=0.913) compared to women that were HIV negative at 
that time (m= -2.97, R2=0.398).  Women whose HIV status was unknown to the surveillance followed 
the same pattern of fertility decline and stall as HIV positive women and declined at the steepest 
rate between 2005 and 2012 (m=-7.11, R2=0.984) (Figure 4.6)  
Figure 4.6 Crude Birth Rates between 2005 and 2012 to all women by HIV status as known to ACDIS  
 
Year Crude rates of live birth per 1000 woman-years 
HIV Negative HIV Positive HIV unknown  
2005 148 113 132 
2006 137 106 118 
2007 153 99 112 
2008 141 100 109 
2009 136 80 99 
2010 115 83 91 
2011 135 82 87 
2012 131 71 79 
(HIV Status determined from the HIV surveillance only) 
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4.1.3 Age-Specific Fertility Rates: 2005-2012 
Age-specific fertility rates were calculated from the number of live births divided by the total 
number of years women were observed to belong to five-year age bands: 15-19, 20-24, 25-29, 30-
34, 35-39, 40-44 and 45-49 years old. The denominator, woman-years, is the sum of the number of 
days that each woman was observed to be resident in the surveillance area within a specific age 
group. Trends demonstrate the typical ASFR pattern. Rates peak amongst women aged 20-24 years 
old and declined with increasing age, before adjusting for sexual activity. 
Figure 4.7 Age-Specific rates of live birth to all women aged 15-19 years 
 
Age Group Live births Woman years at risk Rate per 1000 
woman years 
15-19yr 3,349 36101.89 93 
20-24yr 4,388 27899.30 157 
25-29yr 2,678 21208.55 126 
30-34yr 1,803 16690.62 108 
35-39yr 1,027 14368.89 71 
40-44yr 314 12883.36 24 
45-49yr 45 12665.45 4 
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Patterns of age-specific fertility rates were very similar to the general population of resident women 
who had entered their sexual debut (figure 4.8), except for an apparent inflated rate amongst 
women aged 15-19 years old, which may be due to the exclusion of sexually inactive women that 
would otherwise comprise the majority of this age group. Analysis restricted to entry of sexual debut 
allows for an appropriate comparison between HIV negative and positive women.  
 
Figure 4.8 Age-specific rates of live birth to all women aged 15-49 years between 2005 and 2012 
when limited to only women that had entered their sexual debut 
 
Age Group Live Births Woman years at risk Rate per 1000 woman years 
15-19yr 1412 6118.26 231 
20-24yr 2484 14450.63 172 
25-29yr 1597 12184.05 131 
30-34yr 1096 9634.20 114 
35-39yr 645 8896.91 72 
40-44yr 226 8536.22 26 
45-49yr 35 8576.38 4 
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ASFRs presented by calendar year illustrate a general trend of fertility decline amongst women of all 
ages since 2005. Annualised rates of live birth fluctuated more amongst adolescent women aged 15-
19 years old in the years of 2009 to 2011. Fertility decline was more consistent for older age groups. 
 
Figure 4.9: Crude live birth rates according to age group by calendar year 
 
 
 
4.1.4 Decline in age-adjusted rates of live birth between 2005 and 2012 by HIV Status 
Patterns of annual ASFRs were similar amongst women of different HIV status but were consistently 
lower for HIV positive women per corresponding age.  Rates declined over calendar time amongst all 
age and HIV status groupings although there were exceptions to these trends amongst women aged 
20-24 and 35-39 years old.  
Live birth rates amongst HIV positive women aged 35-39 years old increased consistently between 
2006 and 2011 from 40 births/1000 women to 73 births/1000 women. This was against the crude 
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overall trend for declining birth rates and the only age/HIV group to show a constant increase in 
birth rates over time. In contrast, rates amongst HIV negative women of the same age group were 
consistently higher and dipped briefly in 2008 to 91.7 births per 1000 women before returning to 
134.2 and 125.4 births/1000 women in 2009 and 2010 respectively.   
Fertility decline appears to be more consistent amongst HIV negative women in the most fertile age 
group of 20-24 years old. ASFR declined constantly amongst HIV negative 20-24 year olds from 230 
births/1000 women in 2008 to 164 births/1000 women in 2012. In comparison, HIV positive women 
of the same age experienced a shorter and earlier decline from 197 births/1000 women in 2006 to 
108 births/1000 in 2009, followed by a stall in ASFR decline between years 2009 to 2012. 
This analysis determined a bimodal peak of ASFRs amongst HIV negative women only. The first peak 
in live birth rates occurred amongst 15-19 years old or 20-24 years old and then a second peak at 
either 25-29 or 30-34 years old, occurring in the years 2005, 2007, 2009, 2010 and 2012.  
In contrast, ASFRs peaked only once amongst women living with HIV. A corresponding second peak 
within the ages 29-35 years old was absent amongst HIV positive women and women whose HIV 
status was unknown to the surveillance, with one exception in 2007 amongst women aged 30-34 
years old.  
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Figure 4.10 Age-specific fertility between 2005 and 2012, disaggregated by HIV status 
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Table 4.3 Crude birth-rate by HIV Status, calendar year and age group between 2005 and 2012 
Year Annual ASFR by HIV status 
15-19yr 20-24yr 25-29yr 30-34yr 35-39yr 40-44yr 45-49yr 
HIV negative women episodes 
2005 243.62 274.28 161.81 168.43 110.73 45.60 3.68 
2006 266.30 193.07 196.79 174.37 105.28 49.24 1.64 
2007 300.72 221.60 184.63 205.29 122.30 42.49 9.79 
2008 296.54 230.49 164.07 139.59 91.74 23.08 12.14 
2009 221.65 221.58 151.84 195.55 134.24 35.94 0.00 
2010 195.71 210.46 168.74 97.42 125.36 32.12 6.50 
2011 290.62 206.75 160.53 136.80 90.31 43.47 0.00 
2012 266.57 170.62 154.30 175.08 91.45 25.86 0.00 
HIV positive women episodes 
2005 278.99 190.76 122.49 95.05 63.42 31.13 0.00 
2006 191.21 196.55 148.77 97.26 39.66 8.56 11.44 
2007 186.72 144.83 133.74 131.65 45.68 26.09 0.00 
2008 218.58 169.07 133.34 117.24 42.94 13.36 0.00 
2009 137.89 107.57 129.99 92.21 51.57 12.19 3.87 
2010 145.82 121.26 119.28 109.27 67.23 6.09 0.00 
2011 225.99 127.12 113.02 90.32 72.99 10.94 0.00 
2012 142.16 115.49 109.59 77.95 53.28 17.45 0.00 
Episodes where HIV status is unknown to surveillance  
2005 207.20 177.26 156.64 126.33 79.24 53.43 7.01 
2006 255.37 148.10 127.58 115.16 78.43 29.61 0.00 
2007 209.77 151.53 123.68 128.29 67.27 19.62 13.35 
2008 193.21 184.13 133.83 89.69 40.68 24.03 5.74 
2009 175.18 163.94 107.49 74.69 67.29 27.27 5.35 
2010 150.28 142.67 128.73 103.66 39.70 7.52 2.63 
2011 179.28 143.51 106.39 78.29 64.28 18.06 0.00 
2012 152.96 112.59 97.45 99.31 45.86 21.85 5.90 
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4.1.5 Section summary  
 The average mid-year population of resident women of reproductive age was 25,143 and 
this population varied little annually.  
 Crude Birth Rates declined from 272 births/1000 women in 2005 to 166 births/1000 women 
in 2009. At this time a decline in CBR stalled until 2011.  
 Sexual debut is the most appropriate restriction for a comparison of HIV positive and HIV 
negative woman episodes: according to surveillance data only 4% of the annual mid-year 
population reported being married and 34% answered ‘yes’ to ever having had sex. 
 CBR were lower and decline stalled between 2010 and 2011 when restricted to women who 
had entered their sexual debut.  
 HIV positive women experienced consistently lower CBR than HIV negative women, since 
2005. Women with missing HIV status followed a similar trend to HIV positive women. 
 ASFRs followed a typical pattern with a peak at ages 20-24 years old at 157 births/1000 
women. After restricting to women who had made their sexual debut, rates were inflated to 
peak in the adolescent age group 15-19 years old at 231 births/1000 women. 
 A pattern of bimodal fertility was observed in HIV negative women only. HIV positive women 
showed consistent decline with age group and calendar year, indicating that HIV infected 
women typically limit childbearing at older ages and earlier than HIV negative women. 
 ASFRs declined between 2005 and 2012, with the exception of HIV positive women aged 35-
39 years old who experienced an increase in rates between 2006 and 2011. This increase in 
fertility amongst these HIV positive women coincided with a rapid scale up of access to ART 
through the Hlabisa HIV treatment and care programme after 2005 and could indicate a 
cessation of postponed childbearing amongst these women once ART was made available. 
  
 
 
148 
4.2 Incidence and factors associated with likelihood of live birth amongst women 
known to be HIV negative and positive during annual surveillance rounds 2007-2012 (open 
cohort) 
4.2.1 Cohort characteristics  
A total of 9,972 women entered an open cohort during surveillance years 2007 until 2012 (Figure 
3.2). The dataset included 28,267 annually updated woman episodes, allowing women to contribute 
26,754 women years of follow up (over multiple episodes) in the cohort (Table 4.4).  
Most women entered the cohort in the first two years of inclusion: 57% of women entered the 
cohort in years 2007 or 2008 and in smaller equal proportions in each subsequent year. Median 
follow up time was 1.97 years per woman although this differed by HIV status. Median duration of 
follow up was 1.95 years for HIV negative women, 1.83 years for HIV positive ART-naive women and 
2.6 years for HIV positive women on ART.  
 
Figure 4.11: Lexis diagram of individual entry date and exit date by age between 2007 and 2013 
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4.2.2 Participant characteristics  
The number of woman-years and live birth events observed in this open cohort are presented in 
Table 4.4. The proportions of all woman-years are further listed according to HIV group, to compare 
denominators for following analysis.  
Demographic characteristics  
Notably, women differed by age and parity between HIV statuses at entry and during follow up. 
Women were a median age of 28 years old and had two children at entry (Table 4.4): HIV negative 
women were younger (25 years old) and had one child on average, compared to HIV positive women 
(31 years old) who had a median of two children. During all annual woman episodes median age was 
31 years old and a trend by HIV status remained. Overall, 61% of women lived in a rural area of 
residence as would be expected in the predominantly rural Hlabisa sub-district, although more HIV 
positive women lived in peri-urban or urban areas compared to HIV negative women.  
Relationship and contraceptive use characteristics  
Reported rates of marriage were low: just 11% of women years were to engaged or married women 
in this cohort (Table 4.4). The majority of women reported being in a regular relationship both at 
entry and during follow up. Fewer HIV positive women responded to this question or were in a 
relationship compared to HIV negative women (34% and 55% respectively). HIV positive women 
were less likely to have a regular partner when exposed to ART then during ART-naïve observations. 
Responses to the current relationship status question were high and approximately 70% of women 
answered during each annual episode. 
Women reported using contraception during 29% of all observation time in this cohort (Table 4.4). 
This question was asked to all women regarding contraceptive use at time of last sex. Most women 
preferred to use hormonal methods of contraception, although fewer HIV positive women reported 
using hormonal methods in comparison to HIV negative women. However, more ART-exposed 
women chose to use barrier methods at last sex when compared to ART-naive women. Reported use 
of dual contraception was very low in this cohort overall (1%), although a higher proportion of dual 
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contraceptive users were HIV positive (70%) compared to the proportion of single injectable users 
(47%) and suggests a positive influence of family planning messaging to women living with HIV. 
HIV characteristics  
Women were distributed equally according to HIV status at first entry: 52% women were HIV 
negative, 36% of women were HIV positive ART naïve and 13% of women were HIV positive and 
using ART (Table 4.4). Women of unknown HIV status were excluded for the purpose of this cohort. 
Time-dependant covariates were updated with the next annual HIV surveillance visit and of 26,754 
woman-years in the cohort between 2007 and 2012, a total of 46% were HIV negative, 34% HIV 
positive and 20% on-ART (Table 4.6).  
There were 399 sero-conversions amongst HIV negative women that occurred during observation in 
this cohort.  The date of sero-conversion was estimated by calculating a halfway point between last 
known HIV positive and last known HIV negative test. Recently infected individuals may be 
considered a distinct group; they are likely to have recently engaged in unprotected sexual 
intercourse, are less likely to have initiated ART and are at higher risk of HIV transmission to 
partners. The timing of conception to before or after sero conversion may not be accurately 
modelled for these women, suggesting a best approach could be to exclude this group. However, 
longitudinal data spanning before and after sero-conversion is not typically available in clinical 
studies and these women contribute important information to describe fertility in the Hlabisa setting 
that may be adjusted for with CD4 count and self-reported health measures. This group of women 
were therefore included for analysis.  
As ART was rapidly brought to scale, the proportion of all women in the cohort using ART increased 
from 10% in 2007 to 33% in 2012. Of these women, 9% initiated ART while observed in the cohort. 
The proportion of women on ART is reported in table 4.4 by calendar year.  This proportion is likely 
to continue to grow as more people enrol on ART and survive to older ages in this setting. 
Additionally, more women are likely to remain on lifelong ART after a pregnancy if South Africa is to 
adopt WHO recommendations for PMTCT option B+.  
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Knowledge of own HIV status is high in the area, with 70% of women reporting to know their own 
status during cohort follow up (Table 4.4). Of all women-years that women knew their HIV status, 
60% were to HIV positive women (Table 4.4). Furthermore, a sub-analysis that stratified women by 
HIV status found 79% of HIV positive women and 60% of HIV negative women were aware of their 
own HIV Status (data not shown). This ‘HIV positive’ grouping also included ART-exposed women 
and thus, more women were aware of their HIV positive status compared to HIV negative women. 
When episodes to ART-exposed women were not included, knowledge was equitable, with only 60% 
of HIV positive women reporting knowledge of their HIV status.  
Awareness of the benefits of ART was not widespread amongst either HIV negative or HIV positive 
women. Overall, 52% of women reported knowing about ART and 15% reported no awareness about 
this treatment. This question also had a high non-response rate of 33% of all women-years (Table 
4.4).  
CD4 count measures were available for 62% of HIV positive women at baseline entry to the cohort 
and for 68% of all observed episodes during which a woman was considered HIV positive. The closest 
CD4+ measure recorded in the ARTemis database within 6 months of the woman-episode start date 
was linked to the corresponding annual episode and so it was possible that a CD4+ count not taken 
or recorded in that time period would result in a missing CD4+ measure in time-updated analysis.  
Self-reported general health characteristics  
 Most women reported good self-health (58%), although less of the women describing ‘Excellent, 
Very good or Good’ health were enrolled on ART compared to the general cohort (Table 4.4). The 
proportion of women reporting positive health varied substantially by HIV Status: a separate analysis 
showed that just 53% of women living with HIV reported feeling healthy compared to 85% of HIV 
negative women. More HIV positive women did not answer the question on perceived health and of 
these, ART-exposed women were most likely to not respond to this question or perceive their own 
health as fair or poor.  
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Table 4.4: Number of women-years observed and birth events to women between 2007-2013, by 
characteristic and stratified to compare HIV negative, positive ART naïve and positive onART groups. 
Characteristics 
Women-years (wy) observed Births 
Total wy per 
category (%) 
% of wy to HIV group 
Total 
number of 
births 
% of births to HIV group 
HIV- 
HIV+ 
and 
ART 
naïve 
HIV+ 
and 
onART 
HIV- 
HIV+ 
and 
ART 
naïve 
HIV+ 
and 
onART 
CHARACTERISTICS AT ENTRY 
Proportions of wy at entry  
26,754 (100%) 51% 36% 13% - - - - 
Median Age 28 25 29 34 - - - - 
Median Parity 2 1 2 2 - - - - 
Education 
Never attended 4,085 (15%) 50% 30% 20% 101 (6%) 57% 27% 16% 
At least Primary 5,379 (20%) 44% 35% 21% 436 (25%) 76% 17% 7% 
Secondary 9,236 (35%) 48% 35% 17% 743 (42%) 72% 20% 8% 
Tertiary 5,748 (21%) 46% 35% 19% 366 (21%) 71% 19% 10% 
Unknown 2,307 (9%) 41% 35% 24% 111 (6%) 66% 19% 15% 
Area  
Rural 16,256 (61%) 53% 31% 16% 1,242 (71%) 75% 18% 7% 
Peri-Urban 8,857 (33%) 38% 40% 22% 455 (26%) 63% 24% 13% 
Urban 1,642 (6%) 30% 38% 32% 60 (3%) 65% 22% 13% 
TIME-UPDATED CHARACTERISTICS  
Total proportions  26,754 (100%) 46% 34% 20% 1,757(100%) 72% 19% 9% 
Median Age 31 28 30 35 - - - - 
Median Parity 2 2 2 3 - - - - 
 Age  
15-19 2,774 (10%) 74% 22% 4% 514 (29%) 90% 9% 1% 
20-24 5,175 (19%) 58% 35% 7% 513 (29%) 76% 20% 3% 
25-29 4,547 (17%) 38% 44% 18% 311 (18%) 50% 32% 18% 
30-34 3,892 (15%) 29% 39% 32% 232 (13%) 54% 25% 21% 
35-39 3,670 (14%) 54% 26% 20% 138 (8%) 60% 21% 19% 
40-44 3,515 (13%) 44% 31% 26% 40 (2%) 80% 10% 10% 
45-49 3,181 (12%) 54% 26% 20% 9 (1%) 78% 0% 22% 
Knowledge of own HIV status  
No 4,894 (18%) 67% 33% 0% 333 (19%) 83% 17% 0% 
Yes 18,731 (70%) 40% 32% 28% 1,095 (62%) 63% 23% 15% 
Unknown 3,129 (12%) 54% 46% 0% 329 (19%) 89% 11% 0% 
Most recent relationship  
Single 4,937 (18%) 41% 35% 24% 268 (15%) 75% 15% 10% 
Casual / partner 423 (2%) 51% 39% 10% 30 (2%) 67% 33% 0% 
Eng / Married 3,037 (11%) 68% 19% 13% 132 (8%) 77% 17% 6% 
Regular partner 8,947 (33%)  57% 31% 12% 680 (39%) 70% 22% 8% 
Div / Wid / Sep 1,220 (5%) 50% 31% 19% 80 (5%) 68% 25% 8% 
Other/ unknown 8,190 (31%) 29% 43% 28% 567 (32%) 71% 18% 11% 
  
 
 
153 
Living with partner 
No 10,131 (38%) 55% 32% 12% 701 (40%) 71% 23% 6% 
Yes 3,730 (14%) 62% 24% 14% 188 (11%) 65% 22% 13% 
Unknown 12,893 (48%) 35% 39% 27% 868 (49%) 73% 16% 11% 
Parity  
0 3,616 (14%) 57% 31% 12% 637 (36%) 89% 10% 2% 
1 6,735 (25%) 51% 35% 14% 454 (26%) 68% 24% 9% 
2 5,124 (19%) 37% 40% 23% 273 (16%) 52% 32% 15% 
3 3,745 (14%) 36% 36% 28% 169 (10%) 56% 27% 17% 
4 2,570 (10%) 43% 32% 25% 94 (5%) 59% 19% 22% 
5 1,910 (7%) 48% 31% 21% 54 (3%) 63% 22% 15% 
6+ 3,054 (11%) 46% 34% 19% 76 (4%) 71% 19% 9% 
Self-reported Health 
Fair/Poor 3,498 (13%) 43% 28% 30% 122 (7%) 61% 22% 16% 
Excellent / Very good / 
Good 15,412 (58%) 57% 31% 12% 1089 (62%) 73% 20% 7% 
Unknown 7,844 (29%) 28% 44% 28% 546 (31%) 70% 18% 12% 
Heard of ART 
No 4,009 (15%) 62% 38% 0% 279 (16%) 81% 19% 0% 
Yes 13,993 (52%) 38% 25% 37% 745 (42%) 60% 18% 22% 
Unknown 8,753 (33%) 52% 48% 0% 733 (42%) 80% 20% 0% 
Year  
2007 4,310 (16%) 52% 39% 10% 274 (16%) 74% 23% 3% 
2008 5,414 (20%) 49% 37% 11% 337 (19%) 75% 19% 6% 
2009 4,919 (18%) 48% 35% 18% 299 (17%) 71% 23% 6% 
2010 4,922 (18%) 44% 35% 21% 318 (18%) 62% 23% 15% 
2011 4,187 (16%) 42% 31% 27% 324 (18%) 72% 15% 13% 
2012 3,003 (11%) 43% 24% 33% 205(12%) 77% 11% 13% 
Using contraception (updated annually) 
No 3,985 (15%) 62% 28% 10% 319 (18%) 73% 23% 5% 
Yes 7,660 (29%) 51% 32% 17% 280 (16%) 59% 26% 15% 
Unknown 15,109 (56%) 40% 37% 23% 1158 (66%) 74% 17% 9% 
Form of Contraception  
Barrier methods 1,973 (7%) 41% 33% 27% 105 (6%) 50% 32% 18% 
Oral / IUCD / Microbicides 324 (1%) 64% 26% 10% 13 (1%) 46% 31% 23% 
Injectable 2,563 (10%) 53% 30% 17% 80 (5%) 64% 23% 14% 
Dual 368 (1%) 30% 40% 30% 10 (1%) 20% 60% 20% 
Other/unknown method 2,431 (9%) 58% 32% 10% 72 (4%) 75% 17% 8% 
None 3,985 (15%) 62% 28% 10% 319 (18%) 73% 23% 5% 
Unknown if using  15,109 (56%) 47% 34% 19% 1158 (66%) 71% 19% 9% 
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4.2.3 Incidence of pregnancy in open cohort  
There were a total of 1,757 live births among 9,972 women between the years of 2007 and 2013 
(Figure 3.2 and Table 4.4). Overall crude incidence of live birth was 6.6 births per 100 woman years. 
Incidence of live birth was approximately 3 times greater for HIV negative woman than in HIV 
positive woman episodes at any year of follow up. Cumulatively, 14% of HIV negative women 
experienced 1,286 births at an incidence of 9.7 births/100 HIV negative woman years (95% CI 9.2 – 
10.2), compared to 4% in  HIV positive women who experienced 472 births at an incidence of 3.5 
births/100 woman years (95% CI 3.2 – 3.8). 
A total of 998 women were pregnant at entry to cohort, calculated using a retrospective estimate of 
date of conception 9 months prior to the date of birth. Women that were pregnant at entry later 
experienced 83 (2nd) and 6 (3rd) recurrent births. There were 118 recurrent births in total (70% to 
women that were pregnant at entry to cohort). Women on ART delivered 9% of all first births, 12% 
of second births and 0% of third births. Incidence of first and second births was highest in the 
youngest age group and contrariwise, third births were equally distributed by age. 
Figure 4.12 presents the cumulative proportion of women experiencing a live birth during each 
annual surveillance episode according to HIV status category for that episode. If women were to 
seroconvert, she may contribute to both graphs at different time-points. 
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Figure 4.12 Cumulative proportion of HIV negative and HIV positive women that remain ‘birth-free’ 
during each annual year of follow up 
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Table 4.5 Cumulative numbers of births and attributable birth-free women during each annual year 
of follow up according to HIV status 
Interval (years 
observed) 
Total at 
risk 
Live birth 
Events 
Lost to 
follow up 
Survival Error 95% Conf. Int. 
HIV Negative  
0 – 1 years 4852 245 1257 0.942 0.0036 [0.9345 -0.9486] 
1 – 2 years 3350 38 877 0.9297 0.0041 [0.9213 - 0.9372] 
2 – 3 years 2435 30 683 0.9164 0.0047 [0.9067 - 0.9251] 
3 – 4 years 1722 24 568 0.9011 0.0055 [0.8896 - 0.9114] 
4 -5 years 1130 25 661 0.8729 0.0077 [0.8569 - 0.8872] 
5 – 6 years 444 12 343 0.8345 0.0131 [0.8069 - 0.8585] 
6 – 7 years 89 0 89 0.8345 0.0131 [0.8069 - 0.8585] 
HIV Positive 
0 – 1 years 5120 34 1023 0.9926 0.0013 [0.9897 - 0.9947] 
1 – 2 years 4063 22 875 0.9866 0.0018 [0.9826 - 0.9897] 
2 – 3 year 3166 17 813 0.9805 0.0023 [0.9754 - 0.9846] 
3 – 4 years 2336 18 668 0.9717 0.0031 [0.9650 - 0.9772] 
4 -5 years 1650 14 735 0.9611 0.0042 [0.9521 - 0.9685] 
5 – 6 years 901 6 724 0.9504 0.006 [0.9372 - 0.9609] 
6 – 7 years 171 0 171 0.9504 0.006 [0.9372 - 0.9609] 
HIV Status Events Observed Events Expected 
Negative 1256 760.67 
Positive 501 996.33 
Total 1,757 1,757.00 
 Chi2 570.27 
 Pr>chi2 0.0000 
 
4.2.4 Live birth rates after initiation on ART 
After initiation of ART, women delivered 24 incident births with no recurrent events. Median time to 
birth was 25 months after initiation on to ART (inter quartile range (IQR) 15, 39), twice as long as 
those reported in Johannesburg (Westreich et al., 2012). After 76 months of observation, cumulative 
incidence of live birth was 8% (95% CI 7%, 10%). Comparatively, this is also lower than the 22.9% 
reported in Johannesburg over similar time of observation. CD4 count at ART initiation was known 
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for 82% of women and was not a significant predictor of crude birth rates in unadjusted analysis, 
excluding women pregnant at entry (p=0.2898). 
 
4.2.5 Factors associated with incidence of live birth  
Table 4.6 presents incidence rate of live birth for a range of time-updated socio-economic, self-
reported health and clinical characteristics. Crude incidence is presented for the whole cohort and 
then stratified for HIV infected and HIV uninfected women. Details of the woman-year denominators 
and number of birth events are provided in Table 4.4 
Overall crude incidence of live birth in this cohort decreased with increasing age group, higher 
parity, poorer self-reported health, an urban area of residency, knowledge of own HIV status, being 
single or engaged/married, not living with a partner, an awareness of the benefits of ART, use of 
contraception and use of injectable methods of contraception (Table 4.6). 
Bivariate Poisson analysis of each characteristic adjusted for HIV status. It is notable that adjusting 
for HIV had a minimal effect on associations between individual proximate and distal determinants 
of live birth. Trends for each characteristic remained significant or unchanged to that of univariate 
analysis for all variables, with the exception of an effect of living with a partner and the year of 
annual surveillance round.  
In this open cohort crude birth rates did not decline annually as indicated by results from analysis 
one. This could be explained by the slow pace of decline in recent years, inclusion criteria for women 
of known HIV status only which excludes a proportion of the general population, and that these 
selected years are at a time of a reported stall in fertility decline. In univariate analysis of HIV 
negative or HIV positive women only, year of annual surveillance was not associated with rates of 
live birth.  
The following sections will discuss results for demographic, relationship and HIV related proximate 
and distal determinants of fertility.  
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Table 4.6: Characteristics associated with crude incidence of live birth to all women and by HIV 
status (women can contribute more than once) 
 
Characteristics 
Woman-years 
observed Incidence Rate [95% CI] 
Total % HIV Positive 
Overall Incidence 
(N=26,754) 
HIV Status 
HIV Negative 
(N=12,437 
woman years) 
HIV Positive 
(N=14, 317) 
woman years) 
Trend 
adjusted 
for HIV 
(p-value) 
Overall  n=26,754 49% 6.6 [6.3 – 6.9] 9.7 [9.2 – 10.2] 3.5 [3.2 – 3.8] p<0.001 
Characteristics at entry 
Education at entry 
 Never attended 4,085 50% 2.5 [2.0 – 3.0] 2.9 [2.2 – 3.7] 2.0 [1.4 – 2.8] 
p<0.001 
At least Primary 5,379 46% 8.1 [7.4 – 8.9] 13.2 [11.9 – 14.7] 3.5 [2.9 – 4.3] 
Secondary  9,236 52% 8.0 [7.5 – 8.6] 11.5 [10.5 – 12.5] 4.5 [3.9 – 5.1] 
Tertiary 5,748 54% 6.4 [5.7 – 7.1] 9.4 [8.4 – 10.6] 3.4 [2.8 – 4.1] 
Unknown 2,307 59% 4.8 [4.0 – 5.8] 7.3 [5.9 – 9.2] 2.7 [1.9 – 3.8] 
   p<0.001 p<0.001 P=0.044 
Area at entry 
 Rural 16,256 47% 7.6 [7.2 – 8.1] 10.5 [9.8 – 11.2] 4.1 [3.7 – 4.6] 
p<0.001 
Peri-Urban 8,857 62% 5.1 [4.7 – 5.6] 8.1 [7.2 – 9.1] 3.0 [2.6 – 3.5] 
Urban 1,642 70% 3.7 [2.8 – 4.7] 7.2 [5.3 – 9.7] 1.8 [1.1 – 2.8] 
   p<0.001 p<0.001 p<0.001 
Characteristics updated annually 
 Age  
 15-19 2,774 26% 19.5 [16.9 – 20.2] 22.4 [20.4 – 24.5] 6.9 [5.2 – 9.2] 
p<0.001 
20-24 5,175 42% 9.9 [9.1 -10.8] 12.6 [11.4 – 13.9] 5.9 [4.9 – 7.0] 
25-29 4,547 62% 6.7 [6.1 – 7.7] 9.0 [7.7 – 10.4] 5.3 [4.5 – 6.3] 
30-34 3,892 71% 5.9 [5.2 – 6.8] 10.0 [8.4 – 11.9] 3.9 [3.3 – 4.8] 
35-39 3,670 46% 3.8 [3.2 – 4.4] 6.2 [5.0 – 7.6] 2.2 [1.7 – 2.9] 
40-44 3,515 57% 1.1 [0.8 – 1.6] 1.9 [1.4 – 2.6] 0.4 [0.2 – 0.9] 
45-49 3,181 46% 0.3 [0.1 – 0.5] 0.4 [0.2 – 0.8] 0.1 [0.0 – 0.6] 
   P<0.001 P<0.001 P<0.001 
Knowledge of own HIV status  
 No 4,894 33% 6.8 [6.1 – 7.6] 8.3 [7.4 – 9.3] 3.6 [2.7 – 4.7] 
p<0.001 
Yes 18,731 60% 5.9 [5.5 – 6.2] 9.0 [8.3 – 9.7] 3.6 [3.3 – 4.0] 
Unknown 3,129 46% 10.5 [9.4 – 11.7] 14.5 [12.9 – 16.2] 2.5 [1.7 – 3.7] 
   P<0.001 P<0.001 P=0.233 
Most recent relationship  
 Single 4,937 59% 5.4 [4.8 – 6.1] 9.9 [8.6 – 11.4] 2.3 [1.8 – 2.9] 
p<0.001 
Casual friend / 
partner 
423 49% 7.1 [5.0 – 10.1] 9.2 [5.9 – 14.3] 4.8 [2.6 – 9.0] 
Engaged / Married 3,037 32% 4.3 [3.7 – 5.2] 4.9 [4.1 – 6.0] 3.1 [2.2 – 4.4] 
Regular partner 8,947 43% 7.6 [7.1 – 8.2] 9.3 [8.5 – 10.2] 5.3 [4.6 – 6.1] 
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Divorced / Widowed 
/ Separated  
1,220 50% 6.6 [5.3 – 8.2] 8.8 [6.7 – 11.4] 4.3 [2.9 – 6.3] 
Other or unknown 8,190 71% 6.9 [6.4 – 7.5] 16.8 [15.3 – 18.5] 2.8 [2.4 – 3.3] 
   P<0.001 P<0.001 P=0.424 
Living with partner 
 No 10,131 44% 6.9 [6.4 – 7.5] 8.9 [8.2 – 9.7] 4.3 [3.7 – 5.0] 
p<0.001 
Yes 3,882 38% 5.0 [4.4 – 5.8] 5.2 [4.4 – 6.2] 4.7 [3.7 – 6.0] 
Unknown 12,893 66% 7.5 [5.5 – 10.2] 10.4 [7.4 – 14.7] 3.3 [1.6 – 6.8] 
   P=0.993 P=0.001 P<0.001 
Median Parity at entry 2 2 2  
Parity (time-updated) 
 0 3,616 43% 17.6 [16.3 – 19.0] 26.7 [24.6 – 28.9] 4.7 [3.7 – 5.9] 
p<0.001 
1 6,735 49% 6.7 [6.1 – 7.4] 8.7 [7.8 – 9.8] 4.4 [3.7 – 5.2] 
2 5,124 63% 5.3 [4.7 – 6.0] 7.2 [6.2 – 8.5] 4.0 [3.4 – 4.8] 
3 3,745 64% 4.5 [3.9 – 5.2] 6.6 [5.5 – 8.1] 3.1 [2.4 – 3.9] 
4 2,570 57% 3.7 [3.0 – 4.5] 4.7 [3.6 – 6.2} 2.7 [2.0 – 3.8] 
5 1,910 52% 2.8 [2.2 – 3.7] 3.8 [2.8 – 5.3] 1.8 [1.1 – 2.9] 
6+  3,054 63% 2.5 [2.0 – 3.1] 3.2 [2.5 – 4.2] 1.4 [0.9 – 2.3] 
   P<0.001 P<0.001 P<0.001 
Self-reported Health 
 Fair/Poor 3,498 58% 3.5 [2.9 – 4.2] 4.7 [3.7 –5.9] 2.5 [1.9 – 3.3] 
p<0.001 
Excellent / Very good 
/ Good 
15,412 43% 7.1 [6.7 – 7.5] 9.0 [8.4 – 9.6] 4.3 [3.8 – 4.9] 
Unknown 7,844 71% 7.0 [6.4 – 7.6] 15.2 [13.7 – 16.7] 2.9 [2.5 – 3.4] 
  55% P<0.001 P<0.001 P=0.446 
Heard of ART 
 No 4,009 38% 7.0 [6.2 – 7.8] 9.0 [7.9 – 10.3] 3.6 [2.7 – 4.7] 
p<0.001 
Yes 13,993 62% 5.3 [5.0 – 5.7] 8.3 [7.6 – 9.1] 3.5 [3.1 – 3.9] 
Unknown 8,753 48% 8.4 [7.8 – 9.0] 11.3 [10.5 – 12.3] 3.6 [3.0 – 4.3] 
   P<0.001 P<0.001 P=0.863 
Year of annual surveillance episode 
 2007 4,310 49% 6.4 [5.6 – 7.2] 9.1 [7.9 – 10.4] 3.4 [2.7 – 4.3] 
P=0.063 
2008 5,414 48% 6.2 [5.6 – 6.9] 9.5 [8.4 – 10.7] 3.1 [2.4 – 3.8] 
2009 4,919 53% 6.1 [5.4 – 6.8] 9.0 [7.9 – 10.3] 3.4 [2.7 – 4.2] 
2010 4,922 56% 6.5 [5.8 – 7.2] 9.2 [8.0 – 10.6] 4.3 [3.6 – 5.2] 
2011 4,187 58% 7.8 [7.0 – 8.7] 11.3 [10.0 – 12.8] 3.8 [3.1 – 4.8] 
2012 3,003 57% 6.8 [5.9 – 7.8] 10.1 [8.7 – 11.7] 2.5 [1.8 – 3.6] 
   P=0.022 P=0.057 P=0.678 
Using contraception (updated annually) 
 No 3,985 38% 8.0 [7.2 – 9.0] 9.4 [8.3 – 10.7] 5.8 [4.7 – 7.2] 
p<0.001 
Yes 7,660 49% 3.7 [3.3 – 4.1] 4.2 [3.6 – 4.9] 3.0 [2.5 – 3.6] 
Unknown 15,109 50% 7.7 [7.2 – 8.1] 13.1 [12.3 – 14.0] 3.3 [2.9 – 3.7] 
   P<0.001 P<0.001 P<0.001 
Form of Contraception  
 Barrier methods 1,973 60% 5.4 [4.4 – 6.4] 6.2 [4.7 – 8.0] 4.5 [3.5 – 6.1] 
p<0.001 Oral / IUCD / 
Microbicides 
324 36% 4.0 [2.3 – 6.9] 2.8 [1.2 – 6.1] 6.5 [3.1 – 
13.7] 
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Injectable 2,563 47% 3.1 [2.5 – 3.8] 3.7  [2.8– 4.8] 2.4 [1.6 – 3.5] 
Dual 368 70% 2.7 [1.5 – 5.0] 3.2 [1.2 – 8.4] 2.5 [1.1 – 5.5] 
Other/unknown 
method 
2,431 42% 3.0 [2.4 – 3.7] 3.8 [2.9 – 5.0] 1.8 [1.1 – 2.8] 
None 3,985 38% 8.0 [7.2 – 9.0] 9.4 [8.3 – 10.7] 5.8 [4.7 – 7.1] 
Unknown if using  15,109 53% 7.7 [7.2 – 8.1] 13.1 [12.3 – 14.0] 3.3 [2.9 – 3.7] 
   P<0.001 P<0.001 P=0.235 
 
 
HIV characteristics 
HIV positive status was associated with crude rates of 3.5 births per 100 women [95% CI 3.2 – 3.8], 
three times lower compared to HIV negative periods in a woman episode analysis.  
Knowledge of own HIV status was associated with lower incidence of live birth in overall univariate 
analysis, but not when stratified to HIV negative or HIV positive women only. Lower incidence to all 
women reporting HIV status knowledge conceals an opposite trend amongst HIV negative women, 
who demonstrate higher incidence associated with knowledge, compared to no knowledge, of HIV 
status. Higher incidence to women that know they are HIV negative seems intuitive: HIV negative 
women do not face issues of stigma or risks to health that are associated with a HIV positive status 
and may be encouraged to have children in light of this information. However, the difference was 
non-significant. HIV positive women, alternatively, experienced no difference in incidence of live 
birth associated with knowledge of their status. This finding is more surprising. The hypothesis that a 
HIV diagnosis might encourage women to curtail childbearing behaviours, or use of ART may reverse 
this effect, requires that they are aware of their status. Absence of a univariate trend may be due to 
lack of adjustment for age and parity, as women on ART are likely to be older and have more 
children, and potentially later in their reproductive life than HIV negative women. 
The lower overall cohort incidence associated with HIV status knowledge, while incidence increases 
with knowledge to HIV negative women and shows no difference amongst HIV positive women, 
could be explained by a higher contribution of HIV positive person-years to the ‘Yes’ category, while 
these women demonstrate lower birth rates than HIV negative women. Most women in the cohort 
were aware of their status: 70% of all woman-years were to women that responded ‘yes’ to this 
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question. Of these, the majority were HIV positive: HIV positive women accounted for 58% of all 
woman-years with a ‘yes’ response (Table 4.4). Yet HIV positive women experience lower incidence 
of live birth compared to HIV negative women. Consequently, a HIV positive majority results in the 
lower overall incidence reported in the ‘yes’ category of knowledge of a status in this cohort.  
Table 4.6 provides no evidence that HIV positive women chose to alter their childbearing behaviours 
in this setting. However, all women on ART are aware of their HIV status and this analysis does not 
present associations between knowledge and live birth rates amongst ART naive women and those 
that are exposed to ART. This analysis is presented in Section 4.2.7.   
A significant trend overall, and to HIV negative women, appears to be driven by high birth rates to 
non-responders to this question, categorised as ‘unknown’. Non-response may be because 
individuals already know their status and do not feel the need to disclose this to surveillance. 
Individuals can seek HIV testing and counselling (HCT) from local primary health facilities and already 
be aware of their HIV status when asked to participate in HIV surveillance.  Avoidance of HCT is more 
likely to be associated with riskier sexual behaviour and higher rates of live birth. Others may choose 
to participate in HIV surveillance without prior knowledge of their status. Informed consent 
procedures ask for consent at multiple stages and clarify that the purpose of surveillance is to assist 
with community based research rather than individual knowledge. It is this process that can result in 
discrepancies between participation in surveillance, and individual knowledge of HIV status. The 
process of HIV surveillance is described in more detail on page 85. 
Women experienced a lower incidence of live birth when aware, rather than unaware, of the 
availability of ART (Table 4.6). Awareness of ART was not associated with incidence of live birth to 
HIV positive women and offers no support to the hypothesis that ART would encourage decisions to 
have children. ART is now widely available in this setting and known to women in 52% of observed 
woman-years. The proportion of women aware of ART may well be higher, as responses were 
missing to this question during 33% of woman years.  
In this context, there is no evidence to suggest that awareness of ART is associated with fertility 
amongst HIV positive women and incidence of live birth is lower amongst HIV positive women 
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compared to HIV negative women. HIV positive women contribute more woman-years to ‘Yes’ 
responses to survey questions about awareness of HIV status and awareness of ART. As a result, the 
lower incidence rates of HIV positive women may drive a lower overall incidence to ‘yes’ responses 
in a combined HIV negative and HIV positive cohort. 
 
Demographic characteristics
As expected from the literature, higher educational attainment was associated with lower rates of 
live birth. Univariate analysis found education to be significantly associated with live birth and to be 
likely confounder of the association between HIV status and live birth. Crude incidence was lowest 
amongst women who had never attended school and highest for women who had achieved at least 
primary level education and then declined with increased educational attainment. This association 
remained significant when stratified to only HIV negative or HIV positive woman-years observed, or 
in bivariate analysis adjusted for a woman’s HIV status. 
Rates of live birth declined with age and parity in an overall analysis and when stratified by HIV. 
Crude birth rates were consistently lower during HIV positive episodes at each age group, as 
illustrated in figure 4.13. HIV is associated with approximately halved rates of live birth at any age 
and rates were disproportionately high amongst younger women aged 15-19 and 20-24 years old. 
Live birth rates appear inflated amongst women aged 15-19 years old during HIV negative episodes 
due to the exclusion of women that had not yet entered their sexual debut, women that are most 
likely to lie within this age group. Further, a peak in birth rates amongst women that had entered 
sexual debut and were aged 15-19 years old is in accordance with results from analysis one.  
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Figure 4.13 Age group specific crude birth rates during HIV negative and HIV positive episodes  
a) HIV Negative b) HIV Positive 
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A pronounced effect of HIV occurred amongst women aged 30-34 years old. Crude birth rates 
amongst HIV negative women followed a bimodal trend and a second peak in crude birth rates at 30-
34 years. A second peak was not found in episodes to HIV positive women aged 30-34 years old.  
Incidence of live birth reduced significantly with increasing parity overall and when stratified by HIV 
status. Rates were also consistently lower amongst HIV infected women at any parity level. Most live 
births occurred during HIV negative episodes to women with no prior children (26.7 births/1000 
women [24.6 – 28.9]) at a rate 3 times higher than HIV negative women with one child and almost 6 
times higher than HIV positive women with no children. Unique to HIV positive women, crude rates 
of live birth did not significantly differ between women with parities of zero or one.  
 
Relationship Characteristics  
As discussed in analysis one, rates of marriage were low in this setting and typically occurred at older 
ages. The number of married women disaggregated by age and year is presented in appendix A to 
show that more women aged 15 – 34 years old were in a regular relationship rather than married 
but that after this age, the trend is reversed.  
Median parity amongst women not living with their partner was one child compared to four children 
to women living with a partner. Overall, crude incidence of live birth was lowest amongst married 
women and highest amongst unmarried women in a casual or regular relationship. Incidence of live 
birth was consistently lower during HIV positive women episodes at all categories of relationship. 
Rates did not differ between those reporting a casual or regular relationship and were significantly 
lower in single and married women or those reporting to be divorced, widowed or separated. The 
trend remained significant in an analysis stratified by HIV status.   
Co-residency with a partner was not significantly associated with incidence of live birth in univariate 
analysis. However, the trend became significant once adjusted for HIV status. Against expected 
findings, this analysis determined highest rates of live birth amongst women not living with a 
partner. High rates of live birth to women not living with their partners are likely in the context of 
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low marital rates in the Hlabisa sub-district, as women traditionally live with their parents until 
marriage and new homes are largely unaffordable until later in life. As typical of other 
characteristics, rates of live birth were halved amongst women not living with a partner during HIV 
positive women-years of observation (4.3 births per 100 women [95% CI 3.7-5.0]) compared to HIV 
negative women-years (8.9 births per 100 women [95% CI 8.2-9.7])) (p<0.001). 
In contrast, incidence of live birth during episodes of co-residency did not differ significantly 
between HIV negative and HIV positive women (p=0.513). This finding could be attributed to lower 
rates of live birth observed amongst women that do not co-reside with their partners. Appendix A 
illustrates that incidence of live birth did not significantly differ between HIV positive women that 
were or were not living with a partner and provides evidence that HIV positive women only alter 
their patterns of childbearing outside of less formal relationships.  
 
Contraceptive use characteristics 
Use of contraception is strongly associated with rates of live birth although half of women were not 
using contraception, overall and when stratified by HIV status. Crude incidence of live birth was also 
significantly lower during HIV positive women episodes at all levels of contraceptive use.  
This study still found high rates of 3.7 births per 100 women [95% CI 3.3 -4.1] to women reporting 
contraceptive use during that annual surveillance round compared to not 8.0 [95% CI 7.2 – 9.0]. 
Information about contraceptive use is recorded during the same annual surveillance round that HIV 
status is established a live birth event occurred. In this cohort, women episodes are censored with a 
live birth event and consequently, contraceptive use could actually be recorded at a time that is 
either pre or post conception of a live birth. Women are often initiated on to DMPA injectable 
contraception during their 6-week postpartum visit and this would be captured in the next annual 
episode.  
Respondents were first asked ‘Have you ever used contraceptives’, before being asked to select a 
method they are currently using. Responses to this question were low, with 44% missingness overall. 
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Figure 4.14 Question asked to respondents of the WGH survey regarding contraceptive use 
 
 
HIV positive non-responders to this question on contraceptive use experienced rates of live birth 
four times lower than HIV negative women (3.3 [95% CI 2.9-3.7] births per 100 HIV positive women 
compared to 13.1 [95% CI 12.3-14.0] births per 100 HIV negative women). This provides some 
evidence to suggest that HIV positive women tend not to answer this question due to lower sexual 
activity while HIV negative women may be more sexually active during non-contraceptive episodes.  
Barrier methods of contraception were associated with the highest rates of live birth at 5.4 births 
per 100 women [95% CI 4.4 – 6.4] and dual use of barrier plus a hormonal method of contraception 
was associated with the lowest rates amongst all women 2.7 births per 100 women [95% CI 1.5 – 
5.0]. There was no significant difference between rates of birth amongst dual or injectable users and 
trends were the same for overall analysis and when stratified by HIV status. 
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General Health 
Rates of live birth were double amongst women reporting excellent, good or very good health 
compared to women reporting fair or poor health. This trend was still significant when stratified by 
HIV status: rates were significantly higher amongst HIV positive women reporting good versus poor 
health, but an overall association was non-significant due to the inclusion of missing responses.  
Information for self-perceived health is determined as a self-reported checklist response to the 
question ‘How would you describe your health at present?’  
Figure 4.15 Question asked to respondents of the WGH survey regarding perceptions of their own 
health  
  
 
 
Single item measures of self-reported health have been commonly used in community studies. Five 
point scales for response (Excellent, Very Good, Good, Fair, or Poor) quantify different aspects of 
health that operate within in an individual’s perceptual framework. These measures have 
successfully predicted mortality in some, mostly developed, settings (Idler and Benyamini, 1997). A 
strong association has been reported in this study site: an analysis of Africa Centre demographic 
surveillance data using ‘Excellent’ as baseline self-reported health, showed an ordered increase in 
the adjusted hazard of mortality to women reporting ‘Very Good’, ‘Good’, ‘Fair’ and ‘Poor’ health 
after 4 years of follow up (Olgiati et al., 2012). The same study also described an ordered decrease in 
response rates (from Excellent to Poor).  
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An internal review found that participants could not easily distinguish between options for 
‘Excellent’, Very Good’, ‘and Good’ and that conflation could boost response rates to this question. 
Since 2009, responses have been conflated to three options for ‘Excellent, Very Good and Good’, 
‘Fair’ and ‘Poor’. The final two categories ‘Fair’ and ‘Poor’ were conflated for the purpose of analysis 
in this study due to low response rates to these categories and to provide a more appropriate 
counterfactual to ‘Excellent, Very Good or Good’ (E/VG/G).  
Table 4.4 demonstrates that, even after this conflation, response rates disproportionately favour the 
E/VG/G category in 58% of woman years, compared to 13% of woman years with a F/P response.  An 
implication for this study is that the association reported between E/VG/G and F/P categories may 
be an exaggerated measure of the effect of general health on birth rates in the setting. A five-point 
measure may present a weaker association, assuming that response rates to ‘Excellent’ would be 
higher and that the difference between ‘Excellent’ and ‘Poor’ would be larger than ‘Very Good’ or 
‘Good’ to ‘Poor’.  
In preliminary univariate and bivariate analysis, the conflated variable was found to be a robust 
predictor of live birth rates in the cohort. It offers a valid comparison of the effect of perceived 
health between HIV status and treatment groups and a better predictor of birth rates than 
knowledge of HIV status in univariate analysis.  
An unstated assumption suggests that HIV negative and positive women view health through the 
same perceptual framework. In reality, concepts of general health may differ between HIV negative 
and HIV positive women and these differences may affect response rates and category choice. 
Differences in how HIV positive women consider general health in this setting require more 
qualitative understanding. The results presented in Chapters Five and Six aim to elucidate more on 
this issue. 
Results presented in Table 4.4 suggest patterns of non-response differ according to HIV status for 
this question. Non-response may occur when individuals already know their status and see no added 
value in disclosing this to surveillance or because they have not sought HIV testing and counselling. 
Avoidance of HCT could be associated with riskier sexual behaviour and higher rates of live birth. 
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Reponses to ‘Excellent, Very Good and Good’ were roughly proportionate between HIV negative 
(57%) and HIV positive (43%) woman years. In contrast, HIV positive women accounted for a higher 
proportion of ‘Fair/Poor’ (58%) and missing (unknown, 72%) woman-years.  
Overall, birth rates to non-responders were comparable to women reporting excellent, good or very 
good health for this question. The same trend was observed in an analysis limited to HIV negative 
women and suggests that non-response was not related to the issue of health being surveyed in this 
question. In contrast, rates of live birth to HIV positive non-responders were almost half those of 
women reporting excellent, good or very good health and similar to women reporting fair or poor 
health. Consequently, HIV positive women were more likely to not respond due to poor health and 
these same women experienced lower rates of live birth.  
 
4.2.6 Multivariable analysis of factors associated with incidence of live birth amongst HIV 
negative and positive women  
In a multivariate Poisson analysis adjusted for: education, area of residency, HIV status, age at 
episode, knowledge of HIV status, most recent relationship status, co-residency with partner, parity, 
self-reported health, an awareness of ART, year of annual surveillance, contraceptive use and form 
of contraception used, being HIV positive was associated with a 61% reduced annual likelihood of 
live birth compared to the HIV negative counterfactual group (aHR, 0.39; 95% 0.347 – 0.441) (Table 
4.7).  
I found no evidence that use of ART is associated with a return to high fertility rates in HIV positive 
women. Rather, in an analysis limited to only HIV infected women and adjusted for: education at 
entry, area, exposure to ART, age, knowledge of HIV status, most recent relationship status, co-
residency with partner, parity, year of annual surveillance and contraceptive use, exposure to ART 
was associated with a 38% reduced likelihood of live birth in this group (aHR, 0.62; 95% 0.487 – 
0.799). 
  
 
 
170 
Univariate analysis of HIV positive women only found no association between knowledge of HIV 
status and rates of live birth. In a cohort multivariable analysis, adjusted for significant determinants 
of live birth, knowledge of HIV status was associated with a 46% reduced likelihood of live birth.  
Co-residency was associated with a 27% reduced likelihood of live birth in univariate analysis. Once 
other proximate determinants of fertility were included in this model for adjustment, living with a 
partner was associated with a 73% increased likelihood of experiencing a live birth. In a multivariable 
analysis limited to HIV positive women, this likelihood increased further to 78%. 
Excellent, good or very good self-reported health was associated with doubled likelihood of live birth 
in the cohort of all women. Once adjusted for significant determinants of fertility, likelihood was 
removed entirely and became non-significant. Self-reported health was not a significant predictor of 
live birth amongst HIV positive women and so was not included in a multivariable sub-analysis of this 
group of women. These findings suggest that health is an important contributor to likelihood of live 
birth but the variance was most likely explained by inclusion of other factors, such as HIV status. 
An awareness of ART was no longer significant in multivariable models and this is most likely due to 
the inclusion of HIV positive women in the cohort analysis or exposure to ART. Furthermore, this 
variable was not significant in univariate analysis of HIV positive women, reflecting a uniform 
awareness of treatment. 
Contraceptive use is strongly associated with reduced annual rates of live birth in HIV infected 
women, as women reporting use of any method at most recent sex experienced 75% reduced rates 
in this adjusted analysis. Increasing age group was independently associated with reduced rates in 
this analysis, while being in a relationship and living with a partner alone were not sufficient to 
explain variation in rates of live birth between HIV positive women.  
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Table 4.7 Crude and adjusted hazard of live birth comparing trends by time-updated characteristics for HIV 
positive women and overall cohort 
 
Characteristics 
Crude and Adjusted Hazard ratio [95% CI] 
All episodes HIV positive episodes 
Crude HR 95% CI AHR 95% CI Crude HR 95% CI AHR 95% CI 
Characteristics at entry 
Education at entry 
Never attended 1 - 1 - 1 - - - 
At least Primary 3.286 2.647 – 4.080 1.486 1.187 – 1.861 1.721 1.191 – 2.484 - - 
Secondary  3.254 2.643 – 4.005 1.160 0.932 – 1.446 2.183 1.554 – 3.065 - - 
Tertiary 2.576 2.066 – 3.210  1.091 0.863 – 1.378 1.662 1.151 – 2.399 - - 
Unknown 1.947 1.487 – 2.549 1.194 0.908 – 1.571 1.378 0.841 – 2.097 - - 
Area at entry 
Rural 1 - 1 - 1 - 1 - 
Peri-Urban 0.672 0.603 – 0.748 0.740 0.663 – 0.825 0.739 0.609 – 0.897 0.748 0.592 – 0.946 
Urban 0.478 0.369 – 0.619 0.569 0.438 – 0.739 0.433 0.272 – 0.688 0.490 0.279 – 0.862 
Characteristics updated annually 
HIV status 
Negative 1 - 1 - - - - - 
Positive 0.362 0.326 – 0.403 0.391  0.347 – 0.441 - - - - 
Exposure to ART 
No - - - - 1 - 1 - 
Yes - - - - 0.825 0.682 – 0.998 0.624 0.487– 0.799 
 Age at episode 
15-19 1 - 1 - 1 - 1 - 
20-24 0.535 0.473 – 0.604 0.739 0.646 – 0.846 0.851 0.609 – 1.189 0.709 0.460– 1.094 
25-29 0.370 0.322 – 0.426 0.597 0.502 – 0.710 0.772 0.556 – 1.071 0.557 0.354 – 0.875 
30-35 0.322 0.275 – 0.376 0.488 0.398 – 0.598 0.571 0.405 – 0.804 0.396 0.244 – 0.645 
35-39 0.203 0.168 – 0.245 0.244 0.190 – 0.313 0.316 0.213 – 0.473 0.153 0.086 – 0.273 
40-44 0.061 0.045 – 0.085 0.061 0.042 – 0.089 0.062 0.029 – 0.131 0.042 0.018 – 0.101 
45-49 0.015 0.008 – 0.030 0.013 0.006 – 0.026 0.021 0.005 – 0.086 0.006 0.001 – 0.045 
Knowledge of own HIV status  
No 1 - 1 - 1 - - - 
Yes 0.647 0.556 – 0.754 0.635 0.509 – 0.792 1.004 0.757 – 1.332 - - 
Unknown 0.557 0.492 – 0.629 0.891 0.732 – 1.083 0.704 0.441 – 1.122 - - 
Most recent relationship status 
Single 1 - 1 - 1 - 1 - 
Casual partner 1.307 0.896 – 1.906 0.797 0.545 – 1.167 2.140 1.101 – 4.162 2.214 1.063 – 4.610 
Engaged/Married 0.801 0.650 – 0.986 1.510 1.207 – 1.888 1.367 0.888 – 2.105 2.116 1.345 – 3.329 
Regular partner 1.400 1.216 – 1.613 1.149 0.991 – 1.332 2.339 1.772 – 3.087 2.351 1.568 – 3.526 
Divorced/ Widow / 
Separated  
1.208 0.941 – 1.550 1.382 1.074 – 1.777 1.894 1.203 – 2.982 2.731 1.630 – 4.475 
Other/ unknown 1.275 1.103 – 1.475 1. 214 0.790 – 1.866 1.252 0.941 – 1.665 1.282 0.9233 –1.781 
Living with partner 
No 1 - 1 - 1 - 1 - 
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Yes 0.727 0.619 – 0.855 1.732 1.426 – 2.104 1.093 0.823 – 1.452 1.782 1.236 – 2.569 
Unknown 1.079 0.782 – 1.490 1.014 0.329 – 3.124 0.755 0.355 – 1.605 0.210 0.008 – 5.332 
No partner 0.967 0.875 – 1.069 - - 0.654 0.538 – 0.796 - - 
Parity  
0 1 - 1 - 1 - 1 - 
1 0.383 0.339 – 0.432 0.456  0.402 – 0.519 0.941 0.706 – 1.254 0.931 0.648 – 1.338 
2 0.303 0.263 – 0.350 0.525 0.447 – 0.617 0.854 0.637 – 1.147 1.200 0.817 – 1.761 
3 0.256 0.216 – 0.303 0.574 0.470 – 0.700 0.658 0.472 – 0.916 1.056 0.677 – 1.647 
4 0.208 0.167 – 0.258 0.622 0.482 – 0.803 0.584 0.394 – 0.867 1.557 0.932 – 2.600 
5 0.160 0.121 – 0.211 0.656 0.476 – 0.903 0.382 0.225 – 0.649 1.314 0.681 – 2.534 
6+  0.141 0.111 – 0.179 0.899 0.662 – 1.219 0.304 0.181 – 0.510 1.629 0.812 – 3.267 
Self-reported Health  
Fair/ Poor 1 - 1 - 1 - -  
Excellent/ Very 
good/ Good 
2.028 1.682 – 2.445 0.977 0.806 – 1.184 1.750 1.284 – 2.385   
Unknown 1.996 1.640 – 2.428 1.004 0.783 – 1.287 1.181 0.852 – 1.638   
Heard of ART  
No 1 - 1 - 1 - - - 
Yes 0.765 0.667 – 0.879 0.994 0.834 – 1.184 0.976 0.724 – 1.292 - - 
Unknown 1.205 1.050 – 1.383 0.971 0.808 – 1.167 1.001 0.731 – 1.390 - - 
Year of annual surveillance episode 
2007 1 - 1 - 1 - 1 - 
2008 0.979 0.834 – 1.148 0.831 0.687 – 1.004 0.902 0.658 – 1.237 0.906 0.658 – 1.247 
2009 0.956 0.812 – 1.126 0.720 0.571 – 0.908 0.993 0.726 – 1.359 1.051 0.717 – 1.541 
2010 1.016 0.865 – 1.195 0.861 0.685 – 1.082 1.268 0.946 – 1.701 1.706 1.192 – 2.440 
2011 1.221 1.040 – 1.434 1.068 0.859 – 1.328 1.124 0.813 – 1.553 1.359 0.873 – 2.115 
2012 1.073 0.896 – 1.287 0.817 0.644 – 1.036 0.745 0.491 – 1.126 1.189 0.641 – 2.203 
Using contraception (updated annually) 
No 1 - - - 1 - 1 - 
Yes 0.455 0.388 – 0.534 - - 0.523 0.394 – 0.694 0.350 0.250 – 0.489 
Unknown 0.954 0.843 – 1.080 - - 0.574 0.450 – 0.730 0.653 0.446 – 0.957 
Form of Contraception (updated annually) 
Barrier methods 1 - 1 - 1 - - - 
Oral / IUCD / 
Microbicides 
0.754 0.423 – 1.341 0.881 0.494 – 1.571 1.410 0.640 –3.111 - - 
Injectable 0.586 0.438 – 0.784 0.638 0.475 – 0.856 0.509 0.318 – 0.818 - - 
Dual 0.510 0.267 – 0.976 0.652 0.340 – 1.250 0.538 0.231 – 1.254 - - 
Other  unknown  0.556 0.412 – 0.751 0.520 0.378 – 0.716 0.385 0.225 – 0.660 - - 
None 1.509 1.211 – 1.881 1.662 1.308 – 2.112 1.249 0.881 – 1.770 - - 
Unknown if using  1.440 1.179 – 1.758 1.684 1.358 – 2.089 0.716 0.530 – 0.968 - - 
CD4 count (time-updated) (cells/μl) 
<=250 - - - - 1 - 1 - 
250-350 - - - - 0.774 0.538 – 1.114 0.964 0.624 – 1.490 
350-500 - - - - 1.025 0.744 – 1.412 1.259 0.844 – 1.879 
>500 - - - - 0.756 0.544 – 1.050 0.905 0.597 – 1.371 
Unknown - - - - 0.596 0.460 – 0.772 0.341 0.235 – 0.495 
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4.2.7 Factors associated with rates of live birth in a sub-analysis of HIV positive women  
A sub-analysis of HIV positive women was conducted using the open cohort data after excluding HIV 
negative women. Incidences of live birth observed during HIV positive women years are reported by 
characteristic and by ART exposure in Table 4.8. For the purpose of this analysis, exposure refers to 
enrolment on lifelong ART and use of ART for the purposes of PMTCT.   
Univariate analysis found a minimal association between exposure to ART and reduced crude rates 
of live birth (p=0.0468). This result is contrary to the hypothesis that HIV positive women would be 
encouraged to continue childbearing after initiation on ART. Some women may have enrolled onto 
ART for the purpose of prevent mother-to-child transmission: inclusion of these women would likely 
result in an inflated estimation of incidence of live births during ‘on ART’ woman-years. 
Consequently, women enrolled on lifelong ART may experience even lower incidence of live birth 
and this finding lend more evidence to suggest that HIV positive women are more likely to limit their 
childbearing after they initiate ART.    
In the total cohort analysis, urban area of residence, higher age group, poor self-perceived health, 
higher parity and use of contraception were associated with lower rates of live birth during HIV 
positive woman episodes. Table 4.8 presents trends according to exposure to ART. 
Age-specific rates of live birth were lower amongst ART-exposed compared to ART-naive women at 
all ages, except for women episodes in the 25-29 year old age group. ART exposed women in this age 
group experienced 38% higher rates of live birth (6.9 births/100 ART-exposed woman episodes [5.4-
9.0]) compared to ART-naive women  (4.6 births per 100 ART-naïve woman episodes [3.7-5.7] 
(p=0.017)). This was the only age group in which a trend of lower rates amongst HIV positive women 
was reversed. It is an important finding as it provides evidence that ART may increase fertility 
amongst women of reproductive age that have not yet completed their childbearing. ART exposure 
reverses the mitigating effects of a HIV positive status, either a decision to limit childbearing or 
reduced sexual activity, on fertility. Social norms for small family sizes and low fertility rates suggest 
that women would usually curtail childbearing after this age and so women that wish to have a child 
are encouraged to do so on ART.  Figure 4.16 presents Kaplan-Meier time-to-event analysis 
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estimates comparing incidence by time-updated HIV status and ART exposure for women aged 25-29 
years old.  
Relationship status was not associated with crude incidence of live birth during HIV positive woman 
episodes although this trend was unclear. Women exposed to ART while in a ‘casual relationship’ did 
not give birth at all during ART-exposed periods, compared to an incidence of 6.1 births per 100 ART-
naïve women episodes (p=0.0524). Yet crude rates of live birth were equal amongst women amongst 
ART-exposed and ART-naïve women seeing a regular partner 5.3 [4.3 – 5.9] and 5.3 [3.5 – 6.0] 
births/100 woman episodes respectively.  Crude rates were also lower amongst women that were 
not living with their partner or their living arrangements were unknown to this study while on ART 
and did not differ according to exposure to ART.   
Rates of live birth amongst contraceptive users were less than half those of non-contracepting HIV 
positive women in an analysis of HIV positive as a whole and ART-naïve women. ART-exposed 
women did not follow this same trend. Rates of live birth were similar by use or non-use of 
contraception during ART-exposed women episodes (P=0.500). The key driver of this non-difference 
appears to be due to reduced rates amongst women on ART not using contraception. These findings 
are indicative of sexual activity amongst non-contraceptors on ART rather than an effect of more 
efficacious contraceptive behaviour amongst women on ART. There was no association between 
selected form of contraception and crude rates of live birth amongst ART-exposed women.  
CD4+ count was included as a clinical measure of physiological improvements to health, but no trend 
between CD4+ measure and incidence of live birth was established. An analysis limited solely to HIV 
positive women found no significant association between CD4 count and exposure to ART 
(p=0.5563), suggesting that continued childbearing for these women is not associated with clinical 
health. 
Poor self-perceived health was not associated with lower rates of live birth when episodes were 
stratified by exposure to ART although birth rates were significantly higher amongst women 
reporting themselves to be in good versus poor health across all stratification. 
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Table 4.8: Characteristics associated with incidence of live birth in HIV positive women episodes 
stratified by exposure to ART  
 
Characteristics 
Incidence Rate [95% CI] 
HIV Positive 
(N=14,341 
episodes 
ART Exposure 
(HIV positive women only) 
ART-naïve 
(N=8,502 episodes) 
ART-exposed 
(N=5,839 episodes) 
Trend for 
characteristic 
adjusted for 
exposure to ART 
(p-value) 
Overall Incidence 3.5 [3.2 – 3.8] 3.8 [3.4 – 4.2] 3.1 [2.7 – 3.6] P=0.0468 
Characteristics at entry 
Education at entry 
 Never attended 2.0 [1.4 – 2.8] 2.1 [1.4 – 3.2] 1.9 [1.2 – 3.1] 
P=0.047 
At least Primary 3.5 [2.9 – 4.3] 4.0[3.2 – 5.1] 2.7 [1.9 – 3.9] 
Secondary  4.5 [3.9 – 5.1] 4.7 [4.0 – 5.5] 4.0 [3.1 – 5.1] 
Tertiary 3.4 [2.8 – 4.1] 3.6 [2.8 – 4.5] 3.1 [2.2 – 4.3] 
Unknown 2.7 [1.9 – 3.8] 2.4 [1.5 – 3.8] 3.1 [1.9 – 5.0] 
 P=0.0435 P=0.2630 P=0.0702 
Area at entry 
 Rural 4.1 [3.7 – 4.6] 4.5 [3.9 -5.2] 3.4 [2.8 – 4.2] 
P<0.001 
Peri-Urban 3.0 [2.6 – 3.5] 3.0 [2.5 – 3.7] 3.1 [2.4 – 3.9] 
Urban 1.8 [1.1 – 2.8] 2.0 [1.1 – 3.6] 1.5 [0.8 – 3.0] 
 p<0.0001 p=0.0001 P=0.0410 
Characteristics updated annually 
 Age (updated annually) 
 15-19 6.9 [5.2 – 9.2] 7.2 [5.3 – 9.7] 5.5 [2.5 – 12.0] 
P<0.001 
20-24 5.9 [4.9 – 7.0] 6.2 [5.1 – 7.5] 4.6 [2.9 – 7.4] 
25-29 5.3 [4.5 – 6.3] 4.6 [3.7 – 5.7] 6.9 [5.4 – 9.0] 
30-35 3.9 [3.3 – 4.8] 4.6 [3.7 – 5.1] 4.0 [3.0 – 5.3] 
35-39 2.2 [1.7 – 2.9] 3.9 [3.0 – 5.1] 2.3 [1.6 – 3.4] 
40-44 0.4 [0.2 – 0.9] 0.4 [0.2 – 1.1] 0.4 [0.2 – 1.2] 
45-49 0.1 [0.0 – 0.6] 0.0 [-] 0.3 [0.1 – 1.2] 
 P<0.0001 P<0.0001 P<0.0001 
Knowledge of own HIV status (updated annually) 
 No 3.6 [2.7 – 4.7] 3.6  [2.7 – 4.7] - 
P=0.306 
Yes 3.6 [3.3 – 4.0] 4.0 [3.5 – 4.6] 3.1 [2.7 – 3.6] 
Unknown 2.5 [1.7 – 3.7] 2.5 [1.7 – 3.7] - 
 P=0.2329 P= 0.3062 - 
Most recent relationship per annual episode 
 Single 2.3 [1.8 – 2.9] 2.3 [2.4 – 3.5] 2.3 [2.2 – 3.4] 
P=0.417 Casual friend /partner 4.8 [2.6 – 9.0] 6.1 [3.4 – 11.0] 0.0 [– ] 
Engaged/Married 3.1 [2.2 – 4.4] 3.9 [2.3 – 7.5] 2.0 [1.2 – 7.0] 
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Regular partner 5.3 [4.6 – 6.1] 5.3 [4.3 – 5.9] 5.3 [3.5 – 6.0] 
Divorced/Widowed/Separ
ated  
4.3 [2.9 – 6.3] 5.3 [1.7 – 4.3] 2.7 [1.2 -4.6] 
Other or unknown 2.8 [2.4 – 3.3] 2.8 [2.3 – 16.4] 2.8 [0.7 – 7.0] 
 P=0.424 P=0.394 P=0.706 
Living with partner 
 No 4.3 [3.7 – 5.0] 4.6 [3.9 – 5.5] 3.5 [2.6 – 4.7] 
P<0.001 
Yes 4.7 [3.7 – 6.0] 4.7 [3.5 – 6.4] 4.7 [3.2 – 7.0] 
Unknown 3.3 [1.6 – 6.8] 5.5 [2.1 – 14.7] 2.1 [0.7 – 6.5] 
No partner 2.8 [2.5 – 3.2] 2.9 [2.4 – 3.5] 2.7 [2.2 – 3.4] 
 P<0.0001 P=0.0001 P=0.0666 
Median Parity 2 2 3  
Parity (time-updated) 
 0 4.7 [3.7 – 5.9] 5.5 [4.1 – 7.1] 2.8 [1.6 – 5.0] 
P<0.001 
1 4.4 [3.7 – 5.2] 4.5 [3.7 – 5.5] 4.2 [3.1 – 5.7] 
2 4.0 [3.4 – 4.8] 4.3 [3.4 – 5.3] 3.6 [2.7 – 4.9] 
3 3.1 [2.4 – 3.9] 3.4 [2.5 – 4.6] 2.8 [1.9 – 4.0] 
4 2.7 [2.0 – 3.8] 2.3 [1.4 – 3.7] 3.3 [2.1 – 5.0] 
5 1.8 [1.1 – 2.9] 1.7 [0.9 – 3.2] 2.0 [1.0 – 4.0] 
6+  1.4 [0.9 – 2.3] 1.3 [0.7 – 2.4] 1.6 [0.9 – 3.2] 
 P<0.0001 P<0.0001 P=0.0130 
Self-reported Health (updated annually) 
 Fair/Poor 2.5 [1.9 – 3.3] 3.1 [2.1 – 4.5] 1.9 [1.3 – 3.0] 
P=0.418 
Excellent/Very 
good/Good 
4.3 [3.8 – 4.9] 4.5 [3.9 – 5.1] 4.0 [3.2 – 5.0] 
Unknown 2.9 [2.5 – 3.4] 2.9 [2.4 – 3.6] 2.8 [2.2 – 3.6] 
 P=0.4457 P=0.0945 P=0.4819 
Heard of ART (time-updated) 
 No 3.6 [2.7 – 4.7] 3.6 [2.7 – 4.7] - 
P=0.851 
Yes 3.5 [3.1 – 3.9] 4.0 [3.4 – 4.7] 3.1 [2.7 – 3.6] 
Unknown 3.6 [3.0 – 4.3] 3.6 [3.0 – 4.3]  - 
 P=0.8626 P=0.8509 - 
Year of annual surveillance episode 
 2007 3.4 [2.7 – 4.3] 3.9 [3.0 – 4.9] 1.7 [0.8 – 3.4] 
P=0.268 
2008 3.1 [2.4 – 3.8] 3.2 [2.5 – 4.1] 2.6 [1.7 – 4.1] 
2009 3.4 [2.7 – 4.2] 4.1 [3.2 – 5.1] 2.1 [1.3 – 3.3] 
2010 4.3 [3.6 – 5.2] 4.1 [3.3 – 5.2] 4.7 [3.5 – 6.2] 
2011 3.8 [3.1 – 4.8] 4.0 [2.8 – 5.5] 3.7 [2.8 – 5.1] 
2012 2.5 [1.8 – 3.6] 2.3 [1.1 – 4.9] 2.6 [1.7 – 3.8] 
 P=0.6782 P=0.8760 P=0.1139 
Using contraception (updated annually) 
 No 5.8 [4.7 – 7.2] 6.5 [5.1 – 8.1] 3.9 [2.3 – 6.4] 
P=0.002 
Yes 3.0 [2.5 – 3.6] 3.0 [2.3 – 3.8] 3.1 [2.3 – 4.2] 
Unknown 3.3 [2.9 – 3.7] 3.5 [3.0 – 4.1] 3.0 [2.5 – 3.7] 
 P=0.0008 P=0.0009 P=0.4997 
Form of Contraception (updated annually) 
 Barrier methods 4.5 [3.5 – 6.1] 5.6 [3.9 – 7.9] 3.6  [2.3 – 5.7] 
P=0.457 
Oral/IUCD/Microbicides 6.5 [3.1 – 13.7] 5.3 [2.0 – 14.2] 9.3 [3.0 – 28.7] 
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Injectable 2.4 [1.6 – 3.5] 2.3 [1.4 – 3.7] 2.5 [1.4 – 4.5] 
Dual 2.5 [1.1 – 5.5] 3.1 [1.2 – 8.4] 1.8 [0.4 – 7.0] 
Other/unknown method 1.8 [1.1 – 2.8] 1.5 [0.9 – 2.7] 2.6  [2.3 – 6.4] 
None 5.8 [4.7 – 7.1] 6.5 [5.1 – 8.1] 3.9 [2.3 – 5.9] 
Unknown if using  3.3 [2.9 – 3.7] 3.5 [3.0 – 4.1] 3.0 [2.5 – 3.7] 
 P=0.2347 P=0.3312 P=0.5164 
CD4 count (time-updated) (cells/μl) 
 <=250 4.8 [3.9 – 6.0] 10.9 [7.5 – 15.9] 3.7 [2.8 – 4.9] 
P<0.001 
250-350 3.7 [2.8 – 5.0] 5.3 [3.3 – 8.4] 3.1 [2.2 – 4.5] 
350-500 4.9 [3.9 – 6.2] 9.3 [6.8 – 12.8] 3.2 [2.3 – 4.5] 
>500 3.6 [2.9 – 4.6] 7.4 [5.4 – 10.0] 1.9 [1.3 – 2.8] 
Unknown 2.9 [2.5 – 3.3] 2.8 [2.4 – 3.2] 3.8 [2.6 – 5.7] 
 P<0.0001 P<0.0001 P=0.5563 
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Figure 4.16 Kaplan-Meier estimates of live birth-free survival to women aged 25-29 years old by a) HIV status and by b) ART exposure, in an open cohort 
with a maximum observation time of 6 years. Chart a) illustrates birth survival for HIV positive women in red and HIV negative women in blue and chart b) 
illustrates birth free survival for HIV positive ART-exposed women in red and HIV positive ART-naïve women in blue 
 
a) HIV Negative versus HIV Positive 
                  
b) ART-naive versus ART-exposed 
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4.2.8 Strengths and limitations of dataset and factors measured by demographic surveillance  
This analysis describes the likelihood of live birth to women that: participated in HIV surveillance and 
Women’s General Health between 2007 and 2012, responded ‘yes’ to the question ‘have you ever 
had sex?’ and were resident in the DSA. Exclusion criteria have reduced the overall sample size for 
inclusion in this open cohort. They may also pose a number of limitations for interpretation, which 
will be discussed in this section.  
Non-residents constituted 5-6% of women included in each annual HIV surveillance round. Just over 
50% of residents and non-residents were under the age of 50 years old during the years spanning 
this cohort. Preliminary analysis determined that the proportion of non-residents within each age 
and HIV category were roughly equal and exclusion was unlikely to result in bias. Furthermore, 
analysis restricted to resident women is likely to describe the demographic facing HIV treatment and 
care in this setting. 
A limitation of the Women’s General Health questionnaire design is that questions may be asked to 
a key informant when women are not present during a household visit. Family members may not be 
aware of accurate responses and older or male residents may feel uncomfortable answering such 
questions. These issues are likely responsible for the high degree of missing data for questions in this 
survey, including self-reported health, relationship status and contraceptive use.  
This design better captures women that are more likely to be present in the household on an Africa 
Centre visit date. Consequently, younger age groups were disproportionately excluded and this 
analysis is unlikely to well represent the childbearing behaviours of adolescents. Personal 
communication with fieldworkers suggest that younger household members are usually more willing 
to provide answers of a personal nature than older members of household, but participation from 
adolescents is not as high. This limitation is important as older women may experience lower fertility 
and so this cohort may underestimate actual fertility rates in this setting. However, this effect may 
be outweighed by another restriction to only women that answered ‘Yes’ to ever had sex, resulting 
in a probable overestimation of actual fertility rates within the DSA by this cohort.  
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‘Ever had sex’ was the most valuable exclusion criteria for this dataset to ensure an appropriate 
comparison between HIV negative and HIV positive women. Restrictions around marriage are 
neither culturally appropriate nor statistically useful, as discussed in section 4.1. The proportion of 
women responding to this question increased from 36% to 50% between 2005 and 2012, resulting in 
decreased exclusion according to this variable in later cohort years. Furthermore, the most fertile 
age range of 20-39 years old are less likely to be affected by this exclusion, and the determinant of 
interest, use of ART, is common in older age groups.  
Missing data is a strong limitation of this dataset. Non-response was high and varied by question, as 
described in Table 4.4. Several approaches to treatment of missing data were considered for this 
analysis. High proportions of missing data, up to 56%, meant this dataset did not lend well to 
multiple imputation. Furthermore, the data could not be confidently determined as missing at 
random. Exclusion to women that responded ‘yes’ to ‘Ever Had Sex’ removed a high degree of 
missingness in other variables. In a preliminary analysis, HIV status was unknown to 72% of women 
that refused to answer this question. Excluded women were also less likely to respond to questions 
on contraceptive use or self-reported general health. A complete case analysis would further exclude 
a substantial proportion of this dataset and was considered inappropriate for the purpose of this 
analysis. Finally, inclusion of an additional ‘missing’ category for variables with non-response is 
considered suitable for epidemiological studies and includes more information and transparency of 
analysis.   
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4.2.9 Analysis Two: Section Summary  
x Between 2007 and 2013 there were a total of 1,757 live births among 9,972 women 
x Crude incidence of live birth in this cohort was 6.6 births per 100 woman years overall and 
rates were three times higher amongst HIV negative women compared to HIV positive 
women. Exposure to ART was minimally associated with reduced crude birth rates 
(p=0.0468). 
x Multivariable Poisson regression adjusted for significant proximate and distal determinants 
of fertility found being HIV positive was associated with a 61% reduced annual risk of live 
birth (aHR, 0.39; 95% 0.347 – 0.441) and exposure to ART was associated with a 38% 
reduced risk of live birth (aHR, 0.62; 95% 0.487 – 0.799) compared to ART naïve women. 
x Crude incidence of live birth in the total cohort of HIV negative and positive women 
decreased with increasing age group, higher parity, poorer self-reported health, an urban 
area of residency, knowledge of own HIV status, being single or engaged/married, not living 
with a partner, an awareness of the benefits of ART, use of contraception and use of 
injectable methods of contraception.  
x Inclusion of HIV status and exposure to ART in multivariable analysis resulted in little change 
in trends of live birth per characteristic, with the exception of self-perceived health, which 
was no longer associated with birth rates in multivariable analysis. Variance may be 
explained by actual HIV status and more proximate determinants such as contraceptive use  
x Knowledge of HIV status was associated with a 46% reduced risk of live birth. Non-
responders to this question had different patterns of live birth according to HIV status, 
which could be indicative of different health seeking and risky behaviours. 
x Childbearing was not strongly associated with current parity in HIV positive women. Risk of 
live birth was higher to women in more formal relationships and a reduced risk of live birth 
was strongly associated with contraceptive use. HIV positive women had generally lower 
birth rates compared to HIV negative women except when co-residing with a partner, at 
which time rates were similar irrespective of HIV status. No women initiated on ART and 
reporting to be in a casual relationship experienced a live birth in this cohort.  
  
 
 
182 
4.3 Birth-free survival in a cohort of woman including ‘unknown’ HIV status (closed 
entry in 2007/2008) 
A closed cohort analysis presented in this section 4.3 includes all women who participated in the 
2007 or 2008 surveillance years until censored in 2013 or lost to follow up. This analysis extends 
upon the prior analysis two by including all resident women including those with a HIV status that is 
‘unknown’ to the HIV surveillance. The aim was to provide a comparison of factors associated with 
likelihood of live birth between HIV negative, HIV positive and women with missing data for HIV 
status. I hypothesised to see similar incidence amongst HIV negative and HIV positive women as 
determined in the prior analysis two, due to similar sampling and inclusion criteria, with the 
exception of a closed cohort structure. The effect of ART exposure may be more strongly associated 
with incidence of live birth soon after national roll-out, although I would not expect to see a large 
difference in this setting of low fertility. In which case, analysis two may capture a smaller estimate 
of reduced risk of live birth to women on ART compared to ART-naïve women. Findings were mostly 
comparable between cohorts and the following section will present a summary of the important 
findings.  
 
4.3.1 Characteristics over analysis time 
A total of 1,662 births occurred over 26,397 woman years of follow up. And median follow up was 
longer in this cohort at 3.9 years per woman. During follow up, 1,148 women sero-converted from 
HIV negative to HIV positive and 622 women were observed to initiate ART. These individual 
women-episodes were censored at the date of initiation and categorised as ‘ART-exposed’ in 
subsequent woman-episodes. Characteristics at baseline entry in 2007 or 2008 are presented in 
Table 4.9 and characteristics reported during ‘unknown HIV status’ women-years of follow were very 
similar to HIV negative women episodes. HIV positive women differed from both HIV negative and 
HIV unknown women in education, area of residence, relationship status, contraceptive use and 
health. 
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HIV status was known from the HIV surveillance for 75% of the 7,476 women who participated in the 
HIV surveillance round in years 2007 and 2008. Overall, 56% of women reported to know their own 
status, independent to the whether their status was recorded during surveillance or not. 
Median age at baseline was 32 years and women had a median parity of two children. Age increased 
sequentially amongst HIV unknown, negative and positive women, and women on ART were a 
median of 6 years older than ART-naïve women. Women in all HIV categories had a median of two 
children except when HIV positive women were stratified by exposure to ART: women ‘on-ART’ had 
the highest median age of 37 years old and parity of three children. 
Most (52%) women reported being in a regular relationship and these trends were similar amongst 
women categorised as HIV negative or HIV ‘unknown’ at baseline. HIV positive women were more 
likely to report being single: only 39% were in a relationship compared to 61% of HIV negative 
women.  Self-reported current use of contraception was 36%. Fewer HIV positive women answered 
‘yes’ to using contraception at last sex at entry (27%) compared to HIV negative (41%) and HIV 
unknown (40%) women and ART-exposed women were least likely to report contraceptive use 
(24%). Overall, 78% of women answered the question on which form of contraception they were 
using. Fewer HIV positive women reported not using any contraception at last sex but this group 
were more likely to not respond at baseline. 
Most women reported themselves as being in good health (73%) but this proportion varied by HIV 
Status as 49% of HIV positive women reported feeling healthy compared to 88% of HIV negative 
women and 84% of women with unknown HIV status. More HIV positive women did not answer the 
question on perceived health. ART-exposed women were most likely to not respond or to perceive 
their own health as fair or poor at baseline.  
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Table 4.9 Demographic, relationship and HIV related characteristics to women at first entry to closed cohort in 2007 or 2008, disaggregated by HIV and ART exposure 
Characteristics 
Overall 
All women 
N=7,476 (100%) 
HIV Positive Women 
N= 2,624 (100%) 
HIV Unknown HIV Negative HIV Positive ART-Naïve ART-Exposed 
Births 
N=1,692 
(100%) 
Women 
N=7,476 
(100%) 
Births 
N=563 
(33%) 
Women 
N= 1,852 
(25%) 
Births 
N=744 
(44%) 
Women 
N=3,000 
(40%) 
Births 
N=355 
(21%) 
Women 
N= 2,624 
(35%) 
Births 
N=271 
(76%) 
Women 
N=2,123 
(81%) 
Births 
N=84 
(24%) 
Women 
N= 501 
(22%) 
Median parity  2 2 2 2 2 3 
Median age  32 30 32 33 31 37 
Attained secondary level 
education  
1,190 4,873 65% 438 1,369 74% 520 1,859 76% 232 1,645 62% 192 1,348 63% 40 297 60% 
Rural residency  1,202 4,744 63% 387 1,165 63% 589 2,150 72% 226 1,429 54% 181 1,168 55% 45 261 52% 
Relationship Status  
Single 858 1,592 21% 385 227 12% 322 167 6% 151 1,198 46% 109 915 43% 42 283 56% 
Casual Friend/Partner 18 149 2% 2 43 2% 8 67 2% 8 39 2% 8 30 1% 0 9 2% 
Engaged/Married 69 945 13% 9 274 15% 46 556 19% 14 115 4% 11 95 4% 3 20 4% 
Regular Partner 655 3,916 52% 147 1,069 58% 349 1,834 61% 159 1,013 39% 129 884 42% 30 129 26% 
Div/Widow/Sep 70 847 11% 17 234 13% 34 368 12% 19 245 9% 12 187 9% 7 58 12% 
Unknown 22 27 0.4% 3 5 0.3% 15 8 0.3% 4 14 1% 2 12 1% 2 2 0.4% 
Self-reported Health 
Fair/Poor 85 508 7% 18 79 4% 35 248 8% 32 181 7% 21 128 6% 11 53 11% 
Excellent/Very good/Good 903 5,468 73% 199 1,562 84% 502 2,625 88% 202 1,281 49% 163 1,114 52% 39 167 33% 
Unknown 704 1,500 20% 346 211 11% 237 127 4% 121 1,162 44% 87 881 42% 34 281 56% 
Reported use of 
Contraception 
236 2,682 36% 36 768 41% 121 1,211 40% 79 703 27% 57 585 28% 22 118 24% 
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Form of Contraception  
Barrier methods 69 377 5% 11 126 7% 23 147 5% 35 104 4% 23 88 4% 12 16 3% 
Oral/IUCD/Microbicides  8 26 0.3% 2 7 0.4% 4 13 0.4% 2 6 0.2
% 
2 6 0.3% 0 0 0% 
Injectable 68 223 3% 12 71 4% 37 113 4% 19 39 1% 15 32 2% 4 7 7% 
Dual 8 41 1% 0 17 1% 3 13 0.4% 5 11 0.4
% 
4 9 0.4% 1 2 2% 
Unknown  83 2,015 27% 11 547 30% 54 925 31% 18 543 21% 13 450 21% 5 93 19% 
None 415 3,156 42% 110 852 46% 224 1,593 53% 81 711 27% 71 613 29% 10 98 20% 
Unknown if using 1,041 1,638 22% 417 232 13% 429 196 7% 195 1,210 46% 143 925 44% 52 285 57% 
Knows HIV status  914 4,206 56% 210 1,008 54% 424 1,557 52% 280 1,641 63% 196 1,140 54% 84 501 100% 
Heard of ART 642 2,027 27% 154 490 26% 290 677 23% 198 860 33% 114 359 17% 84 501 100% 
Median CD4 - - - 363 348 374 
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4.3.2 Multivariable analysis of time-to-live birth after participation in the 2007 or 2008 HIV 
surveillance  
 
4.3.3.1 Testing the proportional hazards assumption 
A key assumption of the Cox model, the proportional hazards assumption, states that the hazard 
ratio remains constant over the entire follow up time. The proportional hazards assumption may be 
tested graphically and formally using a post-estimation command that tests for a non-zero slope in a 
regression of the scaled Schoenfeld residuals (Grambsch and Therneau, 1994) 
In a complete cohort analysis, HIV status and other proximal and distal determinants of fertility, 
including: relationship status, parity, self-reported health and method of contraception, violated the 
proportional hazards assumption. This violation is unsurprising and suggests that rates of live birth 
vary over time, with increasing age of participants. It indicates that changes in fertility also occur at 
different (non-proportional) rates over time. Particularly, fertility declines at different rates for HIV 
negative and positive women.  
Table 4.12: Test of proportional-hazards assumption per variable 
 rho chi2 Df Prob>chi2 
Education at entry 0.04200      3.03 1 0.0817 
HIV Status 0.23244      94.58 1 >0.0001 
Knowledge of HIV status -0.09111      14.80 1 0.0001 
Area of residence at entry -0.03752      2.56 1 0.1093  
Age group -0.05056      4.43 1 0.0352  
Relationship status 0.07113      7.87 1 0.0050 
Living with partner -0.02128      0.76 1 0.3820 
Parity 0.06218      6.55 1 0.0105 
Self-reported health -0.05074      4.31 1 0.0380 
Aware of benefits of ART 0.14810      36.55 1 >0.0001 
Using contraception -0.12213      24.90 1 >0.0001 
Global Test - 528.58 11 >0.0001 
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Figure 4.17  Plot of scaled Schoenfeld residuals for each variable against time 
a) Education at entry b) HIV Status 
      
 
c) Knowledge of HIV status 
 
d) Area of residence at entry 
      
 
e) Age group  
 
f) Relationship status 
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g) Currently living with partner 
 
h) Parity group 
      
 
 
i) Self-reported health 
 
 
 
j) Aware of benefits of ART 
 
      
 
k) Contraceptive group 
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A Cox model will not yield reliable interpretations of the complete cohort and stratification was 
required. Some variables of interest became proportional when stratified by HIV status (Table 4.11). 
Section 4.3.3.3 presents results from a multivariable Cox Proportional Hazard analysis stratified by 
HIV status and including only non-volitional variables. 
 
Table 4.11 Test of proportional hazards when stratified by HIV status 
 Prob>chi2 
HIV status 
unknown 
HIV negative HIV positive 
Education at entry 0.6104 0.3730 0.2480 
Knowledge of HIV status 0.0202 0.0002 0.1716 
Area of residence at entry 0.2852 0.3033 0.1291  
Age group 0.0002 0.2599 0.4989  
Relationship status 0.0094 0.0093 0.4032 
Living with partner 0.1542 0.0004 0.3638 
Parity 0.0017 0.1453 0.7125 
Self-reported health >0.0001 0.0001 0.8284 
Aware of the benefits of 
using ART 
>0.0001 0.0010 0.0190 
Using contraception >0.0001 >0.0001 >0.0001 
CD4 count - - 0.0191 
On ART - - 0.3614 
 
 
4.3.3.2 Factors associated with time to live birth in univariate analysis 
Crude incidence of live birth in a closed cohort of all women participating in HIV surveillance rounds 
in 2007 and 2008 was 6.4 births per 100 women years [95% CI 6.1– 6.7]; there was significant 
variation in rates amongst women by HIV status. Highest rates of 9.0 births per 100 woman years 
[95% CI 8.2 – 9.7] were recorded in women with 'unknown' status and the lowest rates were 
reported for women with an HIV positive status at 3.6 births per 100 woman years [95% CI 3.2 – 4.0] 
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This analysis found similar trends in rates of live birth by characteristics as reported in analysis two 
(table 4.12). Trends were also similar when disaggregated by HIV status category and significantly 
lower amongst HIV positive women by each level of characteristic compared to women of unknown 
HIV status. In summary, a univariate analysis of all women episodes detected higher rates of live 
birth amongst women who had attained secondary level education, lived in rural area of residence, 
aged 15-19 years old, had a regular partner, did not have any children, did not report contraceptive 
use at most recent sex and had not yet initiated ART (if HIV positive).  
Use of contraception was associated with a 49% lower risk of live birth. However, this association did 
not change proportionally over time and so could not be included in multivariable analyses.  
Many women experience a birth while reporting themselves as single, suggesting that they may 
engage in more casual relationships during this time. The results suggest being HIV positive may 
prevent the formation of casual relationships. Single women experienced slowest rates of live birth 
when HIV positive: 2.7 births per 100 single HIV positive women [95% CI 2.3 – 3.2] compared to 8.0 
births per 100 single HIV negative women [95% CI 7.2 – 9.0]. Incidence was highest for women in the 
HIV positive category reporting to have a regular or casual partner, compared to being single. 
Comparatively, women with unknown HIV status had the highest incidence of live birth at 11.6 [95% 
10.5 – 12.8] when reporting to be single.  
Rates were also highest amongst women that did not respond to questions on self-reported health, 
HIV status, knowledge of HIV status, co-residency with partner and awareness of the benefits of ART. 
Higher rates amongst non-responders in these categories may reflect less care seeking behaviour. 
Amongst respondents, women who reported to be in excellent, very good or good health 
experienced higher rates of live birth than those reporting poor or fair health. This finding is 
comparable to the effect of general health observed in an open cohort and presented in Section 4.2. 
CD4 count was used to determine a physiological effect of ART on health and although this variable 
was associated with rates of live birth, there was no clear trend.    
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Table 4.12  Crude incidence of live birth per characteristic for overall cohort and by HIV status category 
 
Characteristics 
All women 
(26,386.2 woman years) 
HIV unknown 
(6,276.1 woman years) 
HIV Negative 
(10,116.7 woman years) 
HIV Positive 
(9,993.4 woman years) 
Births 
Women 
years 
exposed 
Incidence Rate Births 
Women 
years 
exposed 
Incidence Rate 
[95% CI] Births 
Women 
years 
exposed 
Incidence Rate 
[95% CI] Births 
Women 
years 
exposed 
Incidence Rate 
[95% CI] 
Overall Incidence 1692 263.8 6.4 [6.1– 6.7] 562 62.8 9.0 [8.2 – 9.7] 774 101.2 7.7 [7.1 – 8.2] 356 99.9 3.6 [3.2 – 4.0] 
Characteristics at entry 
Education at entry 
 
Never attended 109 42.7 2.6 [2.1 – 3.1] 29 7.3 4.0 [2.8 – 5.7] 51 18.8 2.7 [2.1 – 3.6] 29 16.6 1.7 [1.2 – 2.5] 
At least Primary 341 49.4 6.9 [6.2 – 7.7] 101 9.9 10.2 [8.4 – 12.3] 166 20.3 8.2 [7.0 – 9.5] 74 19.1 3.9 [3.1 – 4.9] 
Secondary  764 93.7 8.1 [7.6 – 8.8] 243 22.9 10.6 [9.3 – 12.0] 363 36.1 10.1 [9.1 – 11.2] 158 34.5 4.6 [3.9 – 5.3] 
Tertiary 399 60.4 6.6 [6.0 – 7.3] 163 18.8 8.7 [7.4 – 10.1] 158 19.6 8.1 [6.9 – 9.4] 78 22.0 3.5 [2.8 – 4.4] 
Unknown 79 17.7 4.4 [3.6 – 5.6] 26 3.8 6.9 [4.7 – 10.1] 36 6.4 5.7 [4.1 – 7.8] 17 7.6 2.2 [1.4 – 3.6] 
    P<0.0001   P=0.042   P<0.0001   P<0.014 
Area at entry 
 
Rural 1199 165.1 7.3 [6.9 – 7.7] 384 40.5 9.5 [8.6 -10.5] 589 70.1 8.4 [7.6 – 9.1] 226 54.5 4.1 [3.6 – 4.7] 
Peri-Urban 423 81.8 5.2 [4.7 – 5.7] 146 16.4 8.9 [7.6 – 10.5] 161 27.0 6.0 [5.1 – 7.0] 116 38.5 3.0 [2.5 – 3.6] 
Urban 70 16.8 4.1 [3.3 – 5.2] 32 5.9 5.5 [3.9 – 7.7] 24 4.1 5.8 [3.9 – 8.7] 14 6.9 2.0 [1.2 – 3.4] 
    p<0.0001   P=0.0007   P=0.0016   P=0.0009 
Characteristics updated annually 
 Age (updated annually) 
 
15-19 372 22.8 16.3 [14.7 – 18.1] 127 6.2 20.3 [17.1 – 24.2] 212 12.3 17.3 [15.1 – 19.8] 33 4.3 7.7 [5.5 – 11.0] 
20-24 533 49.7 10.7 [9.8 – 11.7] 181 14.1 12.8 [11.1 – 14.8] 253 21.1 12.0 [10.6 – 13.6] 99 14.6 6.9 [5.5 – 8.3] 
25-29 319 44.4 7.2 [6.4 – 8.0] 105 11.4 9.2 [7.6 – 11.2] 119 14.3 8.3 [7.0 – 10.0] 95 18.7 5.1 [4.2 – 6.2] 
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30-35 265 38.9 6.8 [6.0 – 7.7] 85 9.0 9.4 [7.6 – 11.7] 95 10.5 9.1 [7.4 – 11.1] 85 19.4 4.4 [3.5 – 5.4] 
35-39 143 37.3 3.8 [3.2 – 4.5] 46 8.0 5.7 [4.3 – 7.7] 62 12.1 5.1 [4.0 – 6.6] 35 17.2 2.0 [1.5 – 2.8] 
40-44 49 37.2 1.3 [1.0 – 1.7] 14 7.5 1.9 [1.1 – 3.2] 27 15.0 1.8 [1.2 –2.6] 8 14.7 0.5 [0.3 –1.1] 
45-49 11 33.6 0.3 [0.2 – 0.6] 4 6.5 0.6 [0.2 – 1.6] 6 16.0 0.4 [0.2 – 0.8] 1 11.1 0.1 [0.0 – 0.6] 
    P<0.0001   P<0.0001   P<0.0001   P=0.2163 
Knowledge of own HIV status (updated annually) 
 
No 331 49.3 6.7 [6.0 – 7.5] 83 11.0 7.9  [6.1 – 9.3] 198 30.0 7.6  [6.6 – 8.8] 50 12.3 4.1  [3.1 – 5.4] 
Yes 914 160.0 5.7 [5.4 – 6.1] 210 25.9 8.1 [7.1 – 9.3] 424 55.5 7.6 [6.9 – 8.4] 280 78.6 3.6 [3.2 – 4.0] 
Unknown 447 54.5 8.2 [7.5 – 9.0] 269 25.8 10.4 [9.2 – 11.7] 152 19.7 7.7 [6.6 – 9.1] 26 9.1 2.9 [2.0 – 4.2] 
    P<0.0001   P=0.042   P<0.0001   P<0.014 
Most recent relationship per annual episode 
 
Single 859 129.3 6.6 [6.2 – 7.1] 383 33.1 11.6 [10.5 – 12.8] 324 40.3 8.0 [7.2 – 9.0] 152 56.0 2.7 [2.3 – 3.2] 
Casual friend 
/partner 
18 4.1 4.4 [2.6 – 6.9] 2 0.8 2.3 [0.6 – 9.2] 8 1.7 4.8 [2.4 – 9.6] 8 1.6 5.1 [2.5 – 10.1] 
Engaged/Marri
ed 
69 19.8 3.5 [2.8 – 4.4] 9 4.7 1.9 [1.0 – 3.7] 46 11.5 4.0 [3.0 – 5.4] 14 3.6 3.9 [2.3 – 6.5] 
Regular partner 654 88.5 7.4 [6.8 – 7.9] 148 19.8 7.4 [6.3 – 8.8] 347 38.8 9.0 [8.1 – 9.9] 159 29.9 5.3 [4.5 – 6.2] 
Divorced/Wido
wed/Separated  
70 18.6 3.8 [3.0 – 4.7] 17 3.7 4.5 [2.8 – 7.2] 34 7.2 4.7 [3.4 -6.6] 19 7.6 2.4 [1.6 -3.9] 
Other or 
unknown 
22 3.5 6.3 [4.2 – 9.6] 3 0.6 5.0 [1.6 – 15.6] 15 1.7 8.8 [5.3 – 14.6] 4 1.2 3.4 [1.3 – 9.0] 
    P<0.0001   P<0.0001   P<0.0001   P<0.0001 
Living with partner 
 
No 635 94.0 6.8 [6.3 – 7.3] 148 21.7 6.8 [5.8 – 8.0] 339 39.9 8.5 [7.6 – 9.4] 148 32.3 4.6 [3.9 – 5.4] 
Yes 174 36.7 4.7 [4.1 – 5.5] 28 7.4 3.8 [2.6 – 5.5] 94 19.0 4.9 [4.0 – 6.1] 52 10.3 5.0 [3.8 – 6.6] 
Unknown 24 3.9 6.2 [4.2 – 9.3] 3 0.7 4.5 [1.5 – 14.0] 17 1.9 9.1 [5.6 – 14.6] 4 1.3 3.0 [1.1 – 8.1] 
No partner 859 129.3 6.6 [6.2 – 7.1] 383 33.0 11.6 [10.5 – 12.8] 324 40.3 8.0 [7.2 – 9.0] 152 56.0 2.7 [2.3 – 3.2] 
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    P<0.0001   P<0.0001   P<0.0001   P<0.0001 
Median Parity 2 2 2 2 
Parity (time-updated) 
 
0 472 28.8 16.4 [15.0 – 18.0] 165 7.3 22.5 [19.3 – 26.2] 258 12.0 21.5 [19.0 – 24.2] 49 9.5 5.2 [3.9 – 6.8] 
1 466 66.2 7.0 [6.4 – 7.7] 153 18.3 8.4 [7.1 – 9.8] 212 25.5 8.3 [7.1 – 9.5] 101 22.4 4.5 [3.7 – 5.5] 
2 335 51.4 6.5 [5.6 – 7.3] 122 13.0 9.4 [7.9 – 11.2] 116 16.4 7.1 [5.9 – 8.5] 97 22.0 4.4 [3.6 – 5.4] 
3 172 37.9 4.5 [3.9 – 5.3] 54 8.6 6.2 [4.8 – 8.2] 69 12.0 5.8 [4.6 – 7.3] 49 17.3 2.8 [2.1 – 3.7] 
4 99 26.8 3.7 [3.0 – 4.5] 27 5.6 4.8 [3.3 – 7.1] 42 10.3 4.1 [3.0 – 5.5] 30 11.0 2.7 [1.9 – 3.9] 
5 61 20.1 3.0 [2.4 – 3.9] 17 4.0 4.2 [2.6 – 6.8] 8.7 8.7 3.4 [2.3 – 4.8] 15 7.4 2.0 [1.2 – 3.4] 
6+  87 32.6 2.7 [2.2 – 3.3] 24 5.9 4.1 [2.7 – 6.1] 16.3 16.3 2.9 [2.2 – 3.9] 15 10.4 1.4 [0.9 – 2.4] 
    P<0.0001   P<0.0001   P<0.0001   P<0.0001 
Self-reported Health (updated annually) 
 
Fair/Poor 85 28.6 3.0 [2.4 – 3.7] 18 3.4 5.2 [3.3 – 8.3] 35 12.0 2.9 [2.1 – 4.0] 32 13.1 2.4 [1.7 – 3.4] 
Excellent/Very 
good/Good 
900 142.6 6.3 [5.9 – 6.7] 200 32.2 6.2 [5.4 – 7.1] 498 65.4 7.6 [7.0 – 8.3] 202 45.0 4.5 [3.9 – 5.1] 
Unknown 707 92.6 7.6 [7.1 – 8.2] 344 27.2 12.7 [11.4 – 14.1] 241 23.7 10.1 [9.0 – 11.5] 122 41.7 2.9 [2.4 – 3.5] 
    P<0.0001   P<0.0001   P<0.0001   P<0.0001 
Heard of ART  
 
No 338 46.2 7.3 [6.6 – 8.1] 87 11.4 7.6 [6.2 – 9.4] 198 21.0 9.4 [8.2 – 10.8] 53 13.9 3.8 [2.9 – 5.0] 
Yes 644 115.8 5.6 [5.1 – 6.0] 155 18.4 8.4 [7.2 – 9.8] 291 37.9 7.7 [6.8 – 8.6] 198 59.5 3.3 [2.9 – 3.8] 
Unknown 710 101.8 7.0 [6.5 – 7.5] 320 32.9 9.7 [8.7 – 10.8] 285 42.2 6.7 [6.0 – 7.6] 105 26.6 3.9 [3.3 – 4.7] 
    P<0.0001   P<0.0001   P<0.0001   P=0.2868 
Using contraception  
 
No 415 46.4 8.9 [8.1 – 9.8] 111 11.4 9.7 [8.1 – 11.7] 223 22.2 10.1 [8.8 – 11.4] 81 12.9 6.3 [5.1 – 7.8] 
Yes 236 72.2 3.2 [2.9 – 3.7] 36 15.3 2.4 [1.7 – 3.3] 121 30.6 4.0 [3.3 – 4.7] 79 26.4 3.0 [2.4 – 3.7] 
Unknown 1041 145.2 7.2 [6.7 – 7.6] 415 36.1 11.5 [10.5 – 12.7] 430 48.5 8.9 [8.1 – 9.8] 196 60.7 3.2 [2.8 – 3.7] 
    P<0.0001   P<0.0001   P<0.0001   P=0.0002 
Form of Contraception 
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Barrier 
methods 
69 15.6 4.4 [3.5 – 5.6] 11 3.0 3.6 [2.0 – 6.6] 23 5.6 4.1 [2.7 – 6.2] 35 7.0 5.0 [3.6 – 6.9] 
Oral / IUCD / 
Microbicides 
8 2.6 3.1 [1.6 – 6.3] 2 0.5 4.2 [1.0 – 16.8] 4 1.4 2.9 [1.1 – 7.8] 2 0.7 2.8 [0.7 – 11.2] 
Injectable 68 20.9 3.2 [2.6 – 4.1] 12 3.8 3.1 [1.8 – 5.5] 37 9.6 3.9 [2.8 – 5.3] 19 7.5 2.5 [1.6 – 4.0] 
Dual 8 2.9 2.7 [1.4 – 5.5] 0 0.5 0 [ - ] 3 0.8 3.5 [1.1 – 11.0] 5 1.6 3.1 [1.3 – 7.4] 
Other / 
unknown 
method 
83 30.2 2.7 [2.2 – 3.4] 11 7.5 1.5 [0.8 – 2.6] 54 13.2 4.1 [3.1 – 5.3] 18 9.4 1.9 [1.2 – 3.0] 
None 415 46.4 8.9 [8.1 – 9.8] 111 11.4 9.7 [8.1 – 11.7] 223 22.2 10.1 [8.8 – 11.5] 81 12.9 6.3 [5.1 – 7.8] 
Unknown if 
using  
1041 145.2 7.2 [6.7 – 7.6] 415 36.1 11.5 [10.5 – 12.7] 430 48.5 8.9 [8.1 – 9.8] 196 60.7 3.2 [2.8 – 3.7] 
    P<0.0001   P<0.0001   P<0.0001   P<0.0001 
CD4 count (time-updated) (cells/μl) 
 
<=250 - - - - - - - - - 59 12.1 4.9 [3.8 – 6.3] 
250-350 - - - - - - - - - 44 8.3 5.3 [3.9 – 7.1] 
350-500 - - - - - - - - - 53 10.7 4.9 [3.8 – 6.4] 
>500 - - - - - - - - - 49 12.6 3.9 [2.9 – 5.1] 
Unknown - - - - - - - - - 151 56.3 2.7 [2.3 – 3.1] 
             P<0.0001 
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4.3.3.3 Multivariable analysis 
Multivariable analysis adjusting for area of residence, age group, parity and self-reported health 
found HIV positive women were 57% less likely to experience a live birth compared to HIV negative 
women (Table 4.13). Women whose HIV status was unknown experienced comparable rates of live 
birth to HIV negative women in this adjusted analysis. However this analysis did not meet the 
proportional hazards assumption and the remaining results are presented after stratification.  
Trends in age and parity characteristics were comparable across HIV grouping: rates of live birth 
reduced with increasing age and parity greater than one amongst HIV positive, negative and 
unknown woman episodes.  
An analysis of only HIV positive women adjusted for education and area of residence at baseline and 
time updated age, knowledge of HIV status, relationship status, parity, self-reported health, method 
of contraception used and CD4 count at start of episode, found exposure to ART was associated with 
a 47% reduced risk of live birth. There was no evidence of increased risk within specific age groups 
but data presented here is not stratified by ART exposure, as seen in analysis two. Live birth was 64% 
more likely to HIV positive women in a casual relationship and more than twice as likely in married 
or engaged women, compared to those reporting to be single. Health factors (CD4 count and self-
reported health) were not associated with rate of live birth.
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Table 4.13 Crude and adjusted Cox proportional hazards of live birth to women in closed cohort entering in 2007 or 2008, per characteristic and by HIV 
status 
 
Characteristics 
Crude and Adjusted Hazard ratio [95% CI] 
All episodes HIV Status Unknown HIV Negative HIV positive 
Crude HR 95% CI AHR 95% CI AHR 95% CI AHR 95% CI AHR 95% CI 
Characteristics at entry 
Education at entry 
 Never attended 1 - - - - - - - 1 - 
At least Primary 2.650 2.108 – 3.332 - - - - - - 1.308 0.807 – 2.121 
Secondary  3.127 2.526 – 3.871 - - - - - - 1.233 0.771 – 1.973 
Tertiary 2.584 2.066 – 3.233  - - - - - - 1.083 0.668 – 1.756 
Unknown 1.725 1.275 – 2.335 - - - - - - 1.026 0.547 – 1.923 
Area at entry 
 Rural 1 - 1 - 1 - 1 - 1  
Peri-Urban 0.728 0.649 – 0.817 0.770 0.689 – 0.861 0.954 0.808 – 1.126 0.740 0.621 – 0.881 0.755 0.595 – 0.958 
Urban 0.562 0.444 – 0.711 0.648 0.516 – 0.813 0.719 0.526 – 0.982 0.806 0.555 – 1.171 0.431 0.245 – 0.758 
Characteristics updated annually 
HIV status  
 Negative 1 - 1 - - - - - - - 
 Positive 0.474 0.417 – 0.539 0.427 0.370 – 0.493 - - - - - - 
 Unknown 1.138 1.022 – 1.267 0.951 0.855 – 1.057 - -   - - 
Exposure to ART (HIV positive only)  
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 No 1 - - - - - - - 1 - 
 Yes 0.741 0.571 – 0.962 - - - - - - 0.534 0.390 – 0.730 
 Age at episode 
 15-19 1 - 1 - 1 - 1 - 1 - 
20-24 0.792 0.696 – 0.901 0.955 0.836 – 1.091 1.142 0.929 – 1.403 1.063 0.877– 1.289 0.793 0.514 – 1.223 
25-29 0.572 0.493 – 0.662 0.759 0.642 – 0.898 1.008 0.770 – 1.319 0.924 0.713 – 1.197 0.596 0.380 – 0.932 
30-35 0.539 0.461 – 0.631 0.678 0.563 – 0.816 0.917 0.673 – 1.250 0.913 0.674 – 1.235 0.475 0.295 – 0.766 
35-39 0.312 0.256 – 0.380 0.340 0.267 – 0.433 0.602 0.409 – 0.886 0.458 0.313 – 0.669 0.196 0.109 – 0.353 
40-44 0.110 0.081 – 0.149 0.100 0.072 – 0.140 0.191 0.105 – 0.350 0.152 0.097 – 0.239 0.047 0.020 – 0.114 
45-49 0.027 0.015 – 0.049 0.022 0.012 – 0.041 0.060 0.022 – 0.163 0.029 0.012 – 0.069 0.007 0.001 – 0.054 
Knowledge of own HIV status   
 No 1 - - - - - - - 1 - 
Yes 1.174 1.033 – 1.334 - - - - - - 1.163 0.827 – 1.636 
Unknown 2.077 1.781 – 2.421 - - - - - - 1.055 0.601 – 1.852 
Most recent relationship per annual episode 
 Single 1 - - - 1 - - - 1 - 
Casual friend /partner 0.430 0.267 – 0.693 - - 0.050 0.012 – 0.207 - - 1.375 0.617 – 3.060 
Engaged/Married 0.304 0.234 – 0.396 - - 0.079 0.039 – 0.158 - - 2.357 1.195 – 4.648 
Regular partner 0.672 0.596 – 0.758 - - 0.164 0.131 – 0.205 - - 1.639 1.053 – 2.552 
Divorced/Widowed/Separated  0.339 0.262 – 0.439 - - 0.125 0.075 – 0.209 - - 1.064 0.577 – 1.960 
Other or unknown 1.458 0.930 – 2.287 - - 0.740 0.197 – 2.777 - - 2.212 0.772 – 6.337 
Living with partner 
 No 1 - - - - - - - - - 
Yes 0.681 0.574 – 0.808 - - - - - - - - 
Unknown 2.163 1.410 – 3.320 - - - - - - - - 
No partner 1.622 1.437 – 1.830 - - - - - - - - 
Parity  
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 0 1 - 1 - 1 - 1 - 1 - 
1 0.518 0.456 – 0.589 0.545  0.478 – 0.621 0.493 0.394 – 0.616 0.488 0.405 – 0.589 1.052 0.730 – 1.515 
2 0.506 0.439 – 0.583 0.691 0.592 – 0.807 0.631 0.488 – 0.817 0.536 0.419 – 0.685 1.271 0.874 – 1.850 
3 0.360 0.301 – 0.430 0.643 0.528 – 0.783 0.540 0.384 – 0.759 0.535 0.391 – 0.733 1.133 0.738 – 1.740 
4 0.292 0.235 – 0.363 0.744 0.585 – 0.947 0.582 0.378 – 0.894 0.563 0.390 – 0.813 1.549 0.942 – 2.547 
5 0.239 0.183 – 0.312 0.845 0.628 – 1.137 0.731 0.431 – 1.239 0.630 0.405 – 0.981 1.566 0.817 – 3.004 
6+  0.205 0.160 – 0.263 1.212 0.913 – 1.608 1.092 0.689 – 1.730 0.923 0.612 – 1.394 2.166 1.107 – 4.240 
Self-reported Health  
 Fair/Poor 1 - 1 - - - -  1 - 
Excellent/Very good/Good 1.595 1.273 – 1.998 0.746 0.589 – 0.944 - -   1.382 0.910 - 2.097 
Unknown 2.576 2.047 – 3.242 1.795 1.416 – 2.274 - -   1.225 0.726 – 2.070 
Heard of ART  
 No 1 - - - - - - - - - 
Yes 1.426 1.241 – 1.639 - - - - - - - - 
Unknown 2.003 1.742 – 2.304 - - - - - - - - 
Using contraception  
 No 1 - - - - - - - - - 
Yes 0.512 0.437 – 0.600 - - - - - - - - 
Unknown 1.771 1.547 – 2.028 - - - - - - - - 
Form of Contraception  
 Barrier methods 1 - - - - - - - 1 - 
Oral/IUCD/Microbicides 0.938 0.448 – 1.965 - - - - - - 0.742 0.174 – 3.151 
Injectable 0.976 0.688 – 1.385 - - - - - - 0.570 0.320 – 1.015 
Dual 0.771 0.368 – 1.618 - - - - - - 0.565 0.216 – 1.475 
Other/unknown method 0.329 0.237 – 0.456 - - - - - - 0.262 0.145 – 0.473 
None 1.110 0.853 – 1.444 - - - - - - 1.204 0.792 – 1.829 
Unknown if using  2.044 1.577 – 2.651 - - - - - - 1.166 0.750 – 1.812 
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CD4 count (cells/μl) (HIV positive only) 
 <=250 1 - - - - - - - 1 - 
250-350 1.157 0.773 – 1.733 - - - - - - 1.208 0.797 – 1.830 
350-500 1.134 0.777 – 1.655 - - - - - - 1.244 0.846 – 1.830 
>500 0.932 0.626 – 1.389 - - - - - - 0.957 0.640 – 1.430 
Unknown 0.543 0.400 – 0.738 - - - - - - 0.323 0.230 – 0.454 
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4.3.3.4 Risk of live birth during follow up 
Risk of live birth declined with duration of follow up to all women. Figure 4.18 presents cox 
proportional cumulative hazard models, to illustrate the consistently lower risk of live birth amongst 
HIV positive women throughout duration of follow up.  
Birth-free survival to HIV positive women, according to ART exposure is presented in figure 4.19.  A 
survival model adjusted for education and area of residence at baseline and time updated: age, 
knowledge of HIV status, relationship status, parity, self-reported health, method of contraception 
used and CD4 count at start of episode illustrates the proportion of HIV positive women that 
remained ‘birth-free’ throughout follow up. This information is stratified by ART exposure to 
illustrate that ART-exposed women were consistently at lower risk of live birth and experience fewer 
births during follow up compared to women not yet on treatment.  
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Figure 4.18 Adjusted Cox Proportional cumulative hazard of experiencing a live birth in a closed cohort up to 6 years of follow up since entry 
 
a) HIV Status Unknown b) HIV Negative c) HIV Positive 
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Figure 4.19 Adjusted Cox proportional cumulative birth-free survival amongst HIV Positive women, stratified by exposure to ART 
 
 
  
.9
.9
2
.9
4
.9
6
.9
8
1
Su
rv
iv
al
0 2 4 6
analysis time (years)
ART Naive ART Exposed
Cox proportional hazards regression
Red= ART-exposed, Blue = ART-naïve  
Time (years) 
Bi
rt
h-
fre
e 
su
rv
iv
al
  
  
 
 
203 
4.3.3 Analysis Three: Section Summary  
x This analysis determined similar trends in rates and factors associated with risk of live birth 
by HIV status compared to the open cohort presented in analysis two.  
x Complete closed cohort analysis violates the cox proportional hazards assumption and 
interpretations should be taken from analysis stratified by HIV status.  
x HIV positive women were 57% less likely to experience a live birth than HIV negative women 
and exposure to ART was associated with a 47% reduced risk of live birth.  
x The purpose of this analysis was to compare trends and factors associated with risk of live 
birth with women of ‘unknown’ HIV status. Risk amongst women of ‘unknown’ HIV status 
was highest of all three HIV categories and not significantly different to HIV negative women 
in multivariable analysis. Women with an unknown HIV status were demographically similar 
to HIV negative women, with higher proportions in a relationship, reporting current use of 
contraception and being in good health, compared to HIV positive women.  
x In a stratified analysis, and contrary to an open cohort analysis, CD4 count and self-reported 
health were not associated with rate of live birth amongst HIV positive women. Trends for 
self-reported health persisted but did not achieve significance, which may be due to low 
numbers. 
x HIV positive women were more likely to be single and had lowest incidence of live birth: only 
39% of HIV positive women were in a relationship compared to 61% of HIV negative women. 
HIV ‘unknown’ women were typically younger, more likely to be in a relationship and 
experienced highest incidence of live birth when single. Results suggest positive women may 
be less likely to engage in new childbearing relationships. 
x Incidence of live birth was highest amongst non-responders to questions on self-reported 
health, HIV status, knowledge of HIV status, co-residency with partner and awareness of the 
benefits of ART. Higher rates in these categories may reflect less care seeking or more risky 
sexual behaviour.  
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4.4 Descriptive analysis of contraceptive use amongst women in the closed cohort 
The purpose of this supplementary analysis is to describe likelihood of contraceptive use according 
to HIV status and exposure to ART amongst a cohort of women reported in section 4.3. 
Contraceptive use is one of the strongest proximate determinants of fertility through which a more 
distal effect of ART may operate (Kaida et al. 2006). Contraception is freely available in South Africa, 
although initiation on ART may impact upon patterns of contraceptive behaviour. For example, 
women that wish to preserve their health on ART may experience increased sexual activity and 
chose to use more protective barrier methods, while others may experience lower sexual activity 
and select abstinence.  
The effect of ART use on rates of contraceptive use is not well known in this setting. Contraceptive 
use was a strong proximate determinant of lower rates of live birth in univariate analyses presented 
in sections 4.2 and 4.3. This association persisted in an adjusted analysis presented in section 4.2. 
Contraceptive use was not included in the stratified adjusted analysis presented in section 4.3, as it 
violated the model assumptions.  
HIV positive women and women enrolled on ART demonstrated lower rates of live birth compared 
to HIV negative women in both sections 4.2 and 4.3. This descriptive analysis aims to determine 
whether HIV positive status and use ART are factors associated with higher or lower likelihood of 
women’s contraceptive use in this setting. Contraceptive use may also be influenced self-reported 
health and other potentially confounding factors. However, limitations such as missing data and the 
temporality of this measure meant that further analysis was not feasible within the scope of this 
study. Unadjusted analysis is presented here to describe trends in contraceptive use within the 
cohort discussed in section 4.3. Further studies of contraceptive use in this setting have been 
published elsewhere (Raifman et al., 2014).   
Crude incidence of contraceptive use, associated with other social and health characteristics are 
presented in table 4.14. Results show that HIV infected women were 10% less likely to use 
contraception at last sex than HIV negative women. Comparatively, women of unknown HIV status 
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were 20% less likely to report contraceptive use compared to HIV negative women. There was no 
evidence to suggest that knowledge of HIV status is associated with contraceptive use, counter to 
the proposed hypothesis of modified contraceptive use through childbearing intentions on ART. It 
could reflect an absence or heterogeneous effect of HIV knowledge in an era when ART is widely 
available. Alternatively, women that perceived their health as excellent, good or very good were 40% 
more likely to use contraception. This finding may be indicative of increased sexual activity and a 
wish to preserve good health. 
The characteristics illustrated in this table were selected as determinants of fertility in two cohort 
analyses presented previously. Socio-demographic factors were strongly associated with 
contraceptive use in this area. Women with secondary level education attainment were most likely 
to use contraception, and likelihood decreased at higher levels of educational attainment after this. 
Residents of rural or peri-urban area of location were more likely to use contraception compared to 
women living in urban areas. 
Women aged between 15 and 24 years old reported highest use of contraception and rates of 
contraceptive use declined thereafter with age, although remaining high. Using 15-19 year old 
women as baseline, likelihood of contraceptive use was 30% lower amongst women aged 35-39 
years old, the median age category of women on ART. 
Although highest rates of live birth were observed to women with a regular partner, these women 
were also most likely to report contraceptive use at last sex. This could reflect both higher sexual 
activity or inconsistent contraceptive use, or both. It is possible that this trend could also represent 
some planned behaviour, as partners use contraceptive at last sex and discontinue when trying to 
conceive a child. However, little evidence of such planned behaviour was found in a subsequent 
qualitative study, described in Chapter Five. The likelihood of contraceptive use was reduced by 20% 
when women reported living with their partner compared to women not living with their partner.   
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Table 4.14 Unadjusted likelihood of contraceptive use according to proximate and distal 
determinants of fertility and HIV status 
 
Characteristics 
All women 
(26,386.2 woman years) 
 
No. of 
contraceptive 
users  
Women 
years 
exposed 
Incidence Rate HR 
Overall Incidence 6853 263.9 26.0 [25.4– 26.6] - 
Characteristics at entry  
Education at entry  
 Never attended 747 42.7 17.5 [16.3 – 18.8] 1  
At least Primary 1299 49.4 26.3 [24.9 – 27.8] 1.5 [1.4 – 1.6] 
Secondary  2815 93.7 30.1 [29.0 – 31.2] 1.7 [1.6 – 1.9] 
Tertiary 1660 60.4 27.5 [26.2 – 28.8] 1.6 [1.5 – 1.7] 
Unknown 332 17.7 18.7 [16.8 – 20.9] 1.1 [0.9 – 1.2] 
    P<0.0001  
Area at entry  
 Rural 4348 165.1 26.3 [25.6 – 27.1] 1 
Peri-Urban 2121 81.8 25.9 [24.8 – 27.0] 1.0 [0.9 – 1.0] 
Urban 384 16.8 22.7 [20.6 – 25.1] 0.9 [0.8 – 1.0] 
    P=0.0422  
Characteristics updated annually  
 Age (updated annually)  
 15-19 673 22.8 25.5 [27.4 – 31.8] 1 
20-24 1662 49.7 33.4 [31.8 – 35.1] 1.0 [0.9 – 1.1] 
25-29 1447 44.4 32.6 [31.0 – 34.3] 0.9 [0.9 – 1.0] 
30-35 1152 38.9 29.6  [28.0 – 31.4] 0.9 [0.8 – 0.9] 
35-39 871 37.3 23.3 [21.8 – 24.9] 0.7 [0.6 – 0.7] 
40-44 638 37.2 17.2 [15.9 – 18.6] 0.5 [0.4 – 0.5] 
45-49 410 33.6 12.2 [11.1 – 13.4] 0.3 [0.3 – 0.4] 
    P<0.0001  
Knowledge of own HIV status (updated annually)  
 No 1445 49.3 29.3 [27.8 – 30.8] 1 
Yes 5269 160.0 32.9 [32.0 – 33.8] 1.0 [0.9 – 1.0] 
Unknown 139 54.5 2.5 [2.2 – 3.0] 0.07 [0.06 – 
0.09] 
    P<0.0001  
Most recent relationship per annual episode  
 Single 1000 129.3 7.7 [7.2 – 8.2] 1 
Casual friend /partner 148 4.1 36.0 [30.6 – 42.3] 6.4 [5.4 – 7.6] 
Engaged/Married 746 19.8 37.8 [35.1 – 40.6] 6.8 [6.2 – 7.5] 
Regular partner 4350 88.5 49.1 [47.7 – 50.6] 8.5 [7.9 – 9.1] 
Divorced/Widowed/Separated  535 18.6 28.7 [26.4 – 31.2] 5.0 [4.5 – 5.6] 
Other or unknown 74 3.5 21.3 [16.9 – 26.7] 1.4 [1.1 – 1.8] 
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    P<0.0001  
Living with partner  
 No 4369 94.0 46.5 [45.1 – 47.9] 1 
Yes 1402 36.7 38.2 [36.2 – 40.2] 0.8 [0.8 – 0.9] 
Unknown 82 3.9 21.3 [17.1 – 26.4] 0.2 [0.2 – 0.2] 
No partner 1000 129.3 7.7  [7.3 – 8.2] 0.1 [0.1 – 0.1] 
    P<0.0001  
Parity (time-updated)  
 0 655 28.8 22.8 [21.1 – 24.6] 1 
1 1960 66.2 29.6 [28.3 – 30.9] 1.2 [1.1 – 1.3] 
2 1501 51.4 29.2 [27.8 – 30.7] 1.2 [1.1 – 1.3] 
3 1062 37.9 28.0 [26.4 – 29.7] 1.1 [1.0 – 1.2] 
4 656 26.8 24.5 [22.7 – 26.4] 1.0 [0.9 – 1.1] 
5 429 20.1 21.3 [19.4 – 23.4] 0.8 [0.7 – 0.9] 
6+  590 32.6 18.1 [16.7 – 19.6] 0.7 [0.6 – 0.8] 
    P<0.0001  
Self-reported Health (updated annually)  
 Fair/Poor 961 28.6 34.0 [32.0 – 36.0] 1 
Excellent/Very good/Good 5882 142.6 41.0 [40.0 – 42.0] 1.4 [1.3 – 1.5] 
Unknown 10 92.6 0.1 [0.1 – 0.2] <0.0 [0.002 – 
0.006] 
    P<0.0001  
HIV status (updated annually)  
 Negative 2920 101.2 28.9 [27.8 – 29.9] 1 
Positive 2519 99.9 25.2 [24.2 – 26.2] 0.9 [0.8 – 0.9] 
Unknown 1414 62.8 22.5 [21.4 – 23.7] 0.8 [0.8 – 0.9] 
    P<0.0001  
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4.4.1 Analysis Four: Section Summary  
x HIV status was associated with a small change in contraceptive use and there was no evidence 
for an effect of awareness of own HIV status. Rather, self-reported health was a better predictor 
of contraceptive use in this cohort. HIV infected women were 10% less likely to use 
contraception at last sex than HIV negative women. Alternatively, reporting excellent, good or 
very good were 40% more likely to use contraception.  
x Socio-demographic factors were strongly associated with use of contraception in this area. 
Likelihood of contraceptive use was associated with secondary level education attainment, rural 
or peri-urban residency, age less than 24 years, seeing a regular partner, not co-residing with a 
partner. 
x Rates of contraceptive use remained high in older age groups. 
x Findings demonstrate that HIV positive women are not reporting large changes in contraceptive 
use. Results from this and prior analysis suggest that reduced sexual activity, independent to 
awareness of HIV status, and related to poorer perceived health may explain small changes in 
contraceptive use.
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Chapter Five 
The influence of ART on childbearing desires, attitudes to safer 
conception and contraceptive use in HIV positive women  
5.1 Introduction to chapters presenting qualitative results  
Chapters Five and Six explore how the use of highly active anti-retroviral therapy (ART) influences 
childbearing and contraception amongst women living with HIV, and currently enrolled in a HIV 
treatment and care programme. These chapters’ present results of 35 semi-structured interviews 
with women on ART and healthcare providers in the Hlabisa HIV treatment and care programme. 
Interviews addressed topics of childbearing desires, attitudes towards contraceptive use and 
methods, and safer conception strategies. A discussion of these results is supported by clinic 
observations made by the researcher using a standardised checklist of contraception and safer 
conception activities.  
Section 5.2 outlines the qualitative sample used in chapters five and six, and then presents 
characteristics of sampled women, health workers and clinics. Section 5.3 describes the childbearing 
desires of 23 women using ART in the treatment and care programme. Chapter five concludes with a 
description of the themes relating to factors that influence childbearing desires, and whether 
women follow these desires, including the impact of being on ART and the perspective of health 
workers. Chapter six uses these findings as the context for the findings on contraceptive use 
amongst women in the ART programme, and structural barriers and facilitators affecting access to 
contraception and safe conception services amongst women on ART. 
 
5.2 Client characteristics 
Twenty-one of a total twenty-three women reported a current partner. Definitions ranged from 
casual partners, such as seeing her partner once a month or less through to more frequent visits, 
living together or being married and one woman reported having two male partners. For 
simplification I used the following categories: no partner, has more than one partner, with a partner 
that has not paid isilobolo, has a partner who has paid isilobolo, or married (Table 5.1). Three clients 
were married, and four reported that isilobolo had been paid to their family and they were in the 
process of getting married. The majority (13) has a single partner where isilobolo had not been paid.  
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As is common in this area, twenty women reported not living with partners, but living in a 
homestead with parents, grandparents, sisters or aunties, and usually with their own children. One 
married woman with five children was also living with her family rather than her partner. Male 
partners were often working in cities such as Johannesburg or Durban, and where partners had 
migrated for work, women would see their partners during weekend, monthly or less frequently.  
All women had at least one child at the time of the interview, and about half had given birth while 
living with HIV.  Women had between 1 to 6 children with a median parity of 2, which is in line with 
the national and local total fertility rate of 2.2. Of the twenty multiparous women, nine reported 
having had children by more than one partner.  
Only one woman was in employment at the time of study, which reflects an area where 
approximately 75% of individuals are unemployed. This woman was 48 years old, had no current 
partner, and had sought employment to support her children and grandchildren. Other women in 
the study received support from child grants, and relied on a mixture of economic support from 
family members, fathers of their children or current partners. Table 5.1 presents the demographic 
characteristics of women participating in this study. 
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Table 5.1 Characteristics of female clients interviewed 
Characteristic Frequency (n) 
Ethnicity  
Zulu 23 
Clinic   
A  6 
B  3 
C  6 
D 4 
E 4 
Age group  
18-24  7 
25-34 8 
35-49 8 
Relationship Status  
No partner 2 
Partner (No isilobolo paid) 13 
Partner (isilobolo paid) 4 
Multiple partners 1 
Married 3 
Duration on ART (years)  
1  8 
2 9 
3 0 
4 4 
5 2 
Experienced a pregnancy whilst in the programme 
Yes 11 
No 12 
Parity   
1 3 
2 10 
3 5 
4 1 
5 2 
6 2 
Route of entry  
ANC  14 
HCT 9 
Employed  
Yes 1 
No 22 
Currently living with partner  
Yes 6 
No 17 
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5.2.1 Route of entry into the HIV treatment and care programme 
Women were aware that a person could be HIV infected and look or feel healthy and some said that 
this knowledge had encouraged them to test for HIV, although most had actually discovered their 
HIV status due to a pregnancy or poor health. Referral from antenatal care was the most common 
route of entry in the HIV treatment and care programme, with about half of women diagnosed with 
HIV during a prior pregnancy. Reasons that women specifically sought HIV Counselling and Testing 
(HCT) related to health problems such as recurrent sexually transmitted infection and shingles, or 
one woman, because she suspected her partner was infected with HIV. The maximum time any 
woman had used ART was 5 years with a median duration of 2 years. 
 
5.2.2 Healthcare provider characteristics 
I selected twelve healthcare providers to include six nurses and six HIV counsellors. The 
characteristics of participating health workers are described in table 5.2. The operational manager of 
one clinic was the only nurse trained to initiate woman on ART, and I considered her as an ART nurse 
for the purpose of this study according to her clinical role in the ART programme. 
All health workers were aged over 25 with substantial experience within the HIV treatment and care 
programme at their present clinic, and in some cases, within other programme clinics. Nurses and 
counsellors were employed either by the Department of Health (five) or via the Africa Centre for 
Health and Population Studies (seven), but all were trained and functioned according to the South 
African Department of Health recommendations for care of people living with HIV. 
 
 
 
 
 
213 
 
Table 5.2 Characteristics of health workers interviewed 
Characteristic Frequency (n) 
Ethnicity  
Zulu 12 
Clinic   
A  2 
B  4 
C  2 
D 2 
E 2 
Age group  
25-34 5 
35+ 7 
Occupation   
ART Nurse 5 
Counsellor 6 
Nurse / Operational Manager 1 
Employer  
Africa Centre 5 
Department of Health 7 
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5.3 Desires for childbearing on ART  
5.3.1 Women on ART expressed clear personal views on childbearing  
Semi-structured interviews aimed to identify childbearing desires amongst women on ART, and 
explore the factors that influenced these desires, and whether desires were followed. A research 
assistant asked women a variation on the question ‘do you wish to have a child either now or in the 
future?’ I characterised responses into: a wish to have children now, to have a child in the future 
(postpone), or not to have any more children (Hofferth, 1983). These categories are described 
below.  
 
5.3.2 Does not aspire to have more children at any time (seventeen women) 
The majority of women did not wish to have any more children at all. These women tended to be 
older and have more children than women that wanted to have children in the future, but there 
were no other key demographic differences between desire groups. Most were in a relationship 
where the partner had not paid isilobolo to the woman’s family, although some had a partner who 
had paid isilobolo, were married, or had no current partner. One woman had multiple partners. 
According to the stratification described in Chapter 3, seven women had given birth in the HIV 
treatment and care programme and ten had not. Views on not wanting more children were often 
strong: 
No ways! My sister I don’t think so. That thing is not on my mind… the first thing is that I am 
not married and I have 2 children at home, the second child I got from this person I said that 
our relationship is not clear. Even now I cannot say where we are going with our relationship. 
You know what I am talking about, when I get another child what will people say about that 
and even at home they will say there is something wrong in my mind. With the father of my 
child I trusted him very much. I know now that it is true if people say you better trust a stone 
than a person. 
- 23-year-old mother of two with multiple partners. No experience of being pregnant 
while enrolled in the HIV programme, clinic A 
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5.3.3 Would like a child in the future (five women) 
The wish to postpone childbearing is common in KwaZulu-Natal (Hosegood et al., 2009), and some 
said that they would like to have a child at some time in the future. Women wanted to postpone 
childbearing to let existing children grow older, and to look after her current health.  
I will see it, when he comes to pay isilobola and get married that is when I can see how much 
does he loves my children. After that I will get pregnant for him. 
 
- 23 year old woman with one child and a partner that has not paid isilobolo 
 
5.3.4 Would like a child now (one woman) 
Only one woman said she would like to have another child, and felt that she would like to have this 
child at any time. This woman was in the youngest age group (18-24 years old), and wanted to have 
a son in addition to her current daughter. She felt that this was influenced by the knowledge that 
she would soon be married, and that her aspirations were unaltered following diagnosis with HIV 
and initiation on to ART.  
I always wanted to have 2 children… nothing has change my mind 
- 24 year old woman with one child born within the HIV treatment and 
care programme and a partner who has not paid isilobolo (clinic A) 
 
 
 
5.4 Themes influencing childbearing desires amongst women on ART  
5.4.1 Women on ART had largely achieved their desired family size 
Interviews found that a desire for a family size of two or three children was common, and this figure 
had largely not changed since initiation on ART. All women currently had at least one child, and 
many were satisfied with the age and current number of children they had, and did not want more. 
Desired family size was largely influenced by familial, economic, health and cultural factors. The 
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majority of childbearing had occurred outside of marriage, and unstable relationships, linked to 
unstable financial contributions, also meant women were reluctant to have more children:  
If I can say the truth I don’t have parents I stay with my grandparents so for me to have 
children is a disaster even those two that I have are huge load to my grandparents. I am not 
working now so there is nothing that I do for my children I depend on my other people. At the 
moment you find out that when a man impregnated you he will leave you for somebody else 
even this partner that I have I don’t know what he is going to do. That is why I don’t want to 
have a child anymore I will have to find job and take care of my children. 
- 22-year-old woman with two children and a partner who had not paid isilobolo. Does 
not wish to have children in the future. Clinic D 
 
Some women explicitly said they did not feel like they had enough money for more children, 
because they were unemployed, or that their living arrangements were unsuitable, because they 
lived with extended family members and there would not be room for another child: 
My sister to have a child is something that is out of my mind; it will be better if I am working. 
As I have two children the first one is doing grade 12 and the second one is doing grade 7, I 
am not working I am getting a grant for my second child. All the things I do for my children, 
where will I get the money to raise that child. 
- 42 year old woman with two children and a partner who has not paid isilobolo 
 
One nurse, who felt that reliance on the child grant created ‘stress’ for women in her care that could 
not afford more children, reiterated the potential financial stress of childbearing; 
You see that person that is pregnant; you see that she is ashamed... Crisis. Most of them, 
they are poor, so they depend on their boyfriend. So that’s why.  
-  Department of Health Counsellor, clinic A 
 
Researchers asked women directly about the effect their diagnosis and being on ART had played on 
childbearing desires. Most women said that a HIV diagnosis had not been enough to change lifetime 
goals for childbearing, and while it was difficult news at the time, ‘nothing had changed’ in the time 
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since their HIV diagnosis. For example, a 23-year-old woman said that when she first discovered her 
pregnancy she had felt ‘angry and confused’, and at the time of the interview she was still ‘adjusting’ 
to her treatment, but that she still wished to have two more children in order to achieve her lifetime 
desire for family size. In an era of ART, women generally said that they no longer perceived an HIV 
diagnosis as life threatening. Health workers reassured women that they could live ‘normal’ lives if 
they properly adhere to treatment and women felt encouraged to have long and healthy lives. One 
woman reflected that she felt no different to another person suffering from ‘the flu’. 
You see, my life, I won’t lie to you, I feel better because I have flu like any other person and 
this HIV treatment that I am taking at the moment makes me feel good. 
- 32-year-old woman with five children and a partner who had paid isilobolo. Does not 
want a child, clinic A 
 
A few women considered having another, third, child in the future after feeling encouraged by 
initiation of treatment, but these were the exception.  
When I was pregnant and I found out that I was pregnant I told myself that I would never 
have children again. [It] is the last one that I will carry... but now (since starting ART) I see 
that if I can get 3 children, it will be fine 
- 28 year old woman in a polygamous marriage with two children and no experience of 
childbearing in the programme (clinic C) 
 
5.4.2 Societal, partner and financial pressures influenced desires to limit childbearing on ART 
As described in sections 1.2 and 1.3, the isiZulu tradition of isilobolo requires a man to pay bridal 
wealth to the family of the bride before marriage or sexual intercourse is permitted, and in return 
for this investment, women were expected to prove their fertility soon after marriage. Clients and 
health workers described weddings as an expense that most men could not afford and that they 
thought marriage was no longer a pre-requisite to the decision to have a child in this setting.  
It can cost you thousands... there’s no more marrying. They are now free to be together. Your 
family knows me, my family knows you. So what? It’s like we are extended family, but it’s not 
a family! 
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- Department of Health Nurse, Clinic C 
 
Consequently, women described feeling pressure from partners to bear a child even if they had not 
paid isilobolo; although once this was paid pressure was increased. Women held quite specific 
childbearing desires, but many felt a conflict between their desires not to have a child, and 
traditional expectations of childbearing held by partners. This pressure was particularly pronounced 
when women did not have any children with their current partner, but appeared to lessen for one 
woman whose partner already had children.  
We never talked about that because he already has children from the other woman  
- 28 year old woman in a polygamous marriage with two children and no experience of 
childbearing in the programme (clinic C) 
 
Women discussed scenarios in which they hoped to delay a pregnancy, or find a partner that did not 
want to have more children, but they did not feel they would overcome cultural expectations of 
childbearing with a long-term partner. For example, a 32-year-old woman felt that it would be 
possible to delay childbearing, but her partner had paid isilobolo so cultural expectations would take 
precedence after she was married. For another, being married meant that she would be ‘forced’ to 
have more children. 
My problem is that as [my partner] is the father of this child we have together, and he paid 
isilobolo, it will be selfish of me if I say I will not get other children with him. My parents-in-
law will want me to have children as it is our culture to have a child after marriage, and 
although my partner understands that I am HIV positive, other people will not understand. 
But it will take time for me to have another child. 
- 32-year-old woman with five children and a partner who had paid isilobola. Does not 
want a child, clinic A - Currently pregnant 
 
I will be forced if we are married, if we get married I will get a child for him because he find 
me with children which are not his besides that I don’t have love for children. I will be happy 
if I can find a person who says he does not want children. 
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-  23 year old mother of two with multiple partners and no desire to have more children 
(clinic A) 
 
Some women that did not wish to have another child, would sometimes use qualifiers to illustrate 
when they would be willing to modify their decision to align with cultural expectations, for example, 
that a partner would need to first find employment, or prove his love for her and her children. There 
was a general mistrust of partners, and not all women trusted men to pay isilobolo. Even after 
isilobolo was paid, there was still a risk that he may leave her after a child is born, which influenced 
attitudes to childbearing. 
 
I depend on other people. At the moment you find out that when a man impregnated you, he 
will leave you for somebody else. Even this partner that I have I don’t know what he is going 
to do. That is why I don’t want to have a child anymore I will have to find job and take care of 
my children.  
- 22-year-old woman with two children and a partner who had not paid isilobolo. Does 
not wish to have children in the future. Clinic D 
 
Health workers agreed that there is a strong cultural importance attributed to marriage and 
childbearing. One nurse suggested that women living with HIV felt pressure to have a child after 
marriage. Women raised a concerning point that the only time they would expect to consult with 
nurses at the ART programme about planning to have a child would be once she was married.  
I think it depends on the individual because some of them discover they are HIV positive 
while they still do not have a child, or you do have a child but now you are married to 
somebody else and you don’t have a child with him. And... You just can’t wait to have a child 
with him. Culturally... children are needed.  
- Department of Health Nurse, clinic B 
 
It will happen when I get married because I will have to get a child after marriage.  That is 
when I will consult the clinic and ask ‘what can I do?’ as my partner wants a child  
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– 27 year old women with three children, a partner who has not paid isilobolo and no 
desire to have a child at any time (clinic E) 
 
5.4.3 Personal experiences shaped perceptions of the risk of pregnancy to health  
Interviews probed the post-conception perceptions further, as summarised in Table 5.3. Under 
Stanford’s model for post-conception, I categorised woman’s attitudes to their most recent 
pregnancy as ‘positive’, ‘negative’ or ‘ambivalent’ to understand and define attitudes to future 
planning in the context of a most recent pregnancy. Terms such as ‘planned’ or ‘unplanned’ were 
not at first volunteered by women during interviews until the interviewer, at which time all of these 
women described the pregnancy as unplanned, then introduced the concept. When they were asked 
why the pregnancy was unplanned, women generally expressed ‘there is nothing to explain what 
happened’ or that it ‘just happened’, usually when a partner had refused to use a condom or 
injectable contraceptive use was inconsistent.  In this sense women reflected little planning towards 
having a child, but discussed factors relating to readiness and health, family and partner attitudes, 
religious values, and a lack of contraceptive use or method failure (Stanford et al. 2000).   
We didn’t plan it. It was a mistake; there was no condom that day. He just started at his 
work. His plan does not include a child but it happened 
- 35 year old woman with five children and currently pregnant with 6th child. She has a 
partner who had paid isilobola. Does not wish to have a child in the future, clinic C 
 
Despite little planning, three women viewed a previous pregnancy positively because they had 
wanted another child, felt supported by a partner or because they were married and felt the 
decision was in God’s control. Two women did not report strong positive or negative reactions to 
their most recent pregnancy (Table 5.3). The majority of these women (eight) described negative 
feelings towards their most recent pregnancy due to a mixture of health reasons, because the 
pregnancy was unwanted, or her partner had abandoned them after birth.  
Many experienced poor health during a previous pregnancy, saying they were unable to adapt well 
or felt dizzy or weak. Having received a HIV diagnosis during a prior pregnancy was particularly 
traumatic for these women and further compounded the seriousness of these perceptions of ill 
health. In more extreme cases some women felt that they had ‘nearly died’ during their most recent 
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pregnancy because of their HIV status. Typically these women with adverse experiences were more 
resolved in their desire to stop childbearing, and half of the women in these interviews discussed 
their most recent pregnancy as an important contributing factor that discouraged desires for more 
children.  
I was sick when I was pregnant with this child and she also got sick. I was up and down when 
I was pregnant and even after birth of her. When I was pregnant I didn’t have much time to 
enjoy it. It’s not that I don’t want children because I am HIV positive, what I am afraid of is 
that I can die if I can have another child. To be on HIV treatment that does not give me a 
problem at all. The reason is that when I have a child it happens that I am the one who is sick 
or else the child. 
- 34-year-old women with five children. Married. Clinic A 
 
Some women who had bad past experiences with pregnancy, and did not wish to have another child, 
said that they could not rule out having another child completely.  
I nearly died; I nearly died when I found out that I was HIV positive. I was pregnant by that 
time with child that passed away. I was weak and I was sick so I don’t think to have a child. I 
cannot say I will not have a child, I will, but I nearly died. No-one was taking care of me, not 
even my sisters; I saw that when you are HIV positive you are a problem to people, even your 
relatives. I was ill so what if something like that happens again? When I found out I was HIV 
positive it changed me a lot. I know that my child may not get the HIV virus but I am afraid.  
- 42-year-old woman with two children and a partner who has not paid isilobolo. Has 
been pregnant while enrolled in the HIV programme and does not want a child, clinic A 
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Table 5.3: Post-conception attitudes to planning of previous pregnancies (adapted from Stanford et al. 2000)  
Post-
conception 
attitudes to 
pregnancy 
Interview 
question(s) relating 
to previous 
childbearing 
Dimensions of 
pregnancy 
intentions applied 
to most recent 
pregnancy 
Description of pregnancy 
intention dimension Quotes related to planning for most recent child 
Category of 
prospective 
childbearing 
desire 
Self-
described 
current 
contraceptive 
use 
 
WOMEN WITHOUT EXPERIENCE OF GIVING BIRTH WHILE ENROLLED IN THE HIV TREATMENT AND CARE PROGRAMME 
36-year-old woman, with three children. Has a partner who has not paid isilobolo. Clinic C 
Negative When did you find 
out about your HIV 
status? 
 
 
Readiness related to 
own health 
 
HIV diagnosis and 
discovery of pregnancy at 
same time accentuated 
feeling of surprise and 
concerns for health  
I started HIV treatment in July 2008. You know what I also found out that I am 
pregnant ay! Everything was on me and I thought I was going to die. 
Does not want 
to have more 
children 
None 
Stigma from family 
 
Concerns for stigma from 
family against further 
childbearing 
I don’t want something that will make [people] talk [about me] because with 
these children their grandparents will talk.  
 
I do not want to have children those I have are enough. 
No support from 
partner  
 
Perceived lack of support 
from partner 
The main reason [related to pregnancy intention] is that I was alone raising the 
children that I have there is no one who was helping me so I don’t want anything 
that will make me suffer. 
36-year-old woman with two children. Has a partner who has not paid isilobolo.  Clinic D 
Negative Have you been 
pregnant since you 
started your HIV 
treatment?  
When did you find 
out that you are 
pregnant? 
Did you plan for 
this pregnancy? 
Readiness related to 
own health 
 
Felt that the pregnancy 
was not planned according 
to clinic advice to time a 
pregnancy according to 
appropriate CD4 counts.  
I don’t remember very well but what happened is that they said my womb is not 
good to carry a child. They said I would have to choose whether I keep the child or 
I die and I said its fine they can take out the child because my life is important. By 
that time I was 3 months pregnant and my BP was high. I was swollen the entire 
body. I was 2 months pregnant and I was swollen then I came to the clinic and 
they confirmed that I am really pregnant. They also told me that I must go to the 
hospital because my BP was high. 
 
I didn’t plan for it. 
 
I was shocked because they told us here at the clinic that before we get pregnant 
we must talk to them first so that they will find out whether the CD4 count is good 
or if we need to change treatment they can do that. 
Does not want 
to have more 
children 
None 
23-year-old woman with two children. Has a partner who has not paid isilobolo. Clinic C 
Negative When you didn’t 
know about your 
HIV status how 
many children you 
were planning to 
have? 
No planning or 
contraceptive used 
 
 
 
 
Contraception was 
discontinued without 
express purpose of getting 
pregnant. Method 
discontinued due to side 
effects of DMPA 
I was planning to have 3 children. 
 
 I didn’t plan for it; it just happened but I was not using any contraceptive. 
 
When I gave birth to my first child at hospital they gave me injectable and I was 
using it since then. One of the months I miss an appointment date. I was afraid to 
Does not wish 
to have a child 
in the future 
None. Hopes 
to use 
condom. 
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Did you plan for 
this pregnant? 
 
 
go the clinic because [I thought] they will shout at me. After that I lasted for 
about 6 months [until] I got pregnant. 
 Readiness related to 
own health 
 
Retrospective observed 
that pregnancy negatively 
impacted on her own 
health. Influencing future 
attitudes to childbearing  
The worst thing that happened; after I delivered my child I was very sick and I 
thought I would die. It is bad when you are sick while you have a child. They 
[family] have to take care for both of you. 
 
The serious issue is that I was sick. While I was pregnant and after delivery of my 
child I was sick and now I am afraid that something the same might happen. I 
don’t want to take risks because in all what I am doing I must thing of my 
children. 
32 year old woman with five children and currently pregnant with her sixth child. Has a partner who has paid isilobolo. Clinic A 
Positive  When did you find 
out about your HIV 
status?  
Did you plan for 
your pregnancy? 
 
Religious values 
 
Christian belief places the 
locus of control of 
pregnancy planning 
externally to herself 
I used to say I would have children as long God is able to give [them to] me 
because there are so many people who want children and don’t have.  
Does not want 
a child in the 
future 
Injectable 
only 
 No planning related 
to contraceptive use 
 
Ambivalence suggests 
pregnancies were not 
actively avoided. 
No, there is nothing that I used. Before we were using condoms, but not all the 
time because the child came. If we were using it all the time no child will come. 
 
To be honest I never used contraceptive before maybe that is why I have so many 
children. 
 Readiness related to 
health of child 
 
Pregnancy was accepted 
quickly following 
ambivalence to planning  
It was not something that I planned but it happened and when I find out about 
my pregnancy I had no problem with that. What I was praying for is that my child 
to be alright and be alive 
  
39-year-old woman with four children. Married. Clinic C 
Positive When you find out 
that you are 
pregnant what 
happened? 
Did you plan for 
your pregnancy? 
Adapted positively. 
Value of marriage  
 
 
Values the importance of 
childbearing within a 
marriage mean that the 
pregnancy was wanted.  
I was happy because as I was married I never had a child it was a blessing for me. 
 
It was not something that I planned but I knew that it would happen at any time 
as I was married.  
Does not wish 
to have a child 
in the future. 
None. Clinic 
has suggested 
sterilisation 
30-year-old woman with two children. Has a partner who has paid isilobolo. Clinic B 
Positive If you can tell me 
what changes your 
mind about having 
children? 
 
Partner wish for 
child 
 
Personal life-time goals for 
children and cultural 
values towards having 
children after isilobolo is 
paid 
I wanted to have 2 children [and] I have 2 children but one of them is for me only 
is not for my partner 
Would like to 
have a child in 
the future 
Condom  
 
WOMEN THAT HAVE BEEN PREGNANT WHILE ENROLLED IN THE HIV TREATMENT AND CARE PROGRAMME 
34-year-old women with five children. Married. Clinic A 
Negative Do you wish to 
have children now 
or in future? 
Readiness related to 
health 
 
Concerns about mother-
to-child transmission and 
her own personal feeling 
Never, I don’t want to have children now even this one I am having it was a 
mistake.  
 
Does not wish 
to have more 
children 
Condoms and 
injectable. 
Wants 
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of sickness  You know what I was thinking of abortion when I find out that I am pregnant. It 
was hard to accept it because I didn’t know whether my child would be HIV 
negative or not. I was worried when I became sick and my child was also sick. 
When her result came back saying that she is HIV negative I was very happy and I 
thank God for that. I am happy because I see that it was just sickness not that he 
was positive. 
 
I was sick when I was pregnant this child and she also got sick. I was up and down 
when I was pregnant and even after birth of her. When I was pregnant I didn’t 
have much time to enjoy and it is not that I don’t want children because I am HIV 
positive what I am afraid of is that I can die if I can have another child. 
sterilisation. 
 Partner readiness 
for a child  
 
Partner did not want a 
child and was felt to be 
unsupportive 
We don’t know what happened. He used to ask me why I fell pregnant because he 
mentioned that we mustn’t get children now. 
 
My family said nothing because this is my 5th child. It was hard for [my partner] to 
accept but now it’s better because the child is born. 
 No planning and no 
contraceptive used 
 
Contraception was not 
used but without intention 
of getting pregnant 
He used to call me a foolish woman who allowed [herself to] fall pregnant while 
she knew very well that she is HIV positive. He said all these things while he is the 
one who refused to use a condom. 
28 year old woman with one child and currently pregnant with second child. Polygamous marriage. Clinic B 
Negative How many children 
do you have? As 
you are pregnant 
have you planned 
it? What makes you 
feel to find out that 
you are pregnant? 
 
 
 
 
 
 
No planning and no 
contraceptive used 
 
 
Imperfect use of condoms 
without express purpose 
of getting pregnant  
This is the second child that I am carrying. (Referring to current pregnancy.) It just 
happened I didn’t plan it. There is nothing to explain what really happened 
because I don’t know what happened. Most of the time we used condoms, I don’t 
know what happened to make me to be pregnant. 
 
 
Would like to 
have a child in 
the future 
Imperfect use 
of condom 
 Readiness related to 
health 
 
Ambivalence: Pregnancy 
felt to be mistimed 
according to her current 
child and her HIV-related 
health but the pregnancy 
was accepted 
retrospectively  
I said to him I think it will be better if we can use a condom because I don’t want 
to fall pregnant at the moment I don’t want a child. I knew that I am protecting 
him, as our status is not the same. At first he didn’t understand but at the end he 
agreed. Other times he didn’t use it. 
 
I hate that that I am pregnant because my plans were not involving a child I was 
telling myself that the one that I have is still young. But I accepted it. I was upset. 
But it passes. The reason for that is my CD4 count rises slowly. 
37 year old woman with five children and currently pregnant with sixth. No partner. Clinic C. 
Ambivalent Do you want to 
have another child 
as you are on HIV 
treatment? Have 
you planned this 
pregnancy? 
 
 
No planning and no 
contraceptive used 
 
 
Contraception was 
discontinued due to side 
effects and not with 
intention of getting 
pregnant  
The reason is that I fall pregnant fast after I stopped using injectable. I was taking 
a break things got bad. Let me explain it for you. I was using injectable for almost 
9 years, then I stopped I told myself that let me take a break. 
 
I never told myself that I can fall pregnant so fast because I heard people say that 
if you used injectable for a long time you can stay for about 6 months or a year 
you cannot fall pregnant without using any contraceptive. So it would happen like 
that to me but I didn’t even last for 3 months. 
Does not wish 
to have a child 
in the future 
None. Seeks 
sterilisation 
after giving 
birth 
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 Partner readiness 
for a child 
 
Belief in that partner’s use 
of traditional medicine can 
be used to impregnate a 
woman 
We [my partner and I] never talk about that, the only thing that I used to say to 
him is that I don’t a child now. You know I don’t know what he did because men 
are clever sometimes they used traditional medicines so that I can get pregnant. I 
have a feeling that he did something that I can get pregnant.  
35 year old woman with five children and currently pregnant with sixth child. Has a partner who had paid isilobolo. Clinic C  
Negative When did you tell 
your partner about 
your pregnancy? 
 
 
Readiness related to 
health 
 
 
Imperfect use of condoms 
and misunderstanding that 
Disprin acts as a 
contraceptive. Feeling that 
the pregnancy was not 
wanted 
I was not ready to have this child because that one that I have she [was born via] 
caesarean.  
 
I was thinking that my child would have a problem. They told us during initiation 
[on ART] that it is important to use a condom. It is not easy to use condom some 
times because your partner agrees for the first time but when time goes on he 
changed. Even now my partner does not know his HIV status although I asked 
him. 
Does not wish 
to have a child 
in the future 
Disprin 
 Religious values 
 
Interested to seek 
abortion but felt dissuaded 
according to values against 
abortion 
I even thought of doing abortion and I knew that if I told him earlier he would be 
against it. I bought a newspaper because I wanted to see advert that used to be 
there for an abortion. I told my sister and she said to me it is not a good thing to 
do an abortion because a child is a gift from God.  
 
I was one month pregnant. My sister stopped me to do it otherwise I was willing 
to do it. The way she used to say about abortion I was afraid. 
 Stigma to seeking 
abortion advice 
 
Felt pregnancy was 
unwanted but feared 
stigma at clinics prevented 
action to terminate 
pregnancy. 
There are no other places and I was afraid to ask at the clinic about it because I 
thought they would say why I want to do an abortion, as I am old. 
 
I went to the main clinic for the pregnancy test and they said I must come where I 
collected my HIV treatment and let them know that I am pregnant. 
 
I was afraid. 
23-year-old woman with two children. Has a partner who has not paid isilobolo. Clinic C 
Negative How do you find 
out that you are 
HIV positive? 
How did you feel 
when you find out 
that you are 
pregnant while you 
are on HIV 
treatment? 
 
 
Readiness related to 
health 
 
 
Mistimed in relation to 
current children.  
 
Feeling not ready to cope 
with a pregnancy at the 
same time as HIV 
treatment initiation  
It came as a shock to me. 
 
I was not ready for it because I wanted to raise my child in a good way. To have a 
child quickly made my child not to get the love that I wanted him to have. 
 
 I was angry because I was not ready to have a child and I was adjusting the child 
and myself to HIV treatment. To find out that I am pregnant I confused me a lot. 
Would like to 
have a child in 
the future 
3 month 
injection 
 Stigma from family 
 
Fear of stigma from family  It came as a shock to him; he even asked himself what happened. 
 
[My family] never said anything but there was that shame that I’m pregnant 
again while the child is still young. The reason I thought it made them to keep 
quiet I think they were afraid that it might happen that I will do an abortion. I was 
worried as they were quiet not saying anything. I decided to run away, I went to 
my uncle’s house. My mother phoned telling my uncle that as I ran away it’s 
because I am pregnant at the same time they are quiet about my pregnancy. I 
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was worried because it was not normal that when a child is pregnant at home for 
them to keep quiet. 
 No planning and 
contraceptive 
failure 
 
Imperfect use of condom 
and no use of other 
contraception, without 
express intention to get 
pregnant 
What shocked us is that we were using a condom as I said earlier. Here at the 
clinic told us that we have to use a condom all the time we didn’t know what 
happened. 
 
I was not using anything besides condom. I never thought of using it because I 
was using a condom and here at the clinic they always tell us to use a condom all 
the time when we are having sex. They say it prevents HIV virus for spreading and 
also prevent pregnancy. 
 Adapted positively 
to news 
 
Wider definition of 
adaptation to pregnancy 
also included acceptance 
of HIV diagnosis and 
impact on health  
There was no change because I told myself that as I am diagnosed with this 
disease there is no turning back I need to focus on it on how to keep myself 
healthy. 
22-year-old woman with two children. Has a partner who has not paid isilobolo. Clinic D 
Negative How do you feel as 
you are saying that 
you don’t want to 
have children? 
If I may ask at first 
when you didn’t 
know that you are 
HIV positive how 
many children were 
you wish to have? 
How do you feel 
when you find out 
that you are 
pregnant while you 
are on HIV 
treatment? 
 
 
Readiness related to 
health of child 
 
Adherence to ART affected 
perceptions towards 
planning 
I was hurt because I defaulted on HIV treatment and I thought that what if my 
child came out HIV positive. 
Does not wish 
to have a child 
in the future 
None. Never 
used 
contraception 
No planning and 
contraceptive 
failure  
 
Discontinuation of 
injectable without express 
intent to get pregnant 
I used [injectable] but it didn’t work for me. 
 
I failed to wait for the time they said at the clinic I must wait after I get injectable. 
They told me to wait for 7 days before I have sex but it was in the morning and we 
had no condom in the room so we did unprotected sex. It was after 3 days I got 
injectable. 
 
It was not my first time [to miss an appointment]. I did it before and I missed my 
date. I waited for a month without getting it so I decided to do It, then they told 
me to wait for 7 days [before having sex] and I didn’t.  
 
We didn’t plan it. It was a mistake there were no condom that day. He just 
started at work his plan does not include a child but it happened. 
 No planning or 
contraceptive used 
 
Values towards 
contraceptive use 
My wish when I was growing up I wanted to have 1 child my entire life but things 
didn’t go my way and I am not blaming anyone but me. I should have used 
contraceptives from the beginning. 
 Religious values 
towards abortion  
 
Considered abortion but 
felt it was against Christian 
values 
We talked about that with my partner but I was afraid to do it thinking that how 
will I forgive myself if did something like that taking life of an innocent child. He 
gave me money to go and do an abortion but I failed to do it. 
37-year-old woman with three children. Has a partner who has not paid isilobolo. Clinic E 
Ambivalent How did you feel 
when you find out 
that you pregnant? 
Have you planned 
Readiness related to 
current children 
 
Pregnancy felt to be 
mistimed according to 
readiness of current 
children but another child 
I did not plan for it because my child was still young not even 4 years.  I told 
myself that I will get pregnant after my child has 5 years like the other one, it 
happened when my child was 4 years 
Does not wish 
to have a child 
in the future 
Injectable 
only 
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this pregnancy? 
As you have said 
that you did not 
plan the pregnancy, 
did you think of 
having abortion? 
Before you became 
pregnant did you 
ever used any 
contraceptive? 
 
 
was wanted 
 No planning or 
contraception used 
 
Belief that she could not 
get pregnant on ART 
I asked myself how I became pregnant because people say if you are on HIV 
treatment you do not get pregnant. I asked myself how I became pregnant. I 
came to the clinic to check and they told me I am pregnant.  I asked them how I 
become pregnant because I am on HIV treatment. They said who told me that a 
person doesn’t become pregnant when she is on HIV treatment. 
 
I heard people saying you don’t become pregnant easily when you are on HIV 
treatment. 
 
No I never planned for it to happen. 
 
 I used nothing. Because I was taking HIV treatment, I saw that if I used injectable 
while I am on it I would get sick. 
 Adapted positively 
according to 
religious values 
Abortion would be against 
Christian values 
No I hate abortion, I told myself that children are blessing from God. I conceive 
because God wanted to give me. Children are blessing from God. 
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5.4.4 HIV positive women wished to preserve their general health on ART 
Decisions about family size had largely already been made both before diagnosis and the initiation of 
ART, and only a few women said they had reduced the number of children that they would like to 
have since their diagnosis with HIV. As described above a bad HIV related health experience in a 
previous pregnancy strengthened women’s resolve to not have more children:  
I was planning to have 3 children. The serious issue is that I was sick while I was pregnant and after 
delivery of my child I was sick and now I am afraid that something the same might happen. I don’t 
want to take risks because in all what I am doing I must think of my children. 
- 23-year-old woman with two children, a partner who has not paid isilobolo and no 
experience of childbearing in the HIV treatment and care programme, clinic C. 
 
Health risks did not necessarily bring a decisive end to childbearing desires for women that wished 
to remain flexible to their circumstances. Although it seemed to be rare, in the event that a partner 
might pay isilobola, the risks to personal health were considered secondary to partner and family 
expectations of the woman to ‘give’ a child. Discussions about health focused on adverse effects that 
ranged from the toll that another pregnancy would take on their bodies if they were already unwell, 
to the loss of current good health if they were to go through another pregnancy, through to 
concerns that another pregnancy could be life threatening:  
Eish, I don’t want to have children now they are enough those I have. Yah, you see when you 
are HIV positive, you find out that a person is pregnant and that person doesn’t take HIV 
treatment the child end up being HIV positive.  You see to give birth it makes a person to look 
old. The children that I have are enough for me because is a boy and a girl. 
- 23 year old mother of two, with a partner who has not paid isilobolo  
 
In addition to the risk that another pregnancy could cause to themselves, health risks were often 
described in the context of the ‘stress’ of managing their current children, partners and economic 
factors. For example, a woman’s financial situation was felt to be a source of added ‘stress’ to her 
health, experiences of being abandoned by a previous partner, and the subsequent lack of both 
economic and emotional support, linked to poor health:  
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I am not working at the moment at the same time my health life is not good. My parents died 
2 years back. I stay with my children including this man that came back to my life. My 11 
year old is on HIV treatment and we survive with the grant money. It is hard for me to go and 
look for work because there is no one who will take care of my child...  
Seriously I am not good but I am trying not to think about this because it might affect my 
health and also of my unborn child. If a person does this while he is working its painful. 
Immediately [after] I told him that I am pregnant he ran away. The pregnancy also caused 
my sickness... I am staying at the rented room. There is no one else who can help me; I have 
to take care of my child. I had a quarrel with my brothers because I am having lots of 
children. 
- 36-year-old woman with three children and a partner who has not paid isilobolo. Has 
experience of being pregnant in the HIV programme and does not want to have more 
children, clinic C 
 
In fact family members would often encourage women to preserve their health and stop having 
children after diagnosis with HIV, despite access to ART.  
My family don’t say anything besides that they I must stop having children at the moment 
because I am HIV positive because that will put my life in danger. My mom used to say she 
sees other people who are HIV positive getting sick so she doesn’t want me to be like that. I 
will need to take care of my health. 
- 23-year-old woman with two children and a partner (isilobolo not paid)  
 
Marriage was rare, and married women did not discuss the risk of being ‘abandoned’. Married 
women had less agency to limit childbearing, and the issue of health raised concerns when 
pregnancies were expected. For example, a 28 year old woman in a polygamous marriage and 
pregnant at the time of interview said that she did not plan or want her current pregnancy because 
she had felt unwell during a prior pregnancy, but that she had accepted it and still intended to have 
more siblings for her two current children.  
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Despite strong desires to avoid further childbearing, many women did still not use contraception at 
the time of these interviews, and women often felt ‘not ready’ for a pregnancy due to a lack of 
planning according to their HIV-related health. For those who did use contraceptives, the injectable 
method of contraception was most popular as it could be used either with or without partner 
knowledge and lasted a long time, whereas condoms required negotiating with partners, and only 
one woman reported dual use of condoms and injectables with her current partner.  
 
The reason is that I don’t want to get a child from him, I am not denying that I will have a 
child because is a gift from God. This man has a wife. He can leave me any time when I fall 
pregnant so my solution is to avoid being pregnant for him by using an injectable, as I believe 
that it will prevent me from having a child. 
- 42 year old woman with two children and does not want another child 
 
Although an impact on health was mentioned as an outcome of pregnancy, other HIV specific health 
issues such as risk of HIV transmission during unsafe sex, or concerns that the virus could be passed 
on to future children were not salient in the course of these interviews  (Box 5.3.I). Women 
discussed being aware that ART can reduce the risk of a child being born HIV positive through 
Prevention of Mother to child Transmission (PMTCT), that their ‘baby will be fine’. Being pregnant 
was seen as an incentive to adhere to ART by one woman, who wished to protect the health of her 
child. Few women viewed the risk of mother to child transmission as a deterrent to childbearing. 
There was no problem. I told myself that I will be alright and my child will be alive, my child 
will not have a problem as HIV treatment prevents my child from getting HIV.  
- 37 year old woman with 3 children, a partner who had not paid isilobolo and no desire 
to have any more children, clinic E 
 
It was hard to accept it because I didn’t know whether my child would be HIV negative or 
not. I was worried when I became sick and my child was also sick… to be on HIV treatment 
does not give me a problem at all. The reason is that when I have a child, it happens that I 
am the one who is sick, or else the child. I am the one who can lose my life, or my child. If I 
die what will happen to my other children?  
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- 34 year old married women with five children with no experience of childbearing in the 
HIV treatment and care programme and no desire for another child, clinic A 
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Box 5.3.I THE INFLUENCE OF HIV-RELATED HEALTH UPON ATTITUDES TO CHILDBEARING 
Risk of unsafe sex  
 
They are enough, those I have. Three is enough.  I have HIV now; I don’t want to have 
children with the fact that if you have children it means you are doing unsafe sex. 
- 27 year old women with a partner who has not paid isilobolo, clinic E 
Risk of mother to child transmission  
 
It [being HIV positive] changes a lot. I told myself that I will not get another child because they 
tell us that we must protect ourselves by using a condom but when the time goes on I find out 
that you can have children even if you HIV positive. After I started HIV treatment everything was 
clear that I am like any other people and I will take my HIV treatment accordingly [but] I am 
afraid that my child will be infected.  
- 23 year old woman with one child and would like a child in the future. Clinic E 
Feeling sick while using ART  
 
I am on HIV treatment I don’t know what will happen to my body if it happens that I get 
pregnant maybe my body will be weak. Maybe my child will not be right. As we are taking HIV 
treatment me and my partner it will be a big problem, as I was pregnant and I find out that I am 
HIV positive I started my HIV treatment and luckily my child is HIV negative. I will get sick 
because as I am on HIV treatment I have illness.  
- 32-year-old mother of three children with a partner who has not paid isilobolo. Does 
not want a child, clinic E 
Impact of pregnancy on HIV 
 
They used to say when you keep on bearing children while you are HIV positive the virus 
multiplies itself. I was worried because I didn’t know whether I would die or not.  
- 35 year old woman with five children and currently pregnant with 6th child 
Negative experiences of being pregnant while HIV positive  
 
When I have another child I will have a problem with my life because when I was 
pregnant with this child I was so sick and I came across so many problems…. The serious 
issue is that I was sick while I was pregnant and after I delivered my child I was sick. Now 
I am afraid that something the same might happen. I don’t want to take risks because in 
all what I am doing I must thing of my children.  
- 23-year-old woman with two children and a partner who has not paid isilobolo.  
Ability to care for children  
As I have two children the first one is doing grade 12 and the second one is doing grade 7, I am 
not working I am getting a grant for my second child. All the things I do for my children, where 
will I get the money to raise that child. 
- 42 year old woman with two children and does not want another child 
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5.5 Chapter Summary 
Women did not typically wish to have another child either now or at any time in the future, because 
they felt satisfied with their family size and another child presented economic, health and 
relationship instability risks. A mix of changing economical, societal, partnership and health factors 
that were inclusive, but not limited to use of antiretroviral therapy shaped childbearing and spacing 
aspirations. Desired family size had only changed for a few women since they entered the HIV 
treatment and care programme, or delayed for a small group of women saying they might still like to 
have children in the future. 
Cultural pressures to have a child persisted for women on ART. Theoretical literature, that situates 
desire for a child along a pathway to intention and behaviour (Stanford et al., 2000, Miller, 1994, 
Trussell et al., 1999), may be limited in the Hlabisa setting due to an assumption that women make 
an active decision leading to a pregnancy. First and foremost, women considered partnership 
dynamics and financial stability as key influences of future childbearing intentions, and pressures to 
have a child persisted for women on ART particularly when women did not already have children 
with their current partner. Considering whether they expected to achieve their desires in the future 
and reflecting on their previous pregnancy several women discussed the cultural practice of isilobolo 
and partner preferences as the ‘need’ to have a child.  
Women balanced the ‘need’ for a child with economic and HIV related factors. HIV accentuated the 
perceived risk of another pregnancy and deterred some women from having more children in 
preference to protect their own health. Health was considered in broad terms including the stress of 
social issues and more proximate factors including risk of HIV transmission. For these women, a HIV 
positive status added more than uncertainty to childbearing and strengthened a resolve to avoid 
childbearing. Many described postponement of childbearing without a specified endpoint and 
reported using injectable contraception as a way to effectively avoid another pregnancy without the 
need to discuss their desires with a current partner. Yet most recent pregnancies amongst these 
women had been unplanned and had occurred due to inconsistent contraceptive use, suggesting 
that desires and intentions on ART were not always congruent with behaviour.  
These interviews highlight a concern that HIV treatment and care services are not being utilised by 
women for family planning discussions in order to avoid unwanted pregnancies or for referral for 
termination of pregnancies. Women described a lack of engagement with health services before 
their most recent unplanned pregnancy, suggesting that a traditional concept of family planning ‘for 
a planned pregnancy’ does not apply in this context.    
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Chapter Six 
Factors Associated with Contraceptive Preferences amongst 
Women on ART 
6.1 Introduction to chapter six 
Chapter five determined that social and cultural norms powerfully influenced the childbearing 
decisions of women on ART, and that most women wished to postpone or limit their childbearing. A 
subset of women strongly aspired to limit childbearing altogether through contraceptive use or 
remaining without a partner. Women indicated very little or no planning towards their previous 
pregnancies: all of the thirteen most recent pregnancies to women after their HIV diagnosis were 
considered unplanned. Of women that wished to have a child in the future, women preferred to 
postpone the decision to a time when a partner might find employment or existing children had 
grown older. Some felt that they would have a child if they married, even if that was against their 
own desires for childbearing. At present however, women would often use contraception to 
postpone childbearing without a specific end point in mind. Yet inconsistent use and discontinuation 
of methods had resulted in many unplanned pregnancies amongst these women after HIV diagnosis.  
Chapter 6 builds on findings from chapter five with an investigation on attitudes to contraceptive 
use, and planning for safer conception on ART. This chapter begins with an overview of current 
contraceptive practices amongst women interviewed while ‘on ART’, and then presents themes 
influencing contraceptive preferences and use while enrolled in the HIV treatment and care 
programme in section 6.3. This is followed by a broader discussion of facilitators and barriers to 
family planning in the Hlabisa HIV treatment and care programme in section 6.4. Section 6.5 
concludes with a summary of factors influencing how women make their contraceptive decisions in 
the Hlabisa HIV treatment and care programme.  
 
6.2 Current contraceptive use amongst women on ART 
Interviews determined a universal awareness of a range of contraceptive methods amongst women 
on ART, and also a pervasive fatigue towards consistent use of any form. About half of women were 
using contraception and preferred to use injectable methods, and less frequently, condoms. 
Commonly women preferred to use the injectable Depot Medroxyprogesterone Acetate (DMPA); a 
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long acting reversible progestin-only contraceptive injection administered every 3 months or 
Nuristerate, a progesterone only injectable administered every two months. These methods offered 
a long lasting protection but required quarterly visits to either the primary health clinic or the HIV 
treatment and care facility, depending on a woman’s preference, and also presented a range of 
possible side effects that deterred some from jeopardising their newly improved or current health. 
Consequently discontinuation of injectable methods was also common, and women discussed 
periods of injectable use separated with times they were ‘taking a break’. 
Condoms were used inconsistently and only when women wanted to use them, partners would 
consent and the method was available. Many were aware of the benefits of barrier contraceptive 
methods for safer sex, but reflected that they could not rely on them as a form of pregnancy 
prevention because of inconsistent use. Other methods were not widely discussed by participants 
until raised by the interviewer. The oral pill and the emergency contraceptive pill were not well 
known or liked, and three women had never used contraception because they were ‘lazy towards 
contraception’ or abstaining after a recent pregnancy.  
 
6.3 Themes influencing attitudes to contraceptive use in women on ART 
Ease and reliability of use were the major themes influencing method preference, while side effects 
and knowledge of other methods modified a woman’s ability to use contraception consistently. 
General perceptions of health on ART were a continuous theme throughout the course of these 
interviews and influenced women’s perceptions of contraceptive need in balance with a dislike of 
adverse side effects. 
 
6.3.1 Condoms were used inconsistently to protect health and avoid hormonal side effects  
Condoms were viewed favourably by women, who repeated health advice that they had received at 
the clinic that barrier methods would protect the woman’s own health and in some cases, the health 
of a partner by preventing the transmission of viruses. Women were very aware of the risks of HIV 
transmission to a partner or acquisition of other STI’s, and spoke generally about their wish to 
‘prevent diseases’ or ‘protecting each other from diseases’ as their primary incentive to use 
condoms. Some further expressed feeling that condoms were the only appropriate method for 
women living with HIV and that it is ‘not right’ to use any other methods as an alternative.  
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In addition to this awareness, most women still found it difficult to convince partners to consistently 
adhere to use, and in more pragmatic light women did not consider condoms as a reliable method to 
prevent a pregnancy.  Trust in condom efficacy was a prominent barrier for women even in the 
event that they were used, as some felt that condoms would burst or ‘you cannot trust condoms’, 
government condoms were viewed to be more likely to burst. More than half of the women said 
that they were either currently using condoms or had been using them at the time of their most 
recent pregnancy.  
Healthcare providers encouraged condom use and some women that were motivated to avoid a 
pregnancy said they were using dual protection based upon clinic advice. Other women viewed this 
information as right but at times impractical in the context of difficult partner negotiations. Most 
reflected on a partner’s inconsistency to adherence because they disliked the method or thought it 
led to cramping. One woman even said that her partner threatened to sleep with other women that 
would be willing to do so without a condom, and so she ‘ends up sleeping with him without a 
condom’.  
At the clinic they tell us to use condoms. Yes, they are right [but] when we have to do it becomes 
very hard. Your partner sometimes refused to use it, like my husband. So I decided to use an 
injectable at the moment because I know that when he refused to use a condom but I am safe. 
- 34 year old married women with five children with no experience of childbearing in the 
HIV treatment and care programme and no desire for another child, clinic A 
 
Initiation of ART had a small encouraging effect on couple’s willingness to use condoms as some said 
that partners were more open to using this method since they were on treatment, either because 
the partner was sero-discordant or did not know his own HIV status. 
We are protecting each other from diseases but I am using injectable because I don’t want to 
get pregnant you will never trust a condom because it happens we don’t use it always. 
- 32-year-old mother of three children with a partner who has not paid isilobolo. Does not 
want a child, clinic E 
 
Not all women felt that dual contraception was necessary however. Some women said they had 
switched completely from injectable use to condoms because they had did not like the adverse side 
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effects they had experienced while using injectables, but felt it was important to use a method of 
contraception. Injectable discontinuation was common and although some substituted injectables 
for condom use during these periods, most said they did not.  
While male partners were often portrayed as reluctant to use contraception, there were exceptions 
amongst women who felt empowered to lead condom use, or partners who also wished to protect 
their health. One woman said she ‘forced’ her partner after telling him ‘he is going to die as I am on 
HIV treatment and he is not’. And another woman described her partner as more open to condom 
use since both were diagnosed with HIV, in order to avoid that their antibodies drop. In addition, not 
all women saw it as a bad thing that they did not always use condoms and followed the sentiment 
that ‘it happens that we don’t use it always’. 
 
6.3.2 ART did little to change preferences for the long-lasting and covert nature of DMPA  
Women emphasised that ‘nothing had changed’ in respect to contraceptive preferences since they 
were enrolled in the HIV treatment and care programme and continued using injectable methods of 
contraception after initiating ART. A subset of women emphasised strong aspirations to avert further 
childbearing through use of DMPA as they felt this would be the most efficacious method to ensure 
that they did not fall pregnant in the future and also meant that women did not regularly need to 
return to the clinic as in the case for condoms or oral pills.  
I chose injectable because it is something that is in my blood I will not take it daily. 
Injectables can help me when the condom burst or when with my partner we decided not to 
use it 
- 23-year-old woman with two children. Has a partner who has not paid isilobolo. Clinic 
C 
 
It is better to use it because you do not keep on coming to the clinic. 
- 23 year old woman with two children, a partner (isilobolo not paid) and no experience 
of childbearing in the HIV treatment and care programme, clinic C 
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Yet discontinuation was common and all reported taking ‘breaks’ between injections, which would 
have left times when they were unprotected. Injectable contraception remains effective for 2-3 
months and women favoured the long lasting effect of DMPA because they were not required to 
come back to the clinic frequently or to remember to take the oral contraceptive pill every day.  
None of the interviewed women were currently using the pill and very few reported an interest in 
this method. Women felt that both HIV treatment and the oral contraceptive pill can be occasionally 
missed and that it would be difficult to adhere to a method that required daily attention. Health 
workers supported this sentiment so rarely discussed oral pills while actively encouraging injectable 
forms. At the time of interviews, the Intra Uterine Contraceptive Device (IUCD) was in early stages of 
being rolled out across the Hlabisa sub-district. While no women had yet initiated this method, 
women were encouraged by information about the IUCD because it offered protection against an 
unwanted pregnancy for even longer time periods and did not require repeat visits to a clinic. 
The ability to hide contraceptive use strongly facilitated a woman’s preference and ability to adhere 
to injectables as a way of avoiding a pregnancy without discussing this desire with a partner. Eight 
women sought contraception secretly and these women tended to have more children than other 
participants (Box 6.3.I). Covert use allowed women to assert control over fertility when partner 
consent to condom use was inconsistent or sometimes refused. Some said that partners would 
initiate sex whilst drunk or were ‘cheating’ by not using a condom properly of removing during sex.   
Practically, covert contraceptive use allowed women to enact desires to postpone childbearing 
decision-making until another time but these women often still wished to disclose their 
contraceptive use to partners eventually. While faced with unpredictable condom use and 
expectations of when a woman may ‘need’ to have a child, injectables provided a safer alternative to 
the risk of another pregnancy in the meantime.  
Clinics facilitated women’s covert contraceptive use by allowing clients to store their family planning 
cards within the facility. Health workers further noted that interest in the IUCD was growing in 
popularity as it allowed women to protect themselves against childbearing for a long time without 
need to negotiate with her partner. 
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Box 6.3.I PARTICIPANTS VIEWS TO COVERT CONTRACEPTIVE METHODS  
Women’s views on covert contraceptive use on ART  
 
Even if we speak I told him that I am not using contraceptives I don’t know what is wrong that makes 
me not to conceive. 
 
- 33-year-old woman with one child and a partner who has not paid isilobolo. Does not 
wish to have another child, clinic A 
 
He is cheating when he uses a condom… one day while he was using a condom his sperm was on me. 
I will be in a problem one day and find myself being pregnant. That is when I decided to come to the 
clinic for contraception. 
 
- 42-year-old woman with two children and a partner who has not paid isilobolo. Has been 
pregnant while enrolled in the HIV programme and does not want a child, clinic A 
 
Your partner sometimes refused to use it like my husband. So I decided to use an injectable at the 
moment because I know that when he refused to use a condom but I am safe.  
 
- 34 year old married women with five children with no experience of childbearing in the 
HIV treatment and care programme and no desire for another child, clinic A 
 
 
Health worker views on covert contraceptive use 
 
They don’t tell their partners. Most of the women they use it but they don’t disclose to their 
partners because they know the response they are going to get from their partners. 
- Africa Centre Counsellor, clinic E 
 
You can have injection and leave your card here. 
- Africa Centre Counsellor, clinic E 
 
[Some women] say ‘I hide it’. We carry a card for family planning for one lady who’s afraid to tell her 
husband that she’s using contraceptives. So we said we can keep the card with us. She just comes to 
clinic, has an injection and goes home. Innocent. She mustn’t tell the... I don’t if he’s a husband or 
boyfriend...we have those challenges  
- Department of Health Nurse, clinic A 
 
 
 
240 
 
6.3.3 Side effects of hormonal contraception prevented consistent use on ART 
Many women described patterns of discontinuation, which had often resulted in an unplanned 
pregnancy. Experiences of unplanned pregnancies encouraged a stronger resolve to adhere to the 
method currently. Various side effects were discussed in relation to use of hormonal contraception 
and these factors were prevalent barriers to a woman’s willingness to continue using or adhere 
correctly to the method. Patterns of continuation and discontinuation were fluid according to when 
women felt tired of side effects or needed a ‘break’ from hormonal contraception. Practically, some 
had decided to ‘take a break’ from quarterly injections in the hope that they would remain protected 
for slightly longer. Few actually switched to another method but in this case would protect 
themselves with condoms. As fatigue to hormonal side effects was the main barrier to adherence, 
no women spoke about switching to oral contraception and some had tried to find emergency 
contraception after unprotected sex.  
An emerging and prominent theme was a perception that DMPA made women ‘watery’ or caused 
them to produce excess fluids during sexual intercourse (Box 6.3.II). Health worker’s also found that 
women reported objections from partners that were aware or speculated that a woman was using 
an injectable contraception.  
Prior research has discussed the use of intravaginal insertions amongst women as a long standing 
traditional practice in this setting and use of modern products such as medications, hygiene 
products and commercial products in the vagina amongst women aspiring to be ‘hot’, ‘tight’ and 
‘dry’ during sex (Gafos et al., 2010). The primary aim of using insertions is to improve sexual pleasure 
(although it is uncertain whether this also refers to the woman’s own pleasure), by ensuring the 
woman is in an ‘alright’ state before sex.  In opposition, women on ART saw being ‘watery’ as a 
negative state because it reduced the pleasure of male partners who described the effect as ‘cold’ or 
‘watery’ or ‘not nice’. Other research suggests that being ‘wet’ also refers to an unhealthy state for 
the vagina associated with STI-related discharge, which may further reinforce women’s wishes to 
avoid the stigma of this label.  Just one client described experiencing the effect of being watery 
herself, and did not comment on her own sexual pleasure, but said that it caused her to discontinue 
injectable contraception.  
Prior research determined that partners also viewed the use of intravaginal insertions negatively due 
to the secrecy surrounding this practice, causing partners to be suspicious of sexual inadequacy, 
infidelity and promiscuity (Gafos et al., 2010). Women on ART in this study revealed a parallel 
between the negative dialogue surrounding use of intravaginal insertions and injectable 
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contraception. Although some did not believe this phenomenon to be true, those who had not 
experienced being watery themselves felt the risk could act as a barrier to using that method.  One 
woman worried that being ‘watery’ would reveal her covert contraceptive use and said that some 
men seek traditional medicine to make a woman pregnant when they suspected women of using 
injectables.  Fearing that traditional medicine would be used to make her pregnant added to the risk 
of hiding her own contraceptive use. Consequently, health workers and clients felt this could 
encourage the acceptability of the IUCD, as it is not thought to alter the desirability of women during 
sex.   
 
Box 6.3.II PERCEPTIONS OF BEING ‘’WATERY”  
Women’s views on being ‘watery’  
I was hiding from him. Men know when you are using injectable [and] he can go and use traditional 
medicine to make you pregnant. Sometimes he can tell you that you are watery.  
- 37 year old mother of 6 with no partner and no desire to have more children, No 
experience of being pregnant in the HIV programme, clinic C 
 
I thought of using injectable but I heard people saying that when you are using injections you 
become watery.  
- 35-year-old woman with six children and a partner who had paid isilobolo. Does not 
wish to have a child in the future, clinic C 
 
While I was at the hospital I thought of using injectable but I heard people saying that when you 
use injections you become watery. I can I believe it because I never used injections. 
- 35 year old woman with five children and currently pregnant with 6th child. She has a 
partner who had paid isilobolo. Does not wish to have a child in the future, clinic C 
 
We do talk about it. He used to say injectables make a woman to be watery and I said to him that if 
I don’t use injectables I would get pregnant.  
- 25-year-old woman with three children and a partner who has not paid isilobolo. Does 
not wish to have a child in the future and has not been pregnant while enrolled in the 
HIV treatment and care programme. Clinic D 
Health worker views on the effect of injectables making women ‘watery’ 
Most of the time they say if you are using injection, you have a lot of water. Mm, it’s not true... The 
man will not notice. Unless you tell that I’m doing the family planning, then that’s when the man 
can say you have a lot of water [otherwise] he can’t complain about anything 
- Africa Centre Counsellor, clinic B 
 
A lot of water, to be cold, to be, not nice. You don’t feel as nice. Don’t give your partner happiness. 
                                   Africa Centre Nurse, clinic B  
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More than half of the women also discussed an aversion to excessive menstruation, amenorrhea, 
weight gain, looking old and generally feeling unwell. Particularly, women were concerned for the 
impact of these side effects on their health, and some felt that use of ART at the same time as 
hormonal contraception might somehow amplify these effects. 
Women said they avoided contraceptive methods that would negatively affect their health and 
added that they were at times confused as to whether it was their hormonal contraceptive or ART 
that was causing them to feel sick. Irregular menstruation was the most common complaint amongst 
clients using hormonal contraception and in most experiences ended in discontinuation of the 
method. ‘Heavy bleeding’ was a known side effect and perceived as a sign of ill health amongst 
women on ART. One woman felt that amenorrhea was caused by DMPA when a ‘cloth’ [clot] 
develops inside the woman and this was perceived to be unhealthy in a culture where traditional 
medicine was described to be used to ‘clean the dirt’ from the body. Women were also confused 
about how being on ART affected the strength of either drug. Health workers mentioned that 
interactions between hormonal contraceptive methods and ART were possible and some 
understood this message that injectables were ‘stronger’ than oral pills when combined with ART.   
Because I was taking HIV treatment, I saw that if I used injectable while I am on it I would get 
sick 
- 37 year old woman with 3 children, a partner who had not paid isilobolo and no desire 
to have any more children, clinic E 
 
As I am on treatment when I am on my periods I only go 2 days and it is heavy one and I 
don’t know whether is HIV treatment or is injectable. 
- 42-year-old woman with two children and a partner who has not paid isilobolo. Has 
been pregnant while enrolled in the HIV programme and does not want a child, clinic A 
 
Many simply disliked the pain of using an injection. Other side effects influenced the way in which 
women felt they would no longer be attractive to partners. Weight gain and ‘feeling hungry all the 
time’ while one woman reported avoiding injectable use as her partner claimed it would cause her 
to ‘look old’.   
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The immediacy with which a contraceptive method allowed a woman’s return to fertility was also an 
important factor in a woman’s decision to use this method and interviews found differing views of 
the efficacy of injectable methods. Primarily women believed that prolonged DMPA use could delay 
her return to fertility for when a child might be wanted in the future. Concerns further extended to 
the IUCD:  health workers described beliefs that IUCD insertion could damage a woman’s body. 
They do want to go for family planning but... like, maybe I’m taking a contraceptive method 
for 5 years and [then] when I want to have a baby, I might [be] delayed to conceive. They feel 
that contraception can maybe delay them [from] having a baby. 
- Department of Health Counsellor, clinic A 
 
Women might experience just one or multiple side effects and where the medical implications were 
not widely understood; differing experiences caused women to discuss these effects in terms of 
generally feeling ‘sick’. One health workers summarised the off-putting nature of multiple side 
effects 
What I know is that, mm like medroxyprogesterone, it has a tendency of making your 
appetite too big. So you can eat and eat and eat until you are too fat. And then with 
nuristerate, from experience it makes you nauseous almost the whole month. Every morning, 
you just feel ill from it. Even in the afternoons, it’s terrible. It’s not nice. And then you have 
these periods, which are so irregular, yeah very irregular periods. Sometimes this will go for 
five days, the following month for 3 days, the following month for 7 days, you see and then 
there’s spotting in-between. So yeah, they’re good but then again...  
– Department of Health Nurse, clinic C 
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Box 6.3.III PERCEIVED SIDE EFFECTS OF INJECTABLE METHODS OF CONTRACEPTION 
HEAVY MENSTRUATION  
 
I don’t know really but last I was using injectable and I was bleeding and I decided to stop using it. It 
was hard because it was after I lost my child and find out that this injectable makes me sick I was 
stressed. I don’t remember very well but its long time ago because I used to do injectable only to 
find that I am going to bleed for a long time and decided to stopped using it. I used to go to doctor 
when I bleed a lot I never come to the clinic. 
- 36-year-old woman with three children and a partner who has not paid isilobolo. Has 
experience of being pregnant in the HIV programme and does not want to have more 
children, clinic C 
AMENORRHEA  
  
I used to hear people say if you are using injectable not menstruating can form cloth [clot] when the 
time goes on and that will make you sick and I don’t know whether they are right or wrong. I don’t 
like when the blood is lock inside my body. 
- 23 year old mother of one, with a partner who has not paid isilobolo and does not want a 
child in the future, clinic B 
LOOKING OLD  
 
I do talk but my recent partner does not like a woman who is using injectable, he used to say it is 
better if we use a condom because I will look old when I am using injection 
- 23-year-old mother of two with multiple partners. No experience of being pregnant while 
enrolled in the HIV programme and no desire to have more children, clinic A 
PAIN  
 
I am afraid of even when I am sick I hate when a doctor use it.  
- 23-year-old woman with one child and a partner that has not paid isilobolo. Would like a 
child in the future and has not been pregnant while enrolled in the HIV treatment and 
care programme. Clinic E  
WEIGHT GAIN  
 
I felt hungry all the time 
- 30 year old mother of two, with a partner who has paid isilobolo, clinic B  
RETURN TO FERTILITY  
 
Maybe pill can be the right thing to use because when I want a chid it will easy. 
- 27 year old women with three children, a partner who has not paid isilobolo and no 
desire to have a child at any time, clinic E 
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6.3.4 Misconceptions about ART, contraception and pregnancy persisted despite common 
knowledge about contraceptive availability  
Women were widely aware of injectable and oral contraception, condoms and sterilisation but had 
only a conceptual or no awareness of the intrauterine contraceptive device and emergency 
contraception.  Where women would often discontinue injectable contraception, they described 
condom use as an unreliable back up. Consequently, women had relatively few alternatives to 
contraceptive use when wising to ‘take a break’ from long-term hormonal injectable use.   
Health workers deterred women from using the oral contraceptive pill as they considered it less 
effective than injectable forms of contraception. In addition, health worker’s advised women to 
return for a DMPA injection after two months rather than three in some clinics as they said they had 
received guidance that ART reduces the efficacy of hormonal contraception. This advice was 
contrary to the client’s perceptions of longer lasting protection on injectable or a perceived lack of 
need for contraception while on ART, although this advice was not consistent across all clinics.  
We explain to them, if you’re on ARVs you must use injection. Prefer injection. And we 
explain to them that as they are on ART when they choose the three month injection, they 
must come back after two months. If you choose the two month injection, you must come 
back after one month.  
- Counsellor, Department of health, Clinic A 
 
Especially we talk about [the] injectable; we recommend injection because the pills have an 
effect on ARVS, and so we used to encourage them to do injection for family planning.  
- Counsellor, Department of health, Clinic C 
 
The IUCD was recently re-introduced as a method that is safe to use by women living with HIV, 
unless diagnosed with AIDS.  No women had initiated the IUCD at the time of this study but some 
were aware of a method that could be inserted in the womb. For one 48-year-old woman, her 
knowledge of the IUCD stemmed from when this method had been available in clinics in the past. 
However, a belief that IUCD users could still get pregnant was common and purported as an analogy 
those women could get pregnant and deliver a child ‘holding an IUCD in its hand’. Use of this phrase 
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was entrenched in the programme, which health worker’s attributed to a fear of using a new 
method. 
 
I heard people talking about loop but I don’t know much about it.  
- 37 year old mother of 6 with no partner and no desire to have more children, No 
experience of being pregnant in the HIV programme, clinic C 
 
DoH guidelines were supported by nurse training sessions within the Hlabisa district on how to use a 
WHO developed Family planning provider handbook and how to insert the IUCD. In this context, 
health workers felt that IUCD insertion was favourable as a one off procedure for women who would 
not need to return to the clinic. Health worker felt that the IUCD was well liked but could be difficult 
to educate women to use, and presented mixed views on how well the IUCD was understood within 
the programme. Women compared the values of the IUCD to the injectable, as both could be used 
covertly while the IUCD lasts longer and does not require repeat attendance to the clinic. 
Most of them they are interested, cause every morning for health education we encourage 
them for IUCD  
- Department of Health Counsellor, clinic C 
 
It’s too hard to understand, some they understand, and some they don’t understand. 
- Department of Health Counsellor, clinic A 
 
People say it’s the best. You don’t go all the time to the clinic for contraceptives.  
- 23 year old mother of one, with a partner who has not paid isilobolo and does not want 
a child in the future, clinic B 
 
Sterilisation was the only remaining option for a small group of women who wished to avert further 
childbearing yet these women did not report any immediate plans to act upon this wish. Most 
women had discussed their wish to seek sterilisation with their partners and of these only one said 
that her partner was against the idea but most felt there was still a stigma against seeking this 
procedure. For example, a 39 year old mother of 4 felt feared being stigmatised by her partner’s 
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family and did not seek sterilisation secretly because she felt she would need to stay in hospital too 
long, which could alert family members to her procedure.  
I cannot stay for such a long time at hospital because my in-laws will want to know what I 
am doing there at the hospital. I thought it [sterilisation] would be something for one day. 
They are going to talk. This thing is between me and my husband; no one else should know 
about it. 
- 39-year-old married woman with four children. Has not been pregnant while enrolled 
in the HIV treatment and care programme and does not wish to have a child in the 
future. Clinic C 
 
Misconceptions surrounded the use of ART at the same time as contraception and these were 
relayed during interviews with both health workers and clients. In particular, two women said they 
had believed that it was not possible to get pregnant while using HIV treatment and a 37 year old 
woman attributed her most recent pregnancy to a belief that she was not at risk of conceiving after 
hearing friends discuss that women were less likely to get pregnant while taking ART. 
I asked myself how I became pregnant, because people say if you are on HIV treatment you 
do not get pregnant. I asked [health worker’s] how I became pregnant because I am on HIV 
treatment?  They asked who told me that a person doesn’t become pregnant when she is on 
HIV treatment… I heard people saying you don’t become pregnant easily when you are on 
HIV treatment.  
- 37 year old woman with 3 children, a partner who had not paid isilobolo and no desire 
to have any more children, clinic E 
 
Some believed that the contraceptive effect of DMPA would last longer than 3 months, and thought 
they were at less risk of a pregnancy than was actually true. As a result, these women did not 
reportedly seek another contraceptive method during periods of discontinuation from DMPA or Nur-
Isterate.  
I heard people say that if you used injectable for a long time you can stay for about 6 months 
or a year. You cannot fall pregnant without using any contraceptive. So it would happen like 
that to me but I didn’t even last for 3 months. 
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- 37 year old mother of 6 with no partner and no desire to have more children, No 
experience of being pregnant in the HIV programme, clinic C 
 
Health workers from one clinic also perceived an increased libido to be a side effect of ART. A nurse 
and counsellor both reported seeing clients with ‘hyperactivity’, an increased sexual appetite 
following ART initiation and one nurse claimed to have successfully administered the injectable 
contraception as a counter to this effect of ART: 
That’s why they falling pregnant even though they are using injection the visit is today, 
maybe she will come next month for injection. I think it won’t work. 
- Department of Health counsellor, clinic C 
There is a saying that ARVs makes people more, I don’t know how to say this, but they desire 
sex more than normal. I once saw a lady who was complaining that ever since I started ART, I 
am so active that I feel like ripping every man. She said I can’t even find satisfaction without 
sex, I just feel like I can have sex and sex and sex and sex, like every hour. I just thought that 
if medroxyprogesterone decreases sexual desire, then it might help this woman. And she 
came, she was glowing, fit, and she said thank you!  
– Department of Health Nurse, clinic C 
 
Only one woman reported using traditional methods of contraception. This woman described 
drinking ‘imbiza’ after unprotected sex with the purpose to ‘drain all the dirt’. This concept of  
removing internal ‘dirt’ was a theme overlapping with discussions about amenorrhea, where the 
absence of menstruation was perceived as the retention of dirt and was a disliked side effect of 
injectable contraception. 
Women discussed traditional methods of contraception such as tying wool around a woman’s waist 
under her clothes to prevent falling pregnant whilst wearing it. Women and health workers viewed 
traditional methods as ‘old fashioned’ and reported that women on ART did not typically seek them 
after exposure to health education in the HIV treatment and care programme. 
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6.3.5 Emergency contraception was rarely discussed and not well understood 
In comparison to the IUCD, emergency contraception was scarcely discussed within the HIV 
treatment and care programme. Health workers only considered emergency contraception (EC) as 
suitable in emergency cases, such as incident of sexual violence, and were concerned that clients 
would engage in risky sexual behaviours if this method was promoted during health education 
sessions. 
That’s a serious note. I think, when you do education with emergency pills, we think that they 
always sleep without condom. Wow emergency pills, emergency pills. So that’s why we don’t 
emphasise the emergency pills. Yes we do the counselling, but we don’t emphasise… (EC)  
- Department of Health Nurse, clinic C 
 
Women learned about this method from sisters, family, boyfriends or on the radio. Two women had 
experience of using this method in the past but most were either unaware of this method or, 
contrary to the concerns of health workers, were reluctant to rely on it as a sole form of 
contraception because they mistrusted it’s efficacy, disliked the idea of unsafe sex, or felt that it was 
not appropriate to use during marriage (Box 6.3.IV).  
Some women described alternatives to the concept of taking a pill after unprotected sexual 
intercourse. Antibiotics and an aspirin (Flagyl and Disprin respectively) were both cited as forms of 
emergency contraception that women had used after unprotected sex with a partner. Furthermore, 
one woman reported a friend’s belief in the use of marijuana seeds as a successful form of EC that 
remains in the womb.  
These discussions re-iterated an overlap between traditional practices of intravaginal insertions and 
contraceptive use, and were not tied to women’s use of ART.  Women described similar use of 
modern medications and commercial products for the purposes of emergency contraception and as 
intravaginal insertions. For example, Disprin has been reportedly used and associated with the idea 
of ‘tight sex’ (Gafos et al., 2010), but in the context of these interviews about contraception, has 
been used for pregnancy prevention. Similar concepts of ‘cleaning the dirt’ were applied to stopping 
a pregnancy with Disprin as also discussed in avoiding the sexually undesirable effect of being 
‘watery’ when using injectables.  
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Box. 6.3.IV ATTITUDES TO USE OF EMERGENCY CONTRACEPTION ON ART 
I know emergency contraceptive. I think is the same as morning after pill? I used it but I got pregnant 
- 22-year-old woman with two children and a partner who had not paid isilobolo. Does not 
wish to have children in the future, clinic D 
 
Long time ago I heard people talking about that thing but I never see it. 
- 48-year-old woman with two children. Does not have a partner or desire to have more 
children, clinic D 
 
I will be afraid because I will be doing unsafe sex 
–  27 year old women with three children, a partner who has not paid isilobolo and no desire 
to have a child at any time, clinic E 
 
Emergency contraceptive I don’t like it because I will have to take pill every time I had sex with my 
husband” 
- 34 year old married women with five children with no experience of childbearing in the 
HIV treatment and care programme and no desire for another child, clinic A 
 
 But my sister fell pregnant while using it 
- 23 year old mother of two, with a partner who has not paid isilobolo and does not want 
a child in the future, clinic B 
 
As I said earlier, when I was having sex with [my] partner, I would take 2 Disprin. But I think this time 
it didn’t work for me. 
-  35-year-old woman with six children and a partner who had paid isilobolo. Does not 
wish to have a child in the future, clinic C 
 
I use Flagyl pills when I have sex with my partner.  I am feeling good because they are working for 
me… I have never been pregnant since I started using them. 
- 33-year-old woman with one child and a partner who has not paid isilobolo. Does not 
wish to have another child, clinic A 
 
[My friend] said that when you swallow marijuana seeds it will go straight to the womb and you will 
never have children. 
- 36-year-old woman with three children and a partner who has not paid isilobolo. Has 
experience of being pregnant in the HIV programme and does not want to have more 
children, clinic E 
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6.3.6 Section summary: Factors influencing contraceptive use and preferences on ART 
As is common in the Hlabisa setting, women preferred easy to use and long lasting injectable 
methods of contraception. The women interviewed in this study generally had experience of 
injectable use prior to their enrolment in the ART programme, and continued to use these methods 
after initiation of ART to avoid childbearing and preserve their own health. Side effects of hormonal 
contraception could at times counter the wish to look after health and deterred women from 
consistent use. Many women reported unplanned pregnancies during times when they said they 
were ‘taking a break’ from injectable methods.  
Cultural understandings and practices strongly influenced the way in which women used 
contraception in this setting. The undesirable effect of being ‘watery’ during sex was an entrenched 
theme and significant barrier to use of injectable methods as it conflicted with the cultural onus on 
women to be ‘dry’ in order to be sexually desirable. Partner desires for childbearing facilitated a 
preference for covert use of injectables amongst women on ART. Some women did choose to discuss 
their use with partners however, and especially when condoms were often used inconsistently. 
However, women were concerned that the ‘watery’ effect of injectable use would not only make 
them unattractive to men, but would further reveal covert injectable use to partners, of whom, 
some would turn to traditional medicine in a bid to make her pregnant. 
Some aspects of the cultural practice of intravaginal insertion traditionally performed to achieve 
‘cleanliness’ and desirability were applied to contraceptive practice. Women in other studies have 
used modern products such as Disprin as a form of intravaginal insertion, and in this study some said 
they had used disprin or marijuana after sex as emergency contraception.  
ART use could enhance the severity with which women perceived adverse contraceptive side effects, 
at a time when they may also perceived general health to be poor. This study also determined some 
misunderstandings that were further specific to the use of injectable contraception on ART. Some 
believed that use of ART meant that they did not need contraception, or needed less frequent 
injections, and others felt that concurrent use might adversely affect health or fertility. It highlights 
the need for tailored and culturally sensitive family planning advice for women living with HIV on 
ART, particularly in long periods of postponement when injectable methods are not always used 
consistently.  
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6.4 Structural barriers and facilitators to safer conception and contraceptive use in a 
rural ‘One-Stop-Shop’ HIV treatment and care programme 
Section 6.4 describes the structural barriers to access to contraception and safer conception 
planning faced by women enrolled in this HIV treatment and care programme. This discussion is 
based on results from interviews with clients and healthcare providers and a checklist of 
communication materials and counselling activities in a ‘one-stop-shop’ model of HIV treatment and 
care for family planning services.  
Most women currently using contraception relied solely on DMPA or Nur-Isterate and occasional 
condom use, and typically sought their methods during the same consultation with the ART nurse 
that they received treatment. This meant receiving contraception and treatment in the same room, 
although less frequently clients were escorted to another room, directed to see another practitioner 
in the mobile HIV clinic, or referred up the Primary health clinic main building (on the same facility 
site). These times were mostly in the event that a method was out of stock in the HIV clinic or that 
women wished to seek the newly rolled out IUCD, in which case they were asked to return on a 
specific day when a trained practitioner would be available to fit the device.  
 
6.4.1 Facilitators to safer conception and contraceptive use 
Task shifting co-ordinated ART and contraceptive delivery in a single consultation room  
Operational managers in all five HIV clinics answered ‘Yes’ to the question: “Are family planning 
services such as provision of contraception and counselling of safe conception integrated with the 
HIV services here?”.  Health workers believed integration was achieved through a ‘one-stop-
shopping’ system that provided both HIV treatment and care and contraceptive methods during a 
single client visit, and that family planning was just one of many activities they were expected to 
deliver during a consultation.  
Each of the five clinics determined their own family planning practices, involving health worker task 
identification and systems of referral between the HIV treatment and care building and the main 
(primary health clinic) building. Each of the five clinics were similar in infrastructure and availability 
of resources, and integrated delivery of family planning services were comparable between 
observed clinics within the HIV programme. In all facilities, consultation with an ART nurse provided 
both treatment and contraception in the form of condoms, oral contraceptive pills or DMPA, 
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following separate counselling with the ART counsellor. In four facilities, HIV services were delivered 
in separate HIV treatment and Care park home. One facility integrated HIV services within then 
Primary Health Care (PHC) main building. Health workers felt that a comprehensive ‘one-stop shop’ 
service was the optimal model of care for clients to receive all services under one roof during a 
single consultation, with referral for additional services. 
We do it together, there is a link. If you come for ART, I can give you ART and if you are 
having another need, like family planning, I can do it here. I can give you hypertensive 
treatment, I can give you diabetic, and I can take your sputum. We do everything in each and 
every consulting room in the clinic. Whether it’s the main clinic or the park homes, it’s the 
same. Yes, at the end of the month we collect the statistics and we make one graph of family 
planning, whether it’s going up or going down  
- Africa Centre Nurse, clinic B 
 
A range of contraceptive methods were stored in the same consultation room that HIV treatment 
was administered to clients. These methods were visible to clients only when used during family 
planning counselling and were usually stored in cupboards behind the desk were the HIV nurse 
would sit, in a similar manner to boxes of HIV treatment. Methods stored in the consultation room 
included; DMPA, Nuristerate (a progesterone only injectable administered every two months), the 
oral pill, male and female condoms and the emergency contraceptive pill. Health workers reported 
that these methods were available every treatment visit (i.e. on each monthly visit to the clinic when 
women would return to pick up HIV treatment). Male condoms were also available by registration 
desks, in waiting areas and within both counselling and treatment rooms and so were readily 
accessible to all clients. Other methods of family planning and also psycho-social and financial 
support services were available to women upon referral, as illustrated in figure 6.1.   
In all clinics, clients would first visit the HIV counsellor who would also be expected to deliver family 
planning information and education. Clients would then typically wait in a designated waiting area or 
proceed directly in to the next (different) room, for consultation with an ART nurse, where clients 
can also seek injectable or oral contraception and condoms. A typical pathway of how family 
planning activities were operationalised within the continuum of HIV care is illustrated in figure 6.III. 
There were nuances in which ART nurses were expected to conduct specific or more technical 
elements of FP counselling such as information about the newly available IUCD, and how to achieve 
a safe pregnancy, while nurses themselves felt they had limited time for these discussions. In 
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instances where supplies were out of stock, two clinics described a system of personally escorting 
clients to the relevant offices.  In other cases, referrals were done verbally and were not followed up 
by the referee (figure 6.2).  
 
Figure 6.1 Sexual and reproductive health and related services offered on referral from the HIV 
treatment and care programme 
 Sterilisation was available on referral to the district hospital.  
 Unavailable methods included: spermicidal jellies, creams or foams, diaphragm, contraceptive 
patch (a weekly oestrogen and progestin patch applied to the skin), vaginal ring, cervical caps.  
 A specifically trained nurse was required to insert the IUCD and so this procedure could not take 
place in the same consultation room but this method was available upon appointment within 
treatment rooms. At the time of this study the delivery of IUCD was limited by the availability of 
trained service providers. Clients were asked to attend an appointment when a trained service 
provider was visiting the clinic and in the early stages of roll out, healthcare providers reported 
that clients were interested but some missed appointments.   
 Prevention of mother-to-child transmission (PMTCT) was delivered within antenatal care (ANC) 
services and each clinic operationalized specific days when PMTCT services were made available. 
 Termination of pregnancy was available through referral to the district hospital in Hlabisa or the 
Empangeni Marie-Stopes NGO clinic, an average distance of 100km return journey.  
 Support for victims of gender violence or sexual assault was outlined by clinic guidelines on 
referral from police, provision of PreP and the emergency contraceptive pill and further referral 
on to psychological and social support.  
 Support groups were cited as sources of information and training to develop skills that 
encouraged clients to grow their own fruit and vegetables but no groups were practising during 
the time of this study. 
 A trained psychologist and a nutritionist visited clinics on a monthly rotation  
 Temporary social grants could be occasionally supported and required doctor consultation. 
 Strategies for safer conception were limited. 
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Figure 6.2 Pathways for delivery of family planning services based on observation of five primary 
health clinics in the Hlabisa HIV treatment and care programme, based on interviews with 
healthcare providers, operational managers and a checklist of communication (Appendix E) 
 
 
Health education at the main primary health clinic 
x Rotational talks conducted daily on any health topic  
x Determined by PHC nurses and counsellors 
x Not tailored to people living with HIV and under prioritised family 
planning topics 
x Required attendance from 7.30am, after morning prayer and before an 
appointment 
 
Counselling for family planning and is usually combined with ART  
 FP counselling supposed to take place with HIV counsellor 
 Either in a HIV treatment and care park home or within PHC infrastructure in 
one room by same counsellor  
 Typically limited to a question on client card asking if she is currently pregnant 
or using contraception 
 Or client is referred to nurse for family planning counselling or to main clinic 
for FP methods without counselling 
 
 
 
 
Method and treatment usually provided in same consultation with ART nurse 
 ART and contraception delivered in the same room or nurse escorts client to a 
different room in the same facility for contraception  
 Or client is referred to the Primary Health Care building with or without an 
escort  
 Or client is referred to return on another date to see a trained provider (IUCD) 
 
 
 
Referral to the district hospital for sterilisation or TOP services and further 
referral from the district hospital to other NGO or next level for TOP services 
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Integration of family planning into HIV treatment and care helped to minimise stigma 
Clients and health workers believed that delivery of contraception within the HIV treatment and care 
programme helped clients to avoid stigma and long queues up at the ‘main’ clinic. Women agreed 
that they preferred to receive their contraceptive injection at the same time as their treatment or 
during a clinical assessment visit with the nurse. They cited the convenience of seeking all services in 
one place and that they were able to build trust in health workers as a benefit.  
I thought it would be better if I get everything at one place.  
- 32-year-old mother of three children with a partner who has not paid isilobolo. Does 
not want a child, clinic E 
 
Health care providers felt that private clinics were unaffordable for most of their clients (in this area 
more than 75% of adults are unemployed) and were aware of clinics in the nearest major cities of 
Durban and Johannesburg but not of any other potential sources of contraception. Women were 
aware of limited alternative sources of contraception, such as condoms from the pharmacy or 
termination of pregnancy services as advertised in local newspapers but preferred to seek methods 
from HIV clinics situated within local primary health care clinics closest to their home, unless a 
Department of Health mobile clinic visited closer to their community. These mobile clinics provide 
maternal and child care, but no HIV treatment and care.  
I used to hear people say that there are contraceptives at the chemist and others say you can 
get injectable from the doctors. Those places need money and here at the clinic I get it free.  
- 32-year-old mother of three children with a partner who has not paid isilobolo. Does 
not want a child, clinic E 
 
Health workers viewed the delivery of family planning services in to the HIV treatment and care 
programme as more beneficial than referring clients on to the main PHC for family planning. For 
example a nurse qualified that she felt that a HIV ‘one-stop-shop’ avoided stigma by allowing clients 
to visit park homes, as opposed to the main clinic where HIV uninfected clients also attend. In 
general health workers indicated a preference to double up on some services between the two PHC 
and HIV buildings although recognising a greater burden on resources and limited staff. 
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They fear that if we integrate… if we say they must collect treatment from the main clinic, 
there’s that stigma that people will see them carrying their files. Ah everybody will see. But 
here, all of them, they are at the same level. They are taking their ARVs if they are on this 
side. So we have that fear for our clients. What about the clients if they’re ashamed because 
other clients will see them collecting their drugs. Even now, it happens if we are here, they 
say ‘oh it’s good that you are here sister. We are getting our treatment here, not up [at the 
PHC] at that side, they still have stigma 
- Nurse, Department of health, clinic A 
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6.4.2 Structural barriers to safer conception and contraceptive use 
Family planning was partially integrated into HIV care and under-prioritised counselling  
First and foremost, health workers discussed integration as an issue of shared services and referral 
between the HIV clinic and ‘main’ (PHC) clinic. Family planning was considered part of a one-stop 
shop service, but time for this activity was minimal. Although in practice women received 
contraception from the HIV services, the extent to which family planning services should be 
devolved from PHC to HIV treatment and care for individuals on ART was unclear in all clinics. Nurses 
and Counsellors in the HIV treatment centres had received primary health care and additional HIV 
training, and so identified as ART nurses or ART Counsellors. Both ART and PHC nurses were selected 
randomly to attend further training and tasked to disseminate information through a cascade of 
peer training. Views on how integration was operationalised in each facility differed slightly amongst 
health workers in the absence of formal guidance for implementation of continuum of care.  
One operational manager believed that some ART nurses resisted what they viewed as duplicating 
PHC services. In effect, elements of family planning such as the administration of injectable 
contraception were devolved from the main (PHC) clinic, whereas information and education 
support services were not.  
According to me, integration means … I have to do these clients wholly, completely, not just 
saying I must go there for ARVs and after for family planning… it has been a resistance yeah 
with us as nurses. You see, before, we had the ART nurse and Africa centre this side, 
HIV/AIDS counsellors and department of health and others, and Africa centre… [but] that is 
integration. You know, no ‘I’m an ART sister, full stop’ because she is a registered nurse. She 
knows all the services, besides this ART programme... But then there has been that 
resistance. 
- Counsellor, Africa Centre, Clinic E 
 
Within the HIV treatment and care programme, healthcare providers performed family planning 
duties allocated according to their ART counselling or nurse expertise, effectively separating the 
delivery of contraceptive methods from family planning counselling. Task shifting reduced the 
burden of care upon ART nurses as family planning counselling was presumed to precede a 
consultation with the ART nurse.  
259 
 
Non-attendance of clients was felt to be a particular issue amongst health workers in the HIV 
programme. They felt reflected lazy attitudes amongst some women or, due to the costs of 
transport and childcare and time to reach clinic. Health workers said there was no formal system for 
handling missed appointments and so one nurse described instances of using her personal mobile 
phone to encourage clients to attend after they missed HIV treatment appointments. Descriptions of 
task identification within integrated services are provided in Box 6.4.I. 
Box 6.4.I ATTITUDES TO INTEGRATION OF FP/HIV SERVICES  
 
Mostly it just goes hand in hand with our baseline care. When we discover somebody is HIV 
positive, family planning is part of the health education that we give to them. So sometimes we 
don’t even need to ask because we have to give it to them 
- Nurse, Department of health, clinic B 
 
It is the ART sister who does it. So you just ask the questions, yeah 
- Department of Health Counsellor, Clinic C 
 
They come to us first and then we hear all the problems that the patient is complaining with. Either 
it’s that she is sick or she want to do the family planning, its everything and then we write it down, 
then we come and see blah, blah and give treatment. 
- Counsellor, Africa Centre, Clinic D 
 
 
In practice counsellors said they had received limited training in family planning, and related 
counselling was often easily omitted. Clients considered the advice they received during individual 
consultations in the HIV treatment and care programme as limited and a nurse agreed that some 
clients were unaware of the availability of contraception within the programme. 
They used to say we must prevent ourselves by using condoms only because they prevent 
spreading of diseases. They don’t give us any information or else I have forgotten but 
something like that. 
- 37 year old mother of 5 and currently pregnant with her sixth child, clinic C 
 
They go to the main clinic usually. But even here, should they state that they are also for 
family planning, we do give them. But then we are still educating them, to understand that 
they can get all their services here. So not all of them understand that they can get their 
injections or contraceptives here. 
- Nurse, Department of health, clinic C 
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ART nurses and counsellors regarded ‘health education’ delivered at the ‘main’ PHC as an important 
source of family planning information for all women, inclusive of women on ART. Health workers at 
the primary health care clinic led sessions on a variety of health topics each morning and ART clients 
were expected to attend these health education sessions before walking the short distance down to 
the HIV treatment and care building. Within the programme some viewed family planning as an 
additional service that could not be fully prioritised due to limited human resources and capacity 
within the programme. In this sense, FP was considered to be a ‘fifth room’ activity in a building with 
four rooms and led to partial integrated efforts, in which some activities (delivery of contraceptive 
methods) were achieved and tailored counselling activities were omitted. 
Daily group health education sessions followed Morning Prayers for all clients beginning at 7.30am 
each morning in the Primary Health Care facility and messages aimed to address relevant health 
topics according to a rota determined by nurses and counsellors. However, this session is used to 
discuss a broad range of health issues and there was no dedicated focus on family planning topics 
during this study period. After health education, clients then move to visit the HIV counsellors where 
the family planning counselling during this session is limited to guided questions on the client card.  
Health workers and ART clients presented opposing views on the usefulness of these sessions, as 
illustrated in Box 6.4.II. Women on ART said they had heard of messages related to contraceptive 
use but were sometimes unable to pay attention during these health education sessions if they were 
feeling unwell or that the information was not personalised or relevant.  As a consequence, these 
women preferred to avoid attending health education completely in the interest of saving time.  
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Box 6.4.II ATTITUDES TO FAMILY PLANNING INFORMATION, EDUCATION AND COMMUNICATION 
Health worker views on health education for family planning 
 
Is discussed though not daily, but we do discuss it in the morning. After prayers, we give a 
presentation while they are together in reception, in the main clinic. Because all clients start there 
before they come here. So we alternate, today’s another topic, the other day... you see?  And then 
we do give the individual health education, on different topics 
- Nurse, Department of health, clinic A  
 
Most of the people they don’t come early because they say their time is wasted because of prayer; 
their time is wasted because of health education. Most come after 10am because they know this 
thing of health education and prayer will have stopped, so they come late. 
 Counsellor, Africa Centre, Clinic B 
 
Client views towards family planning counselling in the HIV continuum of care 
I would say they have to tell us about contraceptive methods when we are still waiting for our files, 
even males need to know about contraceptive methods. Because they know about pregnancy and 
[can] explain to us. After that we can continue with what here to do. 
- 32-year-old mother of three children with a partner who has not paid isilobolo. Does not 
want a child, clinic E 
 
They never talk about that here when we collecting HIV treatment but at the main clinic they tell 
them 
- 23-year-old woman with one child and a partner that has not paid isilobolo. Would like a 
child in the future and has not been pregnant while enrolled in the HIV treatment and 
care programme. Clinic E  
 
 
I asked to see any guidelines for family planning service delivery in all of the 5 clinics. The national 
Department of Health had recently provided training workshops for ART and PHC nurses on the use 
of the Family Planning provider handbook and how to perform IUCD insertions amongst all women, 
including women living with HIV who have not yet developed AIDS. Information related to 
contraceptive methods without mention of safer conception strategies. At this time, three out of 
five clinics reported currently using this handbook, but some interviewed nurses and counsellors 
were unaware of this resource. Primary health care facilities measured monthly contraceptive 
acceptors in total and by individual method (Figure 6.3). This information was displayed in main PHC 
facilities and aggregated from HIV treatment and care. However, measures of integration were not 
available and there was no consistent monitoring of family planning use amongst women on ART. 
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Figure 6.3 Observed indicators of family planning acceptance in five study clinics 
 
 
Clinics encouraged IEC activities to differing extents. Support groups were widely discontinued at the 
time of this study due to a shortage of staff. One clinic reported having sought funding to hold an 
education day to encourage questions from clients, which was felt to address many topics including 
family planning.  
Demonstration tools were available in counsellor rooms to facilitate discussions on how to apply a 
male condom as illustrated in figure 6.4. One clinic arranged contraceptive methods on a clipboard 
to illustrate the available method mix. Posters or reading materials were available only in one clinic 
out of five and were reportedly not well utilised by clients. Materials were published in English and 
left in a box by the main clinic entrance but health workers reported that clients were uninterested 
in reading materials and none offered these resources during client consultations.  
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Figure 6.4 Tools and materials for information and education about family planning 
  
 
 
Safer conception topics were not discussed within the HIV treatment and care programme 
Guidelines for safer conception strategies among fertile HIV infected individuals and couples have 
been available from the SA clinicians society since 2011 and these provide recommendations 
tailored to low resource settings such as Hlabisa (Bekker et al., 2011). None of the health care 
workers reported knowledge of guidelines for safe conception counselling and withdrawal 
techniques, natural family planning or lactational amenorrhea methods as recommended in these 
guidelines were not reportedly discussed or promoted for women on ART within the programme.   
HIV counsellors said they did not have formal guidance on how to counsel women about family 
planning within the HIV treatment and care programme. Both counsellors and nurses said they 
would ask clients about their pregnancy intentions, but felt women were not planning, and would 
only return to the clinic after they were pregnant for antenatal care. Unplanned pregnancies were 
seen to be the norm amongst women in their care and that although being on ART was not a barrier 
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to childbearing desires, health workers felt that only married women planned their pregnancies and 
would need advice for safe conception. Difficulties in the absence of firm guidelines led one health 
worker to explain that she felt supervisors criticised their performance.  
They say we don’t talk with the patients. Because they say CD4 is low? Viral load is up, she is 
pregnant. You don’t talk with them. 
- Counsellor, Department of health, Clinic A 
 
Personal medical charts noted current contraception use to provide an indicator for health workers 
to discuss when methods were being continued or discontinued. The reproductive health section of 
the client card was limited to a discussion on current contraceptive use and the data of last use. It 
did not address future pregnancy intentions or adherence to contraception on ART before most 
recent use, as illustrated in figure 6.5. These charts did not introduce or help health workers to 
structure more difficult topics such as emergency contraception, termination of pregnancy, methods 
for safer conception, how to determine a fertile period or alternatives to childbearing that might be 
relevant to women on ART. Furthermore, health workers did not often record FP use in client charts 
in case any family member or partner would see the chart and discovered a woman’s covert use of 
this method. Accordingly, some HWs felt that the medical chart was ineffective as a tool to guide 
discussions on fertility planning for women who wish to have a child or to monitor contraceptive 
use.  
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Figure 6.5 Reproductive health indicators on client cards for women on ART used as the basis of 
family planning counselling during ART counselling sessions.  
 
 
Safer conception strategies such as the fertility awareness method and artificial insemination were 
not well known by nurses and counsellors. Health workers wished to learn more about ways they 
could support women to have a child safely and some had heard doctors talk about these options 
but were unable to remember all the details.  
Artificial insemination was considered an unaffordable strategy for clients in this rural area and the 
nearest services were located in the city of Durban. Few clients had heard of this strategy outside of 
the programme. Limited male attendance and involvement in the programme formed barriers to 
couples counselling in a climate of female-centred care. Yet the importance of partner involvement 
in determining the efficacy of safer conception strategies were emphasised by clients and health 
workers alike. 
Women said they would like to hear more information on what they could do to achieve a safe 
pregnancy from health workers in the HIV programme and counsellors also wished to receive more 
support on how to advise clients achieve a pregnancy safely (Box 6.4.III). They were well versed in 
the clinical terminology of HIV and discussed health in terms of changes to viral load and CD4 counts 
but did not have any personal experiences or plans to prepare for a past or future pregnancy during 
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these interviews. Some said that they sometimes found it difficult to plan according to their health 
and CD4 measures despite health worker advice.  
I was afraid that when I became pregnant I would become sick or my CD4 count would drop 
[and] then I will die. They say if you want a child you need to consult health care workers, 
[but] sometimes it happens without planning, so it is like that. You don’t know about your 
CD4 count. 
- 25-year-old woman with three children and a partner who has not paid isilobolo.  
 
Safe conception topics were not scheduled to be discussed during that month’s health education 
sessions in each of the clinics we sampled and this led to a sense that health workers were 
withholding information amongst clients.  
Here at the clinic they can give me information if I ask them. I don’t think they don’t know 
about it. I think they are lazy to give us some information... they want us to ask them 
sometimes 
- 36 year old woman with a partner (isilobolo not paid), two children and no experience of 
childbearing in the HIV treatment and care programme, clinic D 
 
Gaps in counsellor knowledge and a reliance on health education, fostered by partial integration of 
family planning, created missed opportunities for continued and tailored counselling along this 
process. Information regarding use of family planning was not tailored to ART-specific concerns 
during individual consultations or health education sessions and women mostly felt that health 
workers only promoted injectable or dual contraceptive use. Women did not consistently receive 
family planning in the HIV treatment and care programme and wished to receive more on-going 
support for family planning. 
It is not good at all according to my view.  They tell you once before you even started HIV 
treatment. When time goes on sometimes you forget what they told you. [FP] must be 
something that they always tell us about because we always have sex with our partners, it 
does not mean that as we are HIV positive we don’t do sex. I would be very much happier to 
get it at the same place. Sometimes the dates are the same and I collect HIV treatment then 
go to the main clinic and start another line and that makes my life difficult 
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- 32 mother of three children and does not want a child, clinic E 
 
Box 6.4.III VIEWS AND EXPERIENCES OF SAFER CONCEPTION  
Women’s attitudes to information on safer conception in the clinic 
 
I don’t want to lie; they don’t [talk about family planning]. They have to tell us about condoms, 
contraceptives and also what to do if you want to have a child.  What things need to done before 
having a child, as you are HIV positive and on treatment because they know more things than us. 
-  32-year-old mother of three children with a partner. Does not want a child, clinic E 
 
I never heard of that thing, I would like to know about it 
- 34 year old married women with no desire for another child, clinic A 
 
As I want to a child I would like to know what to do 
-  24 year old woman with one child and a partner who has not paid isilobolo, clinic A 
 
The other nurse [in the main PHC facility] told us that there are days in a month where a woman 
can get pregnant. Woman needs to be careful and know when she started her periods so that 
she can know which dates need to be careful with. [Here] there is nothing they say about family 
planning. 
- 23 year old woman with two children, a partner and would like a child in the future 
 
Health worker attitudes to information on safer conception in the HIV programme 
 
I felt that somehow, somewhere, I have to improve there. Maybe to improve asking women. I 
have to just to help them do it safely. If they want to become pregnant and help them.  
- Counsellor, Africa Centre, Clinic E 
 
I’ve never [discussed how to plan a pregnancy]. I only advise them to come to doctor, when on 
ARVs they want pregnancy, I only advise them to come to doctor so that they have the session 
on this 
- Counsellor, Africa Centre, Clinic A 
 
The [doctor] said he would treat the other for STIs even if there were no STIs, yes, and also 
talked about the 28-day cycle. And the other one talked about something I did not understand. 
Ejaculating in the condom. And then? 
- Nurse, Department of health, Clinic D 
 
 
 
Health worker’s used CD4 counts to subjectively qualify when a pregnancy is appropriate 
Health workers viewed childbearing as an individual’s reproductive right and stressed that women 
should not be discouraged from having a child, but should prioritise her health first and ‘make a 
plan’ for a pregnancy in advance. Health workers placed strong qualifications upon timing by using 
CD4 measures as a discernible indicator of when they considered a pregnancy to be appropriate. 
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Nurses said they were unsure as to the appropriate recommendations for women that would like a 
child and would refer women to see a doctor for further information, but health workers were 
concerned that a rights-based attitude could risk encouraging unplanned pregnancies and jeopardise 
their client’s health. In the absence of practical guidelines on this measure, health workers reported 
mixed views on an appropriate cut-off but suggested CD4 value in the range of 400 – 600 should be 
attained before a woman could consider a pregnancy.  
Women were advised to postpone when CD4 counts were considered too low but many found this 
advice for planning too difficult to follow (Box 6.4.IV). Some clients were apprehensive to disclose a 
wish to have a child or a pregnancy after being ‘shouted at’ in the programme. In one instance a 
women reported switching clinics for this reason and another had considered this move. 
Consequently, health workers felt most clients did not follow their health advice to plan according to 
their CD4 count.  
We tell them... you still have a right to fall pregnant. So we used to tell them before you can 
fall pregnant as your right, you need to come with your partner and make an appointment 
with the doctor. And then, so that bloods can be taken to check your viral load, to check your 
CD4. 
- Nurse, Department of health, clinic C 
 
Many held views that it was not appropriate for a woman living with HIV to have another child 
outside of these circumstances. Failing to plan ‘correctly’ was interpreted by some health workers as 
a lack of intention amongst their clients, or that they are hiding something. Facing these difficult 
issues of planning, health workers varied in their approaches, from emphasising contraceptive use to 
a flexible attitude to managing the antenatal care of an unplanned pregnancy. 
It’s not right for a woman to fall pregnant not knowing her CD4, or if to fall pregnant if CD4 is 
low, or fall pregnant each and every year. So condom is best to prevent everything.  
- Counsellor, Africa Centre, Clinic A 
When the patient is taking ARVs, she comes to you and says... ‘Sister, I’m pregnant’. Mmm. It 
comes to you as a shock, wow, ok we didn’t agree upon this, or we didn’t discuss that it’s ok 
now to have a baby. But we cope to manage those problems.  
- Nurse, Africa Centre, clinic B 
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Box 6.4.IV CLIENT EXPERIENCES OF DISCUSSING A DESIRE FOR A CHILD IN THE CLINIC 
 
We are not used to talk about that. Sometimes I used to say it as a joke. 
- 24 year old woman with one child born within the HIV treatment and care programme 
and a partner who has not paid isilobolo (clinic A) 
 
I became nervous… when she shouted on me 
- 30 year old mother of two, with a partner who has paid isilobolo, clinic B 
 
You know what I worried because I told myself that to be pregnant according to them is not right… It 
was like I committed a crime. [The nurse] continued saying that they are always teaching us about 
using condoms so that we will not get pregnant. She said it would be better if I used an injectable 
after give birth because I don’t listen to what they are saying. I was offended. I even think of 
changing the clinic but my partner said I must not mind them because I know what happened and I 
know that as I go to the clinic I want my life to be better. Sometimes nurses don’t think that you are 
human being all you need is counselling not people who will shout at you. I even thought that they 
spoke like this because I am young.  
- 23 year old woman with two children, a partner (isilobolo not paid) and no experience 
of childbearing in the HIV treatment and care programme, Would like a child in the 
future, clinic C 
 
I knew that I was wrong, as I didn’t speak to a doctor. 
- 28 year old woman in a polygamous marriage with two children and no experience of 
childbearing in the programme, Would like a child in the future, Clinic B 
 
I didn’t do it I was afraid. I thought they would yell at me as they told us that before we get pregnant 
we should come to them first. 
- 25-year-old woman with three children and a partner who has not paid isilobolo. Does 
not wish to have a child in the future and has not been pregnant while enrolled in the 
HIV treatment and care programme. Clinic D 
 
  
 
Access to emergency contraception or referral for termination of pregnancy were not widely 
supported  
Children were considered a ‘gift from God’ and women viewed the act of having an abortion as a sin 
against the Christian faith. Yet, in the context of this study and strong desires to avoid childbearing, 
two women said that they would still consider seeking a termination of pregnancy if they became 
pregnant in the future.  
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My sister, if I find out that I am pregnant I will do [an] abortion because I don’t want to have 
a child. That sin I will find it in heaven.  
– 18-24 year old mother of two with multiple partners and no desire to have more 
children (clinic A) 
 
A pregnancy that was ‘hard to accept’ had led some women on ART to consider a termination of 
pregnancy but was deterred by cultural values. One 34 year old woman with 5 children and previous 
experience of childbearing in the programme said she did not know where to seek termination of 
pregnancy services and feared health workers would stigmatise against a married woman seeking an 
abortion  
You know what? I was thinking of [having an] abortion when I found out that I am pregnant. 
It was hard to accept it because I didn’t know whether my child would be HIV negative or 
not. 
- 34 year old married women with five children with no experience of childbearing in the 
HIV treatment and care programme and no desire for another child (clinic A) 
 
Terminations of pregnancies were legally available in South Africa but awareness about how to seek 
a termination of pregnancy or to obtain EC in the programme was limited.  Health workers did not 
formally or routinely communicate information about these services to clients within the 
programme (Box 6.4.V). Counsellors were uncertain of the actual referral chain but women could be 
referred to the local hospital and services were reportedly administered at the nearest Marie Stopes 
NGO based in Empangeni. Only one client was aware of this NGO.  
A woman described almost seeking Termination of Pregnancy (TOP) services from a newspaper until 
her sister dissuaded her from seeking this procedure.  Women preferred the ease with which they 
could covertly seek a termination of pregnancy service from adverts in the newspaper. TOP services 
were not commonly discussed during interviews or as part of HIV treatment and care and a fear of 
being judged by health workers as ‘too old’ meant that the only woman to pursue a termination of 
pregnancy chose to seek this service from a newspaper. 
I even thought of doing abortion and I knew that if I told him earlier he would be against it. I 
bought a newspaper because I wanted to see advert that used to be there for an abortion. I 
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told my sister and she said to me it is not a good thing to do an abortion because a child is a 
gift from God… I was one month pregnant. My sister stopped me to do it otherwise I was 
willing to do it. The way she used to say about abortion I was afraid. 
- 35-year-old woman with five children, with a partner that has paid isilobolo. 
Clinic C 
 
BOX 6.4.V ATTITUDES TO TERMINATION OF PREGNANCY SERVICES IN THE HIV PROGRAMME 
Client experiences of communication about Termination of Pregnancy services  
They never say anything like [how to seek an abortion].  Nothing at all. 
- 37 year old woman with 3 children, a partner who had not paid isilobolo and no desire 
to have any more children, clinic E 
 
 I didn’t know where to go to for abortion because when you hear people talking they don’t tell you 
all the relevant information that you need. I came here at the clinic but I was afraid to talk to the 
health care workers because what I thought will say that as a married woman why I want abortion. 
Sometimes they will think this child is not for my husband 
- 34 year old married women with five children with no experience of childbearing in the 
HIV treatment and care programme and no desire for another child, clinic A 
 
There are no other places and I was afraid to ask at the clinic about it because I thought they would 
say why I want to do an abortion, as I am old… I bought a newspaper because I wanted to see advert 
that used to be there for an abortion. I told my sister and she said to me it is not a good thing to do 
an abortion because a child is a gift from God. My sister stopped me to do it otherwise I was willing 
to do it. The way she used to say about abortion I was afraid. 
- 35 year old woman with five children and currently pregnant with 6th child. She has a 
partner who had paid isilobolo. Does not wish to have a child in the future, clinic C 
 
Health worker experiences of communicating information about Termination of Pregnancy 
services  
 
No, I don’t. I don’t.  I don’t know about my colleagues but I haven’t talked about it, abortion and 
morning after pill, I don’t know. 
- Counsellor, Africa Centre, Clinic A  
  
To Hlabisa... eh I don’t know whether they do it at Hlabisa but normally they send them to MPA, I 
don’t know  
- Counsellor, Department of health, Clinic B 
 
I don’t know. But I think they’re aware, because in the media they do talk about legal abortion 
- Counsellor, Africa Centre, Clinic A 
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6.4.3 Summary of structural barriers and facilitators to contraceptive use and safer conception 
in the Hlabisa HIV treatment and care programme 
HIV treatment and care delivered a ‘one stop shop’ approach to family planning services whereby 
women on ART could receive their contraceptive methods, primarily injectable methods or 
condoms, during the same consultation that they would receive ART. Facility level integration eased 
client access, adherence and covert use while minimising concerns about possible stigma facing HIV 
positive women seeking family planning services. Efforts to integrate services were partial however, 
and limited to contraceptive provision. Family planning counselling and monitoring of indicators 
were predominantly still perceived as ‘main’ clinic activities and counselling was not consistently 
delivered as part of the HIV continuum of care, nor tailored to ART-specific issues of concurrent use 
and adherence to both ART and hormonal contraception. Adherence to contraceptive use was not 
measured routinely and discontinuation of injectable contraceptive use was common.  
Safer motherhood advice was perceived as limiting rather than supportive. Clinical indicators of 
appropriate timing according to CD4 count and viral load aimed to protect the mother from adverse 
risk to health but were practically difficult for clients to follow and rarely implemented. Unplanned 
pregnancies were reportedly common and highlight the importance of delivering appropriate 
support that is well timed, prior to unprotected sexual intercourse. Other safer conception practices 
were not commonly known amongst health workers or discussed with clients. WHO recommended 
family planning practices for women living with HIV were available at the time of study, but no 
national or provincial guidelines or formalised systems of referral were in place to facilitate 
implementation at the time of observation and both groups of clients and health workers wanted 
more information about safer conception practices. Key structural barriers and facilitators are 
summarised in figure 6.6. 
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Figure 6.6 Structural barriers and facilitators to safer conception and contraceptive use in the 
Hlabisa HIV treatment and care programme  
FACILITATORS BARRIERS 
Women preferred the ease of access to methods 
and treatment in one consultation 
Integration of education activities often 
depended on health worker’s initiative. i.e. 
referral systems and task identification of HW 
roles in family planning were not clear 
Access to one-stop-shop services facilitated 
covert use of family planning i.e. allowing clients 
to store cards in the facilities 
 
‘Health education’ was used as a substitute for 
individual family planning counselling.  FP was 
not prioritised in health education and is easy to 
bypass on route to HIV services. 
Stigma was felt to be minimised by removing 
need for a woman to walk to the main PHC 
building 
Opportunities to discuss childbearing desires or 
support reproductive needs safely during follow 
up visits are missed 
Health workers valued the reproductive rights of 
clients 
HWs used clinical indicators to subjectively 
assess the appropriateness of a pregnancy. 
Introduction of IUCD means women are not tied 
to repeat visits to the clinic 
EC and abortion services were not discussed in 
the programme 
 No guidelines or training to support health 
workers discuss safer conception topics 
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6.5 Summary of qualitative findings in chapters Five and Six 
Pregnancies to women within the HIV treatment and care programme rarely followed an explicit 
intent to have a child. These findings highlight a significant absence of planning for a child amongst 
women on ART within the Hlabisa HIV treatment and care programme, even though women do hold 
personal desires for small family sizes and ideals about how they would prefer to space pregnancies, 
as discussed in chapter five. Traditional psychological pathways posit desire as a precursor to 
intention and behaviour (Miller, 1994), but this study shows that childbearing decisions are 
changeable still in the context of ART use and that women’s behaviour may not always follow 
reported intent.  
Childbearing was culturally valued, but relationship instability and economic adversity were 
commonly described reasons to avoid having another child. Women weighed the costs and benefits 
of having another child according to a range of socio-cultural, economic, relationship and health 
factors, and use of ART was rarely itself a reason to not have a child. Many factors acted as 
heterogeneous influences affecting the decision to have another child, and the contraceptive health 
belief model provides a more relevant framework to discuss the kind of decisions that women are 
making (Figure 6.7) (Hall, 2012).  
Figure 6.7 summarises the results presented in both chapters five and six as factors leading to 
contraceptive decisions specific to women on ART in the HIV treatment and care programme. 
Initially women discussed their desires to have or to avoid a pregnancy and how they anticipated this 
desire might change in the future. Originally discussed in chapter five, these factors influence the 
high ‘motivation to avoid an unwanted pregnancy’ presented in figure 6.7.  
Perceptions of general health prominently added to the perceived threat of another pregnancy, as 
summarised in the far-left ‘perceived threat’ box in Figure 6.7. Typically injectables are the preferred 
method of choice in this setting, and so women on ART are no different to many other women in 
their, sometimes covert, use of this method. Women on ART were encouraged to prevent 
unintended pregnancies in Primary Health Care clinics, and further supported through the 
availability of contraception within the HIV treatment and care programme, as summarised in the 
centre ‘cues to action’ box. In addition some women received support to avoid childbearing by 
partners and family members with shared values for small family sizes or the preserved health of the 
woman.  Despite the wide availability of contraceptive methods in clinics, some important aspects of 
family planning have been neglected in recent years. Emergency contraception and termination of 
pregnancy in particular are rarely addressed in the HIV treatment and care programme, and 
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traditional medicine and newspapers provided significant alternative sources of harmful 
information. Some women hoping to ‘clean the dirt’ and prevent a pregnancy used modern 
medicines such as Disprin or herbal drugs such as marijuana. These alternative forms of EC were 
described according to use of similar modern products in the cultural practice of intravaginal 
insertions to achieve ‘cleanliness’ (Gafos et al., 2010). Women on ART would often still prefer to seek 
an unsafe abortion from newspaper adverts in order to avoid stigma they anticipated at the clinic. 
Information on these issues need to be clearly and routinely communicated to women on ART in 
order to ensure unwanted pregnancies are safely prevented, in an environment in which women are 
encouraged to seek the services they need.  
The long lasting nature and ease of adherence to a single injection in addition to the ability to use 
this method covertly facilitated adherence to DMPA, and allowed women to act independent to a 
partner’s desire for a child. Findings from this study are consistent with other work from South 
Africa, which suggests contraceptive use in HIV positive women is strongly influenced by the culture 
(Todd et al., 2011). Selection and continuation of contraception was influenced by multiple costs and 
benefits, usually related to the long term use of hormonal injectable contraception, summarised in 
the right hand side ‘cost-analysis’ box in figure VI. However, side effects attributed to use of 
hormonal contraception were prominent deterrents to use or continuation. Unique to this context 
was a strong perception that injectable use could make a woman too ‘watery’ during sexual 
intercourse: an important and culturally sensitive deterrent to use amongst some women in this and 
other studies (Gafos et al., 2010, Todd et al., 2011). Partner’s perpetuated the concern that these 
side effects not only impact on her health but also on a woman’s attractiveness and cleanliness. To 
women themselves, ART use could enhance the severity with which they perceived the side effects 
of injectable contraception. Of particular concern was the risk of excessive bleeding at a time that 
women already felt weak on ART.  
Family planning recommendations for dual contraception were well versed amongst participants in 
this study, and added awareness of the risks of transmission had further empowered some women 
to encourage partners to use condoms. Still, most viewed condoms as unreliable for pregnancy 
prevention due to inconsistent use. As such, women ‘taking a break’ from injectable contraception 
would often put themselves at risk of an unplanned pregnancy. In addition, some thought that the 
effects of injectable hormonal contraception would last longer than the stipulated three months or 
even that ART itself would prevent a pregnancy. In this setting, women spend a large proportion of 
their reproductive life using injectable contraception, and these issues of side effects and cultural 
barriers pose issues for long-term continuation of this method, particularly to women on ART who 
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already face concerns for their health. The intrauterine device was in very early stages of being 
rolled out and presented an interesting long lasting alternative to injectables for some. Oral 
contraception was viewed as too difficult to adhere to by both health workers and clients, while 
female condoms were available but not well liked according to health workers.  
The HIV treatment and care programme acts as an important structural factor that may modify and 
enable women’s contraceptive use on ART (Modifying and enabling box, figure 6.VI). This study 
determined a partial level of integration in which a ‘one-stop’ system provided contraception to any 
client that wished to use it during an ART consultation, while family planning information, education 
and counselling (IEC) activities were largely omitted from the HIV continuum of care. Health workers 
supported the reproductive rights of women living with ART but stressed the burden of including too 
many health topics within a HIV treatment consultation and saw family planning as a lower priority 
for these sessions. HIV counsellors were not trained or supported with guidelines to deliver family 
planning IEC tailored to the needs of ART clients and many used subjective CD4 measures to 
determine the appropriate timing for conception without practical advice to achieve a safer 
pregnancy. To the women in these interviews, the uncertain and changing economic and social 
environment in which relationships were formed and childbearing decisions made, this advice was 
restrictive and difficult to follow. Women that did wish to have a child saw this as happening at an 
undefined time in the future and in the absence of further support to have a child; women did not 
often discuss their wish to have a child in the programme. Health education sessions held in the 
main PHC building were instead viewed as key sources of family planning information, leaving 
missed opportunities to address ART-specific concerns for family planning within the HIV treatment 
and care programme.  
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MOTIVATION TO AVOID AN UNINTENDED PREGNANCY 
Figure 6.7 Summary of qualitative results using constructs of the Health Belief Model as applied to contraceptive behaviour and related to attitudes on ART (Hall, 
2012) 
PERCEIVED THREAT OF PREGNANCY 
 Reduced risk to HIV-related health 
through ART use 
 Higher perceived risk of pregnancy on 
health following negative experience 
while living with HIV 
 Reduced risk of mother to child 
transmission through PMTCT  
 Reduced perceived risk of  getting 
pregnant after discontinued injectable 
contraceptive use according to 
misconceptions on ART  
 Partners use of traditional medicine 
CUES TO ACTION 
 Health workers strongly encourage 
injectable contraception 
 Partners share information about EC 
methods 
 Newspapers encourage covert and unsafe 
abortion services  
 
CONTRACEPTIVE COST-BENEFIT ANALYSIS 
Perceived Benefits 
 Long term efficacy 
 Covert use 
 Protecting health 
 
Perceived Barriers 
 Attitudes to side effects on ART 
 Risk of partner discovering use 
 Risk to health on ART 
 Risk to future fertility 
 Access to hospital based methods 
Contraceptive Decision-making in the Hlabisa HIV treatment and care programme 
Demographic 
 Age and current family size determine a woman’s’ 
own wish for a child 
 Modified by financial and health considerations 
 
Social 
 Cultural expectations of marriage/ isilobola 
 Partner wish for a child 
 Stigma of seeking FP as a PLWHIV 
 Religion discourages abortions  
 
Structural 
x One-stop-shop delivery, ease of access to methods, 
minimised stigma, supports covert use 
x Free methods available  
x No support for safer conception  strategies as most 
pregnancies were unplanned or not discussed with 
counsellors 
Psychological 
x Locus of control passed to partners or God  
Reproductive 
x Childbearing experience influences perceptions of how 
dangerous childbearing is to health 
 
MODIFYING AND ENABLING FACTORS 
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Chapter Seven 
Discussion 
 
The issue of HIV and fertility is complicated but relevant to demographic, economic, epidemiological, 
public health and rights-based studies. To set these findings within the wider literature raises 
questions about appropriate counterfactual groups and comparison of methods. In addition to 
methodological differences between studies, however, is a huge variation in fertility in different 
community settings.  Childbearing may be culturally determined and vary between settings. Studies 
investigating fertility and HIV may therefore seek to measure the effect of prevalence at a 
community level, or individual effects of a HIV diagnosis. Before ART was made nationally available, 
estimates suggested that fertility would be reduced by 25-40% in areas of high HIV prevalence in 
sub-Saharan Africa (Zaba and Gregson, 1998). More recent studies suggest that access to ART will 
likely reverse these lower fertility trends due to improved physiological health and increased sexual 
activity or fertility desires, although heterogeneous effects of ART on biological or behavioural 
proximate determinants of fertility could influence fertility in either direction (Kaida et al., 2006). 
7.1 Contribution of this study to the wider literature  
This study took place in the Hlabisa sub-district of KwaZulu-Natal, South Africa and describes the 
association between ART use and fertility in a rural setting of high HIV prevalence and high 
contraceptive prevalence. This study shows that scale up of ART in this rural sub-Saharan African 
setting did not increase the likelihood of live birth amongst HIV positive women. 
This study is important because it describes an effect of individual factors associated with HIV and 
exposure to ART on fertility. By including HIV negative women as well as women who had not 
participated in the HIV surveillance, this study allows a comparison of incidence and behavioural 
factors associated with fertility between women on ART, pre-ART women, HIV negative women, and 
women with missing information about HIV status. These findings describe the factors that are 
associated with differences in fertility according to HIV status and are thus contextualised to women 
that are resident to an area of high HIV prevalence, but may not be easily generalizable to all settings 
of high HIV prevalence.  
279 
 
Additionally, this study qualitatively described key reasons why women on ART may prefer to limit 
childbearing, particularly according to perceptions of their health, and how these desires are often in 
conflict with other socio-cultural reasons for having a child. Women make their childbearing 
decisions in very different circumstances across the continent and the findings from this thesis differ 
from those from other sub-Saharan Africa countries, demonstrating the importance of 
contextualised studies.  
Socio-economic and cultural factors have long driven a demographic fertility decline in this setting, 
and this study suggests that ART does not affect the underlying trend in fertility decline in either 
direction. This work indicates that roll out of ART may have little demographic implication for 
fertility, but there are public health implications of unplanned pregnancies and absence of safer 
conception planning of wanted pregnancies on ART for maternal health. 
 
7.2 Summary of key findings and methodologies 
This discussion presents results from a mixed methodology study and key findings are summarised in 
Table 7.1, reflecting the three study objectives. Findings are displayed according to results sections 
and methodology, which will be briefly summarised below. Chapter Four presented results from a 
quantitative analysis of data from the Africa Centre for Health and Population Studies demographic 
surveillance system (ACDIS), utilising information from approximately 90,000 Zulu-speaking 
individuals over a 438km2 area, starting with a description of annual trends in crude live birth in the 
surveillance area between 2005 and 2011 by HIV status in section 4.1. Information about 
antiretroviral therapy use and CD4 count for HIV-positive women was linked from a clinical database 
(ARTemis) to the demographic dataset (ACDIS) using unique individual identifiers to create two 
cohorts to compare incidence and identify factors associated with live birth in an open cohort of HIV 
positive and HIV negative women participating in annual HIV surveillance between 2007 and 2012 
inclusive (Section 4.2), and a closed cohort of HIV positive and HIV negative women, also including 
women that did not respond during HIV surveillance rounds at entry in 2007 or 2008 (Section 4.3). 
Entry to both cohorts began on 1st January 2007; about three years after roll out of ART began in this 
area in South Africa. The purpose of the second cohort was to include women with ‘unknown’ HIV 
status who were omitted from the initial open cohort due to non-participation in Africa Centre HIV 
surveillance testing and to investigate incidence of live birth, and associated factors, in the general 
population of women resident in the Hlabisa area. Finally, section 4.4 presented an analysis of 
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incidence of contraceptive use and associated factors amongst all resident women in the closed 
cohort presented in section 4.3 (Section 4.4).  
Primary qualitative data from 23 client, 12 health worker semi-structured interviews, and 
observations of five primary health care clinics within or close to the demographic surveillance area 
were reported in Chapters Five and Six, to provide a context for the quantitative results on the 
incidence of live birth in Hlabisa. These interviews were conducted from October until December of 
2012 and describe attitudes to childbearing in an established HIV programme. Section 5.3 presented 
results of semi-structured interviews exploring childbearing desires on ART and section 5.4 followed 
with themes influencing women’s desires to have or avoid more children. Finally Chapter Six 
presented results from these semi-structured interviews alongside observations at each of the five 
PHC clinics to explore structural facilitators and barriers to family planning within the HIV continuum 
of care.   
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Objective Hypotheses Method / section  Key findings 
To investigate 
whether use 
of ART is 
associated 
with 
likelihood of 
a live birth in 
Hlabisa, 
KwaZulu-
Natal. 
Birth rates will be 
lower in HIV 
positive women 
compared to HIV 
negative women. 
 
Section 4.1  
Annual CBR was lower in HIV positive than HIV negative women during a consistent decline in CBR between 2005 
and 2012 and a brief stall in decline between 2010 and 2011. Women with missing HIV status experienced CBR 
similar to HIV positive women.  
Section 4.2  HIV positive status was associated with a 61% reduced annual risk of live birth (aHR, 0.39; 95% 0.347 – 0.441) in multivariable Poisson regression adjusted for significant proximate and distal determinants of fertility. 
Section 4.3  HIV positive status is associated with a 57% reduced annual risk of live birth (aHR, 0.47; 95% 0.649 – 0.817) in multivariable Cox regression adjusted for significant proximate and distal determinants of fertility.  
Incidence of live 
birth has increased 
amongst HIV 
positive women 
since ART roll out, 
comparable to the 
general population. 
Section 4.1  A decline in CBR followed a steeper gradient amongst HIV positive women between 2005 and 2012 (m=-5.73, R2=0.913) than in women that were HIV negative at that time (m= -2.97, R2=0.398). 
Section 4.2  
Calendar year of surveillance was significantly associated with incidence of live birth in univariate analysis but no 
trend was identified. This association was no longer significant when stratified by HIV status or in analysis adjusted 
for other proximate and distal factors associated with fertility. 
Incidence of live 
birth will be higher 
amongst HIV 
positive women 
after exposure to 
ART, between 
comparable age 
groups and health 
Section 4.2  
Exposure to ART was associated with a 38% reduced risk of live birth (aHR, 0.62; 95% 0.487 – 0.799) in 
multivariable Poisson regression of HIV positive women adjusted for age, CD4 categories, self-reported general 
heath and other significant determinants of fertility. 
Section 4.3  
Exposure to ART was associated with a 47% reduced risk of live birth (aHR, 0.53; 95% 0.39 – 0.73) in multivariable 
Cox regression limited to HIV positive women adjusted for proximate and distal determinants of fertility.  
Exposure to ART was associated with a 26% reduced risk of live birth in adjusted Cox analysis of all resident 
women, irrespective of participation in HIV surveillance. However, this model violated Cox proportional hazards 
assumption before stratification by HIV status. 
Exposure to ART will 
encourage women 
to resume 
postponed 
childbearing at 
older ages 
Section 4.1  
HIV negative women demonstrated bimodal patterns of fertility peaking at 15-19 years and 30-34 years old. The 
same trend was not found in HIV positive women, except for an increase in incidence at age 35-39 years old 
between 2006 and 2011. 
Section 4.2  The same bimodal peak in live birth was observed in 15-19 years old and 30-34 years old to HIV negative women and this bimodal trend was not found in episodes to HIV positive women adjusted by calendar year. 
Differences in birth-
free survival on ART 
are most likely to be 
Section 4.2  
Contraceptive use was associated with a 65% reduced risk of live birth in adjusted analysis of HIV positive women 
(aHR, 0.35; 95% 0.250 – 0.489).  Missing data on this variable was not at random, as HIV positive non-responders 
experienced rates of live birth four times lower than HIV negative women (3.3 births per 100 HIV positive women 
Table 7.1 Summary of key findings  
282 
 
due to altered use 
of contraception in 
this setting of high 
prevalence. 
[95% CI 2.9-3.7] compared to 13.1 births per 100 HIV negative women [95% CI 12.3-14.0]). 
Section 4.3 
 
Contraceptive use was associated with 49% reduced risk of live birth in univariate analysis of all women (aHR, 0.51; 
95% 0.437 – 0.600). 
Section 4.4  
HIV infected women were 10% less likely to use any modern method of contraception at last sex, compared to HIV 
negative women. Women reporting excellent, good or very good health were 40% more likely to use 
contraception. 
Women on ART will 
increase 
childbearing due to 
improved 
immunological or 
perceived health 
when aware of their 
HIV status 
Section 4.2  
Knowledge of own HIV status was associated with a 46% reduced risk of live birth in adjusted analysis (aHR, 0.64; 
95% 0.509 – 0.792) but was not significantly associated in an analysis of only HIV positive women, suggesting 
differences in behaviour according to knowledge of being HIV negative compared to HIV positive women (aHR, 
1.00; 95% 0.757 – 1.332).  
Excellent, good or very good self-reported health was associated with doubled risk of live birth in univariate 
analysis of all women (aHR, 2.03; 95% 1.682 – 2.445) but risk became non-significant once adjusted for other 
determinants (aHR, 0.98; 95% 0.806 – 1.184) (page 171). CD4 count was not associated with incidence of live birth 
in a stratified univariate or multivariable analysis of HIV positive women, or following ART initiation (p=0.2898) 
(page 150). 
Section 4.3 
 
Self-reported health was not associated with likelihood of live birth in this cohort, although HIV positive women 
were less likely to report being in good health compared to women with an unknown HIV status. This analysis also 
found no trend for an effect of CD4 count. 
Explore the 
family 
planning 
needs and 
expectations 
of women on 
ART under 
current 
provincial 
guidelines for 
the provision 
of 
contraception 
and safe 
conception 
Women on ART may 
desire more 
children either now 
or in the future 
Section 5.3  
Lifetime aspirations for small family amongst women did not change on ART. Women had largely fulfilled their 
reproductive desires. Of twenty-three women, six said they would like to have a child either now or in the future 
while most did not wish to have a child either currently or at any time in the future.  
Women have ART-
specific family 
planning needs 
Section 5.4  
Women said they would rather not take risks on their health but viewed this risk differently. The potential health 
impacts of being pregnant solidified women’s desires not to have any more children. The importance of a partner’s 
desire traditionally related to his payment of isilobola but women commonly considered childbearing outside of 
marriage with implicit expectations of financial support. Negative experiences of childbearing usually reflected 
situations when partners did not fulfil those expectations and women’s health was threatened. A minority of 
women felt they could not avoid childbearing under cultural expectations, usually when married. Other women 
wished to have more children sometime in the future.  
Section 6.3  
Women preferred long acting and easy to use methods. Some believed that use of ART meant they did not need 
contraception. Side effects were significant barriers to use of injectable contraception and many women ‘took a 
break’ due to concerns about the severity and risk to health. Long-term alternatives to injectable contraception 
were not widely available, although the IUCD had been recently rolled out at the time of study. 
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services to 
women on 
ART. Section 6.4  
Women who had been pregnant in the program said they did not plan for pregnancies while HIV positive or on 
ART, a view supported by health workers. Pregnancies were often viewed as unplanned if not well timed, if women 
experienced poor health, or because partners did not support them. Health workers advised women on ART to 
time pregnancies according to an appropriate CD4 level but women said they found advice limited and difficult to 
follow.  The family planning 
needs of women on 
ART can be 
addressed in a ‘one-
stop-shop’ 
continuum of HIV 
care  
Determine 
where 
women on 
ART currently 
access family 
planning 
services, their 
experiences 
with them 
and whether 
their needs 
are being met 
Section 6.4  
One-stop-shop delivery of injectables and ART facilitated ease of access and helped to alleviate concerns for 
stigma. Women also sought non-governmental condoms from pharmacies and abortion services from newspaper 
adverts, while traditional methods and modern medicines were sometimes used inappropriately as emergency 
contraception.   
Structural barriers 
may result in 
unplanned 
pregnancies on ART 
Section 6.4  
Contraception and ART were typically administered during a single client consultation. Where services were not 
available, referrals were not formalised and women were required to queue again at the main PHC building. Side 
effects of injectables often led to discontinuation. Partial facility level integration neglected aspects of family 
planning, such as monitoring of contraceptive adherence and information, education and counselling in the HIV 
continuum of care.  
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7.3 HIV infection and exposure to ART were associated with reduced likelihood of live 
birth 
A mixed methodology investigation found reduced likelihood of live birth to HIV positive women 
after they initiated ART, between 2005 and 2012, which is consistent with qualitative reports from 
women who prefer to avoid childbearing on ART. Consistent with the literature (chapter Two), this 
study found a substantially lower likelihood of a live birth in HIV positive than HIV negative women: 
HIV positive status was associated with a 61% reduced likelihood of live birth between 2007 and 
2012, in the analysis of approximately 10,000 women of known HIV status in the Hlabisa sub-district, 
adjusted for significant demographic, relationship and health-related factors.  
Contrary to the study hypothesis, and recent studies, women on ART experienced sequentially lower 
likelihood of live birth over time compared to ART-naïve HIV positive women, HIV negative women 
and women whose HIV status was not reported during HIV surveillance. In analysis adjusted for 
demographic characteristics such as age and parity, and proximate and distal determinants of 
fertility, such as partnership and contraceptive use, exposure to ART was associated with a 38% 
reduced likelihood of live birth compared to ART-naïve HIV positive women. Women on ART and 
ART-naïve HIV positive women experienced consistently lower likelihood of having a live birth along 
similar trends as HIV negative women at similar age, parity and area of residence.  
These findings add to an established body of evidence showing lower fertility in HIV positive women 
below that of HIV negative women. It found no evidence that ART is associated with increased 
fertility amongst HIV positive women in an analysis starting three years after national scale up or 
ART began, but in a setting where fertility is low and HIV and ART common.  
 
7.4 Factors associated with lower likelihood of live birth and desires for future 
childbearing  
Decreased likelihood of live birth amongst HIV positive women was associated with changes in 
perceptions of health and reproductive behaviours that suggest a preference to preserve health. A 
quantitative analytical framework presented in Figure 3.2 describes the hypothesised effect of HIV 
status upon proximate and distal determinants of a live birth. The pathway assumes that awareness 
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of an HIV positive diagnosis would influence perspectives towards health and relationships that in 
turn would mediate changes in pregnancy desire, resulting in changes to contraceptive use and live 
birth outcomes. Age and parity may confound this effect, as HIV positive women and women on ART 
are typically older and may already have children. This thesis showed evidence to suggest that 
perspectives towards own health may influence childbearing desires, but provided no evidence that 
HIV positive women alter their contraceptive use in response to childbearing desires. Two cohort 
analyses and 23 semi-structured interviews with clients of the HIV programme suggest that women 
on ART may avoid partnerships to limit childbearing: in cohort analyses, HIV positive women were 
less likely to experience a live birth outside of a regular relationship, while during interviews women 
said they had come to prioritise their own health, and fears of a negative health impact 
strengthened their pre-existing resolve to have no more children, although health usually took 
priority only after they were satisfied with the current number of children. A discussion on the effect 
of relationship, demographic and health factors described in the analytical framework is summarised 
below and then applied to the wider literature in section 7.6.  
Socio-cultural and economic factors play an important role in shaping desires for small family size 
that are related, but not limited, to their health on ART. Most felt that male partners did, or would 
come to, expect children and women usually asserted individual control of fertility through 
injectable use in the meantime. Some women who felt they had enough children already, preferred 
to avoid relationships and traditional expectations of childbearing completely (Section 5.3). A closed 
cohort analysis (section 4.3) showed HIV positive women may be less likely to enter regular 
relationships or are less likely to engage in risky sexual practice during ‘single’ periods compared to 
the general population, including women with missing information about their HIV status: HIV 
‘unknown’ women were most likely to be in a relationship but experienced highest incidence of live 
birth when reporting to be single, compared to lower likelihood when in a regular relationship (aHR, 
0.164; 95% 0.131 – 0.205). Conversely, HIV positive women were more likely to be single than HIV 
unknown women and risk of live birth was proportionally higher in HIV positive women when in a 
regular relationship (aHR, 1.64; 95% 1.053 – 2.552) or married (aHR, 2.36; 95% 1.195 – 4.648) 
compared to being single.  
Rates of marriage were low, with only 15% of women married by ages 45-49 and significantly fewer 
at younger ages (Section 4.1). Marriage is a poor indicator of fertility in this setting and women 
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discussed changeable relationships and previous pregnancy experiences as important issues 
influencing future decisions to have a child (section 5.4). In the open cohort, most births occurred to 
unmarried women with a regular partner (section 4.2) and typically women with a regular partner 
were 40% more likely to have a live birth compared to single women (aHR, 1.40; 95% 1.216 – 1.613). 
HIV positive women were disproportionately more likely to give birth only when in a regular 
relationship than when being single (aHR, 2.34; 95% 1.772 – 3.087) while no women on ART gave 
birth in a casual relationship. While HIV positive women had consistently lower birth rates than HIV 
negative women (aHR, 0.73; 95% 0.62 – 0.855), incidence was similar amongst women co-residing 
with their partners, irrespective of HIV status, indicating that a reduction in fertility can be attributed 
to women outside of established partnerships i.e. a regular partner or living together.  
As expected, women used contraception to avoid childbearing. Contraceptive use was associated 
with reduced incidence of live birth in both cohort analyses: contraceptive use was associated with a 
54% reduced risk of live birth in the open cohort analysis (aHR, 0.46; 95% 0.388 – 0.534) and a 
similar, 49%, reduced risk of live birth in the closed cohort analysis which included women of 
unknown HIV status (aHR, 0.51; 95% 0.437 – 0.600). Also, the lowest incidence was seen in women 
using injectable and dual contraceptive methods. In an analysis limited to HIV positive women and 
adjusted for demographic characteristics and proximate determinants of fertility, contraceptive use 
was associated with a 65% reduced risk of live birth (aHR, 0.35; 95% 0.250 – 0.489) (Section 4.2), 
indicating that HIV positive women regulate their fertility through contraceptive use. The association 
between contraception and live birth may be lower when including missing women who appear 
more sexually active but this variable could not be included in the closed cohort multivariable 
analysis, as it did not meet the proportional hazards assumption.  
Response to this question of contraceptive use reflected variation in sexual activity in a sub-analysis 
where likelihood of contraceptive use was the outcome (Section 4.4). Not co-residing with a partner 
was associated with higher likelihood of contraceptive use and so women appeared more sexually 
active or report more protective sexual behaviour when not living with a partner. HIV positive 
women were 10% less likely to engage in contraceptive use and appeared more likely not to answer 
this question due to lower sexual activity compared to HIV negative women. Women reporting 
themselves as in good, very good or excellent health were 40% more likely to use contraception 
(table 7.1).  
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Women on ART tended to be older but otherwise very similar to other women in Hlabisa. Trends and 
patterns of birth rates in women on ART by demographic determinants of fertility were similar to 
that in the general population of women in Hlabisa. For all women, incidence decreased with 
increasing age group, higher parity and an urban residency. Being aware of one’s own HIV status, 
awareness of the benefits of ART and low perceptions of well-being were associated with lower 
incidence of birth and all women were less likely to give birth while single or engaged/married, not 
living with a partner or using contraception and particularly, selecting injectable methods of 
contraception.  
Semi-structured interviews support these findings and, although limited to women on ART, key 
themes relating to economic and relationship uncertainties appear applicable to all women living in 
the Hlabisa sub-district (Hosegood et al., 2009).  These interviews touched upon multiple factors that 
women on ART discussed in the relation to their decisions to have or avoid another child that is 
fitting with a framework that captures the complexity of decisions such as the Health Belief Model 
for contraceptive behaviour discussed in Chapter Two (page 45). An adapted model for women living 
with HIV and on ART in Hlabisa is presented at the end of Chapter Six (page 246) and frames the 
decision to use contraception as an on-going cost-benefit analysis that constantly balances the risk 
of a pregnancy against adverse side effects of injectable contraceptive use. Structural, familial and 
partner support can also serve to modify contraceptive behaviour in different directions, and 
indicates reasons why behaviours may not neatly follow reported desires. Previous relationships and 
current partners were discussed as an important theme during interviews and it is likely that 
disclosure of HIV status to partner or a partner’s enrolment in to a HIV treatment and care 
programme are important proximate behavioural determinants of live birth that were not measured 
in this surveillance.  
 
7.5 Comparability of two quantitative cohorts and qualitative methods 
Incidence and factors associated with likelihood of live birth were similar in the two quantitative 
cohort analyses. An open cohort measured the relative risk between HIV negative and HIV positive 
women according to a range of demographic factors and determinants of fertility (Section 4.2) and a 
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second closed cohort analysis included women whose information about HIV status is missing from 
the DSS since entry in 2007 or 2008 (Section 4.3).  
Women with missing HIV data are of ‘unknown’ HIV statuses because their information is not known 
to the DSS, even though women may themselves know their HIV status. These women with an 
unknown HIV status were demographically similar to HIV negative women, with higher proportions 
in a relationship, reporting current use of contraception and being in good health, compared to HIV 
positive women. Likelihood of a live birth was highest amongst women of ‘unknown’ HIV status, of 
all three HIV categories, and not significantly different to HIV negative women in multivariable 
analysis.  
The incidence and trends in likelihood of live birth were comparable between HIV negative and HIV 
‘unknown’ women in a closed cohort analysis (Section 4.3). Incidence was highest in women that did 
not participate in HIV surveillance testing in these years, at 9 births/100wy and not significantly 
different from HIV negative women in multivariable analysis. Women may not participate in HIV 
surveillance for a number of reasons such as they have tested in previous years and do not wish to 
test again, or have tested elsewhere and are already aware of status. Women are routinely tested 
during antenatal care and so any woman that had a child since 2001 would likely be aware of their 
status, while HIV positive women that already know their status may be less willing to test 
repeatedly. Analysis showed that these women without DSS data for HIV status showed similar 
characteristics to HIV negative women. A total of 75% of women-years in the analysis were to 
women whose HIV status was known to surveillance and consequently, open cohort analysis findings 
of reduced risk of live birth to women on ART were comparable not only to HIV negative women 
(Section 4.2), but the general population of women resident in Hlabisa (Section 4.3).  
In a closed cohort of all resident women followed from entry in 2007 or 2008 until cohort censorship 
in 2012 or loss to follow up, HIV positive women experienced a 58% reduced risk compared to HIV 
negative women when adjusting for the inclusion of women with missing HIV data. HIV positive 
women composed about a third of the surveillance population, and were less likely to experience a 
live birth than the general population of women residing in Hlabisa. However, this finding should be 
interpreted with care, due to a violation of the Cox proportional hazards model when including all 
women. Analyses were stratified by HIV status to describe factors associated with incidence of live 
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birth in a closed cohort of all resident women, while the open cohort in section 4.2 provides more 
reliable measures of incidence of, and factors associated with, live birth, generalised to the setting.   
Incidence of live birth was generally highest in non-responders across a range of variables. In non-
responders, higher incidence was associated with self-reported health, HIV status, knowledge of HIV 
status, co-residency with partner and awareness of the benefits of ART. Higher rates in these 
categories may reflect less care seeking or more risky sexual behaviour.  
 
Women were eligible to entry into quantitative cohorts from 1st January 2007; about three years 
after ART started to roll out in South Africa, and followed until censoring in 2012 or loss to follow up. 
Consequently, these analyses describe an effect that is more proximate to the start of roll out of ART 
than primary qualitative interviews that began in October of 2012.  Despite this lag in time, findings 
are largely comparable, finding no evidence of ART being associated with increased childbearing and 
a preference to limit childbearing by time women enter HIV treatment and care. There were, 
however, nuances at earlier ages. HIV negative women typically experienced a peak in fertility at 
ages 15-19 and a subsequent decline with age that is attributed with postponement of childbearing, 
until a second peak in fertility at older ages of 30-34 years old. The absence of a bimodal trend in HIV 
positive women suggested that these women are limiting their childbearing at older ages. However, 
there was a small but substantial resumption of postponed childbearing amongst HIV positive 
women at ages 35-39 between 2006 and 2012, soon after ART was rolled out. 
 
7.6 Comparison of study findings with the literature 
7.6.1 Association between HIV and pregnancy or live birth outcome 
An estimated 61% reduced risk of live birth in HIV positive compared to HIV negative women implies 
a larger reduction than previous estimated effects of HIV on population fertility of 25-40%, 
calculated using census data from 13 African countries (Juhn et al., 2008) and mathematical models 
of population-attributable decline in total fertility in Uganda (Lewis et al., 2004) but is smaller than 
other estimates of population-attributable decline in fertility in South Africa (Young, 2005). Assorted 
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measures of the impact are likely due to a number of methodological differences, outcomes and 
variation in settings, and in particular a greater national TFR in Uganda compared to South Africa.  
In 2005 Young estimated that high HIV-associated mortality in men and women of reproductive age 
would effectively remove a cohort of potential childbearing adults. Young speculated that the South 
Africa population would reach 110 million by 2050. Instead the population has remained below 50 
million for almost 50 years (Young, 2005). Demographic health surveys have been utilised to 
compare fertility between HIV negative and HIV positive women and evaluate local community HIV 
prevalence effects on population fertility, including changes in fertility of non-HIV infected women 
(Young, 2005, Juhn et al., 2008).  The aggregate impact of HIV is of demographic interest and has 
implications for economic development across sub-Saharan Africa (Lewis et al., 2004). An estimated 
25-40% lower fertility in HIV positive women was based on two reviews of studies from the pre-ART 
era, totalling 19 studies, used to estimate a population-attributable change in total fertility (PACTF) 
(Zaba and Gregson, 1998, Lewis et al., 2004). Four of the 19 studies used in this model were cohort 
studies and were used to calculate 5-year age group differentials in birth rate between HIV infected 
and uninfected women. Fifteen studies were used to calculate differences in pregnancy risk and 
relative odds of infection. The PACTF was calculated from the age-specific HIV prevalence and 
fertility rates. However, the method employed to model an effect in these two reviews was highly 
limited in scope. Both papers assume a constant effect of HIV on fertility that remains ‘fixed over age 
and time’ although authors recognised the absence of common determinants of HIV and fertility 
such as contraceptive use, marital status and the underlying burden of sexually transmitted diseases 
(Lewis et al., 2004, Zaba and Gregson, 1998). These unadjusted analyses are not likely to reflect the 
‘true’ effect of HIV on fertility in the absence of ART, or offer accurate comparison to findings from 
this thesis.  
This thesis used individual data to measure the effect of a woman’s ART use on fertility as in recent 
studies (Juhn et al., 2008), but did not take into account an effect of reducing mortality on the risk of 
fertility as measured by community HIV prevalence (Young, 2005). Literature of cohort estimates 
from the pre-ART era shows variation in sample size and duration of follow up. In Uganda, around 
3500 women of reproductive age in a rural population-based cohort were followed over seven 
survey rounds and fertility in HIV positive women was 0.74 (95% CI 0.63, 0.87) that of HIV negative 
women when adjusted for age (Carpenter et al., 1997). In a smaller study, 238 HIV positive women 
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and 315 HIV negative women were followed for three years in Zaire, now DRC, and described 
unadjusted and consistently lower fertility rates amongst HIV positive women (Ryder et al., 1991).  
Cohort studies measure individual incidence and can provide stronger evidence for physiological or 
behavioural causation than cross-sectional DHS rounds. The open cohort in section 4.2 measured 
live birth amongst almost 10,000 women between 2005 and 2012, a time when ART was being 
rolled-out, and considered an individual time ‘at-risk’ as the denominator, attributed to a range of 
demographic factors and proximate determinants of fertility in an adjusted analysis. Consequently, 
the estimated 61% reduced risk of a live birth is likely to provide a reliable estimate of the individual 
association between HIV, ART and fertility in this setting of low TFR. Furthermore, this study offers 
evidence that HIV positive women still experience greatly reduced likelihood of live birth in an era of 
ART. 
Information about pregnancy outcomes was limited in the surveillance data used for the analyses in 
this thesis. Pregnancies were identified through annual surveillance and after birth according to 
reports from the head of the household or key informant. As such, pregnancies that did not end in a 
live birth were likely to be under-reported. Live birth as an outcome in this study provides a truer 
description of the outcome being measured but requires careful interpretation when compared to 
other studies that report pregnancy as an outcome.  
 
7.6.2 Association between exposure to ART and pregnancy or live birth outcome 
  A review of the literature identified only three published studies from sub-Saharan Africa 
comparing pregnancy or live birth outcomes of women on ART against pre-ART women. Two of the 
three studies measured pregnancy as an outcome and used the estimated date of conception as the 
incident date. Both studies found higher likelihood of pregnancy amongst HIV positive women 
exposed to ART: Myer et al reported a 74% increased likelihood of pregnancy in a multi-country 
study, and an even stronger association in South Africa alone (Myer et al., 2010) and Makumbi et al 
reported a 46% greater likelihood of pregnancy on ART compared to pre-ART women from Uganda 
(Makumbi et al., 2011) (see Table 2.2, page 66). Neither study reported the proportion of 
pregnancies that ended in live birth as opposed to stillbirth, miscarriage, or TOP. Both these studies 
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show increased incidence of pregnancy on ART associated with lower age, being married, no 
contraceptive use, lower parity and higher CD4 at screening.  
The third study, also from Uganda, compared odds of live birth and pregnancy outcomes according 
to ART exposure (Maier et al., 2009). Findings presented in this thesis are contrary to the higher 
likelihood of live birth on ART reported by Makumbi and Myer, and more consistent with results 
published by Maier et al of 70% lower odds of live birth and 44% lower odds of pregnancy to women 
that had initiated ART compared to pre-ART women. Maier et al enrolled 501 women attending a 
HIV clinic in Uganda and recorded self-reported pregnancy and pregnancy outcomes in the last three 
years, although incidence of stillbirths and miscarriage were not reported. They also conducted a 
cross-sectional survey of pregnancy intentions and found that women on ART actually had increased 
odds of planning a pregnancy in the future despite a lower likelihood of live birth or pregnancy 
(Maier et al., 2009).These three studies may potentially suffer from selection bias due to use of 
clinic-based population data (Galiwango et al., 2013). A limitation of clinical studies is that pre-ART 
counterfactuals are also selected from the clinic but have entered care for reasons of poor health 
that are not measured and could be independently associated with fertility.  
All three studies commenced soon after ART became nationally available and ended prior to changes 
in WHO recommendations to raise eligibility from a CD4+ ≤200cells/µl to CD4+ ≤350cells/µl in 2010. It 
is possible that the increased likelihood in fertility thus measures an early response to ART rollout, in 
women who initiated ART only at advanced HIV progression. Myer et al evaluated the effect of ART 
in multiple countries in Southern Africa between 2003 and 2007, and although the year of study was 
not noted by Makumbi et al, women initiated ART at a CD4+ ≤250cells/µl in a program launched in 
2004 and before the manuscript was submitted in 2010. Finally, Maier et al presented cross-
sectional data that included the fertility histories of women on ART that spanned 3 years prior to 
enrolment in the study between November 2005 and June 2006. The three aforementioned studies 
therefore follow women from initiation of ART at lower immunological measures of health than for 
women included in this cohort after 2010. Furthermore, women ‘on-ART’ were included at any time 
since they initiated ART in any year of this cohort. Studies reporting fertility amongst women that 
enrolled on ART at a CD4+ ≤250cells/µl are likely to report greater and more rapid immunological 
restoration subsequent to initiation and are therefore more likely to measure a vast relative 
difference in fertility according to physiological improvements.  
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Fertility rates in KwaZulu-Natal are high compared to Johannesburg but crude birth rates have 
declined in this setting in the past decades (Section 4.1) (Moultrie et al., 2008b), and the overall total 
fertility rate in this setting is low. Incidence of live birth to women in Hlabisa was double in rural 
areas of residence compared to urban settings and is consistent with lower overall incidence of 
pregnancy in three urban South African study sites included in the Myer study. Myer et al analysed 
4,531 records from HIV positive women enrolled in the mother-to-child transmission programme in 
seven sub-Saharan African countries and the median number of women enrolled at each site was 
410 (range, 211-666). Several design factors were likely to bias towards higher increase in fertility. 
Both pre-ART and on-ART women had received PMTCT for a recent pregnancy and so eligibility for 
this study may be biased towards women with established fertility, by virtue of having a recent 
pregnancy. Also, median age in this study was 27, much lower than a median age of ART-naïve (31 
years) and ART-exposed (37 years) in the closed cohort analysis presented in section 4.3. Myer et al 
report that 26% of pregnancies did not result in a live birth, lower than reported by another study 
from Johannesburg, where 47% of pregnancies to HIV positive women were not carried to term 
(Schwartz et al., 2012).  HIV is associated with adverse pregnancy outcomes in these studies and a 
wider review of the literature (Chapter 2) and so it is possible that a reduced risk of live birth to HIV 
positive women described in chapter 4 may reflect a disproportionately higher incidence of 
infecundity, stillbirth, miscarriage or termination of pregnancies to HIV positive women during a 
pregnancy. A comparison of these studies suggests that women selected for analysis in this Myer 
study were in a more fertile age category and were less likely to be at risk of infertility than the 
general population of Hlabisa. The study by Myer et al did not report on fertility intentions and so 
such inferences would be difficult to make.  
Differences in reported effect of ART are likely due to programme and study design, adjustments 
made in multivariable analysis and importantly, demographic or cultural characteristics. Makumbi et 
al. excluded women that reported use of Depo-Provera within 2 months of entry, while women were 
included in this thesis study cohorts irrespective of contraceptive use. A total of 712 pre-ART and 
244 women initiating ART were enrolled in to a PEPFAR funded HIV treatment and care programme 
where family planning activities were a programmatic priority and regularly monitored. Exclusion of 
women using injectable contraception may result in increased fertility on ART that is attributed to 
physiological improvements in health, than would otherwise be reported if the analysis was adjusted 
for the behavioural mechanisms through which ART may reduce fertility. Total Fertility Rates are 
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higher in Uganda compared to South Africa and prevalent desires to have more children and 
improved immune status were both risk factors associated with higher incidence of pregnancy 
amongst women on ART (Makumbi et al., 2011).  
7.6.3 Immunological restoration of health and self-perceived health on ART 
Studies have found higher incidence of pregnancy following immune restoration after initiation of 
ART, but unlike Makumbi et al, these do not compare incidence with pre-ART women or adjust for 
reported fertility desires. This thesis did not compare incidence of live birth according to duration of 
ART use, but one clinical study from Johannesburg found increasing incidence of pregnancy up to 6 
years after initiation and lower rates of incident pregnancy with decreasing CD4+ cells/µl (Westreich 
et al., 2012). An important limitation of this latter study is a lack of adjustment for sexual activity or 
contraceptive use that may explain behavioural differences between studies.  
Incidence of live birth declined cumulatively following initiation on ART, consistent with more 
literature from Uganda of lower incidence of birth or pregnancy after more than 12 months from 
initiation on to ART (Kaida et al., 2013). Kaida et al reported a peak in pregnancy rates after 6-12 
months following initiation and thereafter a decline. Although the Kaida study did not report on 
fertility intentions, another paper from the same study group found that 85% of women did not 
intend to become pregnant (Snow et al., 2013). Recurrent (second or third pregnancies) to women 
on ART resulted in resurgent peaks in pregnancy incidence at 24 and 48 months after initiation of 
ART. In Johannesburg, multiple pregnancies were particularly common amongst women aged 30-35 
years old (Westreich et al., 2012). In contrast, this thesis observed very few (38) recurrent births in a 
cohort including HIV negative and HIV positive women between 2007 and 2012, and given the long 
birth intervals and low total fertility rate in this area, low incidence of recurrent pregnancies was to 
be expected. Follow up of individual women for the entirety of the cohort was rare however: the 
cohort design was open and half of the sample entered in years after 2007, internal and external 
migratory patterns were common and some women were lost to follow up, while not all women 
participated in the HIV surveillance in all years and were categorised as ‘missing’ and excluded from 
further analysis. As a consequence, median follow up was only 1.97 years per woman and was 
therefore unlikely to capture recurrent births in a setting where long birth intervals are common. 
However, this study did determine increased incidence of childbearing to HIV positive women aged 
35-39 years old between 2006 and 2011 and a 38% higher incidence of live birth amongst 25-29 
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years old when on ART compared to pre-ART, which is contrary to the overall trend of lower 
likelihood on-ART in all other age groups. These findings suggest that while HIV positive women are 
less likely to give birth than women in the general population, women do tend to resume 
childbearing at older ages and the age at which women on ART resume childbearing may be 
lowering. Such an interpretation is consistent with what other authors have described as the ‘now or 
never’ phenomenon of childbearing on ART (Hayford et al., 2012). 
Immune restoration after initiation with ART was not associated with an increase in live birth 
incidence in HIV infected women this area. However, there was limited statistical power for this 
analysis as CD4 cell count information was missing for approximately 40% of the HIV infected 
women, and repeat CD4 counts were frequently not available for women on ART. Further, the CD4 
count is unlikely to correspond closely to the time of conception of the incident pregnancy. The most 
proximate CD4 measure from within 6 months of the HIV surveillance visit date was linked from the 
clinical ARTemis database to a demographic cohort. This value will correspond to CD4 at initiation in 
time updated analysis of women observed to initiate ART during the cohort time frame but 
otherwise provides a more distal measure of baseline CD4 than clinical studies. Consequently, this 
study can say little about the issue of immunological restoration, which is better explored in clinic-
based studies.  
Awareness of being HIV positive appeared to influence women’s behaviour. Knowledge of own HIV 
status was associated with a 46% reduced risk of live birth in adjusted analysis (aHR, 0.64; 95% 0.509 
– 0.792) but knowledge was not significantly associated with a live birth in an analysis restricted to 
HIV positive women (aHR, 1.00; 95% 0.757 – 1.332). Knowledge of being HIV negative compared to 
HIV positive thus appears to influence behaviour differently, as might be expected. Awareness of 
ART was common and was not associated with live birth rates in either univariate or adjusted 
analysis.  
Incidence of live birth was highest to all women self-reporting good, very good or excellent health. 
Results suggest that HIV positive women may protect good health through contraceptive use 
(Section 4.4) but do follow clinical recommendations to plan for pregnancies according to an 
appropriate CD4 count (Section 6.3). The risk to health that another pregnancy could pose was a 
determined as a key theme in semi-structured interviews. Adverse side effects of injectable 
contraception were uncomfortable and occasionally viewed as risky to health, something that was 
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highly valued by women on ART (Section 5.3). Excellent, good or very good self-reported health was 
associated with doubled risk of live birth in univariate analysis of all women (aHR, 2.03; 95% 1.682 – 
2.445) but this association became non-significant once adjusted for other determinants (aHR, 0.98; 
95% 0.806 – 1.184) (page 171). These findings suggest that the association between health and 
incidence of live birth is confounded by the inclusion of other proximate and distal determinants of 
fertility that may act downstream on the causal pathway, such as contraceptive use and actual HIV 
status.   
One other study included subjective well-being as a variable of interest in the association between 
ART and fertility (Maier et al., 2009). Maier et al found that a ‘very good or excellent’ self-assessed 
health status was more likely to be reported by ART-naïve women but was not significantly 
associated with unadjusted odds of live birth in Uganda (adOR 1.61 95% CI 0.95, 2.71) (Maier et al., 
2009). The five levels of response in the Maier study were identical to those in this study (Excellent, 
Very Good, Good, Fair, Poor) and also grouped in to a positive vs. negative health variable, as in this 
thesis. The difference in significance between the studies and this thesis may be attributable to 
author subjectivity and inclusion of ‘Good’ in the counter-factual ‘negative’ group as opposed to the 
‘positive health’ group. It is also likely to be a slightly biased measure of well-being, as the indicator 
was recorded at baseline in a cross sectional survey of incident births up to three years prior. 
Furthermore, perceptions of well-being attributable to a HIV diagnosis can vary culturally, and 
particularly contrast between older people living in Uganda and South Africa (Nyirenda et al., 2013). 
Despite lower functional ability and higher rates of obesity, hypertension and unemployment, older 
people living with HIV reported greater subjective well-being in South Africa compared to Ugandans 
when adjusted for multiple socio-demographic factors. This unusual finding was attributed to the 
availability of social services for older people in South Africa, such as the pension (Nyirenda et al., 
2013). ‘Self-reported’ health was a reliable predictor of actual health and mortality of people living in 
Hlabisa (Olgiati et al., 2012) and results from this thesis suggests that perceived health may be a 
more appropriate indicator of live birth after ART initiation. Kaida et al found that maternal mental 
health was not associated with the hazard of pregnancy after initiation on ART, while physical health 
as measured by a Medical Outcomes Study HIV Health Survey score, was of borderline significance in 
unadjusted analysis and not included for multivariable analysis of women also living in Uganda 
(Kaida et al., 2013).  
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7.6.4 Desires to postpone or avoid childbearing on ART, in a context of low fertility  
This study found little evidence to suggest that women had changed their desired family size in 
response to diagnosis with HIV or initiation on ART. The finding is not surprising in a setting where 
national TFR is just over 2. In two cohort analyses, incidence of live birth declined significantly with 
parity. Chapter 5 reported strong preferences not to have another child, according to social norms 
for an ideal family size of two or three children. All interview participants had living children and 
none wished to have another child if they had two or more. Few women changed their optimal 
family size to between two or three children and were not dramatically different from women 
whose desires had not changed.  
The childbearing desires described in this study may well represent the views of women that had 
mostly achieved their desired family size, within existing social norms. Women discussed a 
combination of factors, often operating simultaneously, that influence their own desires, including; 
previous experiences of childbearing and partner abandonment, current economic and relationship 
uncertainties, expectations of finding a partner and the cultural expectations of childbearing that 
payment of isilobola and marriage could bring. These perspectives were most often reported by 
women who felt satisfied with the number of children they already had and who viewed further 
childbearing as ‘risky’.  
A group of six women said they would like to have a child in the future, in accordance with prevailing 
desires for childbearing on ART also reported in Cape Town (Myer et al., 2007, Cooper et al., 2009). 
They considered that these desires would be susceptible to change, as relationships and 
circumstances evolved. Of these six women, none had discussed their previous pregnancies at the 
clinic. In South Africa women traditionally limit fertility through injectable contraceptive use but 
elements of family planning such as planning for a safer conception and inclusion of male partners 
have been missing. Male perspectives of planning were not addressed in this thesis and a study of 
the effect of ART on planning for a child in Hlabisa is therefore limited to women’s own experiences. 
In Uganda, a desire for more children was an important determinant of higher fertility when either 
the male partner wished to have a child or both the woman and male partner wished to have a child, 
compared to just the woman alone (Makumbi et al., 2011). These results provide evidence of the 
value of male perspectives in future studies.  
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Semi-structured interviews showed that women treated HIV as a manageable chronic condition, 
upon condition of correct adherence to ART. Women generally prioritised the decision to look after 
their own health after social norms for childbearing had been achieved. Findings were in agreement 
with literature that found adherence to ART can encourage positive perceptions of feeling healthy 
(Awiti Ujiji et al., 2010), and other studies describing partner desires for a child as a strong influence 
women’s own childbearing desires and likelihood of a live birth, elsewhere (Makumbi et al., 2011, 
Berhan, 2008) and in this setting (McGrath et al., 2011, McGrath et al., 2013). 
Maier et al reported health preservation behaviours amongst women on ART, who were more likely 
to have disclosed their serostatus to a partner and were more likely to have used contraception or 
abstained from sex during the three months before survey, compared to ART-naive women. This 
thesis that show HIV positive women were disproportionately less likely to give birth in ‘less formal’ 
relationships (single, in a casual relationship or not living with a partner) compared to HIV negative 
women and common preferences to avoid childbearing on ART.  
Most childbearing occurred when women were not married or living with their partners, due to the 
unaffordability of marriage and home ownership in this setting. Marriage rates in Hlabisa are low 
(13%) and did not significantly predict birth rates overall. Women were also well in to their 
reproductive lives by the time they came to live with their partners, with a median parity of four 
children. Modern relationship dynamics appear to provide some autonomy to allow women to limit 
their fertility before marriage, which was highly valued although rare. During interviews, marriage 
was viewed as a distal time that women would culturally ‘need’ or ‘give’ a child. Qualitative results 
suggest an anticipated ‘need’ to give a child was often contradictory to personal preferences to limit 
childbearing. These accounts may describe a prevailing respect for traditional expectations of 
fertility and marriage but also a preference of women on ART to limit their own childbearing in the 
meantime. Indeed, likelihood of live birth doubled amongst married, compared to unmarried, HIV 
positive women in an adjusted analysis. This increase is contrary to the general trend of lower 
fertility after marriage and could reflect the greater autonomy of single HIV positive women to limit 
their childbearing. 
Incidence of live birth was lower to women on ART when in a casual relationship or single. This 
finding suggests that these women are either less sexually active or using more contraception. HIV 
positive women were 78% more likely to give birth if living with a partner than when not living with a 
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partner, converse to a cohort trend of lower incidence of live birth when women were cohabiting 
with a partner. Higher incidence of live birth to HIV positive women living with a partner is unlikely 
to suggest greater sexual activity amongst women already living with partners after a HIV diagnosis, 
but instead reflects that HIV positive women are having less unprotected sex when not living with a 
partner compared to HIV negative women. Semi-structured interviews showed that women on ART 
were aware of partner expectations of childbearing and in some cases actively chose to avoid 
entering into new relationships with expectations for more children. Marriage was rather considered 
by women on ART as a time they would consider an end to their postponement or desires to limit 
childbearing, whilst avoiding childbearing via contraceptive use or not entering in to another 
relationship in the meantime. Many of the women interviewed were indeed in a relationship and the 
cultural ‘need’ to have a child was more pressing when women did not already have a child with the 
current partner. In this setting where the concept of relationship status is fluid but masculine values 
for fatherhood remain strong, a more reliable indicator of the importance of childbearing desires 
could include whether the woman has a child with current partner, a measure that was not available 
in the Africa Centre Demographic Surveillance.  
 
7.6.5 Contraceptive and Childbearing decisions on ART  
The issue of planning is complex. Many women described their most recent pregnancy to be 
unplanned, in line with wider literature showing a high proportion of pregnancies to women on ART 
in South Africa to be unplanned (Schwartz et al., 2012). Health workers agreed with the view that 
women did not plan their pregnancies and rarely discussed their intentions at the clinic. Cohort 
analysis estimated an incidence of 3.1 births/100wy [2.3 – 4.2] to women on ART reporting to use 
contraception at last sex compared to 3.9 births/100wy [2.3 – 6.4] to women on ART not reporting 
to use contraception at last sex. This difference in incidence was non-significant and results suggest 
that lower incidence of live birth to women on ART may, in part, be due to lower sexual activity in 
non-contraceptive users rather than changes in actual use of contraception.  
As expected, use of any modern method of contraception at last sex was associated with a 65% 
lower likelihood of live birth after adjusting for significant variables. Counter to the study hypothesis, 
however, HIV positive women did not report much difference in their contraceptive use and were 
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actually 10% less likely to report using contraception at last sex in this closed cohort of all resident 
women (Section 4.4). Contraceptive use was higher amongst women aged less than 24 years old, 
with a regular partner and not co-residing with their partner. Further, all women feeling in good, 
very good or excellent health, were 40% more likely to use contraception. Increased contraceptive 
use may represent greater sexual activity according to these indicators. In light of lower incidence 
amongst HIV positive women and women on ART, particularly when single or in less formal 
relationships, such findings may allude to less risky sexual behaviour amongst HIV positive women 
when independently charged with the decision to use contraception (i.e. not living with a partner). 
Furthermore, high incidence of both birth and contraceptive use amongst women reporting to be in 
good or very good health suggests that women may be choosing to protect restored health through 
contraceptive use, as described during interviews.    
Rates of live birth were high in women reporting contraceptive use in all three HIV groupings. The 
prevalence of pregnancies amongst women reporting contraceptive use could be due to a time lapse 
between measurement of contraceptive use ‘at last sex’ and the actual date of conception. 
Contraceptive use at last sex was reportedly low (32%) but the large proportion of unknown 
responses (44%) limits the usefulness of an interpretation of this variable. Information about 
contraceptive use is recorded during the same annual surveillance round that HIV status is 
established and a live birth event occurred. In this cohort, women episodes are censored with a live 
birth event and consequently, contraceptive use could actually be recorded at a time that is either 
pre- or post-conception of a live birth. 
Counter to the perspective that women do not plan, it seems that women are constantly considering 
their childbearing decisions as part of an evolving risk benefit analysis that is more in line with the 
health behaviour matrix described on page 246. And for many women on ART, the risk to health 
often outweighs the benefits of having another child and injectable contraceptive use forms a 
fundamental strategy to avoid childbearing. Key reasons that women considered previous 
pregnancies as unplanned were perceptions that the pregnancy had adversely affected her health, 
were not supported by partners and that contraceptive use was inconsistent at the time of 
conception.  
Three-monthly injectable DMPA was the most common method of contraception reported by all 
women in this area, including women on ART. The issue of long-term injectable contraceptive use for 
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the postponement of childbearing raises important issues of side effects during very long birth 
intervals and sustainability in women on ART. Given the reportedly low desires for childbearing, the 
incidence of live birth amongst women on ART in this study seems relatively high. Qualitative 
descriptions of inconsistent injectable use were primarily attributed to a range of unpleasant side 
effects of these hormonal methods that raised health concerns on ART. A small group of women did 
indicate that they felt they did not need contraception by virtue of their ART use, as they did not 
predict being sexually active or they would be less able to conceive. Injectable contraception 
appears to play a key strategy for family planning, to avoid having a child when a woman’s 
circumstances were not conducive to having a child at that time. Qualitative reports of the absence 
of planning thus seem to describe times when women cease to use injectables either for the 
purpose of childbearing, or to ‘take a break’, and remain sexually active without an explicit intent to 
have a child. This has wide implications for suitable alternatives to injectables for women on ART 
that do not wish to become pregnant, counselling to discuss side effects and for the assistance of 
women with preconception care for safer maternal and child outcomes. Women were aware that 
contraceptive methods were available but alternatives to injectable contraception did not suit the 
long term needs of women in this qualitative study. Women preferred being able to access long 
term methods at the clinic and use of methods that required little effort towards adherence, 
alongside minimal side effects. They reported favourable attitudes to the long lasting nature of the 
Intra Uterine Contraceptive Device despite being in the early stages of roll out, particularly as it may 
be used covertly and could be inserted in the clinic as an alternative to injectable use or sterilisation. 
Health workers were concerned that women would abuse EC as routine contraception and so 
preferred not to discuss it at all with clients and this led some women to seek traditional medicine or 
mis-use other clinical products in the place of EC. A limitation of this study is that it did not measure 
intention related to the incident birth event or consistency of contraceptive use and more rigorous 
measures of pregnancy planning are required. These findings highlight a need for improved 
counselling on the availability of EC for the prevention of unwanted pregnancies.  
According to Bongaarts, the principal reasons for non-use include lack of knowledge, fear of side 
effects and social and family disapproval (Bongaarts and Potter, 1983). Qualitative interviews 
suggested that the side effects of DMPA presented strong barriers to consistent adherence to 
women in this study (Section 6.3.3) and also other findings from a multi-cohort study including South 
Africa (Kaida et al., 2008). Further evidence suggests that women on ART need to be better 
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supported with information about the likelihood of amenorrhea and excessive menstruation or 
switched to an alternative method (Kaida et al., 2010). Partner disproval of contraceptive use was 
frequently circumvented through covert use of injectable methods, but concerns about being 'too 
watery' during sex presented a strong barrier to even covert use of DMPA. This is in accordance the 
literature from the area that found a common cross fertilisation of language attributed to 
contraceptive side effects and cultural ideals of attractiveness (Gafos et al., 2010). Being ‘watery’ 
was considered unappealing and jeopardised revealing a woman’s covert use of injectable 
contraception to an unknowing partner, or causing her to become unattractive to her partner during 
sex. Cultural barriers to injectables were reported by health workers and clients alike and 
demonstrate the need for counselling with appropriate information and support to adhere to 
methods, or alternatives to injectable contraceptive use for these women. Social and family 
disapproval was likely to encourage women to avoid childbearing but posed the strongest barriers to 
women who wished to seek termination of pregnancy or sterilisation, as they would be required to 
stay in hospital and explain their stay to household kin. 
Implementation of client-centred fertility- and HIV- services that effectively address the needs of 
women living with HIV requires contextual understanding of which women are likely to become 
pregnant and what they consider to be unmet needs. The next section will address key implications 
for delivery of family planning to women on ART.   
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7.7 Implications and recommendations 
Access to ART has been rapidly scaled in South Africa with resulting implications for population 
projections and delivery of integrated health services.  
A major implication of this thesis is that ART will not encourage a rise in population fertility rates in 
this setting. Quantitative data demonstrated lower fertility amongst HIV positive women compared 
to negative women, lowest of all in women using ART. Characteristically women on ART were older, 
generally at a later stage in their reproductive life cycle and were less likely to have children outside 
of regular or cohabiting relationships compared to HIV negative women. Qualitative results support 
this perspective that women are limiting their childbearing on ART; women described a preference 
to avoid future pregnancies on ART as they had achieved desired family sizes in line with cultural 
norms and because another pregnancy might risk their comprehensive well-being.  
Social and behavioural factors associated with lower fertility among women on ART in this analysis 
are akin to the socio-demographic drivers of a longstanding decline to low fertility in South Africa, 
where long birth intervals and sustained periods of postponement have expedited decades of 
fertility decline. ART could influence population fertility through different, survival mechanisms, as 
increasing numbers of men and women of reproductive age survive a HIV diagnosis on ART. Another 
study from this setting reported on the substantial improvements in survival since ART became 
available (Bor et al., 2013). Yet the crude rates of live birth reported in this thesis demonstrate a 
continual decline since ART roll-out began in 2004 (Section 4.1), according to pervading social norms 
for smaller families described in the qualitative findings.  
The UN projects a world population of 9.2 billion by 2050 under assumptions that fertility will 
continue to decline as ART coverage expands, but depends on ‘significant investment in family 
planning programmes’ (UN, 2007). Access to ART has expanded dramatically since 2004 and 
quantitative findings from this thesis support the UN assumptions for continued fertility decline. 
National projections are important for government planning and the effective implementation of 
such ‘significant investment’.  
Another major implication of this thesis is that the quality of integration within HIV services could be 
improved to better meet the family planning needs of women on ART in this setting. Approximately 
half of women described inconsistent use of injectable contraception, leading to experience of 
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unplanned pregnancies both prior to and during use of ART, and pregnancies were not usually 
planned in accordance with health worker advice. These findings suggest that the current model of 
family planning as an ‘essential affiliated service’ in the HIV continuum of care does not adequately 
ensure safer conception and motherhood.  
As a general recommendation, more information about safer motherhood and routine contraceptive 
management, timed early after initiation on ART and tailored to the reproductive needs and local 
realities of women on ART, is needed to address some of these programmatic gaps.  An adapted 
version of the contraceptive health belief model (page 272) summarises the reasons that women on 
ART prefer to avoid the ‘threat of a pregnancy’ in this setting, and the environmental influences that 
can modify and enable women’s childbearing decisions. The model encapsulates the conflicting 
decisions of women on ART that wish to avoid childbearing through injectable contraceptive use, 
versus the adverse side effects and cultural stigma that being ‘watery’ may bring. Finally the model 
describes the structural ways in which the HIV Treatment and Care programme can facilitate or 
present barriers to family planning delivery.   
Four more specific implications and the resulting policy, programmatic and research 
recommendations are detailed below.  
 
7.7.1 Implication One: Planning for safer motherhood is not currently practiced amongst 
women living with HIV  
Prevention of unintended pregnancies is a key component of global PMTCT strategies for women 
living with HIV and an understanding of this issue is thus important. Evidence from this thesis 
indicates that women on ART and their partners continue to desire or limit childbearing according to 
social norms and values, other than diagnosis with HIV. Women discussed very little pregnancy 
planning amongst women on ART and, in line with health worker views, illustrated narrow 
perspectives towards what planning for a pregnancy involved. Such perspectives on planning were 
limited to waiting for an appropriate CD4 count before conception. 
A small group of women on ART did wish to continue childbearing but no women in this qualitative 
study had discussed intentions to have a child with health workers and the absence of reproductive 
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health discussions may lead to unwanted pregnancies amongst women on ART, or risk harm to the 
mother’s health if a wanted pregnancy is not well timed. Considering qualitative desires to mostly 
limit childbearing and experiences of adverse health during unplanned pregnancies, incidence of live 
birth observed in Section 4.2 and 4.3 amongst women on ART appears relatively high. 
Rates of maternal mortality continue to increase in South Africa (STATSSA, 2013). The South African 
Saving Mothers report suggests that HIV accounts for 43.7% of facility-based maternal deaths 
between 2005 and 2007 (McIntyre, 2005) and that safer motherhood programmes should still pay 
special attention to the needs of pregnant women living with HIV (Zaba et al., 2013).  
There is conflicting evidence to suggest that pregnancy adversely affects HIV progression and risk of 
mortality. Some studies found no evidence  of advanced HIV progression to pregnant women in the 
era before ART (French and Brocklehurst, 1998). Yet mortality was higher amongst women in the 
post-partum period in Malawi (McDermott et al., 1996)  and the Democratic Republic of Congo 
(Ryder et al., 1994). Recent model based estimates of longitudinal data collected between 1989 and 
2012 suggest that HIV positive pregnant or postpartum women living in sub-Saharan Africa had an 
eight times higher risk of death than HIV negative women (Zaba et al., 2013). A meta-analyses of 
twenty three countries confirmed these findings, also reporting an eight times greater risk of 
mortality amongst HIV positive pregnant women compared to HIV negative pregnant women 
(Calvert and Ronsmans, 2013). In the study by Zaba et al, however, excess mortality attributable to 
HIV was far lower in pregnant or postpartum women than in HIV positive women that were not 
pregnant or post-partum, in agreement with the wider literature that suggests evidence for an effect 
of pregnancy on adverse HIV progression is weak (Khan et al., 2006).   
HIV positive women are more susceptible to other direct causes of maternal mortality, such as post-
partum haemorrhage, puerperal sepsis and complications of caesarean section, and also faster 
progression of opportunistic infections such as tuberculosis (McIntyre, 2005). TB is a major maternal 
health concern in KwaZulu-Natal: co-infection with TB amongst HIV positive pregnant women 
increased the risk of maternal mortality by 32 fold compared to HIV negative women, and 
prevalence rates of active TB in HIV infected women were 10 times higher than HIV uninfected 
women before ART was available (Khan et al., 2001).  
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Three recommendations for client-centred reproductive planning counselling for women on ART are 
suggested below: 
 
a. The national framework for integrated health services should be translated into 
operational guidelines for coordinated implementation of family planning within HIV 
services  
The literature calls for client-centred reproductive planning counselling that can address the diverse 
and changing needs of women, to either have a child or avoid an unwanted pregnancy over the 
course of ARV treatment (Cooper et al., 2009, Walter et al., Rutenberg et al., 2000, Peltzer et al., 
2009, Bekker et al., 2011).  
Strategies are available to support services to meet the reproductive needs of women living with HIV 
in low resource settings, according to stated desires to either have a child now, in the future or not 
at all (Bekker et al., 2011, WHO, 2006). However, no guidance for safer conception was available 
during clinic observations, and family planning activities were not well supported with tools, 
supervision or monitoring and evaluation of family planning communication within HIV services.  
Joint policies such as the HIV and AIDS and STI Strategic Plan for South Africa 2007-2011 have since 
demonstrated national commitments to co-ordinated SRH and HIV services, although strategies for 
implementation remained vague (SADoH, 2007a). The most recent South African Department of 
Health Strategic Plan 2014-2019 has specified an administrative objective to ‘improve and co-
ordinate integrated planning for health’ and aims to achieve health system reform using a 
‘framework for Integrated Health Service Plans at all levels of the Health care sector be developed 
and implemented’ by 2018 (page 17) (SADoH, 2014).  
It is a recommendation of this thesis that a national framework is translated into operational 
guidance for District Health management. The purpose of this recommendation is to facilitate 
integration of HIV and family planning in primary health care services. Operational guidance could 
outline routine and tailored counselling for people living with HIV, supported by health worker 
training.  
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b. Reproductive counselling should be conducted routinely and monitored 
Clients prefer to receive their ART and family planning services under one roof, but qualitative 
results showed that women were rarely given the opportunity to discuss planning for a child during a 
clinic visit.  
The WHO continuum of care places family planning as a part of preconception care for maternal 
health, and this has become recent policy in SA (SADoH, 2012). It is a recent concept that 
encapsulates interventions for both medical and behavioural aspects of sexual and reproductive 
health (Schwartz et al., 2012). Client-centred support relies on constant discussion and 
documentation of contraceptive behaviour to aid future discussions (Bekker et al., 2011). Continued 
counselling allows time for behavioural interventions to take effect and requires strong PHC 
infrastructure for referral, workforce training and supportive supervision (SADoH, 2011).  
Primary Health Care facilities currently record the number of family planning acceptors per clinic but 
include no measure of pregnancy planning or method switching. Client files contain a section about 
planning for a pregnancy but are not regularly completed and are not systematically filled. These 
files should be actively completed during every counselling session. Due to the sensitive nature, 
information about contraceptive method use and desires for family planning should be collected 
electronically and stored at the clinic. 
 
c. Training to support provider-led safer conception counselling should be routine in HIV 
services 
 
Routine fertility questions can confirm previous decisions and check if intentions have changed 
(Bekker et al., 2011). However, counsellors were largely unaware of safer conception strategies or 
how to structure a safer conception discussion. Consequently, counsellors expected client-led 
discussions, where women should first disclose an intention to get pregnant before they would 
introduce the topic of planning for a pregnancy. Very few women discussed intentions to have a 
child at the clinic and health workers reported feeling burdened and frustrated at that women 
visited the clinic once already pregnant. 
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In qualitative interviews, HIV nurses and counsellors viewed HIV counsellors as best positioned to 
deliver family planning counselling, before ART nurses deliver family planning methods, within the 
HIV treatment and care programme. A recommendation of this thesis is that HIV counsellors receive 
extra training to deliver safer conception discussions during routine provider-led family planning 
counselling. Key areas that training could effect a change, as identified by this thesis, were health 
worker perceptions of oral contraception and emergency contraception. Re-training would need to 
address the current health worker perspectives needed for gender sensitive counselling to address 
relationships gender dynamics. Such topics may include sexuality and gender norms and exercises to 
build skills for couples counselling (EngenderHealth, 2014). 
Previous NGO interventions have successfully improved family planning counselling in the context of 
HIV testing in KwaZulu-Natal (Bruce and Martin, 2008) and recommend a series of on-site refresher 
training events and the use of clinical aids to facilitate discussions about planning a desired 
pregnancy in the context of local realities (EngenderHealth, 2014). Other recommendations for pre-
conception work-up and counselling as provided by Bekker et al are described in Figure 7.1. 
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Figure 7.I: Table of optimal support strategies for resource intensive and resource limited settings 
according to the HIV status of the couple taken from (Bekker et al., 2011) 
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7.7.2 Implication Two: An injectable-centred culture results in inconsistent use with alternative 
to the current contraceptive method mix  
Low incidence of live birth to women on ART, either in a casual relationship or single, suggests that 
these women are either less sexually active or using more contraception to prevent a pregnancy. 
These findings are supported by strong preferences to avoid childbearing amongst women on ART in 
Chapter Five. Injectable contraceptive use was a key strategy in many women’s fertility plans to 
postpone childbearing but injectable methods often resulted in undesirable side effects or were 
seen as inappropriate while on ART to some women. Many opted to ‘take a break’ with few 
alternatives between long birth intervals. 
A strategy of long term injectable use poses issues of adherence and high risk of unplanned 
pregnancies. Three programmatic recommendations to support consistent contraceptive use within 
HIV treatment and care are presented here: 
 
a. National and provincial policy to supply alternative long acting methods of contraception 
at primary health care facilities  
There is a clear need for alternative non- hormonal methods or options with fewer side effects than 
injectable methods currently provide. The need for alternative methods is heightened by recent 
suggestions that DMPA injectable contraception has been associated with risk of HIV acquisition, 
although evidence remains inconclusive (Morrison et al., 2012, Heffron et al., 2012). An ‘injectable-
centred’ culture persists in family planning at present and national policy could target this issue with 
health worker re-training to make clients aware of previously neglected or newly introduced 
methods such as emergency contraception and the IUCD.  
The intrauterine device was being rolled out at the time of study and none of the women 
interviewed for this thesis yet had experience of the IUCD, but women reported favourably on this 
method primarily due to the long lasting nature and ease of access, through a single visit to the 
clinic. Improved information and counselling could make alternative methods viable. In accordance 
with a situational analysis of reproductive health care for PLWHIV in 10 Primary Health Care clinics 
and one hospital conducted between 2002 and 2003 in the uMkhanyakude district of KwaZulu-Natal 
(Maharaj and Cleland, 2005), counselling prioritised contraceptive efficacy and providers were often 
311 
 
reluctant to raise difficult issues such as partnership and HIV or underutilised methods such as the 
Intrauterine device (IUD) and emergency contraception. Oral contraception and EC are available in 
both the PHC and HIV treatment and care facility but many health workers were concerned that 
women would not adhere to oral contraception or would overly rely on EC. Considering the 
regularity of women ‘taking breaks’, oral contraceptive pills could be utilised as a short interim 
method if women remain sexually active.  
Findings presented in this thesis inform the recommendation that provincial policy guidelines 
facilitate the distribution and access to contraceptive implants at primary health care facilities in 
Hlabisa. This could include additional training for HIV nurses to insert implants at the HIV clinic or for 
a referral system to the adjacent Primary Health Care facility. Contraceptive implants such as 
Implanon® and Jadelle® are viewed as efficacious and long acting alternatives to 3-monthly 
injectables (Jacobstein and Stanley, 2013). Implanon® has been made available at public facilities in 
South Africa under the latest national contraception and fertility planning policy guidelines (SADoH, 
2012), and Jadelle® is now being manufactured and is available at a discounted cost, and studies 
have shown that nurses are equally as effective in administering this method (Bayer, 2012). Both are 
progestogen only subdermal implants with similar adverse side effects to DMPA, hence the long 
term feasibility requires further research but may prove to be limited in this setting.  
Finally, some women wished to seek sterilisation in order to limit their childbearing entirely but 
were deterred by concerns about the cost of transport and time spent at the hospital, which may 
alert family members about the procedure. Strategies that may help women overcome these 
barriers to care could involve travel assistance or tools to negotiate stigma of seeking a sterilisation.  
 
b. Counsellors need to discuss the management of contraceptive side effects during 
counselling 
Women make their family planning decisions according to a complex mixture of factors unrelated to 
childbearing desires. The health belief model for contraceptive behaviour described in Chapter Two 
and adapted to the local context in Chapter 6 provides a useful tool to elucidate the complex 
motivations pre-empting contraceptive decisions of women on ART in Hlabisa.  
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Effective communication to encourage pregnancy planning could respond to the notion of ‘stress’ 
that women described in their interviews, and encourage preservation of good health, which women 
also listed as a motivation to avoid future pregnancies in their interviews. 
Side effects of injectable contraceptive use would on occasion inadvertently cause women to seek 
traditional alternatives such as disprin or marijuana in their place.  Counsellors should discuss the 
common side effects of injectable contraception and how to manage them. Alternative methods 
could be offered to clients if side effects occur and persist, under recommendation 1.3.a. Where 
alternatives are not acceptable, health workers may encourage adherence by addressing 
perceptions about the efficacy of injectables on ART. 
 
c. Strengthened referral links or full integration requires inclusion of reproductive planning 
for safer motherhood within HIV treatment and care  
HIV treatment and care is currently available within a one-stop-shop model directed to deliver all 
aspects of HIV treatment and family planning services either in the programme or on referral. This 
study found different practical levels of integration that helped facilitate access to contraceptive and 
pregnancy services but omitted more complex discussions about emergency contraception, 
relationships and safer conception advice (French et al., 2006, French and Mitchell, 2012). The 
efficacy of one-stop-shop delivery has been challenged in comparison to other models of co-
ordinated resources (French et al., 2006). Integrated services have been advocated for as cost-
effective interventions for combined delivery of family planning and HIV treatment and care. 
However, such model’s risk quality of delivery and this thesis determined only partial levels of 
integration, with reproductive counselling largely omitted from the HIV continuum of care.  
Interventions that aim to increase social support risk added burden to the health workforce, where 
Primary Health Care services are already mandated to offer family planning services. WHO explicitly 
outlines strengthened links between different health system levels for reproductive and sexual 
health delivery. South African guidelines also describe family planning as an essential affiliated 
service to HIV treatment and care and recommend strong referral linkages where integration is not 
possible.  
313 
 
Strengthened referral systems provide an alternative to duplicated family planning services currently 
offered through partial integration within a HIV treatment and care programme (WHO, 2010b). 
Some nurses described frequently missed appointments and using personal mobile phones to check 
on clients that did not attend appointments. Missed appointments are an issue common to both 
PHC and HIV treatment and care services. The burden may be minimised by strategies such as 
personally escorting women to the PHC family planning facility, if required services are not available 
at the HIV clinic, or situating FP counselling earlier in the HIV continuum of care via formal referral to 
a trained counsellor for information about safer sex and safer motherhood before consultation with 
an ART nurse. Finally, regular discussions about the availability of referral services in the local district 
and local hospitals could help to address the perceived stigma around abortion seeking. 
 
7.7.3 Implication Three: Local realities of gender norms and relationships strongly influence 
family planning practices amongst women on ART 
The importance of gender norms and relationship dynamics shaping contraceptive behaviour meant 
that some women did not feel able to negotiate planning for a child, or the timing of a child during 
interviews. Health workers traditionally viewed planning as an activity reserved for married women. 
Findings from this thesis show that women can and often do have a child outside of marriage, and 
that desires to have a child are often postponed and difficult to predict. Where marriage was a poor 
indicator of a woman’s likelihood to have a child, better indicators could include if a woman has a 
child with her current partner and time since her most recent birth. Although not definitive, these 
indicators provide health workers with more information about whether women could feel 
pressured to have a child now or in the near future.  
Motherhood remains an important stage of life for women living in South Africa and is strongly 
influenced by social values and gender norms, particularly in the absence of marital traditions and 
under current re-workings of definitions of relationships and childbearing (Hunter, 2010). Men living 
with HIV have discussed desires for more children in South Africa (Cooper et al., 2009), as 
childbearing is important to continue their lineage in patriarchal societies (Cooper et al., 2007, Paiva 
et al., 2003) or prove virility under masculine social identities in South Africa (Dyer et al., 2004).  
Programs that explore different determinants of fertility intentions between men and women on 
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ART and different ways of delivering gender sensitive information are likely to be more effective 
(Cooper et al., 2009).  
Two recommendations for interventions that address gender norms towards childbearing in this 
setting are presented below: 
 
a. National sexual and reproductive interventions include communication with men 
The United Nations Family Planning Association aims to improve communication between men and 
women and ensure joint responsibilities are taken on issues of sexuality and reproductive health 
throughout adulthood. To this end, the UNFPA advocates that services encourage male participation 
in family planning and foster responsibility for sexual and reproductive behaviour (UNFPA, 2014). 
While these goals may be beyond the scope of PHC clinics, national education interventions 
currently aim to tackle gender issues amongst adolescents (Varga, 2003, Buga et al., 1996) and could 
be expanded to include basic information on pre-conception topics for maternal health alongside 
determinants of childbearing decisions. Further, other ecological approaches have aimed to reduce 
gender-based violence through interventions that target male partners in South Africa and aim to 
promote constructive roles in sexual and reproductive health, based on current ideologies of 
masculinity (Peacock and Levack, 2004). 
High impact practices to maximise investments in family planning advise a systematic and evidence 
based health communication strategy, which may occur through multiple health channels and does 
not solely rely on clinic attendance. Social marketing has been proven effective as a national strategy 
to deliver contraceptive methods alongside commercial marketing techniques that aim to direct 
behavioural changes (JHU, 2013).  
Social marketing has been effective for distribution of underutilised contraceptive methods such as 
emergency contraception and oral contraceptives, in addition to methods such as the Cyclobeads® 
colour coded visual tool, a method developed to help women follow the standard days method and 
time sexual intercourse to their fertility cycle in order to increase the probability of having a child, or 
avoid a pregnancy. A national social marketing strategy could help reinforce behaviour changes 
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messages, directed through community outreach programmes, NGOs, pharmacies and other private 
institutions, without reliance on attendance to the clinic (JHU, 2013). 
  
b. A couples-based safer conception intervention could be trialled in this setting 
The cultural expectation of isilobola payment and desires of partners to have more children were 
influential factors in women’s reported desires to have more children, despite a possible risk to their 
physiological health. Safer conception messages to wait for an ‘appropriate’ CD4 count before 
planning a pregnancy were neither tangible to women on ART nor evidence-based. Under such 
priorities, women rarely followed this advice. 
Interventions that promote male involvement in family planning have been shown to encourage 
couples communication and contraceptive uptake (Shattuck et al., 2011, Hartmann et al., 2012). 
However, male engagement within safer conception interventions remains challenging.  
Recently the feasibility of adding a separate on-site service for safer conception to a one-stop-shop 
setting was proven in South Africa (Schwartz et al., 2014). The intervention introduced an 
appointment system and dedicated staff in order to reduce waiting times for safer conception 
support that aimed to assist couples time pregnancies to when a women’s viral load is low, prevent 
super-infection and minimise the risk of vertical transmission (Schwartz et al., 2014).  
A recommendation of this thesis is that future research considers interventions to improve male 
participation and couples communication in family planning, inclusive of safer conception 
counselling in this setting. Men may be counselled on the health benefits of planning a pregnancy in 
a pre-conception planning intervention or by using the existing framework for health education each 
morning.  
There are considerations to this recommendation. Stigma can still prevent HIV disclosure between 
couples in this setting, where some women interviewed in this thesis were unaware of their 
partner’s HIV status. Therefore future studies would need to measure current dialogue between 
couples, and test the feasibility of a couple based approach. Furthermore, safer conception 
interventions often aim to prevent HIV transmission amongst sero-discordant couples. Of the 
women who did report to know their partner’s status, many were known to be HIV positive. 
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Consequently, a safer conception strategy in this setting may be orientated to prevention super-
infection and to preserve women’s health. Lower male involvement and sero-discordant male 
partner reluctance to take a short course of ART as pre-exposure prophylaxis were significant 
barriers to an integrated safer conception service for couples that wish to have a child. The cost-
effectiveness of such an intervention has not been ascertained (Schwartz et al., 2014) 
 
7.7.4 Implication Four: Reliable measures of pregnancy intention are not available in this 
setting 
Studies suggest that women on ART are continuing to desire more children in some areas of South 
Africa and in line with cultural norms. Findings from this thesis support the view that women on ART 
do not appear to be planning for more children compared to ART-naïve women. However, this study 
is limited by an absence of appropriate pregnancy intention measures. Further, planning may be a 
cultural concept. During interviews women were not planning a set time-frame to become pregnant. 
They often reported to prioritise their own health while negotiating the stability of relationships and 
financial income. They had a plan in mind but this was subject to change. Under such uncertainty, 
women give the appearance of flexibility that is difficult for health workers to respond to.  
Child-bearing decisions are not always rational and women did not always view fertility as within 
their control. Emphasising the cultural importance of isilobolo and expectations for a child and 
Christian views that a child could be seen as a ‘gift from God’, women often situated the notion of 
planning for a child outside her locus of control. Children were rarely planned for but health workers 
felt that married women were more likely to come to the clinic to plan for a pregnancy.  
In the absence of rigorous measures of pregnancy planning, there is a lack of evidence to suggest 
that any changes in childbearing desires following ART initiation directly effect a change in birth 
rates (Maier et al., 2009). An adequate measure of planning is much needed to answer these 
research questions. Two recommendations to support future research in this setting are detailed 
below:  
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a. Multi-item tools are adapted by SA Demographic and Health Surveys to measure 
pregnancy intention  
The first recommendation is that multi-item survey questions are used to measure pregnancy 
intention in the next SA DHS round. These measures would include both men and women plan in 
South Africa and better inform maternal and child health policy and services. They would include 
dimensions such as stopping contraceptive use, preparation for the pregnancy and agreements with 
a partner.  
Constructs of pregnancy intention have historically been developed in the West and their 
applicability to a rural African setting is unknown. Additionally, current measures of intentions are 
out-dated: the last National Demographic Health Survey was conducted in South Africa in 2003, 
before ART was available. The 2003 SA DHS measured the desired timings of a pregnancy for a 
woman i.e. wants birth within next two years, wants to delay birth for two or more years. Since this 
survey was administered, more sophisticated measures of pregnancy planning have emerged (Hall et 
al., 2013, Barrett et al., 2004) but have not been tested in Hlabisa. New and more relevant measures 
are needed. 
Multiple dimensions of intention have important predictive value for maternal and child health 
outcomes and recognise that people are rarely definitive about complex decisions like childbearing. 
Qualitative results from this study confirm that dichotomous ‘yes or no’ choice may not yield a 
useful interpretation of intention. More nuanced measures would better consider aspects of partner 
preferences, expectations of isilobola, family views and attitudes to contraceptive use in the setting, 
that may otherwise appear to conflict with personal desires for childbearing that are difficult to 
communicate. The need for more nuanced reporting of pregnancy desires could be further 
generalised to other settings across South Africa, although cultural practices may differ. To support 
this recommendation, the selected tool should be piloted in local languages and validated for each 
setting. 
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b. The Africa Centre include a multi-item measure of pregnancy planning for analysis 
The second recommendation is that Africa Centre pilots and includes a multi-item measure of 
pregnancy intention to the Women or Men’s General Health module or includes a new module 
within the demographic surveillance.  
The Africa Centre demographic surveillance does not currently include questions about a woman’s 
fertility intention or post-conception attitudes; the absence of such a measure is a limitation of the 
quantitative analysis presented in Chapter Four. The Africa Centre is well situated to longitudinally 
research pregnancy behaviours, with the opportunity to link information about pregnancy intention 
to reproductive, demographic and socio-economic characteristics. A primary advantage is the ability 
to include HIV negative women as a comparison group to women using ART, as demonstrated in this 
thesis. 
The Africa Centre may include a regular prospective measure of pregnancy intention in it’s 
household surveillance, or collect the perspectives of currently pregnant women as a new and 
separate module. These options are outlined in greater detail below: 
 Add questions to the Women or Men’s General Health module. 
Annual household surveillance could capture pregnancy intentions at different times: prospective, 
during pregnancy and during the post-natal period. Such an approach would include men and 
women of reproductive age in the DSA. Furthermore, it is the preferential individual that responds 
to questions in the WGH or MGH, rather than a key informant. However, Women’s and Men’s 
General Health questionnaires remain the most problematic for non-response rates and warrant 
further research into approaches to incentivise pregnancy planning responses.  
 Include a new module within the demographic surveillance.  
If Africa Centre were to include a multi-item tool, it would be feasible to introduce this as a stand-
alone questionnaire. With the aim to measure further complexity around childbearing decision-
making, the London Measure of Unplanned Pregnancy (LMUP) is a psychometrically-validated 
measure of pregnancy intention with the added benefit that it does not assume that women have 
pre-determined childbearing plans or that their intentions necessarily lead to a set behaviour (Hall et 
al., 2013). The LMUP is self-administered and comprises six questions on contraceptive use, timing, 
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intention, desire for a baby, partner discussion, and pre-conceptual preparations. Each point 
increase represents an increase in pregnancy intention and can be interpreted as unplanned, 
ambivalent, and planned. The LMUP is administered in English and has not yet been validated in 
isiZulu, the predominant language of KwaZulu-Natal, but could possibly be used to provide a reliable 
measure of how all women are planning pregnancies in this setting. The LMUP would question 
relevant individuals rather than a key informant. It is most reliable when administered during a 
current pregnancy or close to conception and would be administered as a separate module at least 
once a year, similar to other household demographic surveillance. Ideally, the LMUP would be 
administered during any household visit when a pregnant woman is present. This would incur extra 
time costs from the fieldworkers and households.  
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7.8 Strategy for dissemination 
A strategy to disseminate findings from this thesis is presented in this section. Results have been 
presented at two conferences in poster and oral format to date. At the end of the study, qualitative 
results were directly communicated to management staff at the local tertiary hospital, who are 
responsible for oversight of the decentralised primary health care services included in this study. 
Both these activities are described below. In addition, this section begins with detailed plans for 
publication of four papers from this thesis. All names of participants or clinics were anonymised 
throughout all dissemination activities. 
 
7.8.1 Publication plan 
Current literature suggests that ART use may increase fertility, with unknown implications for 
population growth in areas of high HIV prevalence. This study offers a new perspective: that in this 
high HIV, high Art and low fertility setting there is no evidence of a change in fertility associated with 
ART use. These findings are supported by the comparison of women living with HIV on ART to HIV 
positive women not yet on treatment and HIV negative women. I intend to publish four papers from 
this study; these include a literature review and three papers addressing each of the research 
questions outlined at the start of this thesis. 
The proposed order of submission, theme of each paper and the description of the contents are 
given in Table 7.2.  
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Publication Theme of paper Description of content 
1 A review of the 
current literature on 
the effects of ART on 
fertility in sub-
Saharan Africa. 
This review will describe a systematic search strategy 
presented in section 2.8.1 and a summary of the discussion 
presented in section 2.8.2. It will review 9 quantitative 
studies with a discussion on the study design, reported 
outcome and the direction and reported effect of ART.  
2 A cohort analysis of 
the effect of ART on 
live birth rates. 
The paper will report results of an open cohort analysis 
presented in section 4.2 and addresses research question 
one. It will describe an analysis of proximate and distal 
factors associated with the likelihood of a live birth, using 
demographic surveillance data from the Africa Centre 
between 2007 and 2012. It will report no increase in 
likelihood of live birth attributed to use of ART, and a lower 
likelihood of fertility compared to HIV negative women. The 
paper will conclude with possible implications for studies 
reporting fertility desires and health service delivery in 
South Africa.  
3 A description of 
fertility desires 
amongst women on 
ART. 
This paper will summarise key findings from Chapter Five 
and addresses research question two. It will describe semi-
structured interviews with women enrolled in a local HIV 
treatment and care programme and health workers in this 
programme. Results will describe women’s reported 
fertility desires while on ART and the discussion will expand 
on themes that women reported to influence their 
childbearing desires. The paper will conclude with health 
service implications to support planning for a child or to 
avoid a pregnancy and the need for more rigorous research 
Table 7.2 Publication list and description of papers from this thesis 
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on fertility planning in this setting.    
4 Attitudes to 
contraception and 
family planning in a 
HIV treatment and 
care programme. 
This paper will be based on findings from Chapter Six and 
addresses research question three. It describes semi-
structured interviews with women enrolled in the HIV 
treatment and care programme and observations of the 
same clinics. It will report client and health worker 
attitudes to the delivery of family planning services in a 
one-stop-shop model of HIV treatment and care. Results 
will present factors that influence contraceptive preference 
and use and the influence of ART use. The paper will 
conclude with implications for improved integration of 
family planning in the HIV treatment and care programme 
in this local setting.  
 
7.8.2 Conference and presentations 
Results of this thesis have been presented at two conferences to date: one poster of qualitative 
findings and one oral presentation of quantitative results from this study.   
 The poster was entitled ‘Childbearing in the time of ART: Family planning in a decentralised 
HIV Treatment and Care Programme in rural KwaZulu-Natal’ and displayed at the 6th South 
African AIDS conference. It presented findings related to research question three on the 
attitudes to contraceptive use and childbearing reported during interviews with clients of 
the HIV treatment and care programme.   
 The oral presentation was entitled ‘The effect of national scale up of access to anti-retroviral 
therapy (ART) on rates of live birth in the Hlabisa sub-district of KwaZulu-Natal, South Africa’ 
and was presented a conference called ‘Fertility Transition in the South’, hosted by the 
Oxford Institute of Population Ageing. It presented the results of the open cohort analysis of 
live birth rates to women living with HIV on- and pre-ART.  
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In addition to these conferences I have presented findings at three Africa Centre weekly seminars 
and at the Institute of Global Health’s PhD review. 
 
7.8.3 Feedback to the HIV treatment and care programme 
An objective of this study was to inform local health practitioners of current barriers and facilitators 
about the delivery of integrated family planning and HIV treatment and care. Results from research 
question three were presented to the Hlabisa hospital management team during their monthly 
meeting in June 2013. I presented an overview of the purpose of my study and methodology and 
selected key facilitators and barriers to the delivery of integrated family planning.  
The format was designed as a PowerPoint presentation, but a projector was not available on that 
day. As a conclusion to the meeting, the management team agreed that there was a gap in 
communication particularly around the use of emergency contraception. However, I am not aware 
of any action that has been implemented in response to this meeting.  
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7.9 Strengths and limitations of this research 
7.9.1 Strengths 
x This thesis offers a reliable estimate of the likelihood of having a live birth by HIV status and 
ART exposure, allowing for proximate and distal determinants of fertility in Hlabisa. 
x Use of demographic surveillance data ensured a large study size, with longitudinal follow up 
of nearly 10,000 women between 2007 and 2012.  
x Inclusion of HIV negative women in an analysis with women on ART is novel to the literature.  
x Linkage of CD4 and ART data with a HIV treatment and care programme is an advantage as 
information could be time-updated to provide longer term continuity and prediction 
compared to other cross-sectional studies.  
x The time-updated survival method for longitudinal analysis in both quantitative cohorts 
appropriately adjusts for changes in demographic, clinical and behavioural characteristics 
that are not easily captured in clinical cohort studies  
x Similarity between two cohort studies assures the reliability of measures of incidence and 
associations between risk factors and live birth identified in an open cohort that excluded 
women with missing information about their HIV status from the DSS.  
x The findings relating to hazard of live birth in this study confirmed early studies from the 
same setting  
x Qualitative methods supported quantitative findings that perceptions of health is an 
important determinant of reproductive behaviour to avoid childbearing  
 
7.9.2 Limitations 
x Lack of statistical power due to relatively small numbers of women on ART experiencing a 
live birth may not give accurate estimates of relative risk in stratified analysis. Associations 
followed a similar direction according to characteristics of ART-naïve HIV positive women 
and HIV negative women, suggesting that lack of statistical significance was likely due to an 
issue of sample size and power. However, confidence intervals indicate that these estimates 
are likely to be a reasonable.  
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x Use of demographic surveillance data has limitations. Firstly, women were selected to enter 
the cohort at a specified entry date and visit dates of Africa Centre demographic surveillance 
rounds do not exactly correspond to dates at which ART use and CD4 count data were 
captured in the ARTemis database. Therefore, comparisons are drawn on general 
differences in incidence and factors associated with live birth between HIV positive and HIV 
negative women. Clinical studies that measure time to a live birth event from the date of 
ART initiation and with time updated information on other proximate determinants of 
fertility from this baseline point would provide a more reliable estimate of the effect of 
improved immunological health associated with likelihood of fertility after recent initiation 
on ART. 
x Additionally, variables of interest were not perfectly aligned to the study question. Ideally, 
demographic survey measures would have included questions about pregnancy intention 
prior to conception and detailed relationship questions regarding disclosure of HIV status to 
partner, a male partner’s fertility desire, the number of children that women had with their 
current partner and whether the partner had paid isilobola. However, other indicators such 
as whether or not a woman was living with her partner and broad categories of relationship 
status such as regular and casual partner did determine differences in the way that women 
on ART experienced live birth according to the formality of their relationship. Furthermore, 
adherence to contraceptive use is an important measure that could further elucidate 
differences in reproductive behaviours in this setting.   
x The absence of physiological measures of health and particularly the presence of underlying 
STI prevalence is a major limitation of this study as it prevents a comprehensive assessment 
of the relevance of biological compared to behavioural determinants of fertility. However, 
findings provide a strong argument for the importance of behavioural determinants of 
fertility decline in all HIV groupings and suggest that unmeasured physiological differences 
can otherwise explain a large variation in fertility between HIV positive and HIV negative 
women.  
x High levels of attrition due to migration or non-response meant that women were observed 
for a median time of around 2 out of 5 possible years, depending on HIV category. 
Differences in time spent under observation were adjusted for using person-years as the 
common denominator between HIV groups. It is possible that there may be differences in 
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residency as women living with HIV and on ART are likely to be older and may be less prone 
to travel for health reasons and could be over-represented in this study. However, HIV 
positive women may also be less likely to participate in HIV surveillance after receiving a HIV 
positive response. 
x Information collected in the demographic surveillance was carried out by fieldworkers that 
visit each individual homestead. Data are systematically checked and verified throughout 
collection but it is possible that omissions and mistakes in data collection can occur at 
random. Trends appear to be largely uniform throughout the cohort period. 
x A research assistant was hired to conduct qualitative semi-structured interviews in isi-Zulu, 
as the researcher did not speak the local language. The research assistant received 
comprehensive and on-going training. Training encouraged the RA to probe on topics of 
planning for a child that may not otherwise be volunteered during interviews and could lead 
to skewed responses towards ideals of planning. However, we found that women rarely 
reported planning for a child and clients were unlikely to have been biased during 
interviews.  
x A major limitation of this study is the absence of male partner viewpoints. The study design 
prioritised seeking the viewpoints of health workers for the purpose of this study and due to 
difficulties raised in the recruitment of male partners; the male viewpoint was not addressed 
in this study and would be an important next step for future research that could explore the 
feasibility of interventions for gender sensitive family planning. 
x The cross-sectional nature of in depth interviews are unlikely to unravel the complex nature 
of pregnancy decisions to women living with HIV on ART. Long-term follow up over a life 
course approach and outside of the programmatic setting may offer more insight in to the 
cultural nuances of decision-making.  
x This study found evidence of the need for culturally sensitive assessment of pregnancy 
intentions and health systems interventions and may, therefore, not be generalizable 
outside of the Zulu ethnic population in South Africa.  
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7.10 Conclusion  
A review of the demographic literature and findings from this thesis demonstrate that a transition to 
lower fertility has persisted in this setting for decades and that fertility is likely to continue to decline 
in an era of ART, in line with prevailing social norms.  
Use of ART does appear to influence certain aspects of childbearing in this setting. A reduced 
likelihood of live birth amongst HIV positive women compared to HIV negative women may be 
attributed to both physiological and behavioural differences. This thesis suggests some HIV positive 
women are limiting their childbearing behaviours in order to protect their improved health on ART 
or to avoid another adverse pregnancy experience.  
The cultural context in which women make these choices is important. Women may feel more 
empowered to disclose a wish to limit childbearing when they no longer see the traditional prospect 
of marriage as obtainable. Before arriving at this juncture, women describe regular experiences of 
relationships that end with ‘abandonment’ after a pregnancy. Women found that male partners 
rarely met financial and romantic expectations and this contributed significant anxiety to the 
prospect of ‘giving’ another child outside the security of marriage. The risk to health of another 
pregnancy on ART was seen to compound this pre-existing stress under such uncertainty only after 
some experience of childbearing already in this setting. However, inconsistent injectable 
contraceptive use was common and regularly resulted in unplanned pregnancies. Some posed 
extreme risks to the woman’s own health. These findings indicate a programmatic gap in family 
planning in the HIV continuum of care. Some women were more optimistic about having a child in 
the future and in line with the expectations of marriage. Additionally, women and health workers did 
not usually discuss desires for a pregnancy or that strategies for safer conception were available, 
leaving missed opportunities to minimise risks of HIV transmission and super-infection or support 
safer motherhood.  
In a climate family planning services are being internationally re-prioritised, these findings are 
important. National policies for integration are unlikely to follow one set blueprint and need to 
reflect local realities. In South Africa, scale up of ART is unlikely to instigate a reversal of the national 
fertility decline. This thesis argues a public health perspective that  ‘significant investment’ for family 
planning must prioritise strategies to address the extremely high current rates of maternal mortality, 
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using safer conception and motherhood strategies as outlined in the recommendations section of 
this thesis.  Specific to women on ART, there is a need for tailored reproductive advice that 
encourages consistent contraceptive use when a pregnancy is not desired. Both aspects require 
additional health worker training to change the current ‘injectable-centred’ family planning culture 
and encourages awareness of existing and underutilised methods or safer conception discussions 
where appropriate.  
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Appendices  
Appendix A: Number of women according to their marital status, disaggregated by age and year 
Age Marital Status 2007 2008 2009 2010 2011 2012 
Overall Neg. Pos. Overall Neg. Pos. Overall Neg. Pos. Overall Neg. Pos. Overall Neg. Pos. Overall Neg. Pos. 
15-
19 
Single 64 41 23 87 60 27 123 75 48 159 92 67 123 70 53 78 45 33 
Casual  27 21 6 24 18 6 35 28 7 27 21 6 11 5 6 7 5 2 
Married 4 4 0 1 1 0 3 2 1 8 5 3 3 3 0 6 5 1 
Regular 384 314 70 385 306 79 247 205 42 231 193 38 155 112 43 125 109 16 
Div/Wid/Separated 26 20 6 17 11 6 32 24 8 43 32 11 14 11 3 7 6 1 
Unknown 49 18 31 146 96 50 89 57 32 62 42 20 62 48 14 108 84 24 
20-
24 
Single 67 44 23 61 39 22 175 98 77 221 126 95 195 107 88 166 98 68 
Casual  10 6 4 14 7 7 51 33 18 34 18 16 10 6 4 14 12 2 
Married 10 5 5 10 7 3 17 11 6 29 19 10 19 14 5 11 7 4 
Regular 599 384 215 526 330 196 447 283 164 501 317 184 418 245 173 245 169 76 
Div/Wid/Separated 36 26 10 47 28 19 40 28 12 57 33 24 27 18 9 36 28 8 
Unknown 149 21 128 341 52 289 228 102 126 165 53 112 195 84 111 270 184 86 
25-
29 
Single 37 11 26 53 22 31 137 60 77 163 81 82 185 79 106 176 67 109 
Casual  5 1 4 2 0 2 13 12 1 5 7 -2 6 2 4 4 2 2 
Married 27 22 5 219 17 202 92 21 71 96 32 64 80 33 47 56 13 43 
Regular 368 168 200 356 144 212 178 117 61 227 159 68 209 111 98 140 93 47 
Div/Wid/Separated 28 10 18 28 8 20 18 14 4 29 12 17 21 8 13 20 14 6 
Unknown 122 3 119 337 78 259 234 61 173 256 38 218 223 85 138 264 134 130 
30-
34 
Single 61 27 34 50 11 39 137 27 110 163 34 129 185 34 151 176 29 147 
Casual  8 2 6 2 1 1 13 3 10 5 1 4 6 1 5 4 1 3 
Married 62 48 14 52 34 18 92 48 44 96 50 46 80 50 30 56 28 28 
Regular 243 93 150 231 80 151 178 70 108 227 80 147 209 55 154 140 62 78 
Div/Wid/Separated 16 5 11 16 4 12 18 8 10 29 10 19 21 4 17 20 5 15 
Unknown 166 5 161 363 81 282 234 43 191 256 31 225 223 40 183 264 74 190 
345 
 
35-
39 
Single 65 27 38 63 18 45 116 32 84 188 41 147 162 36 126 180 31 149 
Casual  4 1 3 3 0 3 3 0 3 3 0 3 4 0 4 2 0 2 
Married 118 92 26 91 66 25 122 75 47 135 85 50 144 85 59 62 26 36 
Regular 187 99 88 157 68 89 122 58 64 151 55 96 132 34 98 94 29 65 
Div/Wid/Separated 16 10 6 11 7 4 22 7 15 34 5 29 33 10 23 20 4 16 
Unknown 150 4 146 323 83 240 227 46 181 196 39 157 209 24 185 234 61 173 
40-
44 
Single 96  48 48 62 26 36 120 41 79 123 37 86 133 49 84 127 21 106 
Casual  4 1 3 2 1 1 2 0 2 1 1 0 2 0 2 1 0 1 
Married 148 120 28 113 83 30 151 103 48 177 115 62 171 97 74 82 36 46 
Regular 134 84 50 107 68 39 72 40 32 79 37 42 70 20 50 40 14 26 
Div/Wid/Separated 15 8 7 12 8 4 40 17 23 53 22 31 52 22 30 42 10 32 
Unknown 138 0 138 369 109 260 221 63 158 212 54 158 185 53 132 203 75 128 
45-
49 
Single 139 88 51 112 60 52 148 76 72 164 74 90 171 59 112 131 30 101 
Casual  4 4 0 2 1 1 4 1 3 4 0 4 2 0 2 2 1 1 
Married 140 120 20 100 86 14 178 131 47 205 154 51 188 126 62 82 38 44 
Regular 87 61 26 111 82 29 58 39 19 72 39 33 38 24 14 18 10 8 
Div/Wid/Separated 15 13 2 9 5 4 51 30 21 68 40 28 85 44 41 36 9 27 
Unknown 103 0 103 344 148 196 197 80 117 183 60 123 153 55 98 219 98 121 
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Appendix B 
Interview Schedule:  Women attending Hlabisa HIV treatment and care programme with 
no experience of having a child while in the programme 
 
Introduction to interview 
Thank you for agreeing to take part in this study. Your views and opinions are very important to this 
research. As we have discussed before, you are free to not answer a question or end the interview if 
you feel uncomfortable at any time and this will not affect the treatment you receive at the clinic. 
Any information that you provide today will be treated as strictly confidential and your name will not 
be used in any future reports, so please feel free to give your honest opinions. 
Let us begin with some short questions. 
 
1. Eligibility information (also used to keep a tally of strata) 
1.1 How old are you? 
1.2 Where do you currently live? 
1.3 Are you currently working? 
1.4 When did you find out your HIV status? 
1.5 When did you first start taking HIV treatment?  
1.6 How long have you been attending this clinic? 
1.7 How many children do you have? 
1.8 Have you been pregnant since receiving HIV treatment here or at any of the clinics in the 
area? If so, when was this? 
1.9 What is you marital status? 
1.10 [If has partner] Do you know your partners HIV status? 
 
2. Introductory questions 
2.1 What is a normal day like for you? 
2.2 How did you find out you were HIV positive?  
2.3 What impact did this diagnosis have on your life? 
2.4 Did your diagnosis have an impact on your relationships? Did this change when you started 
treatment? (Attitude to partner, Desire for a relationship, Sex life) 
2.5 Are you currently sexually active? 
2.6 Who knows about your HIV status? 
 
3. Fertility desires  
3.1 Would you like to have more children/children in the future?  Why/Why not 
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- When would you like to have your next child? Why that time? 
- What things do you think will affect when you have another child? 
- Do you think you will actually have more children/children? Why/why not? 
3.2 Did your diagnosis change your views on having children? What about starting treatment did 
that change your views? 
3.3 [If has partner]  Do you know how your partner feels about having more children in the 
future? Have you discussed this with him? 
3.4 What does your family expect from you in terms of having children? What about the 
community? 
3.5 What effect would getting pregnant in the near future have on you? 
- Health 
- Relationship 
- Treatment from the clinic 
 
4. Attitudes to contraceptive use and awareness of method mix 
4.1 Are you currently doing anything to avoid pregnancy? 
[Yes] 
- How long have you used this method? 
- Why that method rather than any other? 
- Likes and dislikes about the method? 
- Any problems using with the method? – Forgetfulness, side effects,  
- Would you prefer to use another method? [Yes] Which method? Why not 
changed? 
 
[No]  
- What are your reasons for not using any forms of family planning? 
 
4.2 Have you ever used any other forms of contraception?  
 [For each method used] 
- When and for how long? 
- Why that method? 
- Likes and dislikes about the method? 
- Any problems using this method? – Forgetfulness, side effects? 
- Why stopped using this method? 
- Would you consider using this method again in the future? 
 
4.3 What other forms of contraception have you heard of? 
- Probe if not mentioned: Injections, implants,  pills, IUDs, patches, emergency 
contraception, condoms, sterilization 
[For each method listed] 
- Would you consider using this method? Why/Why not? 
 
4.4 [If has partner] How does your partner feel about the different family planning 
methods? 
4.5 Did diagnosis impact your use of family planning or how you feel about the different 
methods?   
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4.6 Has being on treatment changed your use of family planning or how you feel about the 
different methods? 
4.7 Are there any forms of contraception or that you feel people should not use at the same 
time as HIV treatment? Why not? 
 
 
5. Experience accessing contraception and views on services 
 
5.1 Where do you usually get advice and supplies of contraceptives? 
- Likes and dislikes about the place 
- How could the experience be improved? 
- Are you given a choice of methods? Which ones? Would you prefer a wider 
choice? 
- Do you know any other places that you could access advice and contraceptives? 
Why do you not use those places?  
- Did your diagnosis influence where you got advice and supplies from? 
- Did starting treatment influence where you got advice and supplies from? 
5.2 Have you ever received advice on family planning or pregnancy from this clinic? What 
advice? Was the advice useful?  
5.3 Would you like to receive more advice on family planning and pregnancy? What advice? 
Where do you think is the best place to give the advice? 
5.4 [If not mentioned in 5.1] Have you ever obtained contraceptives from this clinic? 
[Yes] 
- Why did you not access/continue to access them at the clinic? 
- Likes and dislikes about the service? 
- How could the experience be improved? 
- Were you given a choice of methods? Which ones? Would you prefer a wider 
choice? 
5.5 What attitude do the health workers at this clinic have towards pregnancy and 
contraception? 
5.6 Do you feel able to confide in the health workers about your pregnancy and family 
planning needs? Why/Why not? 
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Appendix C 
Interview schedule: Women with experience of a pregnancy in the HIV treatment and care 
programme 
 
Introduction to interview 
Thank you for agreeing to take part in this study. Your views and opinions are very important to this 
research. As we have discussed before, you are free to not answer a question or end the interview if 
you feel uncomfortable at any time and this will not affect the treatment you receive at the clinic. 
Any information that you provide today will be treated as strictly confidential and your name will not 
be used in any future reports, so please feel free to give your honest opinions. 
Let us begin with some short questions. 
 
 
1. Eligibility information (also used to keep a tally of strata) 
x How old are you? 
x Where do you currently live? 
x Are you currently working? 
x When did you find out your HIV status? 
x When did you first start taking HIV treatment?  
x How long have you been attending this clinic? 
x How many children do you have? 
x Have you been pregnant since receiving HIV treatment here or at any of the clinics in the 
area? If so, when was this? 
x What is you marital status? 
 
 
2. Introductory questions 
x Tell me about your journey to the clinic here today 
- Did you come alone?  
- Who are you staying with? 
x How did you find out you were HIV positive?  
x What impact did your diagnosis have on your relationships?  Did this change when you 
started treatment? (Attitude to partner, Desire for a relationship) 
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x Are you currently sexually active / in a relationship at the moment? 
- How long have you been together,  
- How do you feel about it? 
- Do you know his HIV status? 
 
 
3. Fertility desires  
 
x Would you like to have more children now or in the future?  Why/Why not 
- [Yes]  
- When would you like to have your next child? Why that time? 
- What things do you think will affect when you have another child? 
- Do you think you will actually have more children/children? Why/why not? 
- [No] 
- How do you feel about this  
x Did your diagnosis change your views on having children? What about starting 
treatment did that change your views? 
x [If has partner]  Do you know how your partner feels about having more children in the 
future? Have you discussed this with him? 
x Have you ever spoken about your wishes to your family and friends? 
- What did they say, how did this make you feel 
- What expectations do they have, how does that make you feel –do you agree 
x What effect would becoming pregnant soon have on you and your life? 
- Health 
- Relationship 
 
 
4. Expectations and experiences with pre-conception counselling and of being pregnant 
I would now like to talk to you about your experience of being in the HIV treatment programme 
during your most recent pregnancy.  
 
x How did you feel when you found out you were pregnant 
- Can you tell me why? 
- When did you find out? 
x Was the pregnancy planned? Can you tell me more? I.e. how long were they trying for, 
why now? 
x If unplanned, did you ever consider a termination? Were you ever offered one, would you 
know where to go if you wanted one? 
- Who did you tell when you first found out you were pregnant? (i.e. Partner, 
Family, Friends) 
x How did they react? How did you feel about their reactions? When did you tell them? 
- How did you feel about being pregnant for your health whilst taking treatment 
for your HIV? 
 Were you worried that the pregnancy would impact your health?  
 Do you think it did have an impact on your health?  
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x Before this pregnancy, what support or information did you get from other people or 
services in this area about getting pregnant as a women living with HIV? 
 
[Potential topics include; ways to get pregnant safer for self or partner i.e. timing 
unprotected sex to most fertile period in cycle, artificial insemination, constantly checking 
own health and that of partner]  
 
- Where did you get this information? 
- Can you tell me more about what this means for you and your life? 
- Did you try any of these? 
- Was the support and information useful? 
- Did any of the advice also consider her partner 
- Did she talk about it with her partner 
- Did you want more information and support?   
- Where would be the best place to get this? Why that place? 
 
 
 
x Where do you think is the best place to get this advice? 
x Have you ever received advice on family planning or pregnancy from this clinic 
and within this HIV treatment and care programme?  
- What did they say? 
- Was the support and information useful? 
- Can you tell me more about what this information means for you and your 
life? 
- Did any of the advice also consider your partner? (if she has one) 
- Did she talk about it with her partner 
- Was there any more information and support you felt you needed?   
- How could the family planning services have been better here within the 
HIV treatment and care programme? 
x Were you able to confide in the health care providers here in the programme 
about your pregnancy? 
 [Yes] 
- When did you tell them and why then?  
- What did you hope to gain from talking to them at this time? 
- How did they react? 
Pause for definition 
We are looking to find out more about your experiences of family planning here at the clinic.  
We describe family planning as; “the Information and methods that help you to decide when 
to have a child at the right time for you. It helps women to decide how to space, limit or 
prevent births in order to reach their desired number of children. This information can be 
about which contraceptive methods are available and safer ways to get pregnant for 
individuals and couples living with HIV” 
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- Did you consider talking to them before you got pregnant? Please tell me more 
about why. 
  [No] 
- Please tell me more about why? 
- Before you became pregnant were you using any methods to prevent 
pregnancy? 
[Yes] 
- What method were you using?  
- Tell me about using this method at the time you became pregnant? 
[No] 
- What were the reasons you were not using any method? 
- Have you ever tried using any? Reasons.  
- What changed your mind? 
 
 
 
 
5. Knowledge and experiences of contraception and contraceptive delivery  
I would like to know about your views on contraception and condoms.  
 
x Are you currently doing anything to avoid pregnancy?  
x (this can be a modern, traditional or any method she considers as contraception) 
[Yes] 
x Please tell me more about what you are using? I.e. what, how it works? 
x Why that method rather than any other? 
x Are there any other reasons why this method? 
x Have you ever had any problems using with the method? – Forgetfulness, side 
effects,  
x Would you prefer to use another method? [Yes] Which method? Why not 
changed? 
[No]  
x What are your reasons for not using any forms of family planning? 
x Have you ever used any other forms of contraception?   
- *For each method used* 
- How did you hear about this? 
- When and for how long? 
- Why used that method? 
x Any problems using with the method? – Forgetfulness, side effects? 
x Why stopped using method? I.e. health or treatment concerns? 
x Would you consider using this method again in the future? 
x What other forms of contraception have you heard of? 
- e.g. Injections, implants,  pills, IUDs, patches, emergency contraception, 
condoms, sterilization 
- Would you consider using any of these methods? Why/Why not? 
x How do you feel about using other methods such as the IUD or emergency 
contraception? 
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- Would you consider using this method? Why/Why not? 
 
x [If has partner] How does your partner feel about the different family planning 
methods? 
x How does being on treatment affect your feelings towards family planning and 
different contraceptive methods? 
- I.e. are there any forms of contraception that people should not use at the 
same time as HIV treatment?  
- Which, why? 
x Where do you usually get advice about your chosen method or contraceptive 
supplies? 
- Why here? 
- Are you offered a choice of methods here? Which ones?  
- How could the experience be improved? 
- Do you talk to anyone or get any advice whilst collecting this method? 
- Do you know of any other places that you could access advice and 
contraceptives? Why do you not use those places?  
x Did your diagnosis influence where you got advice and supplies from? 
- Did starting treatment influence where you sought these services? 
x [If not mentioned already] Have you ever received contraceptives from this clinic? 
x [Yes] 
- Were you given a choice of methods? Which ones? Would you prefer a 
wider choice? 
- Did someone talk to you about your options? 
- Did they ever discuss emergency contraception or the IUD? 
- How could the experience be improved? 
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Appendix D 
Interview Schedule: Health care providers working in the HIV treatment and care 
programme 
 
Introduction  
Thank you for agreeing to take part in this study. Your views and opinions are very important to this 
research. As we have discussed before, you are free to not answer a question or end the interview if 
you feel uncomfortable at any time. Any information that you provide today will be treated as strictly 
confidential and your name will not be used in any future reports, so please feel free to give your 
honest opinions. 
Let us begin with some short questions. 
 
1. Eligibility information  
 How old are you? 
 How long have you been working here at this clinic? 
 What is your job title at this clinic? 
 
2. Introductory question 
 What duties does your job involve? 
o Time spent with ART clients? Other services. How often? 
 
3. Situation of Family Planning within the ART programme 
 How do you feel family planning is placed in this HIV treatment and care programme? 
 When is family planning discussed? 
o Offered during regular counselling? IEC? 
o Which are the most useful methods of education here in the programme? 
 What all possible topics do you counsel on family planning for women here in the 
programme 
 Do you feel women on ART have different family planning needs? 
 How is FP being prioritised 
o What is done well, what is done not as well. 
 How integrated is FP with the main clinic 
o When are referrals offered? How are these followed up?  
o How is counselling/method provision defined by each. 
 How do you view this integration 
o Challenges / successes?  
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4. Use of family planning amongst HIV positive women on treatment 
 
 Are many HIV positive women attending this clinic using family planning?  
- What for? Or why not? 
 
 How is contraception discussed here in the programme? 
- Where do women seek them? 
- Which contraceptives are women interested in? 
- What information is given at the time contraceptives are provided? 
- How is information provided i.e. Individual/group talks/leaflets? 
- Who initiates these discussions? 
 
 Do you think the available contraception mix meets the needs of your patients  
o Why do you think women chose these methods? 
o What methods are available? 
o Are you satisfied with the available mix? 
o Do you think being on treatment influences the methods women use? 
 
 Which methods do you feel most comfortable recommending to a woman on treatment, 
why? 
- Why? 
- Are there any you do not think they should use? 
- Probe: Injections, implants, pills, IUDs, patches, emergency contraception, 
condoms, sterilization 
 
 Specifically I am interested to know your views on the IUD and emergency contraception. 
How easy is it to access these methods for women on treatment? 
- Are these methods available to women within the clinic? 
- Do many women choose to use these methods? How? 
- Do you face any problems with providing these services here at the clinic? 
- Have you been trained to administer these services and would you feel able to do 
so? 
- If not, is there anyone else who can? 
 
 
4. Pre-conception counselling and pregnancy planning 
 
 How do you feel women on treatment may be planning their pregnancies? 
- What influences whether women want to get pregnant? 
- What is the effect of treatment? 
 
 In your experience, how willing are women to talk to health providers about their wish to 
get pregnant? 
o When do these discussions happen? Are women ever asked about their pregnancy 
desires? Who asks? When? 
o What do you think prevents women from talking about their desires here at the 
clinic? 
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 How do you feel advising a woman on ART who wants to get pregnant? 
- Have you experienced this in the past? 
- How do you consider woman, partner and child health? 
- How do you feel providing this information? 
- Have you seen any protocols, guidelines of training related to this? 
- Do you think women follow the advice? Why/Why not? 
 
 What support is offered on ways to achieve a safe conception for women on treatment? 
- When is this provided?  
- What topics are discussed? 
- How are couples encouraged to come together? 
 
 
5. Alternative family planning services 
 
 If you needed to refer a woman for more family planning services, where would you refer 
her to? 
- How would you do this? 
- Where to? 
 
 Are there any other places that women can access Family Planning advice in this area, this 
can mean for contraception or how to get pregnant or any place a woman feels able to 
discuss her needs such as traditional healers?  
- What advice and methods are available at these places? 
- Are these services suitable for women on ART? 
- Which are most popular? Why? 
- Do you ever refer women to these places? When? How? 
 
 
6. Barriers to FP in the programme 
 
 What are the main barriers you face delivering family planning services to women in this 
clinic? How would you improve the services offered at this clinic? 
 
 What additional support would you like to improve provision of conception, advice and 
family planning counselling? 
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Appendix E 
Checklist of clinic communication materials and counselling activities  
 
1. Facility Identification 
Date of observation  
Facility Name  
Type of Facility  PHC - HIV (Facility Level integration)  
District Hospital  (referral to other 
buildings/departments) 
 
Standalone ART clinic  
Location  
 
 
2. Integration in the Primary Health Care Clinic with the HIV treatment and care programme 
2.1 In addition to HIV treatment, which of the following HIV services are also offered by this 
facility?  
 
Service Yes No Referred 
HIV counselling and testing    
 VCT    
 Provider initiated testing and counselling    
Home based care    
Psychological and social support    
HIV prevention, information and services for PLHIV    
HIV prevention, information and services for general 
population 
   
PMTCT    
Paediatric treatment    
Sexual and reproductive health services    
 Medical male circumcision for adults and 
neonates 
   
 Condom provision    
 Termination of pregnancy    
 Provision of contraception    
 Counselling and information on safe conception    
 Youth friendly services    
Access or referral to food security programmes    
Poverty alleviation support / access to benefits    
Support for victims of gender violence / sexual assault    
 
2.2 Are family planning services such as provision of contraception and counselling of safe 
conception integrated with the HIV services offered here at the clinic? 
(I.e. are clients routinely counselled or referred on these topics?) 
Yes / No 
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___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________ 
 
No: Continue to 2.8 
 
If YES 
 
2.3 Do the hours of operation for family planning in this primary health care clinic coincide with 
HIV counselling, treatment and care?  
Yes.  
Whenever HIV services are open, FP counselling is also 
open. 
 
Sometimes.  
There are times when FP services are open that HIV 
services are closed. Please Explain 
 
No.  
Whenever FP services are open HIV services are closed. 
 
Other  
 
 
ART Programme (If Separate) 
 
2.4 Which of the following HIV services also deliver family planning services such as 
contraception and counselling on safe conception, or routine referral? 
 
Service Yes No 
HIV Counselling and Testing   
 Offered during the same clinic visit   
 Located in the same service site and with the same 
provider 
  
 Located within the same service site with a different 
provider 
  
 Referred to a different service site within the facility   
 Referred to a different service site within the facility     
 Referred to another facility   
Treatment and care     
 Offered during the same clinic visit   
 Located in the same service site and with the same 
provider 
  
 Located within the same service site with a different 
provider 
  
 Referred to a different service site within the facility   
 Referred to a different service site within the facility     
 Referred to another facility   
Home based care   
PMTCT   
Following a ‘Yes’ to any of the above, please comment on service site. 
 I.e. is this the same or a different room/building/department? 
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_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
__________________ 
 
 
 
 
2.5 Do you have a way of following up with FP clients that have been referred to by the HIV 
treatment and care programme, or after you have referred to the hospital? 
Yes/No. Comments: 
___________________________________________________________________________
___________________________________________________________________________ 
 
 
2.6 How are FP clients referred in case of routine referrals? 
Verbally  
Written referral  
Other  
 
 
2.7 Are there any indicators for the integration of HIV treatment and care with FP services 
systematically reviewed in the facility quality monitoring activities (e.g. in monthly meetings) 
 
Yes. Please explain. 
 
 
No 
Other 
 
 
 
2.8 Are there any written guidelines and protocols are available for health care providers to 
practice FP here at the clinic? i.e.  
 
- National Contraception Policy guidelines,  
- KwaZulu-Natal  5 point contraceptive provincial strategy 
Others? Please list 
___________________________________________________________________________
___________________________________________________________________________
________________ 
 
 
 
2.9 Do any of these guidelines recommend that safe conception counselling and services are 
offered to clients of the HIV treatment and care programme? 
Yes / No 
Comments:__________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________ 
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2.10 Are the following contraceptive methods EVER available to clients accessing Family 
Planning here in the  
1) Primary health care clinic 
2) HIV treatment and care programme (if separate).  
 
How often is each method available at this ART clinic? 
1 = Everyday 
2 = At least once a week but not every day 
3 = At least once a month but not every week 
4 = Less than once a month 
Contraceptive Method 
ART 
clinic 
(Y / N) 
Frequency 
Main 
Clinic 
(Y / N) 
Frequency 
Combined oral contraceptives (COCs)  1 / 2 / 3 / 4  1 / 2 / 3 / 4 
Progestogen-only pills (POP)   1 / 2 / 3 / 4  1 / 2 / 3 / 4 
Progestogen only injectables  1 / 2 / 3 / 4  1 / 2 / 3 / 4 
Combined injectable contraceptives   1 / 2 / 3 / 4  1 / 2 / 3 / 4 
Implants (Norplant)  1 / 2 / 3 / 4  1 / 2 / 3 / 4 
Male Condom  1 / 2 / 3 / 4  1 / 2 / 3 / 4 
Female Condom  1 / 2 / 3 / 4  1 / 2 / 3 / 4 
Intra Uterine Device (copper)  1 / 2 / 3 / 4  1 / 2 / 3 / 4 
Intra Uterine Device (levonorgestrel)  1 / 2 / 3 / 4  1 / 2 / 3 / 4 
Spermicidal jellies, creams or foams  1 / 2 / 3 / 4  1 / 2 / 3 / 4 
Diaphragm  1 / 2 / 3 / 4  1 / 2 / 3 / 4 
Female Sterilisation (Tubal Ligation)  1 / 2 / 3 / 4  1 / 2 / 3 / 4 
Male Sterilisation (Vasectomy)  1 / 2 / 3 / 4  1 / 2 / 3 / 4 
Combined Patch  1 / 2 / 3 / 4  1 / 2 / 3 / 4 
Combined Vaginal Ring  1 / 2 / 3 / 4  1 / 2 / 3 / 4 
Cervical caps  1 / 2 / 3 / 4  1 / 2 / 3 / 4 
Emergency Contraception  1 / 2 / 3 / 4  1 / 2 / 3 / 4 
 
 
2.11 Are the following methods EVER discussed or promoted for women on ART either in 
the main clinic or in the HIV treatment and care programme? 
a) Withdrawal (coitus interruptus)     ART / PHC / Both 
b) Natural family planning/ periodic abstinence   ART / PHC / Both 
c) Lactational amenorrhea      ART / PHC / Both 
 
 
3. Information Education and Communication materials 
 
3.1 Are any family planning group talks or counselling sessions available for clients of the 
treatment and care programme at this clinic?     
Yes/No 
 If yes; 
 Who is invited to participate?_________________________________________ 
Where are these sessions offered? ________________________________________ 
How often are these sessions held? I.e. Daily / weekly / monthly? 
________________ 
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3.2 Which of the following family planning counselling materials are available in the HIV 
treatment and care programme during  
- Individual counselling sessions 
- Group talks 
Material Individual 
Counselling  
Group 
Counselling 
Sessions  
Flip charts      
Leaflets     
Posters     
Contraceptive samples    
Anatomical models    
Audiotapes, videotapes or films   
 
 
3.3 What topics are covered in group talks? (multiple options possible) 
 Counselling Topic Yes / No 
Contraceptive methods  
 Emergency contraception   
 Termination of pregnancy    
Preconception counselling   
 Fertility desires   
 Partner HIV testing  
 Methods for safer conception / risk reduction  
 How to determine a woman’s fertile period  
 Optimal HIV management and other health 
aspects 
 
 Risks of MTCT  
 Possible use of pre-exposure prophylaxis  
 Need to identify infertility at an early stage  
 Alternatives to childbearing   
    
*If possible to observe group counselling* 
3.4 What is the format for these talks/counselling session?(multiple options possible) 
Format Yes / No 
Only the provider speaks     
Provider discussed issues with clients   
Provider asked clients for questions  
Tape, video or film was played without discussion  
Tape, video or film was played with discussion  
Contraceptive samples were shown  
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Visibility: For observer to complete individually. 
3.5 What family planning information materials are visibly available in clinics for clients of the 
ART programme 
 
Material Yes / No Source i.e. 
DoH 
Location (ART/Main clinic) 
Posters  
 
   
Leaflets  
  
   
Posters  
  
   
Contraceptive samples 
 
   
Anatomical models  
 
   
Other. Comments 
 
 
   
 
 
3.6 What topics are addressed in these information materials 
Topic Yes / No Comments 
Contraceptive methods   
 
 
Safe conception methods   
 
 
Pregnancy and HIV   
 
 
Treatment and HIV   
 
 
Other   
 
 
 
3.7 Where are these materials available  
Location Yes / No Comments 
At reception    
 
In the waiting area   
 
In treatment room   
 
Other   
 
363 
 
 
 
Any other comments 
 
Thank you to management for helping with this study. We kindly ask permission to take sample 
leaflets from the clinic or photos of posters available at these services. 
Further notes/comments: 
 
 
Adapted from Johns Hopkins observation tool and the IPPF rapid assessment tool for service 
integration (IPPF and WHO),  
 
http://pdf.usaid.gov/pdf_docs/PNACG547.pdf 
 
 
  
364 
 
Appendix E: Ethical approval certification and recertification 
UCL Ethical Approval  
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University of KwaZulu-Natal ethical approval  
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